prostate cancer (Cancer)
Information
- Disease name
- prostate cancer
- Disease ID
- DOID:10283
- Description
- "A male reproductive organ cancer that is located_in the prostate." [url:http\://www.cancer.gov/dictionary?CdrID=445079, url:https\://www.genome.gov/Genetic-Disorders/Prostate-Cancer]
Disease area statistics
Chromosome band
| Gene symbol | Chromosome | Start | Stop | The number of variant |
|---|---|---|---|---|
| PMS2 | 7 | 5,970,957 | 6,009,122 | 50 |
| MSH6 | 2 | 47,783,145 | 47,806,953 | 46 |
| FBXO11 | 2 | 47,806,920 | 47,906,498 | 40 |
| MSH2 | 2 | 47,403,156 | 47,483,223 | 38 |
| EPCAM | 2 | 47,369,311 | 47,387,020 | 10 |
| KCNK12 | 2 | 47,509,290 | 47,570,985 | 10 |
| KMT2A | 11 | 118,436,492 | 118,526,832 | 2 |
| TET1 | 10 | 68,560,337 | 68,694,487 | 2 |
| MLH1 | 3 | 36,993,518 | 37,050,846 | 2 |
| TP53 | 17 | 7,668,421 | 7,687,490 | 2 |
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02353819 | Active, not recruiting | Phase 1 | Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer | October 2015 | December 2030 |
| NCT01583920 | Active, not recruiting | N/A | Focal Salvage HDR Brachytherapy for the Treatment of Prostate Cancer | July 2012 | July 2028 |
| NCT01618851 | Active, not recruiting | N/A | Phase II Study to Evaluate Conventional Radiation Therapy Followed by Radiosurgical Boost in Clinically Localized Prostate Cancer | November 2009 | February 2025 |
| NCT03381326 | Active, not recruiting | CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC. | December 15, 2014 | December 2023 | |
| NCT04926181 | Active, not recruiting | Phase 2 | Apalutamide Plus Cetrelimab in Patients With Treatment-Emergent Small Cell Neuroendocrine Prostate Cancer | March 16, 2022 | February 28, 2025 |
| NCT03061539 | Active, not recruiting | Phase 2 | Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature | February 6, 2018 | June 2027 |
| NCT04122976 | Active, not recruiting | A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described | January 30, 2020 | October 7, 2026 | |
| NCT01936883 | Active, not recruiting | N/A | Improving Quality of Life After Prostate Brachytherapy: a Comparison of HDR and LDR Brachytherapy | January 2014 | December 2029 |
| NCT03531099 | Active, not recruiting | Phase 3 | Phase 3, Multicenter, Randomized Study, Evaluating the Efficacy and Tolerability of Focused HIFU (High Intensity Focused Ultrasound) Therapy Compared to Active Surveillance in Patients With Significant Low Risk Prostate Cancer | October 2, 2018 | October 2, 2026 |
| NCT02772588 | Active, not recruiting | Phase 2 | AASUR in High Risk Prostate Cancer | May 2016 | May 2026 |
| NCT02243033 | Active, not recruiting | Phase II Laser Focal Therapy of Prostate Cancer | May 2016 | November 2036 | |
| NCT02594072 | Active, not recruiting | N/A | Androgen Suppression With Stereotactic Body or External Beam Radiation Therapy (ASSERT) | April 2016 | December 2024 |
| NCT00186368 | Active, not recruiting | Microarray Analysis of Gene Expression in Prostate Tissues | April 6, 1999 | December 2030 | |
| NCT03857477 | Active, not recruiting | The BARCODE 1 Study (Full Study): The Use of Genetic Profiling to Guide Prostate Cancer Targeted Screening. | March 14, 2019 | September 1, 2027 | |
| NCT03561220 | Active, not recruiting | N/A | A Prospective Comparative Study of Outcomes With Proton and Photon Radiation in Prostate Cancer | July 5, 2018 | April 1, 2026 |
| NCT03703778 | Active, not recruiting | Real-life Evaluation of the Effect of ADT in Prostate Cancer Patients in Asia (READT Asia Study) | May 22, 2016 | December 31, 2025 | |
| NCT04262609 | Active, not recruiting | Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy | July 1, 2019 | December 1, 2025 | |
| NCT02333435 | Active, not recruiting | Phase 2 | Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life | January 2015 | December 2023 |
| NCT02985957 | Active, not recruiting | Phase 2 | A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) | March 26, 2017 | January 7, 2025 |
| NCT05617885 | Active, not recruiting | Phase 1/Phase 2 | Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer | August 9, 2023 | June 1, 2026 |
| NCT04693169 | Active, not recruiting | N/A | [Al18F]PSMA137 PET/CT Imaging for PSMA-Positive Cancer Patients | January 15, 2021 | December 12, 2024 |
| NCT05202301 | Active, not recruiting | A Study Using Available Data to Learn to What Extent Patients With Prostate Cancer Who Received Second Generation Androgen Receptor Inhibitors Took Their Medication as Prescribed or Stopped Taking Their Medication Completely | January 15, 2022 | June 30, 2024 | |
| NCT01961843 | Active, not recruiting | N/A | Abiraterone Acetate for Castrate Resistant Prostate Cancer | October 2013 | December 31, 2024 |
| NCT02692105 | Active, not recruiting | Phase 3 | Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer | May 2016 | April 2026 |
| NCT01309672 | Active, not recruiting | Phase 2 | S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy | August 9, 2011 | October 2024 |
| NCT03073395 | Active, not recruiting | Phase 1 | Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer | July 21, 2017 | February 28, 2023 |
| NCT03957252 | Active, not recruiting | Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer | June 6, 2019 | December 2024 | |
| NCT03701581 | Active, not recruiting | Phase 2/Phase 3 | 4-aminopyridine Treatment for Nerve Injury | June 5, 2021 | August 5, 2025 |
| NCT04782713 | Active, not recruiting | N/A | Smart Prostate Specific Antigen (PSA) Screening Study | December 17, 2021 | November 2024 |
| NCT01972867 | Active, not recruiting | N/A | Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients | May 13, 2021 | May 2024 |
| NCT01230866 | Active, not recruiting | Phase 3 | Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer | November 2010 | |
| NCT05605964 | Active, not recruiting | Phase 3 | Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate | January 25, 2023 | December 31, 2024 |
| NCT02923180 | Active, not recruiting | Phase 2 | Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer | February 14, 2017 | December 2024 |
| NCT03910660 | Active, not recruiting | Phase 1/Phase 2 | A Trial of BXCL701 and Pembrolizumab in Patients With mCRPC Either Small Cell Neuroendocrine Prostate Cancer or Adenocarcinoma Phenotype. | February 12, 2019 | December 2025 |
| NCT03511196 | Active, not recruiting | Early Phase 1 | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer | September 17, 2018 | June 2024 |
| NCT02649855 | Active, not recruiting | Phase 2 | Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer | January 19, 2016 | August 8, 2024 |
| NCT03934840 | Active, not recruiting | Phase 2 | CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone | October 10, 2019 | May 2025 |
| NCT01314118 | Active, not recruiting | Phase 2 | IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigen | May 2011 | July 2025 |
| NCT04751929 | Active, not recruiting | Phase 2 | Abemaciclib With or Without Atezolizumab for mCRPC | August 20, 2021 | December 20, 2025 |
| NCT04068896 | Active, not recruiting | Phase 1/Phase 2 | Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy | October 16, 2019 | January 2025 |
| NCT04197141 | Active, not recruiting | Phase 2 | Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer | February 7, 2020 | March 2027 |
| NCT03665922 | Active, not recruiting | N/A | Biomarkers of Sulforaphane/Broccoli Sprout Extract in Prostate Cancer | May 1, 2019 | December 31, 2024 |
| NCT05065944 | Active, not recruiting | Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center | November 16, 2021 | August 19, 2024 | |
| NCT05276492 | Active, not recruiting | Phase 1 | Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. | January 24, 2023 | November 1, 2025 |
| NCT03600350 | Active, not recruiting | Phase 2 | pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer | September 10, 2018 | November 2024 |
| NCT03159676 | Active, not recruiting | Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | May 12, 2017 | June 2029 | |
| NCT00761124 | Active, not recruiting | N/A | Informed Decision-Making Regarding Prostate Specific Antigen (PSA) Screening in 50-70 Year Old Latino Men | April 2003 | February 2026 |
| NCT00579514 | Active, not recruiting | N/A | Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients | March 2000 | March 2025 |
| NCT05801965 | Active, not recruiting | N/A | A Digital Therapeutic Solution for Cancer Patients | April 6, 2023 | September 1, 2024 |
| NCT03317990 | Active, not recruiting | N/A | Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy. | April 9, 2018 | April 2025 |
| NCT01643954 | Active, not recruiting | N/A | Retrospective/Prospective Analysis of Surgical Outcomes of Robotic Prostatectomy at The James | September 23, 2008 | December 2025 |
| NCT00580476 | Active, not recruiting | Assessing Depression in a Geriatric Cancer Population | September 2006 | June 10, 2025 | |
| NCT01688492 | Active, not recruiting | Phase 1/Phase 2 | Combining Ipilimumab With Abiraterone Acetate Plus Prednisone in Chemotherapy and Immunotherapy-naïve Patients With Progressive Metastatic Castration-resistant Prostate Cancer | September 2012 | September 2024 |
| NCT04037358 | Active, not recruiting | Phase 2 | RAdium-223 and SABR Versus SABR for Oligometastatic Prostate Cancers | August 9, 2019 | December 2028 |
| NCT01342367 | Active, not recruiting | N/A | Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer | December 17, 2010 | February 2026 |
| NCT03934827 | Active, not recruiting | Phase 1 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour | April 10, 2019 | December 31, 2022 |
| NCT05500846 | Active, not recruiting | N/A | Targeted Cryoablation of Prostate Cancer Lesions: An Investigator-initiated Trial | October 19, 2021 | December 31, 2024 |
| NCT00352924 | Active, not recruiting | Agriculture Health Study | April 30, 1993 | ||
| NCT04136353 | Active, not recruiting | Phase 3 | Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate | March 31, 2020 | July 31, 2028 |
| NCT05150236 | Active, not recruiting | Phase 2 | EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPC | April 29, 2022 | December 2024 |
| NCT03999151 | Active, not recruiting | N/A | Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II) | May 11, 2018 | August 28, 2028 |
| NCT03017794 | Active, not recruiting | Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy | January 4, 2017 | December 31, 2024 | |
| NCT00329043 | Active, not recruiting | Phase 2 | Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | May 2006 | December 31, 2025 |
| NCT04245670 | Active, not recruiting | N/A | 5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost: | May 31, 2018 | January 31, 2025 |
| NCT03630666 | Active, not recruiting | N/A | Comparison of Intermittent Androgen Deprivation Therapy With or Without Irradiation Recovery in Prostate Cancer Patients | December 4, 2018 | June 2026 |
| NCT00967863 | Active, not recruiting | N/A | Radiation Therapy in Treating Patients Receiving Hormone Therapy for Prostate Cancer (GETUG-AFU 18) | October 2008 | October 2026 |
| NCT02077335 | Active, not recruiting | Phase 2 | Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer | April 2014 | March 2026 |
| NCT00924027 | Active, not recruiting | Phase 2 | A Study of Patients Receiving High-Dose Rate Brachytherapy | April 14, 2009 | July 5, 2025 |
| NCT04305925 | Active, not recruiting | Early Phase 1 | Focal Laser Ablation of Prostate Cancer | March 16, 2020 | October 31, 2025 |
| NCT04503265 | Active, not recruiting | Phase 1/Phase 2 | A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies | August 12, 2020 | January 2025 |
| NCT05523856 | Active, not recruiting | New Treatment Modalities for Localized Prostate Cancer | April 2014 | December 2027 | |
| NCT00809991 | Active, not recruiting | Phase 2 | Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate | December 22, 2008 | September 2025 |
| NCT04383210 | Active, not recruiting | Phase 2 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | September 29, 2020 | March 2025 |
| NCT01809691 | Active, not recruiting | Phase 3 | S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer | March 8, 2013 | October 2027 |
| NCT03315871 | Active, not recruiting | Phase 2 | Combination Immunotherapy in Biochemically Recurrent Prostate Cancer | March 20, 2018 | January 31, 2025 |
| NCT01325506 | Active, not recruiting | Effectiveness of Open and Robotic Prostatectomy | September 2010 | February 2024 | |
| NCT01514669 | Active, not recruiting | Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer | January 2012 | February 2025 | |
| NCT00984321 | Active, not recruiting | N/A | A Pilot Study of Geriatric Specific Interventions for Quality of Life in Elderly Patients With Cancer | September 2009 | September 2024 |
| NCT00860652 | Active, not recruiting | N/A | Radiotherapy - Adjuvant Versus Early Salvage | March 3, 2009 | December 2026 |
| NCT01777802 | Active, not recruiting | Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy | January 2013 | December 2033 | |
| NCT01739062 | Active, not recruiting | N/A | The ProCaRis Study: Prostate Cancer Risk Assessment in General Practice | February 2013 | October 30, 2031 |
| NCT01436968 | Active, not recruiting | Phase 3 | Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer | September 2011 | December 2024 |
| NCT04663997 | Active, not recruiting | Phase 2 | 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer | August 11, 2021 | July 31, 2025 |
| NCT02319837 | Active, not recruiting | Phase 3 | Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) | December 17, 2014 | September 19, 2026 |
| NCT03381105 | Active, not recruiting | From PSA to Stockholm3: Study Part 1 | September 1, 2017 | December 31, 2030 | |
| NCT02454543 | Active, not recruiting | N/A | Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases | May 2015 | December 31, 2026 |
| NCT03983954 | Active, not recruiting | Phase 1 | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors | October 10, 2019 | October 1, 2026 |
| NCT01584258 | Active, not recruiting | Phase 3 | Prostate Advances in Comparative Evidence | August 7, 2012 | December 2027 |
| NCT06154499 | Active, not recruiting | Archive Prostate. Observational Study of Patients Who Underwent Radical Prostatectomy Surgery | April 8, 2004 | February 13, 2025 | |
| NCT00951535 | Active, not recruiting | Phase 2 | A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17 | July 20, 2009 | October 2025 |
| NCT01492751 | Active, not recruiting | Effectiveness of Localized Prostate Cancer Treatments | April 2003 | December 2025 | |
| NCT03778112 | Active, not recruiting | N/A | MRI Guided SBRT for Localized Prostate Cancer | May 23, 2016 | March 2029 |
| NCT01508390 | Active, not recruiting | N/A | Hypofractionated Stereotactic Body Radiation Therapy as a Boost to the Prostate | June 2011 | December 2027 |
| NCT04742361 | Active, not recruiting | Phase 3 | Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer | September 8, 2021 | June 2024 |
| NCT05311618 | Active, not recruiting | Phase 1 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | May 11, 2022 | June 2025 |
| NCT03254420 | Active, not recruiting | N/A | Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. | August 30, 2016 | December 2028 |
| NCT03637543 | Active, not recruiting | Phase 2 | Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer | October 18, 2018 | March 31, 2025 |
| NCT04138914 | Active, not recruiting | N/A | Phase II Trial of Focal Cryotherapy for Prostate Cancer | March 1, 2019 | March 2041 |
| NCT05735652 | Active, not recruiting | An Observational Study of Radiotherapy After Injection of SpaceOAR Hydrogel | November 3, 2022 | September 30, 2024 | |
| NCT03445559 | Active, not recruiting | N/A | A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging | April 9, 2018 | February 28, 2024 |
| NCT01835977 | Active, not recruiting | Phase 2 | Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer | June 2015 | January 2025 |
| NCT00911118 | Active, not recruiting | Phase 1 | Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer | May 2009 | May 2025 |
| NCT03334500 | Active, not recruiting | Early Phase 1 | Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer | July 14, 2017 | December 16, 2025 |
| NCT04972097 | Active, not recruiting | N/A | Pivotal Study of the NanoKnife System for the Ablation of Prostate Tissue | March 29, 2022 | July 2024 |
| NCT00977457 | Active, not recruiting | Phase 1 | Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery | November 26, 2007 | December 30, 2024 |
| NCT02452008 | Active, not recruiting | Phase 2 | Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer | May 3, 2016 | December 2025 |
| NCT05354440 | Active, not recruiting | Post Marketing Clinical Follow Up of the BioProtect Balloon Implant System | January 1, 2022 | January 2026 | |
| NCT04890314 | Active, not recruiting | Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment | May 15, 2021 | May 30, 2026 | |
| NCT01197625 | Active, not recruiting | Phase 1/Phase 2 | Vaccine Therapy in Curative Resected Prostate Cancer Patients | September 2010 | September 2025 |
| NCT00859781 | Active, not recruiting | Phase 2 | 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer | June 2009 | December 2025 |
| NCT03912883 | Active, not recruiting | Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting | October 12, 1999 | December 2030 | |
| NCT06047509 | Active, not recruiting | N/A | Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance | September 14, 2023 | October 1, 2025 |
| NCT03388619 | Active, not recruiting | Phase 1 | Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy | January 17, 2018 | December 8, 2025 |
| NCT03700099 | Active, not recruiting | Phase 2 | Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide | September 3, 2019 | April 1, 2025 |
| NCT05155618 | Active, not recruiting | N/A | Intervention Study in Prostate Cancer Patients Undergoing Radiotherapy | November 8, 2021 | December 2025 |
| NCT02920229 | Active, not recruiting | N/A | 68Ga-PSMA HBED-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated | November 2015 | September 2023 |
| NCT03207594 | Active, not recruiting | Improving Evidence-Based Care for Cancer Patients | September 1, 2016 | August 31, 2024 | |
| NCT04207255 | Active, not recruiting | Phase 2 | Addition of Opaganib to Androgen Antagonists in Patients With mCRPC | March 27, 2020 | May 31, 2024 |
| NCT03471650 | Active, not recruiting | Phase 2 | Study of PSMA-targeted 18F-DCFPyL PET/CT for the Detection of Clinically Significant Prostate Cancer | March 29, 2018 | March 7, 2025 |
| NCT04249947 | Active, not recruiting | Phase 1 | P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) | February 28, 2020 | September 2036 |
| NCT05498623 | Active, not recruiting | MR Fingerprinting for Diagnostic of Prostate Cancer | September 1, 2022 | December 2024 | |
| NCT05146973 | Active, not recruiting | Phase 2 | External Beam Therapy With Theranostic Radioligand Therapy for Oligometastatic Prostate Cancer (ProstACT TARGET) | August 30, 2022 | August 30, 2024 |
| NCT03809000 | Active, not recruiting | Phase 2 | A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery | April 15, 2019 | September 15, 2029 |
| NCT00769223 | Active, not recruiting | Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate Cancer | February 25, 1993 | January 31, 2025 | |
| NCT03087903 | Active, not recruiting | N/A | A Study of Grape Seed Extract in Asymptomatic Non-Metastatic Prostate Cancer Patients With Rising PSA | January 18, 2018 | January 2026 |
| NCT04090528 | Active, not recruiting | Phase 2 | pTVG-HP DNA Vaccine With or Without pTVG-AR DNA Vaccine and Pembrolizumab in Patients With Castration-Resistant, Metastatic Prostate Cancer | October 21, 2019 | October 2026 |
| NCT02255890 | Active, not recruiting | Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device | November 2014 | April 2025 | |
| NCT05176756 | Active, not recruiting | N/A | RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR) | April 14, 2022 | March 1, 2025 |
| NCT02009449 | Active, not recruiting | Phase 1 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors | November 15, 2013 | August 25, 2024 |
| NCT01410942 | Active, not recruiting | Phase 2 | Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy | February 8, 2012 | February 1, 2025 |
| NCT01653093 | Active, not recruiting | N/A | 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer | September 20, 2007 | December 31, 2024 |
| NCT05224869 | Active, not recruiting | N/A | Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer | August 30, 2021 | December 2024 |
| NCT03889119 | Active, not recruiting | N/A | Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer | October 21, 2016 | December 31, 2025 |
| NCT03253744 | Active, not recruiting | Phase 1 | Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy | July 5, 2018 | February 16, 2025 |
| NCT03204123 | Active, not recruiting | Phase 2 | PSMA PET Imaging of Recurrent Prostate Cancer | June 26, 2017 | June 2024 |
| NCT06429878 | Active, not recruiting | N/A | The Long Term Effect of MRI Before Radical Prostatectomy. | December 1, 2009 | May 19, 2026 |
| NCT03141671 | Active, not recruiting | Phase 2 | Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) | November 24, 2017 | December 31, 2025 |
| NCT05452824 | Active, not recruiting | N/A | Participating in Tai Chi to Reduce Anxiety and Keep up Physical Function | June 21, 2021 | October 2024 |
| NCT01990196 | Active, not recruiting | Phase 2 | Neoadjuvant Phase 2 Study Comparing the Effects of AR Inhibition With/Without SRC or MEK Inhibition in Prostate Cancer | September 23, 2014 | September 30, 2025 |
| NCT05100472 | Active, not recruiting | Phase 2 | A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer | October 19, 2021 | October 19, 2025 |
| NCT04557501 | Active, not recruiting | Phase 3 | PSMA PET/CT Guided Intensification of Therapy in Patients at Risk of Advanced Prostate Cancer | January 6, 2021 | January 2029 |
| NCT03520478 | Active, not recruiting | Phase 3 | A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer | May 30, 2018 | April 30, 2025 |
| NCT03436654 | Active, not recruiting | Phase 2 | Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma | June 21, 2018 | February 14, 2025 |
| NCT04660929 | Active, not recruiting | Phase 1 | CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors | February 2, 2021 | December 31, 2024 |
| NCT03383016 | Active, not recruiting | Diet, Physical Activity and Related Candidate Biomarkers in Relation to Prostate Cancer Risk (BIOCaPPE) | June 20, 2013 | September 2025 | |
| NCT04558398 | Active, not recruiting | N/A | Impact of Exercise on Mitochondria in Cancer Patients. | August 5, 2021 | March 30, 2024 |
| NCT01546987 | Active, not recruiting | Phase 3 | Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | May 2012 | June 2029 |
| NCT04619069 | Active, not recruiting | Phase 1/Phase 2 | Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer | October 27, 2020 | October 2027 |
| NCT02657863 | Active, not recruiting | Cancer DNA Detection in Blood and Urine | November 2014 | December 2027 | |
| NCT02905318 | Active, not recruiting | Phase 2 | Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer | July 4, 2017 | December 30, 2024 |
| NCT04045717 | Active, not recruiting | Phase 2 | Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0 | April 10, 2020 | February 16, 2032 |
| NCT02783950 | Active, not recruiting | N/A | Genomics in Michigan Impacting Observation or Radiation | January 17, 2017 | August 2024 |
| NCT02723734 | Active, not recruiting | Validation Study on the Impact of Decipher® Testing - VANDAAM Study | April 13, 2016 | July 6, 2024 | |
| NCT01368588 | Active, not recruiting | Phase 3 | Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | July 2011 | July 2031 |
| NCT04733768 | Active, not recruiting | Phase 2 | 18F-PSMA-1007 PET/CT Imaging in Patients With Biochemically Recurrent or High-risk Prostate Cancer | August 31, 2021 | July 2024 |
| NCT01542021 | Active, not recruiting | N/A | Androgen Deprivation Therapy Prior to Prostatectomy for Patients With Intermediate and High Risk Prostate Cancer | February 2012 | February 2025 |
| NCT01411345 | Active, not recruiting | N/A | MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial | July 12, 2012 | February 13, 2028 |
| NCT02972060 | Active, not recruiting | Phase 2 | ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer | December 1, 2017 | December 2036 |
| NCT03098836 | Active, not recruiting | Phase 2 | Apalutamide and Abiraterone Acetate in African American and Caucasian Men With Metastatic Castrate Resistant Prostate Cancer | July 10, 2017 | February 22, 2025 |
| NCT02766543 | Active, not recruiting | N/A | Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate Cancer | September 21, 2016 | December 31, 2028 |
| NCT02242773 | Active, not recruiting | N/A | MRI Based Active Selection for Treatment Trial | November 12, 2014 | September 2024 |
| NCT04113811 | Active, not recruiting | N/A | Microwave Needle Thermoablation for Treatment of Localized Prostate Cancer | October 8, 2019 | December 31, 2024 |
| NCT05230251 | Active, not recruiting | Phase 2 | Radioligand fOr locAl raDiorecurrent proStaTe cancER | March 17, 2022 | December 2024 |
| NCT02489318 | Active, not recruiting | Phase 3 | A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC | November 27, 2015 | September 5, 2024 |
| NCT05041504 | Active, not recruiting | N/A | A Web-based Peer Navigation Program for Men With Prostate Cancer | May 13, 2022 | July 2024 |
| NCT01802242 | Active, not recruiting | N/A | Tumor TARGET Prostate Cancer | October 2012 | May 2025 |
| NCT06193993 | Active, not recruiting | Phase 1 | Effect of Low-dose 500 mg Abiraterone Acetate in Treatment of Metastatic Prostate Cancer Patients | November 30, 2021 | September 2026 |
| NCT04635059 | Active, not recruiting | Phase 2 | Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate Cancer | June 1, 2021 | May 30, 2027 |
| NCT00936390 | Active, not recruiting | Phase 3 | Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer | September 2009 | October 2025 |
| NCT03568188 | Active, not recruiting | Phase 2 | Efficacy Evaluation of Focused HIFU (High Intensity Focused Ultrasound) Therapy in Patients With Localized Intermediate Risk Prostate Cancer | September 28, 2018 | September 28, 2025 |
| NCT01737242 | Active, not recruiting | UK Genetic Prostate Cancer Study: Epidemiology and Molecular Genetics Studies | January 1993 | December 2027 | |
| NCT03253978 | Active, not recruiting | N/A | SPORT High-Risk Trial Evaluating SABR in Prostate Cancer | January 18, 2016 | April 30, 2026 |
| NCT03518606 | Active, not recruiting | Phase 1/Phase 2 | Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumours | June 20, 2018 | December 30, 2024 |
| NCT03526510 | Active, not recruiting | N/A | Hypofractionated Boost vs Conventionally Fractionated Boost for Localized High Risk Prostate Cancer | June 2011 | December 2024 |
| NCT03377881 | Active, not recruiting | N/A | Prostate Cancer Detection Using the Stockholm3 Test and MR/Fusion Biopsies | April 4, 2018 | December 10, 2030 |
| NCT02735252 | Active, not recruiting | N/A | PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer | May 25, 2016 | July 31, 2025 |
| NCT04845503 | Active, not recruiting | N/A | Stereotactic MRI-guided Radiation Therapy for Localized prostatE Cancer | March 25, 2021 | March 25, 2028 |
| NCT03795337 | Active, not recruiting | N/A | Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-II) | March 5, 2019 | December 31, 2025 |
| NCT04000880 | Active, not recruiting | N/A | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health | March 4, 2020 | August 31, 2024 |
| NCT02799706 | Active, not recruiting | Phase 3 | Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer | September 25, 2017 | June 2026 |
| NCT05079698 | Active, not recruiting | Phase 1 | A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer | October 1, 2021 | October 2024 |
| NCT02339168 | Active, not recruiting | Phase 1 | Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer | June 22, 2016 | December 2025 |
| NCT03663218 | Active, not recruiting | Phase 1 | PRE-ProstAtectomy MRI-GuidEd Stereotactic Body RadioTherapy for High-Risk Prostate Cancer Trial (PREPARE SBRT) | October 24, 2018 | March 2026 |
| NCT04560725 | Active, not recruiting | N/A | PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer | October 22, 2020 | December 1, 2024 |
| NCT04558866 | Active, not recruiting | Phase 2 | Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial) | June 9, 2021 | June 2025 |
| NCT04019327 | Active, not recruiting | Phase 1/Phase 2 | A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer | July 11, 2019 | July 2027 |
| NCT03261271 | Active, not recruiting | N/A | Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy | August 28, 2017 | February 28, 2025 |
| NCT02623933 | Active, not recruiting | N/A | MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients | September 24, 2015 | May 13, 2027 |
| NCT03444844 | Active, not recruiting | Phase 1/Phase 2 | Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer | May 10, 2018 | July 2022 |
| NCT03507608 | Active, not recruiting | Early Phase 1 | Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression | May 10, 2019 | December 2028 |
| NCT02803086 | Active, not recruiting | Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer | February 2014 | December 2026 | |
| NCT02946996 | Active, not recruiting | Phase 2 | Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy | December 28, 2016 | May 31, 2024 |
| NCT02366494 | Active, not recruiting | Micro RNAs to Predict Response to Androgen Deprivation Therapy | April 29, 2015 | June 2025 | |
| NCT03246347 | Active, not recruiting | Phase 2 | A Trial of Androgen Deprivation, Docetaxel, and Enzalutamide for Metastatic Prostate Cancer | August 23, 2017 | March 2028 |
| NCT01864096 | Active, not recruiting | Phase 3 | The Metformin Active Surveillance Trial (MAST) Study | October 2013 | August 2024 |
| NCT06347614 | Active, not recruiting | Modified Radical Prostatectomy for Prostate Cancer Patients With Enlarged Prostate and Severe Lower Urinary Tract Symptoms: a Single-center, Retrospective Study | September 1, 2021 | December 31, 2024 | |
| NCT00567580 | Active, not recruiting | Phase 3 | Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer | February 2008 | |
| NCT04340245 | Active, not recruiting | Exploiting Risk-Based Risk Stratification in Early Prostate Cancer to Discriminate Progressors From Non-Progressors | July 1, 2020 | December 1, 2028 | |
| NCT03093428 | Active, not recruiting | Phase 2 | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC | June 9, 2017 | June 2024 |
| NCT04030338 | Active, not recruiting | Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer | July 19, 2019 | July 2025 | |
| NCT03569241 | Active, not recruiting | Phase 2 | PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases | April 27, 2018 | April 30, 2025 |
| NCT02481648 | Active, not recruiting | N/A | Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer | July 2015 | December 2024 |
| NCT00579072 | Active, not recruiting | The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older | August 2006 | December 2024 | |
| NCT03345563 | Active, not recruiting | N/A | Project HERO: Health Empowerment & Recovery Outcomes | July 19, 2019 | December 31, 2030 |
| NCT06298305 | Active, not recruiting | Artificial Intelligence & Prostate Cancer | September 1, 2022 | December 2024 | |
| NCT04176497 | Active, not recruiting | Phase 2 | PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study | July 16, 2020 | February 7, 2028 |
| NCT00268476 | Active, not recruiting | Phase 2/Phase 3 | Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy | July 8, 2005 | December 2030 |
| NCT05416996 | Active, not recruiting | A Study of Telemedicine Shared Medical Appointments (SMAs) Versus Individual Telemedicine Visits for People With Prostate Cancer | June 5, 2022 | June 2025 | |
| NCT03768349 | Active, not recruiting | Early Phase 1 | PSMA and C-11 Choline PET in Patients With Biochemical Recurrence of Prostate Cancer | January 3, 2019 | December 1, 2024 |
| NCT02425592 | Active, not recruiting | Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE) | April 2015 | May 2025 | |
| NCT01655836 | Active, not recruiting | Phase 1 | High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | October 4, 2012 | January 1, 2040 |
| NCT01171898 | Active, not recruiting | Phase 1/Phase 2 | Safety, Pharmacokinetic and Proof-of-Concept Study of ARN-509 (Apalutamide) in Castration-Resistant Prostate Cancer (CRPC) | July 2010 | December 2024 |
| NCT03689699 | Active, not recruiting | Phase 1/Phase 2 | Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) | October 11, 2018 | January 2025 |
| NCT05521412 | Active, not recruiting | Phase 1/Phase 2 | EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T | September 29, 2022 | December 2026 |
| NCT00525720 | Active, not recruiting | Phase 2 | Brachytherapy for Prostatic Carcinoma Patients | August 2006 | September 30, 2027 |
| NCT02768363 | Active, not recruiting | Phase 2 | Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) | May 2016 | |
| NCT01272050 | Active, not recruiting | Phase 3 | Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery | January 6, 2011 | December 2024 |
| NCT02274779 | Active, not recruiting | Phase 2 | Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer | August 20, 2014 | July 2026 |
| NCT03706365 | Active, not recruiting | Phase 2/Phase 3 | A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer | November 26, 2018 | June 2026 |
| NCT06043947 | Active, not recruiting | Survival Monitoring in Russian Cancer Registries | August 1, 2023 | January 31, 2024 | |
| NCT02473003 | Active, not recruiting | N/A | Physical Training and Cancer-a Multicenter Clinical Trial | March 2015 | December 2025 |
| NCT03525288 | Active, not recruiting | Phase 2/Phase 3 | PSMA-PET Guided Radiotherapy | May 15, 2018 | April 30, 2026 |
| NCT03787680 | Active, not recruiting | Phase 2 | Targeting Resistant Prostate Cancer With ATR and PARP Inhibition (TRAP Trial) | October 31, 2019 | January 2027 |
| NCT03269422 | Active, not recruiting | Phase 1 | Radiotherapy to the Prostate and Dominant Intra-Prostatic Lesion (DIL) | August 28, 2017 | August 28, 2024 |
| NCT02415621 | Active, not recruiting | Early Phase 1 | Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer | April 13, 2015 | December 2024 |
| NCT01368055 | Active, not recruiting | N/A | Hypofractionated Proton Radiation Therapy for Low and Intermediate Risk Prostate Cancer | September 2011 | September 2036 |
| NCT04662996 | Active, not recruiting | N/A | Search for Predictive Factors of Resistance to Treatment for Metastatic Castration-resistant Prostate Cancer by Studying the Expression of microRNAs | June 23, 2021 | November 30, 2023 |
| NCT02044172 | Active, not recruiting | N/A | Prostate Testing for Cancer and Treatment | June 1, 2001 | March 31, 2027 |
| NCT03385655 | Active, not recruiting | Phase 2 | Prostate Cancer Biomarker Enrichment and Treatment Selection | August 1, 2018 | December 31, 2025 |
| NCT02430480 | Active, not recruiting | Phase 2 | Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer | June 3, 2015 | June 1, 2025 |
| NCT01851018 | Active, not recruiting | N/A | Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment | May 2012 | June 2025 |
| NCT00868803 | Active, not recruiting | Aberrant Gene Expression Prostate Carcinoma | April 1995 | April 2025 | |
| NCT03348670 | Active, not recruiting | Phase 2/Phase 3 | Pharmacogenomics IND EXEMPT SNP Clinical Study - Abiraterone and Single Nucleotide Polymorphisms | August 18, 2023 | May 28, 2024 |
| NCT04879563 | Active, not recruiting | Phase 2 | Artificial Intelligence Supporting CAncer Patients Across Europe - the ASCAPE Project | February 1, 2021 | June 30, 2024 |
| NCT03030625 | Active, not recruiting | N/A | VMAT for Dominant Intraprostatic Lesion | March 13, 2017 | January 31, 2025 |
| NCT02759783 | Active, not recruiting | Phase 2/Phase 3 | Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases | November 2016 | October 2024 |
| NCT02788773 | Active, not recruiting | Phase 2 | Durvalumab With or Without Tremelimumab in Metastatic Castration Resistant Prostate Cancer | December 15, 2016 | June 30, 2024 |
| NCT05453604 | Active, not recruiting | N/A | Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications | June 18, 2020 | December 2023 |
| NCT04239599 | Active, not recruiting | N/A | Trial of Hypofractionated IMRT Boost Versus Conventional IMRT Boost for Localized High Risk Prostate Cancer | March 31, 2011 | December 31, 2023 |
| NCT03089203 | Active, not recruiting | Phase 1 | CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer | March 8, 2017 | December 8, 2038 |
| NCT04298983 | Active, not recruiting | Phase 2 | Abemaciclib in Combination With Androgen Deprivation Therapy for Locally Advanced Prostate Cancer | February 25, 2021 | April 2026 |
| NCT03338790 | Active, not recruiting | Phase 2 | An Investigational Immunotherapy Study of Nivolumab in Combination With Rucaparib, Docetaxel, or Enzalutamide in Metastatic Castration-resistant Prostate Cancer | December 19, 2017 | September 15, 2024 |
| NCT03042468 | Active, not recruiting | Phase 1/Phase 2 | Phase I Dose-escalation Study of Fractionated 177Lu-PSMA-617 for Progressive Metastatic CRPC | December 2016 | December 2025 |
| NCT01140373 | Active, not recruiting | Phase 1 | Adoptive Transfer of Autologous T Cells Targeted to Prostate Specific Membrane Antigen (PSMA) for the Treatment of Castrate Metastatic Prostate Cancer (CMPC) | June 2010 | June 2024 |
| NCT04541030 | Active, not recruiting | Integrated Genomic Prostate Score With MRI Targeted Prostate Biopsies | September 2, 2020 | March 1, 2025 | |
| NCT05587192 | Active, not recruiting | N/A | Radical Prostatectomy Without Prostate Biopsy Following PSMA PET/CT Based on Diagnostic Model | November 10, 2022 | June 30, 2024 |
| NCT01617161 | Active, not recruiting | N/A | Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer | July 25, 2012 | August 2027 |
| NCT00430183 | Active, not recruiting | Phase 3 | Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer | May 8, 2007 | October 2030 |
| NCT04301414 | Active, not recruiting | Early Phase 1 | Non-fucosylated Anti-CTLA-4 (BMS-986218) + Degarelix Acetate vs. Degarelix Acetate Alone in Men With High-risk Localized Prostate Cancer | February 25, 2020 | June 2025 |
| NCT05458856 | Active, not recruiting | Phase 3 | Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate | August 30, 2022 | July 12, 2024 |
| NCT02302105 | Active, not recruiting | N/A | Randomized Trial of Prostate Only or Pelvic RT in High Risk Prostate Cancer | November 25, 2011 | October 23, 2025 |
| NCT05110495 | Active, not recruiting | Early Phase 1 | Windows Trial of INsulin-like Growth Factor Neutralising Antibody Xentuzumab in MEN Scheduled for Radical Prostatectomy (WINGMEN) | December 17, 2021 | December 2023 |
| NCT05671094 | Active, not recruiting | N/A | Implementation of a Multimodal Prehabilitation Program in Robotic Oncological Surgery | January 13, 2023 | December 31, 2024 |
| NCT04291664 | Active, not recruiting | Phase 1 | PK and Dose Escalation and Expansion Study of DST-2970 | January 31, 2020 | March 31, 2023 |
| NCT04821622 | Active, not recruiting | Phase 3 | Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC | May 12, 2021 | August 7, 2027 |
| NCT04147806 | Active, not recruiting | Phase 2 | A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer | August 1, 2016 | July 13, 2026 |
| NCT06060587 | Active, not recruiting | Phase 2 | Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone | October 19, 2023 | December 22, 2030 |
| NCT05682742 | Active, not recruiting | N/A | Clinical Investigation of the da Vinci Surgical System | December 12, 2022 | August 31, 2028 |
| NCT04701021 | Active, not recruiting | Phase 1 | TENDU Vaccine in Patients With Relapse After Primary Radical Prostatectomy | February 17, 2021 | December 31, 2023 |
| NCT03507725 | Active, not recruiting | N/A | Early Staged Consent Before Prostate Biopsy | April 11, 2018 | April 2025 |
| NCT03725761 | Active, not recruiting | Phase 2 | Sacituzumab Govitecan in Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Second Generation AR-Directed Therapy | October 24, 2018 | April 2025 |
| NCT04100811 | Active, not recruiting | Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform | December 1, 2019 | December 31, 2024 | |
| NCT00578240 | Active, not recruiting | Molecular Studies and Clinical Correlations in Human Prostatic Disease | April 1990 | December 2025 | |
| NCT03870269 | Active, not recruiting | N/A | Using Virtual Reality (VR) Models for Robotic Prostatectomy - UNC | February 25, 2019 | September 30, 2022 |
| NCT02339701 | Active, not recruiting | N/A | Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer | January 7, 2015 | December 31, 2024 |
| NCT04896580 | Active, not recruiting | N/A | IIT2020-20-SHIRAZIP-WALK: Nature Walks | June 21, 2021 | May 2024 |
| NCT04029714 | Active, not recruiting | N/A | Prostate Cancer Active Surveillance Trigger Trial (PCASTT-UK): Comparing Current Practice for Men With Prostate Cancer on Active Surveillance (AS) to an AS Protocol With Standardised Triggers for Transitioning to Curative Treatment | September 19, 2019 | December 2033 |
| NCT06126172 | Active, not recruiting | N/A | Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions | February 15, 2022 | February 27, 2024 |
| NCT03493945 | Active, not recruiting | Phase 1/Phase 2 | Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) | May 1, 2018 | December 31, 2024 |
| NCT02874014 | Active, not recruiting | Phase 2 | Prospective Evaluation of Hypofractionation Proton Beam Therapy With Concurrent Treatment of the Prostate and Pelvic Nodes for Clinically Localized, High Risk or Unfavorable Intermediate Risk Prostate Cancer | July 25, 2016 | October 31, 2024 |
| NCT03543189 | Active, not recruiting | Phase 1/Phase 2 | Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy | October 3, 2018 | December 2024 |
| NCT04489745 | Active, not recruiting | Phase 2 | Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer | December 2016 | January 2025 |
| NCT04487847 | Active, not recruiting | Phase 1/Phase 2 | 18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer | September 1, 2020 | December 31, 2023 |
| NCT04100018 | Active, not recruiting | Phase 3 | A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer | February 6, 2020 | June 27, 2024 |
| NCT03158922 | Active, not recruiting | The BARCODE 1 Pilot Study | April 29, 2016 | April 1, 2024 | |
| NCT04848909 | Active, not recruiting | N/A | Stereotactic Body Radiotherapy (SBRT) Post Prostatectomy | June 3, 2021 | December 2027 |
| NCT00831142 | Active, not recruiting | Characterization of Prostate Cancer With 3T MR | June 2006 | May 31, 2025 | |
| NCT02042807 | Active, not recruiting | Phase 2 | To Evaluate the Effect of MCS® in Prostate Cancer Prevention | October 2014 | December 2024 |
| NCT00937586 | Active, not recruiting | Prostate Cancer Prospective Cohort | May 2000 | June 2025 | |
| NCT04060589 | Active, not recruiting | ReIMAGINE Prostate Cancer Risk | September 3, 2019 | May 31, 2025 | |
| NCT05622162 | Active, not recruiting | Phase 3 | Prospective Comparative Study for Patients With Biochemical Recurrence Prostate Cancer Detecting by 18F-JK-PSMA-7 | December 19, 2022 | June 2024 |
| NCT04422132 | Active, not recruiting | Phase 2 | Randomized Phase II Trial of Salvage Radiotherapy for Prostate Cancer In 4 Weeks v. 2 Weeks | September 24, 2020 | December 31, 2025 |
| NCT02003924 | Active, not recruiting | Phase 3 | Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | October 31, 2013 | October 31, 2024 |
| NCT01885949 | Active, not recruiting | Phase 2 | Tivozanib + Enzalutamide in Adv Prostate Cancer | September 3, 2013 | June 2026 |
| NCT04661176 | Active, not recruiting | Evaluation of the Sentinel™ PCC4 Assay for Diagnosis, Prognosis and Monitoring of Prostate Cancer in Puerto Rico | November 30, 2020 | December 31, 2024 | |
| NCT03734653 | Active, not recruiting | Early Phase 1 | Testosterone Therapy in Castration Resistant Prostate Cancer | January 18, 2019 | August 2025 |
| NCT02095249 | Active, not recruiting | N/A | Prostate Hypoxia - TIC | September 2014 | January 2028 |
| NCT02312401 | Active, not recruiting | Phase 2 | Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy | December 2014 | December 2025 |
| NCT02177292 | Active, not recruiting | N/A | High-Dose Lymph Node Intensity Modulated Radiation Therapy and Hypofractionated Prostate (SIB) | June 23, 2010 | December 2026 |
| NCT03009981 | Active, not recruiting | Phase 3 | A Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate Cancer | March 6, 2017 | January 1, 2025 |
| NCT03934606 | Active, not recruiting | Evaluating an Alternative Clinical Genetics Cancer Care Deliver Model | January 1, 2018 | December 31, 2024 | |
| NCT00667069 | Active, not recruiting | Phase 3 | Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer | April 7, 2008 | April 2025 |
| NCT02903368 | Active, not recruiting | Phase 2 | Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy | October 19, 2016 | June 2024 |
| NCT05079828 | Active, not recruiting | N/A | Head-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007 | July 7, 2022 | November 1, 2024 |
| NCT01441687 | Active, not recruiting | N/A | Comparing the Reliability of Expressed Prostatic Secretion (EPS) and Post Massage Urine (PMU) for the Prediction of Prostate Cancer Biopsy Outcome | July 14, 2009 | December 31, 2024 |
| NCT02194842 | Active, not recruiting | Phase 3 | Phase III Radium 223 mCRPC-PEACE III | October 2015 | December 2028 |
| NCT04377152 | Approved for marketing | Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer | |||
| NCT04348682 | Approved for marketing | Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging | |||
| NCT04452136 | Approved for marketing | Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer | |||
| NCT04100694 | Available | Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor | |||
| NCT05974410 | Available | Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients | |||
| NCT04337099 | Available | A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer | |||
| NCT00818480 | Completed | Phase 2 | An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155 | February 2006 | August 2012 |
| NCT00139191 | Completed | N/A | Study Evaluating the Correlation Between C-11 Acetate Uptake and Retention as Measured by PET and FAS in Prostate Cancer | July 2005 | May 2006 |
| NCT01615406 | Completed | Phase 1 | A Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate Cancer | April 2012 | |
| NCT00011349 | Completed | Early Stage Prostate Cancer Cohort | January 2001 | January 2010 | |
| NCT00456989 | Completed | Phase 1/Phase 2 | Study of Taxotere and Doxil to Treat Advanced Androgen-Independent Prostate Cancer | January 2004 | August 2010 |
| NCT01278914 | Completed | Phase 1/Phase 2 | Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Androgen Resistant Metastatic Prostate Cancer | February 1, 2002 | July 2006 |
| NCT03761160 | Completed | N/A | Mobile Health App to Mitigate the Metabolic Effects of Androgen Deprivation Therapy | July 16, 2019 | July 10, 2020 |
| NCT01813370 | Completed | A Registry for Patients Treated on the Clinical Trial TAX 3503 | March 2013 | March 4, 2022 | |
| NCT00059631 | Completed | Phase 1 | Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone | March 20, 2003 | June 17, 2015 |
| NCT04340765 | Completed | N/A | 18F-fluorocholine and 18F-fluoride PET in Prostate Cancer | February 1, 2018 | December 31, 2019 |
| NCT00292045 | Completed | Phase 1 | Immunization With NY-ESO-1 Protein Combined With CpG 7909 in Patients With Prostate Cancer | October 27, 2004 | January 9, 2006 |
| NCT03949517 | Completed | Phase 1/Phase 2 | 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU Therapy | April 9, 2019 | March 7, 2022 |
| NCT00924313 | Completed | Phase 1/Phase 2 | Positron Emission Tomography and Magnetic Resonance Imaging for Prostate Cancer | September 10, 2008 | April 19, 2011 |
| NCT02274623 | Completed | Phase 1 | Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid | December 2014 | March 17, 2017 |
| NCT01434290 | Completed | Phase 2 | Radiation Therapy in Treating Patients With Prostate Cancer | September 2011 | May 20, 2022 |
| NCT00744549 | Completed | Phase 2 | Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance | May 2008 | December 2013 |
| NCT00520546 | Completed | Phase 3 | Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer | December 2007 | June 2011 |
| NCT02833883 | Completed | Phase 1 | Use of an Experimental Drug, CC-115, With Enzalutamide in Men With Castration-Resistant Prostate Cancer | July 2016 | January 13, 2023 |
| NCT00853697 | Completed | Phase 2 | Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer | March 2009 | November 2012 |
| NCT00020891 | Completed | Phase 2 | CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy | March 2001 | |
| NCT01094665 | Completed | N/A | MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer | November 2009 | October 8, 2015 |
| NCT00884273 | Completed | Phase 3 | Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients | August 2009 | March 2011 |
| NCT05140512 | Completed | Phase 1 | Pharmacokinetics, Pharmacodynamics and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® | February 4, 2021 | November 26, 2021 |
| NCT03447028 | Completed | Effect of TyG Index on Outcomes of Radical Prostatectomy | January 1, 2007 | December 30, 2012 | |
| NCT01423006 | Completed | N/A | Pilot Study on Focal Prostate Radio-Frequency Ablation | August 2011 | March 2013 |
| NCT03386812 | Completed | Investigating Bone and Skeletal Muscle Interaction in Men With Prostate Cancer | October 1, 2017 | November 29, 2020 | |
| NCT02585362 | Completed | N/A | Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program | March 2016 | October 2018 |
| NCT03331367 | Completed | N/A | Investigating and Characterizing the Immune Response to Prostate Cancer | September 14, 2017 | February 25, 2020 |
| NCT00692874 | Completed | Quality of Life Analysis of Treatment in Patients With Prostate Cancer on Adjuvant Zoladex Therapy | June 2008 | September 2010 | |
| NCT00063882 | Completed | Phase 3 | Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer | June 2003 | December 22, 2022 |
| NCT03362359 | Completed | Phase 1/Phase 2 | Ga-68-PSMA-11 in High-risk Prostate Cancer | October 9, 2017 | July 6, 2020 |
| NCT00423475 | Completed | Phase 3 | Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer | October 2006 | |
| NCT02840552 | Completed | Phase 3 | The Safety and Efficacy of 18F-Fluoromethylcholine (18F-FCH) PET/CT in Prostate Cancer | September 2016 | March 2018 |
| NCT02445976 | Completed | Phase 2 | Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. | May 2015 | January 2019 |
| NCT05773703 | Completed | Early Phase 1 | Exploratory PK and Imaging Study of PSMA-Targeted Trillium Compounds and PTI-122 in Metastatic Prostate Cancer | December 8, 2022 | December 12, 2023 |
| NCT00774436 | Completed | Phase 2 | Study of Focal Cryoablation in Low-Risk Prostate Cancer | October 14, 2008 | July 23, 2019 |
| NCT00658229 | Completed | Phase 3 | The Physical Exercise and Prostate Cancer Study | November 2008 | May 2012 |
| NCT00111618 | Completed | Phase 2 | Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer | May 2005 | August 2008 |
| NCT02512835 | Completed | Understanding the Value of Community Vital Signs in Primary Care | October 2015 | November 1, 2016 | |
| NCT00442000 | Completed | Outcomes Comparison of Robotic, Retropubic, and Perineal Prostatectomy | January 2005 | December 2009 | |
| NCT00003781 | Completed | Phase 2 | Docetaxel in Treating Patients With Stage IV Prostate Cancer | December 1998 | June 2003 |
| NCT01434342 | Completed | Early Phase 1 | Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients | October 1, 2011 | January 1, 2015 |
| NCT00044980 | Completed | N/A | Diet and Exercise-Based Counseling Program Compared With a Standard Counseling Program in Patients With Early-Stage Prostate Cancer | July 2002 | December 2006 |
| NCT02142608 | Completed | Phase 1/Phase 2 | A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer | August 2014 | January 2016 |
| NCT03572387 | Completed | Phase 2 | A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment | August 20, 2018 | July 8, 2022 |
| NCT01376674 | Completed | T-cell-immunity During Standard Radiotherapy in Localised Prostate Cancer | March 2011 | ||
| NCT06244680 | Completed | Super-fast 3T Prostate MRI Using High Gradient Strength and Deep Learning | November 1, 2023 | December 31, 2023 | |
| NCT01729442 | Completed | N/A | Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound Elastography | October 2012 | October 2014 |
| NCT01864135 | Completed | N/A | Improved Prostate Cancer Diagnosis - Combination of Magnetic Resonance Imaging and Biomarkers | March 2013 | November 2015 |
| NCT05378854 | Completed | N/A | Training Data Collection & AI Development | July 31, 2022 | April 10, 2023 |
| NCT02453139 | Completed | N/A | Exercise, Prostate Cancer and Circulating Tumour Cells | October 2014 | June 2017 |
| NCT02154672 | Completed | Prostate Cancer Screening in Men With Germline BRCA2 Mutations | May 2014 | November 1, 2019 | |
| NCT01036321 | Completed | Phase 2 | Phase II Clinical Trial of Purified Isoflavones in Prostate Cancer: Comparing Safety, Effectiveness | December 11, 2009 | April 16, 2018 |
| NCT01950143 | Completed | N/A | Effect of Sulforaphane on Prostate CAncer PrEvention | August 2013 | October 31, 2017 |
| NCT00002723 | Completed | Phase 3 | Low, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate Cancer | January 1996 | March 2008 |
| NCT00771966 | Completed | Phase 4 | Radical Prostatectomy and Perioperative Fluid Therapy | October 2008 | October 2009 |
| NCT02176161 | Completed | Phase 2 | Metformin Prostate Cancer Adjuvant Trial | June 2014 | July 21, 2021 |
| NCT01756638 | Completed | Phase 2 | A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer | June 6, 2012 | October 17, 2014 |
| NCT01135849 | Completed | B-Receptor Signaling in Cardiomyopathy | November 2008 | October 2010 | |
| NCT00698711 | Completed | Phase 1 | Vaccination of Prostate Cancer Patients With MUC-2-KLH Conjugate Plus the Immunological Adjuvant QS21 | November 1997 | March 2009 |
| NCT00079001 | Completed | Phase 3 | Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases | January 2004 | October 2014 |
| NCT02391480 | Completed | Phase 1 | A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer | April 14, 2015 | July 5, 2019 |
| NCT02382094 | Completed | Phase 3 | Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy | June 2005 | July 2012 |
| NCT00425334 | Completed | Phase 2 | Safety Study of Hemospan® in Prostatectomy Patients | July 2005 | November 2007 |
| NCT01915316 | Completed | Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy | February 2014 | February 2015 | |
| NCT00335491 | Completed | N/A | Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors | March 2006 | March 2010 |
| NCT02080689 | Completed | N/A | Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery | May 2014 | February 1, 2017 |
| NCT00584792 | Completed | Diet, Genetic Variation and Prostate Cancer Among African Americans | August 2006 | December 2007 | |
| NCT00272038 | Completed | Phase 2 | Single Agent Erlotinib in Chemotherapy-naive Androgen Independent Prostate Cancer | December 2005 | October 2010 |
| NCT01968447 | Completed | N/A | Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex | February 2014 | October 2015 |
| NCT03199586 | Completed | Phase 1 | Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies | December 21, 2017 | May 7, 2020 |
| NCT01795703 | Completed | Phase 2 | A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel | June 2012 | October 2014 |
| NCT01036594 | Completed | Phase 2 | Ketoconazole and Dexamethasone in Prostate Cancer | December 11, 2009 | October 9, 2014 |
| NCT00035217 | Completed | Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program | |||
| NCT00049309 | Completed | Phase 2 | Low-Fat Diet and/or Flaxseed in Preventing Prostate Cancer | January 2003 | May 2006 |
| NCT02911350 | Completed | Phase 1 | Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer | May 2000 | December 2016 |
| NCT00310479 | Completed | N/A | Clinico-pathologic Correlative Study of 3T Magnetic Resonance Spectroscopy in the Localization of Prostate Cancer | June 2006 | March 2008 |
| NCT01254864 | Completed | Phase 2 | Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies | March 16, 2011 | December 7, 2023 |
| NCT04321187 | Completed | Influence of Prostate Cancer Radiation on Aging | September 1, 2019 | March 31, 2023 | |
| NCT03311555 | Completed | Phase 2 | A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) | March 28, 2018 | December 22, 2022 |
| NCT00316927 | Completed | Phase 3 | Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | December 2002 | April 2007 |
| NCT04389918 | Completed | N/A | Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate Cancer | October 26, 2020 | February 26, 2024 |
| NCT02917161 | Completed | N/A | Prostatic Artery Embolization Before Radical Prostatectomy in Prostate Cancer: A Proof-of-concept Study | September 2016 | August 3, 2017 |
| NCT00416390 | Completed | N/A | Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia | March 2011 | |
| NCT00087659 | Completed | N/A | A Prostate Cancer Study in Men Undergoing Androgen Deprivation Therapy | December 2003 | May 2007 |
| NCT01931644 | Completed | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | July 2013 | April 2024 | |
| NCT00405210 | Completed | Phase 1 | Pharmacokinetic Study of BAY43-9006 and Taxotere to Treat Patient With Prostatic Cancer | September 2006 | December 2009 |
| NCT02628041 | Completed | Phase 2 | HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer | October 2015 | February 2021 |
| NCT01613651 | Completed | Phase 3 | Robotic Assisted Laparoscopic Prostatectomy With or Without Pelvic Drain Placement in Reducing Adverse Events After Surgery in Patients With Prostate Cancer | August 24, 2012 | September 11, 2017 |
| NCT00372840 | Completed | N/A | Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer | May 2006 | March 2013 |
| NCT02680041 | Completed | Phase 3 | 18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment | June 1, 2016 | November 1, 2017 |
| NCT02663817 | Completed | N/A | DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy | June 19, 2015 | April 4, 2019 |
| NCT00116753 | Completed | Phase 2 | A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer | January 2005 | November 2006 |
| NCT03028584 | Completed | Survivorship Care Plans in a Community Oncology Practice | September 11, 2017 | March 23, 2018 | |
| NCT02818816 | Completed | Phase 4 | Preoperative Brimonidine on IOP of Patients Undergoing RALP | February 29, 2016 | August 7, 2017 |
| NCT00278070 | Completed | Phase 2 | Metronomic Oral Vinorelbine in Patients With Metastatic Tumors | January 2006 | February 2008 |
| NCT01964170 | Completed | Phase 3 | A Study to Compare the Effect of ASP3550 With Goserelin in Patients With Prostate Cancer | August 13, 2013 | August 8, 2016 |
| NCT04098809 | Completed | N/A | Impact of Catheter Size on Peri-Operative Pain After Robotic Assisted Laparoscopic Prostatectomy | November 9, 2017 | November 7, 2018 |
| NCT03196778 | Completed | N/A | Low Dose Hemi-body Radiation For Recurrent Prostate Cancer | September 25, 2017 | July 18, 2022 |
| NCT00336934 | Completed | N/A | Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer | November 2005 | December 2010 |
| NCT03373006 | Completed | Phase 2 | A Phase II Study to Evaluate Axumin PET/CT for Risk Stratification for Prostate Cancer | February 27, 2018 | January 30, 2020 |
| NCT00500110 | Completed | Phase 2 | Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | June 2003 | February 2010 |
| NCT00004928 | Completed | Phase 1 | Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer | October 1999 | October 2004 |
| NCT00150995 | Completed | Phase 2 | Tetrathiomolybdate in Hormone Refractory Prostate Cancer | May 2001 | April 2006 |
| NCT00954044 | Completed | N/A | Exercising Together: An Intervention for Prostate Cancer Survivors and Spouses | January 2010 | June 2011 |
| NCT02730975 | Completed | Phase 1 | Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer | May 12, 2014 | October 10, 2020 |
| NCT00054106 | Completed | Phase 1 | Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer | December 10, 2002 | September 22, 2008 |
| NCT02111187 | Completed | Phase 1 | A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer | April 2014 | January 18, 2017 |
| NCT01138527 | Completed | Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach | June 2010 | July 2019 | |
| NCT00020995 | Completed | Phase 2 | Low-Fat, High-Fiber Diet Compared to a Standard Diet in Treating Patients With Prostate Cancer | August 2001 | January 2010 |
| NCT01212991 | Completed | Phase 3 | A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer | September 16, 2010 | February 14, 2019 |
| NCT02114164 | Completed | N/A | Study of Carbon Dioxide Exchange Patterns During Robotic Prostatectomies | August 2016 | July 15, 2019 |
| NCT02163083 | Completed | N/A | Detection of Lymphnodes Using ICG During RARP | August 2014 | April 2017 |
| NCT01477749 | Completed | Phase 2 | Sipuleucel-T Manufacturing Demonstration Study | June 2012 | June 2014 |
| NCT00020735 | Completed | Phase 2 | Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer | April 2001 | June 2009 |
| NCT00421694 | Completed | Phase 2/Phase 3 | Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide | ||
| NCT00124566 | Completed | Phase 2 | Study of Irofulven in Patients With Hormone-refractory Prostate Cancer | June 2004 | December 2009 |
| NCT03502213 | Completed | Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance | July 1, 2014 | June 30, 2018 | |
| NCT02813226 | Completed | N/A | Assessment of New Molecular Imaging Strategies for Prostate Cancer | February 16, 2017 | December 17, 2021 |
| NCT00123838 | Completed | N/A | Positioning and Tracking the Prostate During External Beam Radiation | July 2005 | September 2008 |
| NCT00003232 | Completed | Phase 3 | Combination Chemotherapy in Treating Pain in Hormone Refractory Metastatic Prostate Cancer | November 24, 1997 | February 10, 2009 |
| NCT00257478 | Completed | Phase 2 | A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Chemotherapy | March 2007 | |
| NCT00041301 | Completed | Assessing Quality of Life of Patients With Prostate Cancer | March 2002 | November 2005 | |
| NCT03203460 | Completed | N/A | Exercise During Active Surveillance for Prostate Cancer | July 1, 2018 | May 31, 2021 |
| NCT01993160 | Completed | N/A | 18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer | December 2013 | December 2016 |
| NCT02916537 | Completed | Phase 1 | A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057 | September 2016 | August 28, 2017 |
| NCT00441532 | Completed | N/A | Study On Lidocaine Vs. Placebo Pain Control During Transrectal Ultrasound Guided Prostate Biopsy | August 2005 | August 2006 |
| NCT01417676 | Completed | N/A | DAPROCA Pelvic Lymph Node Irradiation to Prostate for High Risk Prostate Cancer: Phase I/II Study | April 2011 | May 2019 |
| NCT00987376 | Completed | Phase 1 | Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration | November 2003 | September 2009 |
| NCT00022399 | Completed | Phase 2 | Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer | April 25, 2002 | January 31, 2005 |
| NCT04172649 | Completed | N/A | Acupuncture With Press Tack Needles for Perioperative Pain After Open Radical Prostatectomy | March 1, 2020 | December 31, 2021 |
| NCT00900185 | Completed | Study of a Polymorphism in Patients With Prostate Cancer | |||
| NCT00038194 | Completed | Phase 1 | Phase I Trial of Fixed Dose STI571 (Imatinib Mesylate) With Escalating Doses of Docetaxel in Patients With Metastatic Androgen-Independent Prostate Cancer | October 2001 | September 2005 |
| NCT03604757 | Completed | Phase 2 | 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks | April 25, 2018 | December 19, 2019 |
| NCT00005828 | Completed | Phase 2 | Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | December 2000 | June 2008 |
| NCT03600129 | Completed | N/A | Qudratus Lumborum Block for Postoperative Pain After Endoscopic Prostatectomy. | July 25, 2018 | October 21, 2019 |
| NCT00710658 | Completed | N/A | Internet Support for Cancer Patients | May 2006 | November 2008 |
| NCT00572468 | Completed | N/A | Statin Therapy Versus Placebo Prior to Prostatectomy | December 2007 | April 30, 2017 |
| NCT00834392 | Completed | N/A | Exercise in Men With Prostate Cancer | October 2008 | December 2010 |
| NCT03035487 | Completed | N/A | Urology of Virginia Case Series | December 2016 | February 2018 |
| NCT01672905 | Completed | PSA Antibody Levels in Samples From Patients With Prostate Cancer Treated on Protocol ECOG-E9802 | December 7, 2012 | January 7, 2013 | |
| NCT04924218 | Completed | N/A | Evaluation of the Effect of Endoscopic Urethral Procedures Applied After Radical Prostatectomy on Urinary Incontinence | November 15, 2020 | May 26, 2021 |
| NCT01964638 | Completed | N/A | Use of Multi-Parametric MRI With Prostate Biopsy for Cancer Diagnosis. | June 2012 | March 2013 |
| NCT00007540 | Completed | Study of Prostate Cancer in Black and White U.S. Veterans | April 1998 | September 2000 | |
| NCT00859729 | Completed | Phase 1/Phase 2 | Dose Finding Study of a DNA Vaccine Delivered With Intradermal Electroporation in Patients With Prostate Cancer | December 2008 | November 2011 |
| NCT00038168 | Completed | Phase 1/Phase 2 | Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma | June 2000 | January 2003 |
| NCT02004223 | Completed | N/A | Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate Cancer | January 2014 | December 2018 |
| NCT00004149 | Completed | Phase 2 | Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy | September 1999 | August 2003 |
| NCT02209584 | Completed | Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients | May 2014 | December 8, 2015 | |
| NCT05040672 | Completed | Evaluation of Knowledge and Practice About Prostate Cancer in Male Employees | June 1, 2021 | July 29, 2022 | |
| NCT02264379 | Completed | Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma | December 2014 | August 2021 | |
| NCT00634647 | Completed | Phase 2 | Satraplatin and Prednisone to Treat Prostate Cancer | February 19, 2008 | May 1, 2012 |
| NCT00694551 | Completed | N/A | PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment | December 2, 2008 | December 6, 2018 |
| NCT00084526 | Completed | Phase 1/Phase 2 | Computed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate Cancer | November 2003 | February 2007 |
| NCT00551525 | Completed | Phase 2 | Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate Cancer | April 2008 | December 2016 |
| NCT03853902 | Completed | N/A | Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate | January 26, 2016 | November 23, 2018 |
| NCT00861614 | Completed | Phase 3 | Study of Immunotherapy to Treat Advanced Prostate Cancer | May 2009 | August 2015 |
| NCT01744262 | Completed | N/A | A Comparison of Totally Intravenous and Inhalation Anesthesia for Intraocular Pressure During Robot-Assisted Laparoscopic Radical Prostatectomy | May 2011 | March 2012 |
| NCT06170164 | Completed | Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes? | October 8, 2015 | November 25, 2015 | |
| NCT05294627 | Completed | Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population | January 1, 2020 | October 1, 2023 | |
| NCT01620515 | Completed | Phase 2 | Two-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate Cancer | February 21, 2012 | October 21, 2015 |
| NCT02516709 | Completed | Linear Source Registry for Prostate Cancer | June 2015 | June 2023 | |
| NCT00020254 | Completed | Phase 2 | Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer | June 2000 | |
| NCT00846976 | Completed | Phase 3 | Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer | December 1994 | June 2013 |
| NCT02911649 | Completed | N/A | Reducing Sedentary Behaviour With Technology | September 2016 | March 2019 |
| NCT02588001 | Completed | N/A | Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide | October 1, 2015 | March 31, 2021 |
| NCT02200809 | Completed | N/A | MR-guided Focal Laser Ablation of the Prostate | July 2014 | December 2019 |
| NCT01780701 | Completed | Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer | January 2013 | March 2017 | |
| NCT01324583 | Completed | Phase 1 | Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer | January 2011 | November 2014 |
| NCT00002703 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | January 1996 | September 2005 |
| NCT01346839 | Completed | N/A | Effectiveness of Electronic Health Record-Based Interventions for Improving Follow-Up in Primary Care | February 2011 | August 2012 |
| NCT03235557 | Completed | CyberKnife for Prostate Cancer Patients Aged 70 y or More | October 2014 | December 2021 | |
| NCT00394810 | Completed | Phase 2 | Efficacy and Pharmacodynamic Study of Panzem® NCD in Patients With Hormone-Refractory Prostate Cancer | November 2006 | November 2008 |
| NCT02410044 | Completed | Prospective PRO/QoL Registry for Patients With Bone Metastases of Breast or Prostate Cancer | December 23, 2014 | August 16, 2020 | |
| NCT04986280 | Completed | Diagnostic Accuracy and Performance of 18F-PSMA-1007 | July 13, 2021 | March 30, 2024 | |
| NCT00002924 | Completed | Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy | January 1997 | June 2006 | |
| NCT01979848 | Completed | MRI Temperature Mapping of the Prostate and Urogenital Pelvis Cooled by an Endorectal Balloon | June 2013 | November 2015 | |
| NCT02630641 | Completed | Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone. | October 2015 | November 2017 | |
| NCT02080650 | Completed | N/A | Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) | March 2014 | July 19, 2016 |
| NCT04446429 | Completed | N/A | Anti-Androgen Treatment for COVID-19 | October 21, 2020 | January 21, 2021 |
| NCT00268892 | Completed | Phase 2/Phase 3 | Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer | January 2006 | December 2009 |
| NCT01960998 | Completed | N/A | Perioperative Post-Prostatectomy Incontinence Home Telehealth Program | August 11, 2014 | September 30, 2019 |
| NCT01085422 | Completed | Phase 1 | A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer | April 2010 | June 2011 |
| NCT00814788 | Completed | Phase 2 | Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer | December 2008 | January 2016 |
| NCT04307056 | Completed | N/A | Evaluation of HIFU in TREATMENT OF LOCALIZED PROSTATE CANCER and OF RECURRENCE AFTER RADIOTHERAPY | March 23, 2015 | August 24, 2022 |
| NCT05202340 | Completed | Factors Affecting Androgen Deprivation Therapy Choice in Prostate Cancer Patients | January 7, 2022 | February 28, 2023 | |
| NCT00561262 | Completed | Phase 2 | High-Intensity Focused Ultrasound Therapy in Treating Patients With Localized Prostate Cancer | May 2006 | April 2011 |
| NCT03619980 | Completed | A Non-Interventional Study to Evaluate Time to Event and Healthcare Resource Utilisation for Prostate Cancer Participants Throughout the Disease Trajectories Until Progression or Death | September 13, 2018 | November 28, 2018 | |
| NCT03979079 | Completed | Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical Model | January 2010 | January 1, 2017 | |
| NCT06167824 | Completed | Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation Therapy | June 19, 2014 | July 15, 2014 | |
| NCT01546623 | Completed | Phase 3 | A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy | March 2012 | April 2014 |
| NCT00003162 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | February 1998 | |
| NCT00908674 | Completed | Androcur Effects on Quality of Life | June 2008 | January 2010 | |
| NCT01774071 | Completed | Phase 1/Phase 2 | Study of 89Zr-DFO-MSTP2109A in Patients With Prostate Cancer | January 2013 | May 2, 2023 |
| NCT04130776 | Completed | 4Kscore Using Serum Stored Uncentrifuged | October 4, 2017 | October 31, 2018 | |
| NCT02789878 | Completed | Phase 2 | Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer | January 24, 2019 | August 1, 2022 |
| NCT00416533 | Completed | Phase 2 | Docetaxel, Doxorubicin, and Prednisone in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | August 2004 | |
| NCT00919477 | Completed | Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg | May 2009 | March 2012 | |
| NCT02077634 | Completed | Phase 2 | Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE) | May 2014 | April 1, 2019 |
| NCT03660085 | Completed | N/A | Prostate Cancer - Patient Empowerment Program | December 18, 2019 | May 18, 2022 |
| NCT02107391 | Completed | Phase 2 | Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer | March 2012 | June 2016 |
| NCT00421902 | Completed | N/A | Acupuncture Treatment for Hot Flashes Study | January 2006 | June 2012 |
| NCT00064194 | Completed | Phase 3 | Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia | November 28, 2001 | April 30, 2008 |
| NCT03358563 | Completed | Early Phase 1 | Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer | January 17, 2018 | September 2, 2022 |
| NCT02499497 | Completed | Phase 2 | A Selective Androgen Receptor Modulator for Symptom Management in Prostate Cancer | February 29, 2016 | October 31, 2020 |
| NCT00193271 | Completed | Phase 2 | Adjuvant Docetaxel and Estramustine Phosphate for High Risk Localized Prostate Cancer | August 2004 | May 2007 |
| NCT00664456 | Completed | Phase 3 | Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer | April 2008 | June 30, 2023 |
| NCT01188187 | Completed | Phase 3 | Comparison of Docetaxel/Prednisone to Docetaxel/Prednisone in Combination With OGX-011 in Men With Prostate Cancer | November 2010 | June 2014 |
| NCT02488096 | Completed | N/A | Improving Prostate Cancer Detection Using MRI-Targeted TRUS-Guided Biopsy | December 2015 | January 2019 |
| NCT02796807 | Completed | Phase 2 | Correlation Between SUV on 68Ga-HBED-CC-PSMA and Gleason Score in Prostate Cancer | May 2016 | December 2017 |
| NCT03419741 | Completed | N/A | Brain Stimulation For Cancer Smokers | October 21, 2017 | October 20, 2020 |
| NCT00564928 | Completed | Phase 2 | A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer | November 2007 | July 2010 |
| NCT00667862 | Completed | Phase 2 | Efficacy and Safety Study of Panobinostat in Participants With Metastatic Hormone Refractory Prostate Cancer | March 18, 2008 | November 5, 2010 |
| NCT00963911 | Completed | N/A | Validation of a Screening Tool in Geriatric Oncology | August 5, 2008 | March 8, 2015 |
| NCT01521949 | Completed | Phase 2 | Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA | November 4, 2011 | February 1, 2018 |
| NCT02015871 | Completed | Phase 3 | An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer | January 2014 | August 1, 2017 |
| NCT03424213 | Completed | Race-related Alternative Splicing: Novel Targets in Prostate Cancer | January 30, 2018 | July 14, 2021 | |
| NCT01120262 | Completed | S9346A Blood Samples From Patients With Metastatic Prostate Cancer Previously Treated With Bicalutamide and Goserelin | February 2010 | July 2010 | |
| NCT01549951 | Completed | Phase 2 | Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer | May 2012 | January 2015 |
| NCT02499848 | Completed | Phase 2 | Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer | July 2015 | June 2016 |
| NCT02649439 | Completed | Phase 2 | Prostvac in Patients With Biochemically Recurrent Prostate Cancer | December 22, 2015 | October 1, 2022 |
| NCT00049257 | Completed | Phase 2 | Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | October 2002 | March 2009 |
| NCT00242112 | Completed | N/A | Defining the Extent and Grade of Prostate Cancer Using Dynamic Contrast Enhanced Diffusion Weighted and BOLD MRI | June 2005 | February 2008 |
| NCT02536014 | Completed | N/A | Effect of Dexmedetomidine on Heart-rate Corrected QT(QTc) Interval Prolongation During Robotic-assisted Laparoscopic Radical Prostatectomy -Randomized Blind Clinical Trial- | August 2015 | January 2016 |
| NCT04397016 | Completed | N/A | Cost Talk: Discussing Cancer Care Costs | June 12, 2020 | July 2, 2022 |
| NCT00432601 | Completed | N/A | Testing the Helpfulness of 2 Decision Aids for Prostate Cancer | August 2008 | September 2012 |
| NCT01353625 | Completed | Phase 1 | Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. | April 25, 2011 | March 12, 2021 |
| NCT04534309 | Completed | N/A | Behavioral Weight Loss Program for Cancer Survivors in Maryland | September 22, 2020 | June 30, 2023 |
| NCT01417182 | Completed | Phase 1 | Biodistribution and Pharmacokinetic Study of 18F-DCFBC Prostate Specific Membrane Antigen Based PET in Patients With Advanced Prostate Cancer | September 2010 | September 2014 |
| NCT01499381 | Completed | EMBRACE1: Prostate Biorepository | December 2011 | July 2012 | |
| NCT02876237 | Completed | N/A | Geriatric Determinants of General Repercussion of Radiotherapy for Patient Over 75 Years With Prostate Cancer | February 2015 | August 2017 |
| NCT00024232 | Completed | Phase 2 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | June 2001 | February 2004 |
| NCT03807492 | Completed | Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR) | January 16, 2019 | February 7, 2024 | |
| NCT00342771 | Completed | An Epidemiological Study of Genetic Risk Factors for Prostate Cancer in African-American and Caucasian Males | November 8, 2004 | August 6, 2020 | |
| NCT00844792 | Completed | Phase 2 | Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer | October 2008 | December 2013 |
| NCT00468286 | Completed | Phase 2 | Investigating Efficacy and Safety of Two Degarelix Three-Month Dosing Regimens in Patients With Prostate Cancer Requiring Androgen Ablation Therapy | May 2007 | August 2008 |
| NCT03232125 | Completed | N/A | Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position | August 1, 2017 | June 12, 2020 |
| NCT00036543 | Completed | Phase 3 | A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer | May 2001 | |
| NCT00080808 | Completed | Phase 2 | Nerve-Sparing Radical Prostatectomy With or Without Nerve Grafting Followed by Standard Therapy for Erectile Dysfunction in Treating Patients With Localized Prostate Cancer | August 2001 | July 2009 |
| NCT02681614 | Completed | N/A | Pilot Study Evaluating the Role of Histopathology Correlation in Treatment Planning | July 21, 2016 | February 11, 2018 |
| NCT01545154 | Completed | The Use of Transperineal Ultrasound for Radiation Therapy Treatment Planning and Image Guidance in the Treatment of Prostate Cancer | February 2012 | October 2013 | |
| NCT05797727 | Completed | N/A | Real-Life Pilot Feasibility Study (LC_RLP) | January 15, 2023 | December 6, 2023 |
| NCT00617669 | Completed | Phase 3 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer | January 2008 | July 2011 |
| NCT01386684 | Completed | Real Life Evaluation of Lupron in the Management of Prostate Cancer: A Canadian Post Marketing Observational Study | June 28, 2011 | September 8, 2016 | |
| NCT01707966 | Completed | Phase 3 | Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy | September 2012 | July 2016 |
| NCT00631527 | Completed | Phase 1 | Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | February 2008 | |
| NCT00751205 | Completed | Phase 2 | Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) | August 2008 | August 2010 |
| NCT00331773 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Stage II Prostate Cancer | April 2006 | December 22, 2022 |
| NCT00510718 | Completed | Phase 1 | A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer | July 23, 2007 | April 2, 2018 |
| NCT02702856 | Completed | Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer | May 2014 | June 2015 | |
| NCT00002721 | Completed | Phase 1 | Doxorubicin Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | March 1995 | June 2013 |
| NCT00450411 | Completed | Phase 2 | Ultrasound-Guided Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer Previously Treated With External-Beam Radiation Therapy | May 2007 | May 20, 2022 |
| NCT00005947 | Completed | Phase 3 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | November 1999 | September 2004 |
| NCT03179410 | Completed | Phase 2 | PD-L1 Inhibition as ChecKpoint Immunotherapy for NeuroEndocrine Phenotype Prostate Cancer | February 1, 2018 | December 18, 2020 |
| NCT00195039 | Completed | Phase 2 | Treatment With Radiolabeled Monoclonal Antibody HuJ591-GS (177Lu-J591) in Patients With Metastatic Prostate Cancer | August 2004 | October 2013 |
| NCT01411319 | Completed | N/A | MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer | December 27, 2011 | March 2, 2020 |
| NCT00032006 | Completed | Phase 2 | Hormone Therapy Followed By Internal Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer | February 2002 | October 2003 |
| NCT03504995 | Completed | N/A | Efficacy and Safety Assessment of IRE of Localized Prostate Cancer. | April 19, 2018 | April 30, 2020 |
| NCT05582759 | Completed | N/A | Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation Therapy | October 24, 2022 | December 1, 2023 |
| NCT01250717 | Completed | Phase 2 | Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer | January 2001 | May 2011 |
| NCT00380055 | Completed | N/A | Reducing Cancer Disparities for American Indians in the Rural Intermountain West | October 2006 | December 2010 |
| NCT03882697 | Completed | Ability of Cardio Q for Prediction of Hypotension | January 1, 2019 | September 24, 2020 | |
| NCT00046943 | Completed | Phase 3 | Atrasentan in Treating Patients With Prostate Cancer | September 2002 | |
| NCT01940276 | Completed | Phase 2 | Abiraterone Race in Metastatic Castrate-resistant Prostate Cancer | October 2013 | October 8, 2019 |
| NCT00339534 | Completed | Survey of Prostate Cancer in Accra, Ghana | June 26, 2002 | May 15, 2020 | |
| NCT00233610 | Completed | Phase 3 | Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer | December 2003 | October 2007 |
| NCT05806853 | Completed | Phase 2 | PET/MR for Prostate Cancer Restaging: a Phase II Prospective Monocentric Study | June 3, 2020 | October 5, 2022 |
| NCT00757692 | Completed | Phase 2 | Efficacy and Safety Study of Vandetanib (ZD 6474) in Combination With Bicalutamide Versus Bicalutamide Alone in Patients With Chemotherapy Naive Hormone Refractory Prostate Cancer. | January 2009 | November 2012 |
| NCT01393730 | Completed | Phase 2 | Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer | September 2011 | March 15, 2017 |
| NCT01191931 | Completed | Prostate HistoScanning for the Non-invasive Detection and Staging of Prostate Cancer and Characterization of Prostate Tissues (PHS-02) | February 2008 | June 2012 | |
| NCT00987753 | Completed | Phase 1/Phase 2 | Study Evaluating the Safety and Tolerability of L-377202 | March 1999 | November 2001 |
| NCT00394511 | Completed | Phase 3 | Radiation Therapy After Prostatectomy in Treating Patients With Stage III Prostate Cancer | August 1988 | |
| NCT00002938 | Completed | Phase 2 | Surgery in Treating Patients With Prostate Cancer | May 1997 | January 2010 |
| NCT02659527 | Completed | Phase 3 | PET/MRI in Patients With Suspected Prostate Cancer | January 2016 | August 2022 |
| NCT02341404 | Completed | Phase 2 | A Study of 2-hydroxyflutamide (Liproca Depot), Injected Into the Prostate in Patients With Localized Prostate Cancer | May 2012 | May 2015 |
| NCT00203918 | Completed | Prostate Cancer Utilities and Cost-Effectiveness Analysis | January 2004 | February 2013 | |
| NCT05489341 | Completed | Artificial Intelligence and Radiologists at Prostate Cancer Detection in MRI: The PI-CAI Challenge | February 1, 2022 | November 1, 2023 | |
| NCT03001895 | Completed | Phase 2 | Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer | July 1, 2017 | October 5, 2018 |
| NCT03365518 | Completed | N/A | Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBT | December 29, 2017 | November 30, 2020 |
| NCT02978586 | Completed | A Pilot Study of [Ga-68]PSMA PET/MRI for the Assessment of PSMA-positive Tumors | March 14, 2018 | October 25, 2019 | |
| NCT00754000 | Completed | The AIM Study: Assessing the Impact of Margin Reduction | July 2008 | September 2009 | |
| NCT00392938 | Completed | Carbon-11 Acetate and Fludeoxyglucose F 18 PET Scan of the Bone in Patients With Metastatic Prostate Cancer That Has Spread to the Bone | December 2005 | ||
| NCT00004065 | Completed | Phase 1 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | July 1999 | March 2005 |
| NCT01075308 | Completed | Phase 2 | SB939 in Treating Patients With Recurrent or Metastatic Prostate Cancer | June 28, 2010 | February 13, 2015 |
| NCT01496157 | Completed | Phase 1/Phase 2 | Evaluation of Prostate-specific Membrane Antigen (PSMA)-Based PET Imaging of Primary Prostate Cancer | September 11, 2012 | September 17, 2017 |
| NCT00391690 | Completed | Phase 4 | Evaluation of Bone Markers as Diagnostic Tools for Early Detection of Bone Metastases in Patients With High Risk Prostate Cancer | February 2006 | |
| NCT01253213 | Completed | Early Phase 1 | BR55 in Prostate Cancer: an Exploratory Clinical Trial | July 2010 | December 2012 |
| NCT00006392 | Completed | Phase 3 | S0000 Selenium and Vitamin E in Preventing Prostate Cancer | July 2001 | September 2012 |
| NCT00002520 | Completed | N/A | Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer | December 7, 1990 | |
| NCT00644488 | Completed | Phase 1 | A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer | July 2008 | March 2009 |
| NCT00715078 | Completed | Phase 2 | To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen | October 2008 | May 2015 |
| NCT02856100 | Completed | Comparison of PSMA-based 18F-DCFPyL PET/CT to Conventional Imaging in the Evaluation of Patients With Castration-Resistant Prostate Cancer | August 3, 2016 | January 2020 | |
| NCT00078910 | Completed | Phase 2 | Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer | August 2003 | September 2006 |
| NCT01367418 | Completed | Phase 3 | Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy | September 2010 | March 2012 |
| NCT00003038 | Completed | Phase 1 | Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors | October 1997 | January 2003 |
| NCT03556904 | Completed | Phase 2 | FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE) | December 10, 2018 | July 28, 2023 |
| NCT00337155 | Completed | Phase 2 | BAY88-8223, Dose Finding Study in Patients With HRPC | May 2006 | December 2009 |
| NCT00140374 | Completed | Phase 1/Phase 2 | Vaccination Priming and Vaccine Boosting Trial of Allogeneic Human GM-CSF Gene Transduced Irradiated Prostate Cancer Cell Vaccines (GVAX® Vaccine for Prostate Cancer) | December 1998 | February 2001 |
| NCT00887458 | Completed | Phase 2 | A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy | July 2009 | December 2013 |
| NCT03376360 | Completed | Functional Medical Imaging Quantization in Prostate Cancer | October 1, 2015 | May 1, 2017 | |
| NCT02224482 | Completed | N/A | Trial of an Online Multimedia Program to Boost Coping & Function for Prostate Cancer Survivors (PROGRESS) | February 2012 | June 2017 |
| NCT00643994 | Completed | N/A | CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution | December 2007 | January 27, 2021 |
| NCT00284752 | Completed | Phase 2 | Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer | August 2005 | December 2011 |
| NCT00632905 | Completed | Bone Health Observational Study | September 2007 | March 2016 | |
| NCT00557037 | Completed | Phase 2 | A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer | November 2007 | November 2009 |
| NCT02252484 | Completed | N/A | Energy Balance for Prostate Cancer Survivorship | October 2014 | June 2016 |
| NCT01619813 | Completed | Phase 2 | Reolysin Combined With Docetaxel and Prednisone or Docetaxel and Prednisone Alone in Metastatic Castration Resistant Prostate Cancer | December 14, 2012 | May 20, 2016 |
| NCT00004211 | Completed | Phase 1/Phase 2 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | July 1999 | January 2002 |
| NCT03888742 | Completed | The Effect of Androgen Deprivation Therapy on Gut and Urinary Microbiota in Patients With Prostate Cancer | November 12, 2018 | June 7, 2021 | |
| NCT00573833 | Completed | N/A | Internal Radiation Therapy in Treating Patients With Prostate Cancer | November 2007 | September 2014 |
| NCT00901342 | Completed | Phase 2 | Open Label Study of Sipuleucel-T in Metastatic Prostate Cancer | October 2009 | June 2015 |
| NCT00815750 | Completed | N/A | Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients | August 2008 | July 2014 |
| NCT00769548 | Completed | Phase 3 | Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer | April 1995 | December 2016 |
| NCT00345813 | Completed | Phase 2 | Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer | October 2003 | July 2006 |
| NCT00562380 | Completed | Phase 1 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | October 2005 | June 2010 |
| NCT00134706 | Completed | Phase 2 | A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer | January 2004 | September 2009 |
| NCT06158178 | Completed | Evaluation of the Predictive Role of Choline PET/CT on the Survival of Patients Affected by Prostate Cancer. | August 8, 2017 | November 23, 2017 | |
| NCT00381966 | Completed | N/A | Study of Robotic Template Guidance for Needle Placement in Transperineal Prostate Brachytherapy | June 2006 | December 2008 |
| NCT00292019 | Completed | Robotic Laparoscopic Radical Prostatectomy | March 4, 2004 | June 30, 2016 | |
| NCT01050842 | Completed | Early Phase 1 | Bicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate Cancer | February 2010 | October 4, 2012 |
| NCT00305747 | Completed | Phase 1 | Diindolylmethane in Treating Patients With Nonmetastatic Prostate Cancer That Has Not Responded To Previous Hormone Therapy | August 2005 | September 2010 |
| NCT00668083 | Completed | Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer | September 2007 | July 2008 | |
| NCT00165386 | Completed | N/A | MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients | July 2001 | January 2006 |
| NCT00632138 | Completed | Phase 3 | Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate | January 2005 | July 2011 |
| NCT00045227 | Completed | Phase 2 | Vaccine Therapy With or Without Docetaxel in Treating Patients With Metastatic Prostate Cancer | August 2002 | October 2007 |
| NCT00216099 | Completed | Phase 2 | Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer | February 2005 | March 2009 |
| NCT02821728 | Completed | N/A | Sulphate Accumulation in Prostate | April 2016 | April 2017 |
| NCT00547339 | Completed | Phase 1/Phase 2 | Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer | July 2006 | November 28, 2022 |
| NCT00006044 | Completed | Phase 1 | Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy | February 2000 | |
| NCT01685983 | Completed | Phase 2 | A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer | August 30, 2011 | March 6, 2018 |
| NCT02425163 | Completed | Phase 2 | Shear Wave Elastography of Prostate Cancer | March 2012 | January 2015 |
| NCT00654186 | Completed | Phase 2 | Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients | February 2008 | September 2012 |
| NCT01812746 | Completed | Phase 2 | A Phase 2 Study to Determine the Safety and Efficacy of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension), Administered to Patients With Metastatic Castration-Resistant Prostate Cancer | April 2013 | April 2016 |
| NCT02315989 | Completed | N/A | Early-Phase Safety of Proton Therapy Equipment | August 2014 | February 2015 |
| NCT00041847 | Completed | Gene-Environment Interaction in Prostate Cancer | July 2001 | July 2005 | |
| NCT00585962 | Completed | Phase 2 | Proton Beam Radiation Therapy for Early Stage Adenocarcinoma of the Prostate | February 2004 | |
| NCT00137618 | Completed | N/A | Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening | November 2004 | September 2008 |
| NCT00668642 | Completed | Phase 2 | Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer | March 2007 | May 2013 |
| NCT02620033 | Completed | N/A | Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy | September 1, 2015 | December 31, 2021 |
| NCT00258401 | Completed | N/A | Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy. | May 2005 | June 2006 |
| NCT00816452 | Completed | Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer | January 2009 | July 2010 | |
| NCT01614548 | Completed | Management of Prostate Cancer in Central China | January 2003 | December 2011 | |
| NCT02346526 | Completed | Phase 2 | A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer | April 2015 | December 2020 |
| NCT05343689 | Completed | N/A | Pneumatic Compression and Post-induction Hypotension | May 4, 2022 | December 14, 2022 |
| NCT00329797 | Completed | Phase 3 | Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy | March 2006 | November 2014 |
| NCT05239377 | Completed | MiProstate - Information Hub for the Prostate Cancer Care Flow | February 21, 2017 | December 10, 2021 | |
| NCT02111954 | Completed | Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients | April 2014 | October 28, 2016 | |
| NCT03793543 | Completed | Phase 1 | Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer | March 27, 2019 | October 15, 2021 |
| NCT00001469 | Completed | Genetic Analysis of Hereditary Prostate Cancer | January 1, 1995 | July 17, 2009 | |
| NCT00773305 | Completed | Efficacy of Prostate Seed Implantation for Local Control of Early Stage Prostate Cancer | October 2008 | October 2012 | |
| NCT00765479 | Completed | Phase 2/Phase 3 | Soy Protein in Preventing Recurrent Cancer in Patients Who Have Undergone Surgery for Stage II Prostate Cancer | December 2006 | July 2013 |
| NCT00244998 | Completed | Phase 2 | Fulvestrant in Treating Patients With Advanced Prostate Cancer | September 2005 | June 2012 |
| NCT04500080 | Completed | N/A | Feasibility and Safety of Physical Exercise in Men With Prostate Cancer | April 14, 2020 | September 30, 2022 |
| NCT03085095 | Completed | Phase 3 | A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer | April 18, 2017 | November 26, 2021 |
| NCT06075498 | Completed | N/A | Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum Block | February 5, 2022 | June 21, 2023 |
| NCT00738673 | Completed | Phase 2 | Degarelix as Second-Line Hormonal Treatment After Prostate-specific Antigen (PSA)-Failure in GnRH Agonist Treated Patients With Prostate Cancer | July 2008 | December 2011 |
| NCT00014456 | Completed | Phase 1 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | March 2000 | October 2005 |
| NCT00992186 | Completed | Phase 2 | A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer | September 2009 | July 2011 |
| NCT00908141 | Completed | Phase 2 | GM-CSF in Treating Patients With Relapsed Prostate Cancer | June 2006 | July 2010 |
| NCT05615909 | Completed | PRO-MR-RT Systematic Patient-reported Outcomes to Pelvic Online MRgRT | November 19, 2020 | November 1, 2022 | |
| NCT00418080 | Completed | Phase 2 | Survival Outcomes and Tumor Molecular Profile Following Bicalutamide Neoadjuvant Therapy | April 2002 | December 2006 |
| NCT05326282 | Completed | N/A | Evaluating the Role of Ultrasound in Prostate Cancer | December 6, 2021 | February 27, 2024 |
| NCT00748046 | Completed | Phase 1 | Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton | August 2008 | October 2009 |
| NCT03252821 | Completed | N/A | Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy | August 15, 2017 | September 20, 2019 |
| NCT00002511 | Completed | Phase 3 | Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer | December 1992 | |
| NCT04102553 | Completed | Phase 3 | F-18-PSMA-1007 Versus F-18-Fluorocholine PET in Patients With Biochemical Recurrence | March 6, 2019 | March 19, 2021 |
| NCT01411332 | Completed | N/A | Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial | October 31, 2011 | November 22, 2021 |
| NCT03938766 | Completed | N/A | Upregulation of PSMA Receptors After Androgen Deprivation Therapy on PSMA PET/CT Imaging in Prostate Cancer | February 2, 2018 | February 1, 2020 |
| NCT00082147 | Completed | N/A | Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer | April 29, 2004 | June 11, 2018 |
| NCT02225925 | Completed | N/A | Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound | October 1, 2014 | February 28, 2023 |
| NCT01522118 | Completed | Phase 1 | MR-guided Focused Ultrasound Treatment of Prostate Cancer: Focal Therapy for Locally Non-Advanced Disease | January 2011 | June 2012 |
| NCT00804245 | Completed | Phase 1 | C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer | August 2008 | August 2013 |
| NCT01599182 | Completed | Metabolic Effects of Treatment in Intermediate and High-Risk Prostate Cancer | February 2012 | December 2014 | |
| NCT01059513 | Completed | Hypo-fractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer | January 26, 2010 | March 19, 2020 | |
| NCT01553838 | Completed | N/A | A Prospective Study to Evaluate MRI Guided Biopsy Compared With Transrectal Ultrasound Guided Biopsy of the Prostate in Men With Increased PSA Values | January 2012 | October 2013 |
| NCT00002677 | Completed | Phase 1 | Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors | August 1995 | March 2003 |
| NCT02853409 | Completed | Quality of Life of Patients With Locally Advanced and Metastatic Prostate Cancer | January 2014 | December 2015 | |
| NCT02202447 | Completed | Phase 1 | Phase 1 of EC1169 In Patients With Recurrent MCRPC | May 2014 | November 29, 2018 |
| NCT02989623 | Completed | N/A | Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA | September 1, 2015 | April 25, 2019 |
| NCT00777452 | Completed | A Prospective Longitudinal Study of Health-Related Quality of Life in Men With Clinically Localized Prostate Cancer | March 2005 | December 2007 | |
| NCT00100243 | Completed | Phase 2 | Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy | May 2004 | September 2005 |
| NCT01118741 | Completed | N/A | Study of Recurrent Prostate Cancer With Rising Prostate Specific Antigen (PSA) | May 2010 | June 2012 |
| NCT00061347 | Completed | Phase 1 | Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment | May 23, 2003 | April 19, 2018 |
| NCT00728663 | Completed | Phase 2 | Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer | June 2008 | April 2010 |
| NCT02918968 | Completed | Phase 4 | Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer | November 2, 2016 | March 27, 2020 |
| NCT02477137 | Completed | N/A | Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer | July 20, 2015 | March 7, 2018 |
| NCT00620295 | Completed | Phase 1 | Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors | March 2007 | October 2009 |
| NCT01826617 | Completed | Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome | December 2010 | December 2014 | |
| NCT00005634 | Completed | Phase 1 | Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | January 2000 | October 2002 |
| NCT01868386 | Completed | Phase 1/Phase 2 | Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate | April 2013 | December 2020 |
| NCT00622973 | Completed | Phase 3 | USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | September 2007 | March 2011 |
| NCT00061126 | Completed | Phase 2 | ABX-EGF (a Monoclonal Antibody) Given to Patients With Prostate Cancer With or Without Tumor in Other Parts of the Body | April 2003 | |
| NCT04186845 | Completed | Phase 3 | Imaging Study to Investigate Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Suspected Prostate Cancer Recurrence (SPOTLIGHT) | May 5, 2020 | October 12, 2021 |
| NCT04638049 | Completed | N/A | Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT) | August 25, 2020 | August 8, 2022 |
| NCT01040624 | Completed | N/A | Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer | December 2009 | April 11, 2022 |
| NCT02043236 | Completed | N/A | Strategies to Improve Bone Health in Men on ADT | November 2013 | December 31, 2017 |
| NCT00918229 | Completed | N/A | Pilot Study to Assess the Safety and Efficacy of BioProtect Balloon in Prostate Cancer Subjects | June 2009 | May 2011 |
| NCT01630590 | Completed | Phase 2 | Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer | January 8, 2014 | April 6, 2021 |
| NCT00636558 | Completed | Phase 1 | Coxsackie Virus A21 Administered Intravenously (IV) for Solid Tumour Cancers (PSX-X04) | February 29, 2008 | January 12, 2012 |
| NCT00578409 | Completed | Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data | May 2004 | April 2010 | |
| NCT02834416 | Completed | Phase 3 | ADT Exercise Trial and Economic Analysis | August 2016 | March 31, 2020 |
| NCT04350788 | Completed | N/A | Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program | August 3, 2017 | April 15, 2019 |
| NCT02507427 | Completed | Phase 1/Phase 2 | Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study) | July 26, 2015 | March 19, 2018 |
| NCT06217770 | Completed | Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment | April 1, 2023 | January 4, 2024 | |
| NCT00676286 | Completed | Phase 1 | Biological Investigations in Active Surveillance (BIAS) IGAR 2008 I 19 in Prostate Cancer Using High Field MRI (3 Tesla), PET, and Biomarkers | November 2008 | March 2016 |
| NCT03744494 | Completed | N/A | Cosmetic Appeal, HRQoL and Effectiveness of Simple and Pseudotesticular Techniques of Orchidectomy in Prostate Cancer | March 2, 2016 | February 26, 2018 |
| NCT00004071 | Completed | Phase 2/Phase 3 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | August 1999 | September 2007 |
| NCT05354427 | Completed | Retrospective Evaluation of Commercial Spacers in Prostate Cancer Patients | June 18, 2020 | January 1, 2022 | |
| NCT04946214 | Completed | N/A | A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer Patients | May 26, 2021 | August 4, 2022 |
| NCT00004635 | Completed | Phase 3 | Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer | March 1, 2000 | March 30, 2010 |
| NCT02292524 | Completed | N/A | Prostate Biomarkers in Men Consuming Tomato Products | May 2002 | October 2004 |
| NCT00630344 | Completed | Phase 2 | RAD001 and Bicalutamide for Androgen Independent Prostate Cancer | February 2008 | May 2012 |
| NCT02906241 | Completed | N/A | PACCT: Partnering Around Cancer Clinical Trials | September 20, 2016 | July 17, 2021 |
| NCT00513721 | Completed | Retrospective Study of Positive Biopsy Specimens on Patients Undergoing a Prostatectomy | July 2007 | May 2009 | |
| NCT03956108 | Completed | N/A | Active Surveillance for Low-risk Prostate Cancer - Evaluation of the Efficacy of Minimally Invasive Active Surveillance | August 1, 2018 | March 1, 2020 |
| NCT03353740 | Completed | Phase 3 | Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence | September 20, 2017 | September 1, 2020 |
| NCT00570700 | Completed | Phase 2 | Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer | July 2007 | February 2012 |
| NCT01992042 | Completed | Phase 2 | Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer | February 2014 | December 2016 |
| NCT04087980 | Completed | N/A | Ablation of Prostate Tissue Utilizing Sterile Water Vapor in Patients With Intermediate Risk Localized Prostate Cancer | April 10, 2020 | May 25, 2022 |
| NCT00782366 | Completed | Predictive Genetic Risk Assessment Trial | March 2008 | January 2010 | |
| NCT02618200 | Completed | N/A | Creation of an Image Database for the Development of a Computer Aided Diagnostic (CAD) System in Patients With Prostate Cancer | February 1, 2016 | August 31, 2017 |
| NCT03682146 | Completed | N/A | Laparoscopic vs Robotic-Assisted Radical Prostatectomy | November 2014 | December 2021 |
| NCT03423927 | Completed | N/A | Benefits of an Intervention Combining Hypnosis and Self-care for Prostate Cancer Patients | October 14, 2013 | June 15, 2016 |
| NCT00299741 | Completed | Phase 2 | Study of SU11248 in Men With Advanced Prostate Cancer | March 2006 | June 2008 |
| NCT01105338 | Completed | Phase 2/Phase 3 | Lycopene or Green Tea for Men at Risk of Prostate Cancer | August 2009 | August 2010 |
| NCT00003614 | Completed | Phase 2 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | February 4, 1999 | |
| NCT02993497 | Completed | N/A | Respiratory Measurement Using Infrared Camera and Respiratory Volume Monitor (ExSpiron 1Xi) for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia | February 5, 2017 | July 4, 2017 |
| NCT03105869 | Completed | N/A | Repeatability of Positron Emission Tomography (TEP) With fluorométhyl-(18F)-diméthyl-2-hydroxyéthyl-ammonium | December 16, 2014 | December 31, 2016 |
| NCT00311623 | Completed | Phase 1/Phase 2 | Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer | August 2006 | June 2010 |
| NCT04615494 | Completed | Internal Carotid Artery Blood Flow in Robot-Assisted Laparoscopic Prostatectomy | November 17, 2020 | January 22, 2021 | |
| NCT01748500 | Completed | Phase 2 | Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer | January 2013 | March 2021 |
| NCT00459186 | Completed | Phase 1/Phase 2 | The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer | November 2005 | December 2012 |
| NCT05803096 | Completed | Phase 4 | Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain | December 12, 2021 | September 9, 2022 |
| NCT00585637 | Completed | Phase 1 | Vitamin D for Chemoprevention | October 2007 | December 2013 |
| NCT02110667 | Completed | Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy | April 2014 | December 31, 2016 | |
| NCT01418040 | Completed | PROstate Cancer Imaging, Treatment and Toxicity (PROCITT) | November 28, 2012 | July 20, 2017 | |
| NCT00913263 | Completed | Phase 1/Phase 2 | An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate | June 2009 | July 2011 |
| NCT02773251 | Completed | Phase 4 | The Effect of Guardix-solution for the Prevention of Postoperative Intestinal Adhesion and Intestinal Obstruction After Laparoscopic Pelvic Cavity Surgery | November 2011 | |
| NCT01686958 | Completed | N/A | Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate Cancer | March 13, 2013 | June 11, 2019 |
| NCT01744366 | Completed | Phase 3 | One Month Degarelix/Comparator Treatment for Prostate Cancer in Chinese Population | January 2013 | May 2015 |
| NCT01220973 | Completed | Phase 2 | Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | February 2009 | November 18, 2014 |
| NCT00428714 | Completed | Phase 2 | Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy | January 2007 | January 2011 |
| NCT01400555 | Completed | Phase 1 | A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | September 1, 2011 | February 28, 2017 |
| NCT00127478 | Completed | Phase 2/Phase 3 | A Long Term Safety Study With Atrasentan | July 2001 | June 2007 |
| NCT04186819 | Completed | Phase 3 | Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer (LIGHTHOUSE) | February 12, 2020 | February 18, 2022 |
| NCT00004929 | Completed | Phase 1 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | September 1999 | June 2008 |
| NCT01825642 | Completed | Phase 2/Phase 3 | Prospective Randomized Trial of Seminal Vesicle-Sparing Prostatectomy and Nerve-Sparing Radical Prostatectomy in Men With Clinically Localized Prostate Cancer | September 2006 | December 2012 |
| NCT02470910 | Completed | N/A | Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning | July 2015 | July 2018 |
| NCT01234311 | Completed | Phase 3 | A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer | March 2011 | August 2015 |
| NCT04936334 | Completed | Phase 2 | The Role of 68Ga-PSMA-11 PET (Prostate Specific Membrane Antigen) in Surgery Guidance in Prostate Cancer | June 11, 2021 | July 19, 2022 |
| NCT00756392 | Completed | N/A | Magnetic Resonance (MR) Spectroscopy in Localized Prostate Cancer | October 2008 | April 2014 |
| NCT00077402 | Completed | Phase 2 | Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer | November 2003 | February 2011 |
| NCT03339531 | Completed | N/A | Optimized 2D-RT for Prostate Cancer | February 2, 2015 | December 18, 2015 |
| NCT02516995 | Completed | N/A | Functional Magnetic Resonance Imaging for High Throughput Curietherapy Planning in Prostate Cancer | August 2010 | July 2014 |
| NCT04704804 | Completed | Feasibility of MRI Workflow Alone in External Radiotherapy for the Treatment of Brain and Prostate Tumors | July 24, 2020 | July 15, 2021 | |
| NCT02503748 | Completed | N/A | Prostate Cancer E-Health-Tutorial | July 2015 | February 15, 2017 |
| NCT02564120 | Completed | North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) | January 2011 | December 31, 2018 | |
| NCT01823549 | Completed | Nutritional Supplements & Complementary/Alternative Medicine by Prostate & Breast Cancer Patients | December 11, 2002 | December 31, 2023 | |
| NCT00385580 | Completed | Phase 2 | Phase II Study of Dasatinib (BMS-354825) for Androgen-deprived Progressive Prostate Cancer | January 2007 | October 2010 |
| NCT02830880 | Completed | Phase 2 | FACBC Prostate Therapy Response | July 2016 | September 30, 2019 |
| NCT03507543 | Completed | Phase 1 | The Safety and Pharmacokinetics of IMP4297 in Patients With Advanced Solid Tumors | February 3, 2017 | March 17, 2021 |
| NCT00598312 | Completed | Phase 3 | Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer | April 2007 | August 2008 |
| NCT01283373 | Completed | Phase 1 | A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer | March 2011 | January 2016 |
| NCT04854993 | Completed | Phase 3 | Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy | July 13, 2021 | September 23, 2022 |
| NCT03511664 | Completed | Phase 3 | Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer | May 29, 2018 | December 13, 2023 |
| NCT01900561 | Completed | N/A | Optimizing Veteran-Centered Prostate Cancer Survivorship Care | April 17, 2015 | February 7, 2018 |
| NCT02376296 | Completed | Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients | February 2015 | February 10, 2018 | |
| NCT04746638 | Completed | Phase 1 | Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26 | February 1, 2021 | June 1, 2023 |
| NCT00186420 | Completed | Phase 2 | Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and Radiation | July 2003 | September 2009 |
| NCT04751201 | Completed | N/A | Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study) | September 1, 2021 | July 13, 2022 |
| NCT02300389 | Completed | N/A | Comparing Hypofractionated Radiotherapy Boost to Conventionally Fractionated | December 2011 | December 2019 |
| NCT04179968 | Completed | Phase 2 | The Role of 68Gallium PSMA-11 in Enhancing Diagnosis of Primary and Metastatic Prostate Cancer | January 27, 2020 | July 15, 2022 |
| NCT00003367 | Completed | Phase 3 | Diet and PSA Levels in Patients With Prostate Cancer | April 1998 | December 2002 |
| NCT04763824 | Completed | N/A | KanSurvive: Testing a Model for Improving Cancer Survivorship Care in Rural Practice | November 18, 2020 | December 18, 2023 |
| NCT02057939 | Completed | Phase 2 | Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) | April 2014 | June 5, 2019 |
| NCT04158817 | Completed | Early Phase 1 | 68Ga-THP-PSMA PET/CT in Prostate Cancer: Clinical Stage and Restage | November 1, 2019 | March 31, 2023 |
| NCT00676780 | Completed | Phase 2 | Green Tea Extract and Prostate Cancer | May 2004 | December 2008 |
| NCT01220869 | Completed | Phase 3 | A Study of Degarelix in Taiwanese Patients With Prostate Cancer | December 2010 | October 2012 |
| NCT00117949 | Completed | Phase 2 | Study Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486 | April 2002 | January 2004 |
| NCT04170478 | Completed | N/A | Transperineal Laser Ablation for Focal Treatment of Prostate Cancer | August 1, 2020 | October 15, 2021 |
| NCT02613273 | Completed | N/A | CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate Cancer | July 18, 2016 | June 30, 2022 |
| NCT02379260 | Completed | N/A | Development of a Therapeutic Education Program for Patients Operated for Prostate Cancer | May 2015 | November 2015 |
| NCT01530269 | Completed | Phase 2 | C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma | April 2012 | January 2019 |
| NCT02328807 | Completed | N/A | Focal Prostate Radio-Frequency Ablation | December 29, 2014 | July 8, 2021 |
| NCT02106416 | Completed | N/A | Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development | August 2013 | April 2016 |
| NCT00931528 | Completed | Phase 3 | Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy | November 2009 | November 2014 |
| NCT00193193 | Completed | Phase 2 | Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma | August 2000 | February 2007 |
| NCT02793284 | Completed | N/A | Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy | January 9, 2017 | February 15, 2022 |
| NCT01174368 | Completed | Phase 2 | Efficacy Trial of the Implantation of Mouse Renal Adenocarcinoma Macrobeads in Subjects With Castration-Resistant Prostate Cancer Resistant to Taxanes (Docetaxel, Cabazitaxel) and Evidence of Disease Progression on Androgen-axis Inhibition and/or Immunotherapy in the Form of Sipuleucel-T | June 2010 | April 2017 |
| NCT02737332 | Completed | Phase 2 | A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer | March 21, 2016 | February 27, 2017 |
| NCT02353715 | Completed | Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing | July 7, 2015 | November 14, 2018 | |
| NCT03873090 | Completed | N/A | SBRT in 4 Fractions for Prostate Cancer | June 12, 2013 | May 23, 2018 |
| NCT02825875 | Completed | Study of the Clinical Utility of PSMA Imaging in the Evaluation of Men With Prostate Cancer | June 8, 2016 | April 2020 | |
| NCT01351688 | Completed | Phase 1 | An Open Label Prostate Cancer Study in Japanese Patients | August 2011 | May 2013 |
| NCT02380274 | Completed | Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) | March 27, 2015 | January 14, 2021 | |
| NCT00753415 | Completed | Phase 1 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | August 2008 | April 2011 |
| NCT02020876 | Completed | Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations | August 2012 | December 2013 | |
| NCT00584532 | Completed | Phase 2/Phase 3 | Effects of a Genistein Concentrated Polysaccharide (GCP) for Prostate Cancer on Active Surveillance. | November 2003 | December 2007 |
| NCT00083005 | Completed | Phase 2 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate | March 2004 | December 2007 |
| NCT06179706 | Completed | 11C-choline PET/CT Based Helical Tomotherapy as Innovative Treratment Approach for Bone Metastases in Prostate Cancer Patients. | October 27, 2015 | November 25, 2015 | |
| NCT00882232 | Completed | Phase 1 | Cross-linked Hyaluronan Gel Reduces Rectal Toxicity Due to Radiation Therapy for Prostate Cancer | September 2008 | September 2009 |
| NCT03156244 | Completed | Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients | May 8, 2017 | May 5, 2018 | |
| NCT00003290 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Prostate Cancer | January 1998 | August 2004 |
| NCT03199872 | Completed | Phase 1/Phase 2 | RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours | March 30, 2017 | March 29, 2019 |
| NCT01560858 | Completed | Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State | April 2012 | May 2013 | |
| NCT00348595 | Completed | Phase 1/Phase 2 | Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer | July 20, 2006 | June 29, 2016 |
| NCT00030654 | Completed | Phase 3 | Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer | October 2002 | February 4, 2005 |
| NCT03477591 | Completed | N/A | Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions | October 1, 2018 | July 1, 2021 |
| NCT02325557 | Completed | Phase 1/Phase 2 | ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) | June 4, 2015 | January 22, 2020 |
| NCT06094322 | Completed | N/A | Evaluation of Rapid T2-weighted and DWI MR Sequences Reconstructed by Deep Learning for Prostate Imaging | July 28, 2022 | April 9, 2024 |
| NCT01072513 | Completed | N/A | Semen Analysis After Proton Therapy for Prostate Cancer | March 2010 | July 2015 |
| NCT00087347 | Completed | Magnetic Resonance Imaging of Lymph Nodes Using Ferumoxytol in Patients With Primary Prostate or Breast Cancer | September 2004 | ||
| NCT00140478 | Completed | Phase 2 | Mifepristone (RU-486) in Androgen Independent Prostate Cancer | February 2005 | January 2008 |
| NCT01867710 | Completed | Phase 2 | Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy | July 16, 2013 | June 5, 2018 |
| NCT01943500 | Completed | Collection of Blood Specimens for Circulating Tumor Cell Analysis | September 30, 2013 | August 26, 2016 | |
| NCT04545632 | Completed | Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor | June 10, 2020 | June 24, 2021 | |
| NCT03128710 | Completed | Prostate Cancer Survey | March 15, 2017 | February 15, 2018 | |
| NCT00582556 | Completed | Phase 2 | Zometa on Bone Mineral Density in Prostate Cancer Patients Undergoing Androgen Ablation Therapy | April 2003 | March 2013 |
| NCT03214055 | Completed | Effect of Mannitol on Optic Nerve Sheath Diameter in Patients Undergoing Robotic Prostatectomy | July 12, 2017 | August 20, 2017 | |
| NCT01051570 | Completed | Phase 2 | Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel | February 2010 | September 2013 |
| NCT01656161 | Completed | Phase 3 | Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer | July 2012 | August 2013 |
| NCT06214000 | Completed | Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney | December 20, 2021 | June 21, 2022 | |
| NCT02543255 | Completed | Phase 2 | Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) | September 2016 | July 20, 2021 |
| NCT00002633 | Completed | Phase 3 | Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer | February 8, 1995 | January 6, 2012 |
| NCT00822510 | Completed | Phase 1 | Telephone Counseling: Men With Prostate Cancer & Partners | September 2006 | October 2009 |
| NCT00005623 | Completed | Phase 3 | Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer | December 1999 | January 2004 |
| NCT04614363 | Completed | Phase 1/Phase 2 | 68 Ga-PSMA for High Risk Prostate Cancer | October 13, 2020 | April 25, 2023 |
| NCT00303875 | Completed | Phase 2 | Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight | December 2003 | May 2009 |
| NCT00433446 | Completed | Phase 2 | S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | April 2007 | July 2011 |
| NCT02430792 | Completed | N/A | Effectiveness of Community-based Football in Prostate Cancer | May 2015 | February 2018 |
| NCT01875250 | Completed | Phase 2 | Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer | July 22, 2013 | February 28, 2020 |
| NCT01391143 | Completed | Phase 1 | Safety Study of MGA271 in Refractory Cancer | July 2011 | April 18, 2019 |
| NCT01535040 | Completed | Phase 2 | Memantine Hydrochloride in Helping Cancer Survivors Stop Smoking | August 1, 2012 | February 1, 2014 |
| NCT05304169 | Completed | Phase 4 | Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. | November 14, 2017 | June 15, 2020 |
| NCT00200824 | Completed | Phase 2 | Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health | May 2000 | January 2005 |
| NCT00619996 | Completed | Phase 2 | Study of Sorafenib and Docetaxel in Metastatic Prostate Cancer | March 2007 | January 2009 |
| NCT02858128 | Completed | WB-DW-MRI vs CHOLINE-PET/CT for Selecting Treatments in Recurrent Prostate Cancer | October 2014 | March 2015 | |
| NCT01565928 | Completed | Phase 1 | Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer | January 24, 2012 | February 26, 2018 |
| NCT01511536 | Completed | Phase 1/Phase 2 | Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate Cancer | March 2012 | December 2014 |
| NCT03851926 | Completed | Hypofractionated Radiotherapy for Prostate Cancer | October 5, 2016 | October 5, 2021 | |
| NCT00087165 | Completed | Phase 2 | GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer | January 2005 | December 2006 |
| NCT00030901 | Completed | Phase 3 | S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate | February 2000 | November 2011 |
| NCT00105053 | Completed | Phase 1/Phase 2 | Vaccine Treatment for Hormone Refractory Prostate Cancer | March 2005 | September 2007 |
| NCT01325844 | Completed | N/A | The Effects of Epidural Anesthesia on the Bioavailability of Nitric Oxide and Renal Function in Patients Undergoing Laparoscopic Surgery | November 2010 | October 2011 |
| NCT01558583 | Completed | N/A | Online Study of Colorectal Cancer and Prostate Cancer Screening Decision Making | July 2011 | October 2011 |
| NCT01867424 | Completed | Phase 2 | Gadoxetate Enhanced Imaging Study to Detect Prostate Cancer | May 14, 2013 | December 8, 2016 |
| NCT00002848 | Completed | N/A | Group Therapy Compared With Educational Materials in Patients With Prostate Cancer | April 1997 | September 2004 |
| NCT00693238 | Completed | N/A | Proton Therapy for Low and Intermediate Risk Prostate Cancer | April 2008 | April 25, 2022 |
| NCT00416325 | Completed | Phase 1 | Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer | September 2006 | |
| NCT00005048 | Completed | Phase 1 | Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | April 1997 | |
| NCT01543659 | Completed | Phase 1/Phase 2 | Clinical and Molecular Correlates of Positron Emission Tomography (PET) With 89Zr-DFO-huJ591 in Metastatic Prostate Cancer | February 21, 2012 | March 21, 2024 |
| NCT04359758 | Completed | N/A | Streamlined Genetic Testing in Prostate Cancer | March 1, 2020 | November 1, 2021 |
| NCT00643617 | Completed | N/A | CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry | October 22, 2007 | April 7, 2022 |
| NCT05800483 | Completed | N/A | Improving Decision-Making for Low Health Literate Prostate CA Patients | March 1, 2020 | December 31, 2022 |
| NCT03169933 | Completed | N/A | Combined, Intensified and Modulated Adjuvant Therapy in Prostate Carcinoma | January 2, 2004 | January 2, 2017 |
| NCT00003903 | Completed | N/A | Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer | July 1999 | August 2007 |
| NCT01302041 | Completed | Phase 2 | A Study to Test if Enzalutamide is Effective and Safe in Prostate Cancer Patients Who Have Never Had Hormone Therapy | May 6, 2011 | April 27, 2017 |
| NCT01028885 | Completed | Phase 1 | MRI-Guided Radiation Therapy in Treating Patients Who Have Undergone Surgery to Remove the Prostate | June 2009 | June 2018 |
| NCT01344564 | Completed | N/A | Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide | April 2011 | August 2012 |
| NCT01674270 | Completed | Phase 2 | Degarelix Neo-Adjuvant Radical Prostatectomy Trial | August 2012 | November 2015 |
| NCT06168864 | Completed | Development of Artificial Intelligence Models for Segmentation and Characterization of Prostate Cancer: a Single-center Retrospective Observational Study. | January 6, 2020 | June 1, 2022 | |
| NCT00004879 | Completed | Phase 1 | Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer | April 2000 | |
| NCT00052845 | Completed | Phase 2 | Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | November 2002 | April 2009 |
| NCT06372704 | Completed | Is the HIFEM Procedure an Effective Treatment for Men With Post-prostatectomy Incontinence? | February 1, 2024 | April 5, 2024 | |
| NCT02796898 | Completed | Phase 1/Phase 2 | Study of the Efficacy, Safety, and Pharmacokinetics of SM88 in Patients With Prostate Cancer | June 2016 | May 30, 2019 |
| NCT01020604 | Completed | PROstaTE Cancer Treatment and Obesity in Zoladex-Astrazeneca Treated Patients | November 2009 | March 2013 | |
| NCT00673127 | Completed | Phase 2 | Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer | February 2005 | December 2012 |
| NCT05127850 | Completed | N/A | MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer | March 22, 2022 | April 30, 2024 |
| NCT02349022 | Completed | Phase 2 | Comparison of PET With [89Zr]-Df-IAb2M and [111In]-Capromab Pendetide in the Detection of Prostate Cancer Pre-Prostatectomy | January 2015 | July 2016 |
| NCT03693742 | Completed | N/A | MSG Use With 18F-DCFPyL PET/CT Imaging | November 4, 2019 | May 8, 2020 |
| NCT00003740 | Completed | Phase 2 | Trastuzumab in Treating Patients With Prostate Cancer | October 1998 | September 2002 |
| NCT00651222 | Completed | Influence of Hormone Therapy on Heart Attack Incidence in Men Undergoing Prostate Brachytherapy | |||
| NCT02584179 | Completed | N/A | Biparametric MRI for Detection of Significant Prostate Cancer | December 2015 | December 1, 2018 |
| NCT03002220 | Completed | Phase 2 | Trial of Rad-223 Activity in Asymptomatic Patients With mCRPC While on Abiraterone or Enzalutamide Besides AR-V7 Status | November 2016 | |
| NCT00805701 | Completed | Phase 4 | Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation | January 2009 | April 2014 |
| NCT00958477 | Completed | Phase 1 | A Study to Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer | October 2008 | March 2011 |
| NCT02485379 | Completed | N/A | Assessment of Prostate MRI Before Prostate Biopsies | July 2015 | November 2016 |
| NCT00278993 | Completed | Phase 2 | Evaluating E7389 in Patients With Hormone Refractory Prostate Cancer With Advanced and/or Metastatic Disease Stratified by Prior Chemotherapy | January 2006 | January 2008 |
| NCT00042731 | Completed | N/A | Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy | July 2002 | August 2006 |
| NCT00587431 | Completed | Phase 2 | Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer | July 2003 | February 2008 |
| NCT01664923 | Completed | Phase 2 | Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer | August 2012 | January 2018 |
| NCT00114985 | Completed | Phase 2 | Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding | April 2001 | October 2008 |
| NCT01288534 | Completed | Phase 2 | Hypofractionated Stereotactic Body Radiation Therapy (SBRT) | January 2011 | January 2016 |
| NCT03803475 | Completed | Phase 3 | Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients | October 11, 2018 | August 25, 2020 |
| NCT00181597 | Completed | Phase 2 | Trilostane for Androgen-Independent Prostate Cancer | March 2004 | January 2006 |
| NCT05324098 | Completed | N/A | Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation Therapy | March 8, 2022 | July 31, 2023 |
| NCT00140348 | Completed | Phase 1/Phase 2 | Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine | December 2001 | April 2005 |
| NCT00171639 | Completed | Phase 3 | The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis | June 2004 | March 2007 |
| NCT00274287 | Completed | Phase 2 | GM-CSF for Maintenance of Prostate Cancer for Patients Responding to Taxotere | January 2006 | December 2010 |
| NCT02726113 | Completed | Phase 2 | Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing Prostatectomy | October 2011 | December 2015 |
| NCT05447637 | Completed | PROCLAIM: Germline Genetic Testing for Prostate Cancer Patients | November 1, 2019 | May 31, 2022 | |
| NCT00054015 | Completed | Phase 2 | 3-AP in Treating Patients With Advanced Prostate Cancer | December 2002 | January 2008 |
| NCT00923104 | Completed | An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin | April 23, 2009 | ||
| NCT02113657 | Completed | Early Phase 1 | T-Cell Responses to Neoantigens Post Treatment With Ipilimumab in Men With Metastatic Castration-Resistant Prostate Cancer | August 20, 2014 | November 4, 2019 |
| NCT05613881 | Completed | N/A | Symptom Management, Education and Telephone Follow-up, Quality of Life, | May 15, 2022 | December 1, 2022 |
| NCT03162523 | Completed | Experiences With HDR-brachytherapy in Norway | January 2004 | October 15, 2016 | |
| NCT00134654 | Completed | Phase 2 | Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer | March 2003 | June 2011 |
| NCT00003103 | Completed | Phase 1/Phase 2 | Chemotherapy in Treating Patients With Solid Tumors | August 1997 | August 2002 |
| NCT01401972 | Completed | Conventional Ultrasound for Imaging of Prostate Cancer Extent and Response in Human Cancer Patients | September 2008 | September 2018 | |
| NCT00217516 | Completed | Phase 1 | Selenium in Treating Patients Who Are Undergoing Brachytherapy for Stage I or Stage II Prostate Cancer | March 2005 | October 2008 |
| NCT02635256 | Completed | N/A | Hypofractionated Radiosurgery for Localised Prostate Cancer | December 2015 | December 31, 2019 |
| NCT01667536 | Completed | Phase 2 | A Phase 2 Study With MIP-1404 in Men With High-Risk PC Scheduled for RP and EPLND Compared to Histopathology | August 2012 | December 2013 |
| NCT01415089 | Completed | N/A | Tailored Web-Based Intervention for Cancer Patients and Family Caregivers | May 2009 | June 2011 |
| NCT03749993 | Completed | N/A | Evaluation of a MRI-based Prostate Cancer Screening Program | January 10, 2019 | May 1, 2023 |
| NCT01858688 | Completed | N/A | A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer | September 2013 | April 2023 |
| NCT03001869 | Completed | Phase 3 | 68Ga-PSMA PET/CT in Prostate Cancer | July 1, 2017 | July 1, 2023 |
| NCT00897793 | Completed | Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer | January 2006 | July 2010 | |
| NCT00528866 | Completed | Phase 2 | Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy | April 2008 | May 14, 2018 |
| NCT00052000 | Completed | Phase 1 | A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer | November 2002 | |
| NCT01146340 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer | May 2010 | April 2016 |
| NCT01366053 | Completed | Hormone Sensitive Prostate Cancer Patients Switched to Degarelix Therapy After Failing on GnRH Agonists | March 2011 | July 2015 | |
| NCT00838201 | Completed | Phase 3 | Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer | February 1, 2009 | May 3, 2012 |
| NCT00448695 | Completed | Phase 1 | MRI Targeted Focal Laser Thermal Therapy of Biopsy Confirmed Prostate Cancer | March 2007 | October 2008 |
| NCT00003084 | Completed | Phase 2 | Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | December 1997 | November 2002 |
| NCT03284684 | Completed | Kinetics of Perioperative Circulating DNA in Cancer Surgery | January 22, 2018 | November 11, 2018 | |
| NCT02344017 | Completed | Phase 1/Phase 2 | Safety and Pharmacokinetics of ODM-204 in Patients With Metastatic Castration-Resistant Prostate Cancer | February 2015 | January 2019 |
| NCT00065442 | Completed | Phase 3 | Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | July 2003 | January 2009 |
| NCT03859804 | Completed | N/A | Comparison of Pain Levels in Fusion Prostate Biopsy and Standard TRUS-Guided Biopsy | December 1, 2016 | February 1, 2019 |
| NCT04260737 | Completed | N/A | Interactive Decision Aid for Men Diagnosed With Prostate Cancer | February 26, 2020 | July 31, 2023 |
| NCT01284920 | Completed | Phase 1/Phase 2 | A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patients | November 2, 2010 | July 2, 2014 |
| NCT02064608 | Completed | Phase 1 | Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer | October 2014 | June 2018 |
| NCT02083185 | Completed | Phase 2 | A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer | March 26, 2014 | February 23, 2017 |
| NCT02465892 | Completed | N/A | Pillars4Life Trial | May 2015 | October 2016 |
| NCT02085096 | Completed | N/A | Problem Solving Therapy for Prostate Cancer Spousal Caregivers | July 1997 | September 2005 |
| NCT02397408 | Completed | Phase 2 | 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer | April 9, 2015 | June 30, 2015 |
| NCT00323882 | Completed | Phase 1/Phase 2 | Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer | January 2006 | July 2013 |
| NCT00182741 | Completed | Phase 2 | Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer | September 2004 | August 2006 |
| NCT00219271 | Completed | Phase 4 | Effect Of Zoledronic Acid On Circulating And Bone Marrow-Residing Prostate Cancer Cells In Patients With Clinically Localized Prostate Cancer | September 2003 | September 2009 |
| NCT00126165 | Completed | Phase 1/Phase 2 | Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer | September 2004 | August 2011 |
| NCT00136526 | Completed | Phase 2 | Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer | December 2002 | October 2007 |
| NCT02131649 | Completed | N/A | PET/MRI for Men Being Considered for Radiotherapy for Suspected Prostate Cancer Recurrence Post-Prostatectomy | February 2015 | January 2021 |
| NCT01960881 | Completed | Evaluation of Diet and Exercise in Prostate Cancer Patients | September 19, 2013 | August 10, 2021 | |
| NCT01377753 | Completed | Phase 2 | MR Image Guided Therapy in Prostate Cancer | August 12, 2011 | July 31, 2018 |
| NCT00390468 | Completed | Phase 2 | Tandutinib in Treating Patients With Progressive Prostate Cancer and Bone Metastases | October 2006 | November 2009 |
| NCT00082732 | Completed | Phase 1 | Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer | July 28, 2000 | February 27, 2006 |
| NCT02463799 | Completed | Phase 2 | Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC | February 22, 2016 | December 12, 2019 |
| NCT02055716 | Completed | Phase 1 | Sulforadex in Healthy Human Males MAD | January 2014 | May 2014 |
| NCT00258284 | Completed | Phase 2 | Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer | August 2003 | November 2007 |
| NCT00819156 | Completed | Phase 2 | Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer | February 2004 | September 2005 |
| NCT00342784 | Completed | Identification of Prostate Cancer Genes | November 8, 2004 | July 30, 2018 | |
| NCT04602208 | Completed | FOCAL HIGH-INTENSITY FOCUSED ULTRASOUND FOR PRIMARY LOCALIZED PROSTATE CANCER: MIDTERM ONCOLOGICAL OUTCOMES | March 1, 2020 | October 1, 2020 | |
| NCT00453661 | Completed | Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities | March 2007 | September 28, 2020 | |
| NCT00978991 | Completed | Duke Urology Database and Specimen Bank | January 1988 | November 2012 | |
| NCT02105675 | Completed | Phase 2 | Phase II Study of DCVAC/PCa Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer | February 2012 | February 20, 2017 |
| NCT02033447 | Completed | Early Phase 1 | Magnetic Nanoparticle Thermoablation-Retention and Maintenance in the Prostate:A Phase 0 Study in Men | December 2013 | January 2015 |
| NCT04681144 | Completed | A Study to Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its Safety | April 8, 2021 | November 21, 2022 | |
| NCT01412853 | Completed | N/A | Spectro-IRM and Evaluation Response to Prostatic Radiotherapy | February 2008 | December 2016 |
| NCT00031889 | Completed | Phase 2 | Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer | August 2001 | June 2002 |
| NCT02097303 | Completed | Phase 2 | Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis | March 2014 | December 2015 |
| NCT00967018 | Completed | Phase 3 | A Long Term Safety Study of Degarelix in Patients With Prostate Cancer | August 2009 | December 2011 |
| NCT02034955 | Completed | N/A | Prostatectomy Adaptive Radiation Therapy (ART) | July 2013 | May 16, 2023 |
| NCT00006101 | Completed | Phase 2 | Eflornithine in Treating Patients At High Risk of Developing Prostate Cancer | October 1998 | December 2012 |
| NCT02186444 | Completed | Navigator Guided e-Psychoeducational Intervention | June 2, 2014 | August 17, 2017 | |
| NCT00214422 | Completed | Early Phase 1 | Intensity Modulated Radiation Therapy for Prostate Cancer | September 19, 2005 | April 18, 2018 |
| NCT03674996 | Completed | N/A | Safety and Security Evaluation of Patients Submitted to Minimally Invasive Radical Prostatectomy | March 22, 2017 | December 23, 2019 |
| NCT00841113 | Completed | Phase 3 | Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer | January 1999 | February 2003 |
| NCT00877682 | Completed | N/A | Prostate Conformal Cryotherapy | April 6, 2009 | January 14, 2018 |
| NCT03615131 | Completed | Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate Cancer | September 1, 2015 | March 30, 2017 | |
| NCT02512185 | Completed | Towards Optimal Prescription of Chemotherapy in Prostate Cancer | July 2015 | December 31, 2019 | |
| NCT00108264 | Completed | Phase 1 | Tumor RNA Transfected Dendritic Cell Vaccines | September 2005 | |
| NCT01574846 | Completed | Prospective Multicentre Non-interventional Study of VANTAS® for the Treatment of Patients With Advanced Prostate Cancer | January 2011 | April 2014 | |
| NCT00138138 | Completed | Phase 2 | Psychostimulants for Fatigue in Prostate Cancer | October 2002 | August 2006 |
| NCT00028574 | Completed | Phase 3 | Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer | December 2001 | April 2007 |
| NCT01685268 | Completed | Phase 1/Phase 2 | A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone Acetate | September 2012 | December 2014 |
| NCT00017563 | Completed | Phase 2 | Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer | September 2000 | |
| NCT02552394 | Completed | Phase 1 | J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts | July 2015 | January 3, 2021 |
| NCT03511235 | Completed | Clinical Outcomes in Men With Prostate Cancer Who Selected Active Surveillance Using Prolaris® Testing | March 12, 2018 | July 31, 2018 | |
| NCT01694784 | Completed | N/A | Understanding and Discouraging Overuse of Potentially Harmful Screening Tests | September 2012 | June 2014 |
| NCT02479945 | Completed | N/A | Peripheral vs. Selective Tumor Marker Venous Sampling in Prostate Cancer | January 2012 | April 25, 2013 |
| NCT03664193 | Completed | N/A | MRI-guided Stereotactic Body Radiotherapy (SBRT) With Simultaneous Integrated Boost for Prostate Cancer | August 24, 2018 | January 28, 2020 |
| NCT05772598 | Completed | Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires | March 15, 2023 | August 2, 2023 | |
| NCT01704274 | Completed | Phase 2 | GTN Therapy on Biomarkers of Immune Escape in Men With Biochemical Recurrence of Prostate Cancer After Primary Therapy | April 2012 | December 2019 |
| NCT00234299 | Completed | N/A | Effects of ASA on Prostate Tissue | December 2005 | December 2015 |
| NCT00808418 | Completed | Phase 1 | A Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium Given With a Fixed Dose of Docetaxel and Prednisone in Patients With Metastatic Prostate Cancer | November 2008 | May 2010 |
| NCT01303705 | Completed | Phase 1 | Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer | October 14, 2010 | July 5, 2016 |
| NCT04672460 | Completed | Phase 1 | A Bioequivalence Study Between the Proposed and Current Talazoparib Capsule Formulation and Food Effect Study for the Proposed Talazoparib Capsule Formulation in Participants With Advanced Solid Tumors | December 21, 2020 | July 22, 2022 |
| NCT00003307 | Completed | Phase 2 | Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate Cancer | March 1998 | June 2001 |
| NCT05820113 | Completed | N/A | Deep Learning Super Resolution Reconstruction for Fast and Motion Robust T2-weighted Prostate MRI | August 1, 2022 | November 30, 2022 |
| NCT00252941 | Completed | Phase 1/Phase 2 | Prophylactic Urethral Stenting With Memokath After Prostate Implantation for Prostate Adenocarcinoma | November 2005 | November 2006 |
| NCT00091390 | Completed | Phase 2 | Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer | July 2004 | December 2016 |
| NCT01296139 | Completed | Phase 1 | Ferumoxytol Enhanced MRI for the Detection of Lymph Node Involvement in Prostate Cancer | January 26, 2011 | March 19, 2015 |
| NCT00499421 | Completed | Evaluation of Intraprostatic Fiducial Markers For External Beam Radiation Therapy | September 14, 2005 | January 26, 2023 | |
| NCT00071968 | Completed | Phase 2 | Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse | August 2003 | |
| NCT00653757 | Completed | Phase 1/Phase 2 | Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer | March 2002 | December 2007 |
| NCT02257827 | Completed | Phase 3 | Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule | January 2009 | January 2013 |
| NCT00773773 | Completed | N/A | Combination of Serum Measurements of Molecular Biomarkers and Serum Protein Profiling Can be Used to Predict Which Patients Undergoing Prostatic Biopsy Will be Diagnosed With Cancer | October 14, 2008 | March 8, 2024 |
| NCT01428869 | Completed | Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer | August 2011 | August 2011 | |
| NCT00436956 | Completed | Phase 2 | AZD2171 to Treat Prostate Cancer | October 16, 2006 | February 5, 2014 |
| NCT01710098 | Completed | Treatment of Prostate Cancer With Firmagon® | June 2012 | September 24, 2015 | |
| NCT05886751 | Completed | N/A | Randomized Trial of Trust in Online Videos About Prostate Cancer | August 18, 2021 | January 7, 2022 |
| NCT04400656 | Completed | PROState Pathway Embedded Comparative Trial | September 8, 2020 | August 31, 2022 | |
| NCT02425228 | Completed | Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer | December 4, 2014 | December 18, 2018 | |
| NCT01607879 | Completed | Phase 2 | Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation | March 2014 | February 16, 2021 |
| NCT00030602 | Completed | Phase 2 | Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer | January 2000 | December 2001 |
| NCT00605488 | Completed | N/A | The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer | April 25, 2006 | April 6, 2017 |
| NCT00545766 | Completed | Phase 2 | Vinflunine in Hormone Refractory Prostate Cancer (HRPC) | May 2007 | January 2009 |
| NCT00003323 | Completed | Phase 2 | Hormone Therapy in Treating Patients With Prostate Cancer | May 1998 | March 2010 |
| NCT00403000 | Completed | Phase 2 | Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | December 2004 | April 2013 |
| NCT00946309 | Completed | Phase 1/Phase 2 | Effects of Sulforaphane on Normal Prostate Tissue | July 2010 | May 2015 |
| NCT01083368 | Completed | Phase 1/Phase 2 | Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy | January 2009 | October 2014 |
| NCT00003124 | Completed | Phase 2 | Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer | May 1997 | January 2007 |
| NCT02957357 | Completed | Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors | February 2016 | January 31, 2019 | |
| NCT00007644 | Completed | Phase 3 | Prostate Cancer Intervention Versus Observation Trial (PIVOT) | November 1994 | January 2010 |
| NCT00895310 | Completed | Phase 2 | Use of Low Dose Ketoconazole in Prostate Cancer That Does Not Respond to Hormone Therapy and Prior Chemotherapy | May 2009 | May 2015 |
| NCT00707356 | Completed | Phase 2 | Study of WST11 in Patients With Localized Prostate Cancer | September 2008 | July 2012 |
| NCT04687709 | Completed | To Investigate the Role of Gut Microbiome in ADT Related Metabolic Changes in Prostate Cancer Patients | January 14, 2021 | September 26, 2023 | |
| NCT05184725 | Completed | N/A | CARINAE for Stress Relief in Perioperative Care | January 10, 2022 | May 31, 2022 |
| NCT01286987 | Completed | Phase 1 | Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors | January 3, 2011 | January 30, 2017 |
| NCT00925418 | Completed | Phase 3 | Evaluation of the Cryotherapy in the Prevention of Nails Toxicity Induced by Taxotere® in Breast or Prostate Cancer | September 2006 | July 2011 |
| NCT02882178 | Completed | Consensus Method to Evaluate the Conformity of Prescription of a Chemotherapy | November 2013 | April 2015 | |
| NCT02080052 | Completed | N/A | Robot-Assisted MRI-Guided Prostate Biopsy | July 25, 2013 | January 2016 |
| NCT00072670 | Completed | Phase 2 | A Phase 2 Study of Trabectedin (Yondelis) in Adult Male Participants With Advanced Prostate Cancer | January 2004 | November 2008 |
| NCT01005225 | Completed | Genetic Investigation of Solid Tumors Cohort | February 2008 | May 2014 | |
| NCT01065441 | Completed | Phase 1/Phase 2 | Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer | December 2010 | July 2013 |
| NCT04596917 | Completed | N/A | Music Listening as a Postanesthesia Care Unit (PACU) Nursing Intervention | October 6, 2020 | December 30, 2020 |
| NCT00992615 | Completed | N/A | Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer | ||
| NCT03816904 | Completed | Involvement of SK3 Calcium Channel in Taxane Neuropathy | February 6, 2019 | June 12, 2020 | |
| NCT02135653 | Completed | A Feasibility Study Followed By A Randomized Phase II Study Of Yoga For Radiation Therapy Side Effects In Prostate Cancer | March 2013 | December 2019 | |
| NCT00116220 | Completed | Phase 3 | Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer | September 1995 | February 2015 |
| NCT01729676 | Completed | Impact of the Geographical FACTor on the Prostate Cancer Stage at Hormonal Therapy Initiation | May 2013 | May 2014 | |
| NCT00132301 | Completed | Phase 3 | Chemotherapy After Prostatectomy (CAP) For High Risk Prostate Carcinoma | June 2006 | September 2016 |
| NCT00036790 | Completed | Phase 1 | Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer | February 2002 | |
| NCT01813097 | Completed | Combination Iodine 125 Seed Implants and LHRH Agonists for Locally Advanced (Stage T3) Prostate Cancer | February 2008 | ||
| NCT00496249 | Completed | The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer | July 2007 | January 2008 | |
| NCT00897351 | Completed | Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803 | July 10, 2008 | February 10, 2009 | |
| NCT00905086 | Completed | Psychosocial Adjustment After Radiation Therapy in Patients With Cancer | August 2008 | May 2009 | |
| NCT00181558 | Completed | Phase 2 | Atrasentan and Zometa for Men With Prostate Cancer Metastatic to Bone | December 2001 | December 2006 |
| NCT01331083 | Completed | Phase 2 | A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer | September 9, 2011 | November 27, 2015 |
| NCT00087854 | Completed | Phase 1/Phase 2 | Study of Individualized Amonafide to Treat Prostate Cancer | March 2004 | December 2005 |
| NCT03103152 | Completed | Phase 2/Phase 3 | A Study to Examine the Effectiveness of Aspirin and/or Vitamin D3 to Prevent Prostate Cancer Progression | December 2016 | March 31, 2020 |
| NCT05605171 | Completed | N/A | Posterior Urethrovesical Anastomotic Reconstruction in Comparison to Conventional Urethrovesical Anastomosis | March 19, 2014 | March 23, 2019 |
| NCT01513733 | Completed | Phase 1 | The CATCH Prostate Cancer Trial: Cabazitaxel And Tasquinimod in Men With Prostate Cancer | January 2012 | June 2016 |
| NCT00663832 | Completed | Phase 1 | A Dose Finding Study With I.V. Panobinostat (LBH589), Docetaxel, and Prednisone in Patients With Hormone Refractory Prostate Cancer | February 2008 | |
| NCT04144127 | Completed | N/A | Soccer Intervention in Prostate Cancer Survivors | October 25, 2019 | July 15, 2022 |
| NCT00136487 | Completed | Phase 2/Phase 3 | Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer | October 2002 | September 2006 |
| NCT02232685 | Completed | N/A | Whole Body Bone Scan vs 18F-Choline PET/CT in Prostate Cancer | September 2014 | July 2016 |
| NCT01084759 | Completed | N/A | A Pilot Study of Parenteral Testosterone and Oral Etoposide as Therapy for Men With Castration Resistant Prostate Cancer | March 2010 | October 2014 |
| NCT04247217 | Completed | Immune Profiling After HDR in Local Relapsed Prostate Cancer | February 19, 2020 | December 23, 2021 | |
| NCT00672594 | Completed | Phase 2 | Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy | July 2006 | September 2013 |
| NCT00028769 | Completed | Phase 2 | S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer | December 2001 | July 2011 |
| NCT00946920 | Completed | Phase 3 | A Trial of Degarelix in Patients With Prostate Cancer | June 2009 | March 2011 |
| NCT00003256 | Completed | Phase 2 | Flavopiridol in Treating Patients With Recurrent Prostate Cancer | May 1998 | April 2004 |
| NCT02882958 | Completed | Validation of Software-based Fusion of Ultrasound and MRI Images of the Prostate | March 2016 | December 2018 | |
| NCT00078585 | Completed | Phase 2 | PROSTVAC®-VF/TRICOM™ Vaccine for the Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | November 2003 | January 2009 |
| NCT03500419 | Completed | N/A | Penile Length Maintenance Post-Prostatectomy | March 23, 2018 | December 28, 2020 |
| NCT00583492 | Completed | Phase 2 | Randomized Trial of Suicide Gene Therapy and Prostate Cancer | December 2007 | September 2013 |
| NCT01090765 | Completed | Phase 1/Phase 2 | A Phase I/II Study of TRC105 in Metastatic Castrate Resistant Prostate Cancer (CRPC) | February 23, 2010 | April 17, 2015 |
| NCT05880446 | Completed | N/A | PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ) | October 6, 2023 | March 29, 2024 |
| NCT00055731 | Completed | Phase 3 | Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse | November 14, 2002 | December 31, 2022 |
| NCT00866554 | Completed | Phase 2 | Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy | March 2009 | December 2019 |
| NCT02293707 | Completed | Phase 2 | A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer | November 2014 | November 2019 |
| NCT01812902 | Completed | N/A | Prospective Study Comparing Extended With Limited Pelvic Lymphadenectomy in Intermediate and High Risk Prostate Cancer Patients Undergoing Radical Prostatectomy | February 2012 | April 2018 |
| NCT00976755 | Completed | Phase 2 | Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer | September 14, 2009 | August 8, 2019 |
| NCT01804231 | Completed | N/A | Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer | July 9, 2013 | October 12, 2016 |
| NCT00959959 | Completed | Phase 1 | ARMOR1: Study of TOK-001 to Treat Castration Resistant Prostate Cancer | October 2009 | August 2012 |
| NCT00169676 | Completed | Registry and Database Lap Prostatectomy | June 2003 | April 2016 | |
| NCT05516329 | Completed | Phase 1/Phase 2 | Study of 18F-Thretide PET/CT in Patients With Prostate Cancer | August 20, 2022 | September 1, 2023 |
| NCT02297386 | Completed | Phase 1 | [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer | November 2014 | August 2018 |
| NCT03030885 | Completed | Phase 1 | Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | January 19, 2017 | April 2, 2019 |
| NCT00801242 | Completed | Phase 3 | Intermittent Treatment With Degarelix of Patients Suffering From Prostate Cancer | December 2008 | July 2013 |
| NCT00574769 | Completed | Phase 1/Phase 2 | Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer | February 17, 2010 | February 17, 2017 |
| NCT00726596 | Completed | Phase 2 | Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer | August 2008 | January 2018 |
| NCT00084552 | Completed | N/A | Intensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate Cancer | December 11, 2003 | May 5, 2016 |
| NCT00705835 | Completed | Phase 1 | Vaccine Therapy of Prostate Cancer Patients With Recombinant Soluble Prostate-Specific Membrane Antigen (Rs-PSMA) Plus the Immunological Adjuvant Alhydrogel | January 2003 | January 2008 |
| NCT01194271 | Completed | Phase 2 | Neoadjuvant Ipilimumab in Prostate Cancer | September 2010 | October 2015 |
| NCT02061345 | Completed | PET Imaging in MCI Following ADT for PCa | April 2014 | January 2022 | |
| NCT02514213 | Completed | Phase 1 | Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer | July 2015 | December 12, 2017 |
| NCT02381015 | Completed | N/A | Clinical Validity and Utility of Genomic-targeted Chemoprevention of PCa: Aim 4a | June 2011 | June 2012 |
| NCT00082927 | Completed | Phase 3 | Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain | April 2003 | July 2011 |
| NCT04827459 | Completed | N/A | Sleep Coach: A Mobile App to Address Insomnia Symptoms Among Cancer Survivors | May 12, 2021 | August 8, 2022 |
| NCT02241122 | Completed | N/A | MRI and Biomarkers in Prostate Cancer | April 2015 | April 1, 2018 |
| NCT01083199 | Completed | Phase 4 | Global Performance Evaluation of the AMS CONTINUUM™ Device | October 2007 | November 2010 |
| NCT00208988 | Completed | N/A | A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening | May 2003 | August 2003 |
| NCT02793882 | Completed | Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer | September 2013 | April 24, 2017 | |
| NCT00559429 | Completed | Phase 1 | Study of Docetaxel +153 Sm-EDTMP in Patients With Hormone-Refractory Prostate Cancer | December 2004 | October 2008 |
| NCT00251225 | Completed | Phase 2 | A Study of Imatinib and Docetaxel in Prostate Cancer | August 2005 | March 2014 |
| NCT03762616 | Completed | N/A | Urology San Antonio MRI/MicroUS Comparison | November 28, 2018 | November 4, 2019 |
| NCT00286793 | Completed | Phase 1/Phase 2 | Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC | February 2006 | November 2009 |
| NCT00010231 | Completed | Phase 1 | Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | June 1999 | November 2002 |
| NCT02946008 | Completed | Phase 1 | Neoadjuvant Stereotactic Body Radiotherapy Prior to Radical Prostatectomy for High Risk Prostate Cancer | March 27, 2017 | July 12, 2019 |
| NCT00069745 | Completed | Phase 3 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | September 2003 | March 2007 |
| NCT04064047 | Completed | N/A | Anorectal Application of 5% Lidocaine Cream Reduces Pain Prior to Periprostatic Nerve Block During Transrectal Ultrasound Guided Biopsy | December 2016 | July 2017 |
| NCT02141490 | Completed | Phase 2 | Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers | May 15, 2014 | November 20, 2018 |
| NCT00604526 | Completed | Phase 1 | High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy | September 2006 | December 2014 |
| NCT02871752 | Completed | N/A | Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education | August 10, 2016 | January 30, 2023 |
| NCT01620710 | Completed | Phase 2 | Safety Study of a Shorter (Hypofractionated) Radiotherapy for the Prostate Bed With or Without the Pelvic Lymph Nodes | February 2012 | September 30, 2017 |
| NCT05518799 | Completed | N/A | CYP3A4 Activity in Patients With Prostate Cancer Versus Male Patients With Other Solid Tumours | April 22, 2021 | December 2, 2022 |
| NCT05318131 | Completed | N/A | Sleep, Exercise, Nutrition and Survivorship in Prostate Cancer | August 30, 2022 | October 12, 2023 |
| NCT02414971 | Completed | Relationship of Mitochondrial Enzymes With Cancer Related Fatigue | April 2015 | January 14, 2019 | |
| NCT00899184 | Completed | DNA Changes in Patients With Prostate Cancer | May 23, 2006 | May 30, 2007 | |
| NCT02137746 | Completed | Phase 2 | Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer | December 2013 | March 20, 2017 |
| NCT00561314 | Completed | Phase 2 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Localized Prostate Cancer | July 2007 | January 2012 |
| NCT04266392 | Completed | Early Phase 1 | Molecular Imaging of Prostate Cancer Using Radiofluorinated PSMA Ligand | December 16, 2019 | October 15, 2021 |
| NCT00560482 | Completed | Phase 2 | Efficacy Study of ABR-215050 to Treat Prostate Cancer | December 2007 | August 2015 |
| NCT01547416 | Completed | Phase 4 | The Effect of Combined General/Epidural Anesthesia Versus General Anesthesia on Diaphragmatic Function | November 2011 | May 2012 |
| NCT03604211 | Completed | SBRT for Oligometastatic Lymph Node Recurrence in Prostate Cancer: a Single Institution Experience | January 2010 | July 2018 | |
| NCT03609528 | Completed | N/A | CamPROBE: Developing a Safer and Simple Device for Local Anaesthetic Transperineal Prostate Biopsies | February 15, 2019 | October 2, 2019 |
| NCT01827813 | Completed | N/A | Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies | June 2007 | February 2013 |
| NCT01574937 | Completed | Phase 1 | XL-184+Abiraterone in Post-Chemo CRPC | April 3, 2012 | July 1, 2021 |
| NCT01177436 | Completed | N/A | Prostate Cancer Antigen 3 (PCA-3) Gene Project | September 2009 | December 2011 |
| NCT01174953 | Completed | N/A | High Risk Prostate Cancer Prevention Study | July 2010 | March 2013 |
| NCT04889651 | Completed | Phase 1 | A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers | April 15, 2021 | June 22, 2021 |
| NCT00005847 | Completed | Phase 2 | Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | April 5, 2001 | |
| NCT04621500 | Completed | Phase 2 | Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among Veterans | June 4, 2019 | February 4, 2022 |
| NCT03429244 | Completed | Phase 2 | PSMA-PET for Biopsy and Treatment Guidance in Primary Prostate Cancer | April 15, 2019 | May 1, 2022 |
| NCT04021394 | Completed | Influence of EMT on CTCs and Disease Progression in Prostate Cancer | June 5, 2019 | December 1, 2022 | |
| NCT00422708 | Completed | Phase 4 | Local Anesthesia for Prostate Biopsy | June 2006 | June 2008 |
| NCT00140387 | Completed | Phase 1/Phase 2 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®) | May 1999 | March 2001 |
| NCT00016913 | Completed | Phase 2 | Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | May 2001 | May 2008 |
| NCT02212197 | Completed | Phase 2 | Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer | September 2014 | March 2016 |
| NCT00052481 | Completed | Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer | September 2002 | April 2004 | |
| NCT00002597 | Completed | Phase 3 | Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | October 1994 | May 14, 2018 |
| NCT00129142 | Completed | Phase 3 | Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy | October 2003 | November 2007 |
| NCT02653248 | Completed | Phase 1 | SBRT for Organ Confined Prostate Cancer | August 2010 | December 2021 |
| NCT01243385 | Completed | Phase 2 | Metformin Hydrochloride as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Prostate Cancer | December 23, 2010 | August 9, 2019 |
| NCT00002760 | Completed | Phase 3 | Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer | August 1996 | April 2009 |
| NCT01649635 | Completed | Phase 4 | Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer | July 2012 | June 2016 |
| NCT00888654 | Completed | Phase 2 | Diindolylmethane in Treating Patients With Stage I or Stage II Prostate Cancer Undergoing Radical Prostatectomy | August 2009 | April 2014 |
| NCT01310192 | Completed | Phase 1 | Cancer Localization in the Prostate With F-18 Fluorocholine Positron Emission Tomography | June 2004 | July 2008 |
| NCT00104741 | Completed | Phase 3 | Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer | September 10, 2003 | October 15, 2015 |
| NCT02125175 | Completed | N/A | BIOPROP20: Biologically Optimised IMRT for Prostate Radiotherapy Hypofractionated Radiotherapy With Intra-prostatic Boosts to Tumour Nodules in Men With Intermediate and High Risk Prostate Cancer | January 2014 | September 2019 |
| NCT02014337 | Completed | Phase 1 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | January 2014 | December 2017 |
| NCT00263107 | Completed | Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfaction. | August 2004 | June 2005 | |
| NCT03333785 | Completed | N/A | Randomized Trial of eOncoNote | February 5, 2018 | February 17, 2021 |
| NCT00792961 | Completed | N/A | Real Time Microscopic Imaging During Robot Assisted Prostate Cancer Surgery | November 2008 | December 2009 |
| NCT01762241 | Completed | N/A | Xbox Kinect Training in Men With Prostate Cancer | February 2015 | June 2018 |
| NCT00582842 | Completed | Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer | May 14, 2002 | December 21, 2022 | |
| NCT00498797 | Completed | Phase 2 | E3-Hormone Refractory Prostrate Cancer Taxotere Combination | December 2005 | September 2008 |
| NCT00509444 | Completed | Phase 3 | Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial | October 2006 | December 2010 |
| NCT00134056 | Completed | Phase 3 | S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy | August 2006 | February 2016 |
| NCT01250483 | Completed | Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) | January 2001 | December 2009 | |
| NCT02104362 | Completed | N/A | Single Fraction Early Prostate Irradiation (SiFEPI) | February 2014 | June 14, 2021 |
| NCT02485964 | Completed | N/A | A Pilot Study to Assess the Immunogenicity of Candidate PSA Peptides for a Prostate Cancer Vaccine | August 2015 | December 2018 |
| NCT03635866 | Completed | N/A | PET/MRI Study of Men With Highly Suspicious MRI Lesions That Showed no Clinically Significant Prostate Cancer Following MRI Fusion Targeted Biopsy | January 2, 2019 | October 9, 2020 |
| NCT04574401 | Completed | Phase 1 | A Phase 1 Study of IS-002 Injection in Patients Undergoing Robotic Prostatectomy | October 10, 2020 | September 20, 2021 |
| NCT00196807 | Completed | Phase 3 | Prostate Cancer Screening: Fostering Informed Decisions | August 2004 | November 2006 |
| NCT00852007 | Completed | Phase 1/Phase 2 | A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 | February 2009 | February 2016 |
| NCT00921193 | Completed | N/A | Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer | May 2009 | January 2011 |
| NCT00203424 | Completed | Phase 2 | Treatment of Prostate Cancer With Adjuvant Bevacizumab Plus Erlotinib | January 2006 | June 2010 |
| NCT00406939 | Completed | Phase 1 | Vector Delivery of the IL-12 Gene in Men With Prostate Cancer | June 1998 | December 2007 |
| NCT03536065 | Completed | N/A | Post-Discharge Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery | August 1, 2017 | March 1, 2019 |
| NCT03075735 | Completed | Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC) | January 15, 2013 | December 15, 2018 | |
| NCT00182052 | Completed | Phase 3 | Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer | September 2000 | August 2003 |
| NCT04852224 | Completed | Strength, Aging, and Memory in Prostate Cancer | October 1, 2021 | April 26, 2023 | |
| NCT02721433 | Completed | Phase 4 | 4-weekly Versus 12-weekly Administration of Bone-targeted Agents in Patients With Bone Metastases | August 2016 | April 2020 |
| NCT03043807 | Completed | Phase 2 | A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy | February 22, 2017 | October 17, 2022 |
| NCT01875393 | Completed | Phase 3 | Efficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer | May 2013 | March 2015 |
| NCT02903160 | Completed | Phase 2 | Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC) | January 13, 2017 | November 15, 2021 |
| NCT00767286 | Completed | Phase 3 | Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | November 2003 | |
| NCT03662204 | Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | August 23, 2018 | March 31, 2022 | |
| NCT00003343 | Completed | Phase 3 | Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer | March 1998 | |
| NCT02969577 | Completed | N/A | Staying Strong and Healthy During Androgen Deprivation Therapy (ADT) for Men | March 7, 2017 | July 31, 2020 |
| NCT00023829 | Completed | Phase 3 | Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer | August 2001 | June 2004 |
| NCT03035032 | Completed | Phase 4 | A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients | June 23, 2017 | November 19, 2019 |
| NCT06119438 | Completed | N/A | Aromatherapy on Pain and Anxiety of the Patients Undergoing Prostate Biopsy | January 1, 2020 | April 1, 2020 |
| NCT02886598 | Completed | Safety and Efficacy of Firmagon® (Degarelix) for Injection | September 2016 | March 26, 2019 | |
| NCT00476645 | Completed | Phase 2 | Fulvestrant in Hormone Refractory Prostate Cancer | September 2006 | December 2009 |
| NCT00005044 | Completed | Phase 3 | Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | February 2000 | May 20, 2022 |
| NCT03535987 | Completed | Pilot Cohort Study of Rb-82 Myocardial PET Imaging to Evaluate Coronary Microvascular Dysfunction in Men With Prostate Cancer Receiving Androgen-Deprivation Therapy | March 15, 2018 | October 19, 2019 | |
| NCT01516866 | Completed | Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy | November 2011 | January 1, 2018 | |
| NCT00246753 | Completed | Phase 2 | Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | October 2005 | May 2013 |
| NCT00004001 | Completed | Phase 3 | S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy | October 1999 | January 2007 |
| NCT02981368 | Completed | Phase 2/Phase 3 | Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer | November 2016 | July 2018 |
| NCT01844999 | Completed | N/A | Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks | August 1, 2013 | June 30, 2017 |
| NCT01440855 | Completed | N/A | Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting | February 2005 | October 2009 |
| NCT00242918 | Completed | Phase 2 | Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate Cancer | May 2003 | November 2007 |
| NCT01553188 | Completed | Phase 2 | AMG 386 and Abiraterone for Advanced Prostate Cancer | February 8, 2012 | July 1, 2018 |
| NCT01752140 | Completed | N/A | A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10-core Biopsy Scheme | January 2009 | July 2010 |
| NCT02918357 | Completed | Phase 2/Phase 3 | Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence | September 15, 2016 | September 21, 2017 |
| NCT03776045 | Completed | N/A | PROState Cancer Patients Initiating Hormone Therapy: Effect of Exercise on CARDIOvascular Health (PROSCARDIO) | August 12, 2013 | February 3, 2016 |
| NCT02268175 | Completed | Phase 2 | Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate | October 2014 | December 2021 |
| NCT01751438 | Completed | Phase 2 | Best Systemic Therapy or Best Systemic Therapy (BST) Plus Definitive Treatment (Radiation or Surgery) | March 18, 2013 | April 19, 2023 |
| NCT00003026 | Completed | Phase 3 | Hormone Therapy in Treating Patients With Advanced Prostate Cancer | April 1997 | |
| NCT00199485 | Completed | Phase 4 | Angelica Sinensis for the Treatment of Hot Flashes in Men Undergoing LHRH Therapy for Prostate Cancer | October 2002 | June 2008 |
| NCT00295750 | Completed | Phase 3 | The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer | February 2006 | October 2007 |
| NCT00659438 | Completed | Phase 2 | Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate Cancer | February 2008 | July 2011 |
| NCT00398281 | Completed | Phase 3 | Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer | November 2006 | September 2012 |
| NCT00577876 | Completed | N/A | Assessment of the Functional Significance of Accessory Pudendal Arteries | September 2006 | October 2011 |
| NCT00946881 | Completed | Phase 1/Phase 2 | Safety and Tolerability Study Using WST11 In Patients With Localized Prostate Cancer | July 2009 | August 2012 |
| NCT04535921 | Completed | Fear of Cancer Recurrence in Genitourinary Cancer | November 5, 2019 | August 31, 2022 | |
| NCT01985932 | Completed | N/A | Functional MRI Use in Prostate Radiation Treatment Planning | July 2012 | December 2015 |
| NCT00132522 | Completed | Phase 1 | EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide | May 2005 | April 2009 |
| NCT01257425 | Completed | Phase 2 | Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg | December 2010 | May 2012 |
| NCT01842438 | Completed | N/A | A Couple Support Intervention for Prostate Cancer | October 2012 | August 2015 |
| NCT01594502 | Completed | Validation of Digital Morphometry for Cancer Risk in Benign Prostate Biopsies | September 2011 | July 2016 | |
| NCT06299046 | Completed | Bleeding After Robot-assisted Radical Prostatectomy: a Respective Study | December 1, 2022 | January 1, 2023 | |
| NCT01902251 | Completed | Phase 1 | Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients | November 2012 | October 2013 |
| NCT00769795 | Completed | Phase 2 | Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer | October 2008 | November 2011 |
| NCT00373035 | Completed | Biomarkers in Patients Undergoing Transrectal Ultrasound Prostate Biopsy | February 2006 | ||
| NCT00685516 | Completed | N/A | Green Tea, Black Tea, or Water in Treating Patients With Prostate Cancer Undergoing Surgery | September 1, 2007 | April 1, 2015 |
| NCT00004043 | Completed | Phase 2 | Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer | February 1999 | March 2003 |
| NCT02788825 | Completed | N/A | STHLM3-MR: Comparing Standard With Targeted Prostate Biopsies | April 2016 | August 2017 |
| NCT00003312 | Completed | Phase 2 | Brachytherapy in Treating Patients With Prostate Cancer | September 1998 | November 2013 |
| NCT00339664 | Completed | Analyses of Human Samples Collected in Clinical Trials | July 2, 2003 | March 26, 2020 | |
| NCT00924092 | Completed | Phase 1 | An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ... | March 13, 2009 | August 2, 2012 |
| NCT03177759 | Completed | Living With Prostate Cancer (LPC) | September 9, 2016 | August 31, 2019 | |
| NCT00963755 | Completed | F-18-Fluorocholine PET/CT and MR Imaging/ Spectroscopy in the Management of Primary and Recurrent Prostate Cancer | August 2009 | January 2018 | |
| NCT03783741 | Completed | The Biopsychosocial Burden of Prostate Biopsy | January 2014 | October 2016 | |
| NCT00684905 | Completed | Phase 2 | Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy | April 2000 | October 2005 |
| NCT05589558 | Completed | N/A | Prospective Comparison of the Four Biopsy Methods for Prostate Cancer Detection | October 1, 2020 | February 25, 2022 |
| NCT00193856 | Completed | Phase 3 | RADAR Trial - Randomised Androgen Deprivation and Radiotherapy | October 2003 | August 2017 |
| NCT00147212 | Completed | Phase 2 | ET 743 (Yondelis) in Men With Advanced Prostate Cancer | June 2002 | April 2008 |
| NCT00085566 | Completed | Phase 1/Phase 2 | Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer | March 2004 | February 2008 |
| NCT00514540 | Completed | Phase 2 | Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer | May 2006 | April 2013 |
| NCT02311049 | Completed | Phase 2 | Hypofractionated Radiotherapy for Prostate Cancer | June 1, 2013 | June 14, 2020 |
| NCT00374049 | Completed | Phase 1 | MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer | June 2006 | December 2015 |
| NCT00658697 | Completed | Phase 2 | Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer | June 2008 | June 2015 |
| NCT01371513 | Completed | Korean Practice Patterns for Screening PCA(Prostate Cancer) | May 2010 | June 2011 | |
| NCT00039299 | Completed | Phase 1 | Biological Therapy in Treating Patients With Prostate Cancer | March 2002 | June 2003 |
| NCT01275872 | Completed | N/A | Effect of Guided Imagery and Progressive Muscle Relaxation as a Means to Improve the Psychological Well-being and the Quality of Life for Patients With Breast and Prostate Cancer | April 2010 | October 2011 |
| NCT05137067 | Completed | Phase 2 | A Novel Approach for Alleviating the Side Effects of Chemotherapeutic Agents. | January 20, 2021 | May 25, 2023 |
| NCT00384839 | Completed | Phase 2 | Vidaza to Restore Hormone Thx Prostate | April 2006 | November 2009 |
| NCT01341652 | Completed | Phase 2 | Phase II PAP Plus GM-CSF Versus GM-CSF Alone for Non-metastatic Prostate Cancer | May 23, 2011 | June 30, 2020 |
| NCT00121212 | Completed | N/A | Positron Emission Tomography in Prostate Cancer | July 2003 | October 2015 |
| NCT01959542 | Completed | N/A | Early Changes In Multiparametric MRI In Prostate Cancer | December 2013 | June 2017 |
| NCT01485861 | Completed | Phase 1/Phase 2 | Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy | January 11, 2012 | August 31, 2022 |
| NCT04823910 | Completed | Personalizing Docetaxel Dosing in Advanced Prostate Cancer | July 6, 2021 | December 31, 2022 | |
| NCT02462447 | Completed | Carbon-11 Labeled Sarcosine in Prostate Cancer | June 2015 | February 8, 2017 | |
| NCT03228810 | Completed | Genetic Biomarker Discovery for Metastatic Prostate Cancer | May 2, 2017 | April 9, 2019 | |
| NCT00151060 | Completed | Phase 2 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | December 1998 | June 2006 |
| NCT03056638 | Completed | Phase 3 | Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer | March 28, 2017 | August 16, 2023 |
| NCT00378690 | Completed | Phase 3 | A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD | March 2006 | December 2012 |
| NCT00006359 | Completed | Phase 2 | Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer | September 2000 | March 2012 |
| NCT02103088 | Completed | N/A | Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their Partners | May 2014 | February 2021 |
| NCT01878773 | Completed | N/A | Prostate Delineation: High Quality Volume CT | October 2012 | August 11, 2017 |
| NCT03869216 | Completed | N/A | Fostering Shared Decision-making About Prostate Cancer Screening Among Clinicians and African American Men | August 17, 2020 | December 31, 2023 |
| NCT00021450 | Completed | Phase 3 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | April 2001 | January 2016 |
| NCT02375776 | Completed | N/A | Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention | March 2015 | December 2019 |
| NCT00490763 | Completed | Active Surveillance in Prostate Cancer | February 13, 2006 | September 6, 2021 | |
| NCT01431391 | Completed | Phase 2 | Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer | September 2011 | December 2014 |
| NCT00752739 | Completed | Phase 2 | Selenium in Treating Patients With Prostate Cancer | August 2002 | April 2007 |
| NCT01098552 | Completed | Participation in Procurement of Tissue, Serum, Plasma, Cell Bank, DNA and RNA Samples, and Urine for Biological Studies Related to Prostate Cancer and Prostate Cancer Treatment Follow Up | February 2010 | November 2012 | |
| NCT00450957 | Completed | Phase 1 | Lycopene in Healthy Male Participants | October 2006 | November 2007 |
| NCT03852030 | Completed | N/A | Mind-Body Health in Uro-Oncology: Research Study | July 2012 | July 2016 |
| NCT04516707 | Completed | Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO | January 1, 2016 | May 1, 2018 | |
| NCT01254513 | Completed | Phase 2 | Feasibility of a Chemotherapy With Docetaxel-Prednisone for Castration-resistant Metastatic Prostate Cancer Elderly Patients | December 9, 2010 | April 27, 2017 |
| NCT04009174 | Completed | N/A | Multi-modality Prostate Cancer Image Guided Interventions | February 12, 2012 | June 21, 2023 |
| NCT00003238 | Completed | Phase 2 | Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | February 1998 | |
| NCT00016146 | Completed | Phase 1 | Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer | July 2000 | March 2009 |
| NCT02032550 | Completed | N/A | Treatment Preference and Patient Centered Prostate Cancer Care | June 2013 | January 26, 2018 |
| NCT00900835 | Completed | N/A | Pain and Fatigue Management in Patients With Breast Cancer, Prostate Cancer, Colon Cancer, or Lung Cancer | June 2005 | August 2010 |
| NCT01954004 | Completed | Open Registry Measuring Impact of Genomic Testing on Treatment of Prostate Cancer Patients | April 2013 | September 2014 | |
| NCT00054977 | Completed | Phase 1 | Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors | February 2003 | September 2006 |
| NCT03792841 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC | February 5, 2019 | July 3, 2023 |
| NCT00444730 | Completed | Urology Database for Outcomes Research | January 2007 | August 2014 | |
| NCT04838613 | Completed | Phase 3 | Study of Diagnostic Performance of [18F]CTT1057 in BCR | September 30, 2021 | November 23, 2023 |
| NCT00414388 | Completed | Phase 1/Phase 2 | Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer | December 2006 | March 2012 |
| NCT00433797 | Completed | Phase 1/Phase 2 | Dietary Intervention With Phytochemicals and Polyunsaturated Fatty Acids in Prostate Cancer Patients | June 2007 | December 2013 |
| NCT01215526 | Completed | A Study Into the Effectivity and Safety of Firmagon, Prescribed for Treatment of Patients With Advanced Prostate Cancer | October 2010 | July 2015 | |
| NCT02124668 | Completed | Phase 2 | A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | September 23, 2014 | May 25, 2017 |
| NCT02954783 | Completed | N/A | PROstaTe Cancer - Exercise-STudy (PRO-TEST) | November 2016 | December 2019 |
| NCT01083771 | Completed | N/A | Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer | February 2009 | August 2012 |
| NCT03331458 | Completed | N/A | Physical Activity in Men Newly Diagnosed With Prostate Cancer: A Feasibility Study | April 17, 2018 | March 21, 2019 |
| NCT00741039 | Completed | Phase 2 | Prospective Trial of Vaccine Responses Against Pneumococcus and Influenza in Adult Cancer Patients 65 Years of Age and Older | August 2008 | August 2012 |
| NCT05399940 | Completed | The Relationship Between Serum PSA Levels and WBC, Delta Neutrophil Index (DNI) and Other Hematological Parameters | January 1, 2018 | May 20, 2022 | |
| NCT00063609 | Completed | Phase 4 | The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy | April 2003 | April 2005 |
| NCT03618355 | Completed | Phase 1 | Trial of eRapa in Prostate Cancer Patients | August 28, 2018 | December 2, 2019 |
| NCT00595218 | Completed | N/A | Patient Preference Survey for Radiation Oncologists | April 2006 | April 2008 |
| NCT03543670 | Completed | Phase 2 | Evaluation of Oncoxin-Viusid® in Prostate Cancer | September 16, 2017 | December 30, 2018 |
| NCT00811876 | Completed | Retrospective, Non-interventional Study of Depo-Eligard®. | September 2008 | December 2009 | |
| NCT00924469 | Completed | Phase 2 | A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer | November 2009 | March 2012 |
| NCT00439751 | Completed | Phase 3 | Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy | April 2007 | June 2016 |
| NCT03209492 | Completed | Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer" | April 1, 2016 | December 1, 2017 | |
| NCT01308580 | Completed | Phase 3 | Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate Cancer | April 2011 | August 2015 |
| NCT02526784 | Completed | Phase 3 | A Trial Evaluating Two Subcutaneous Injection Techniques and Intramuscular Administration of Degarelix in Patients With Prostate Cancer | December 2015 | June 2017 |
| NCT02102646 | Completed | Phase 4 | MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism | April 2014 | October 2015 |
| NCT00003104 | Completed | Phase 2 | Computer Planned Radiation Therapy in Treating Patients With Prostate Cancer | June 1997 | October 2005 |
| NCT04925180 | Completed | A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe | October 18, 2021 | December 31, 2021 | |
| NCT00465725 | Completed | Phase 1 | A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors | April 2007 | July 2009 |
| NCT00283803 | Completed | Phase 2 | Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer | March 12, 2002 | October 2011 |
| NCT01009736 | Completed | Phase 1/Phase 2 | Effects of Tomato-Soy Juice on Biomarkers in Patients With Prostate Cancer Undergoing Prostatectomy | January 2008 | |
| NCT03832803 | Completed | N/A | Less to Hold - A Comparison of Bladder Toxicities (Side Effects) in Patients Undergoing Prostate Radiotherapy Between Patients Treated With Empty Bladder and Those on a Drinking Protocol. | March 1, 2017 | January 25, 2019 |
| NCT02229565 | Completed | Molecular Mechanisms Underlying Prostate Cancer Disparities | November 2014 | October 14, 2019 | |
| NCT03011606 | Completed | N/A | Robotic Surgery After Focal Ablation Therapy | February 2016 | October 21, 2019 |
| NCT00544336 | Completed | Family Quality of Life Among Families With a Member Who is a Cancer Patient | August 2007 | May 2009 | |
| NCT01763944 | Completed | N/A | Carbohydrate Restriction and Prostate Cancer Growth | December 16, 2013 | August 20, 2018 |
| NCT00054574 | Completed | Phase 2 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | November 2002 | February 2004 |
| NCT03120832 | Completed | Phase 1 | Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients | December 2016 | December 2018 |
| NCT00381173 | Completed | Phase 1 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | November 2006 | October 2008 |
| NCT00186108 | Completed | Phase 1 | A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer | October 2002 | September 2005 |
| NCT00276549 | Completed | Phase 2 | Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer | October 2005 | March 2008 |
| NCT02135445 | Completed | Phase 2 | Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer | June 2014 | December 2015 |
| NCT02232724 | Completed | N/A | Choline PET/CT vs. Dual Time Point FDG PET/CT in Prostate Cancer | November 2014 | February 2018 |
| NCT00953277 | Completed | Phase 4 | Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer | August 2009 | April 2015 |
| NCT03913039 | Completed | Reduction of Prostate Biopsy Morbidity | May 1, 2019 | December 31, 2021 | |
| NCT04089553 | Completed | Phase 2 | An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer | August 29, 2019 | April 11, 2023 |
| NCT02326246 | Completed | N/A | MRI in Active Surveillance of Prostate Cancer | October 2014 | January 2017 |
| NCT00215683 | Completed | Phase 2/Phase 3 | An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer | February 2005 | November 2009 |
| NCT01434004 | Completed | N/A | Eating, Activity, and Stress Education | January 2003 | July 2007 |
| NCT00003115 | Completed | Phase 3 | Epidural Hydromorphone Compared With Hydromorphone Infusion in Treating Patients With Prostate Cancer Undergoing Radical Prostatectomy | June 1996 | February 2004 |
| NCT02643303 | Completed | Phase 1/Phase 2 | A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers | December 28, 2016 | February 23, 2022 |
| NCT05613842 | Completed | Phase 2 | Copper-64 SAR Bombesin in PSMA Negative Prostate Cancer (BOP) | August 9, 2022 | June 6, 2023 |
| NCT00006019 | Completed | Phase 2 | Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer | May 2000 | August 2003 |
| NCT00462124 | Completed | N/A | Evaluation of the Safety and Efficacy of the BioProtect Balloon in Prostate Cancer Subjects Undergoing Radiotherapy | June 2007 | May 2009 |
| NCT04009083 | Completed | N/A | Axumin PETMRI Imaging Following Focal Cryo-ablation (FCA) | June 19, 2019 | January 7, 2021 |
| NCT03025633 | Completed | N/A | Explaining the Invisible Using the PEARL System | November 2016 | February 2018 |
| NCT00678054 | Completed | Phase 2 | Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA) | April 1999 | October 23, 2015 |
| NCT00807820 | Completed | Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR Brachytherapy | March 2008 | January 2012 | |
| NCT03278197 | Completed | N/A | Evaluation of a Web-based Decision Aid Tool for Prostate Cancer Patients | January 2015 | February 2017 |
| NCT01571544 | Completed | Phase 4 | The Use of Thermal Suits as Preventing Hypothermia During Surgery | November 2012 | November 2014 |
| NCT02092948 | Completed | Phase 1 | Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer | August 22, 2013 | January 6, 2017 |
| NCT00193232 | Completed | Phase 2 | Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer | May 2004 | February 2007 |
| NCT00309894 | Completed | Phase 2 | Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy | April 2004 | December 2007 |
| NCT02828839 | Completed | N/A | Prostate Biopsy Access Needle & Needle Guide Feasibility Study | November 2015 | January 31, 2022 |
| NCT00887198 | Completed | Phase 3 | Abiraterone Acetate in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer | April 28, 2009 | May 25, 2017 |
| NCT01790451 | Completed | Phase 1 | Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans | August 2013 | October 2014 |
| NCT03193645 | Completed | Observational Prospective Study Describing the Global Patient Care and Follow-up of Prostate Cancer Patients Treated With Degarelix | June 27, 2017 | January 31, 2019 | |
| NCT03573011 | Completed | Phase 2 | PSMA PET/CT for Prostate Cancer | June 15, 2018 | February 18, 2019 |
| NCT00017576 | Completed | Phase 2 | Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy | December 2000 | July 2006 |
| NCT00685646 | Completed | Phase 3 | Androgen Blockade Therapy With or Without Zoledronic Acid in Treating Patients With Prostate Cancer and Bone Metastases | May 2008 | January 2014 |
| NCT00534196 | Completed | Implant Radiation Therapy Using Radioactive Iodine in Treating Patients With Localized Prostate Cancer | July 2005 | December 13, 2021 | |
| NCT02928432 | Completed | Phase 2 | SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone | June 2013 | January 2017 |
| NCT01903408 | Completed | Phase 2 | Radiotherapy of the Prostate and the Pelvic Lymph Nodes After Neoadjuvant Antihormonal Treatment | May 2009 | May 2020 |
| NCT02423928 | Completed | Phase 1 | Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer | May 2015 | August 16, 2019 |
| NCT03162003 | Completed | Irish Programme for Stratified Prostate Cancer Therapy | February 2015 | October 8, 2020 | |
| NCT01059643 | Completed | Phase 2 | A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck | April 2011 | December 2012 |
| NCT03739684 | Completed | Phase 3 | Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer | November 27, 2018 | August 29, 2019 |
| NCT00669656 | Completed | Phase 2 | Herbal Therapy for Treatment of Recurrent Prostate Cancer | July 6, 2008 | October 14, 2014 |
| NCT02064283 | Completed | N/A | Early Assessment of Treatment Response Using Functional Diffusion Mapping | May 2007 | October 2012 |
| NCT05679193 | Completed | Phase 2 | Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence | January 2, 2023 | January 27, 2024 |
| NCT01487720 | Completed | Phase 2 | GEMOX in Docetaxel-Refractory Castration-Resistant Prostate Cancer | October 2008 | October 2013 |
| NCT00580970 | Completed | Phase 2 | Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury | April 2007 | August 2015 |
| NCT00013247 | Completed | N/A | Facilitating Shared Decisionmaking About Prostate Cancer Screening | December 2002 | |
| NCT00030277 | Completed | Phase 1 | High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer | October 2001 | December 2008 |
| NCT00199537 | Completed | Bone Loss in Men on Androgen Blockade as Adjuvant Therapy for Prostate Cancer | February 2005 | February 2008 | |
| NCT02224911 | Completed | Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer | September 11, 2014 | October 21, 2019 | |
| NCT00340600 | Completed | Continuation of Follow-up of DES-Exposed Cohorts | March 18, 1998 | November 13, 2020 | |
| NCT02895230 | Completed | Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study | January 1, 2016 | May 17, 2022 | |
| NCT01759771 | Completed | Phase 2 | Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial | January 3, 2013 | May 11, 2020 |
| NCT03554317 | Completed | Phase 2 | COMbination of Bipolar Androgen Therapy and Nivolumab | September 5, 2018 | January 6, 2023 |
| NCT00964002 | Completed | Phase 2 | Efavirenz in Treating Patients With Metastatic Prostate Cancer | May 2008 | April 8, 2014 |
| NCT00455624 | Completed | Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer | November 2002 | May 2006 | |
| NCT00737893 | Completed | Phase 2 | Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy | July 1, 2017 | December 31, 2019 |
| NCT00086736 | Completed | Phase 2 | Neoadjuvant Eflornithine and Bicalutamide Compared With Eflornithine Alone, Bicalutamide Alone, and No Neoadjuvant Therapy in Treating Patients With Localized Prostate Cancer Undergoing Brachytherapy or Radical Prostatectomy | November 2001 | November 2003 |
| NCT01585246 | Completed | Phase 1/Phase 2 | Saw Palmetto: Symptom Management for Men During Radiation Therapy | October 2011 | April 2015 |
| NCT03070145 | Completed | N/A | Exercise Intervention Among Men With Prostate Cancer Initiating Androgen Deprivation Therapy | December 8, 2017 | December 12, 2019 |
| NCT05381311 | Completed | Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study | September 3, 2021 | December 11, 2022 | |
| NCT03205176 | Completed | Phase 1 | AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas | June 30, 2017 | April 8, 2021 |
| NCT00035997 | Completed | Phase 4 | Open-label Trial on the Effect of I.V. Zoledronic Acid 4 mg on Bone Density in Hormone Sensitive Prostate Cancer Patients With Bone Metastasis | April 2002 | January 2004 |
| NCT00007579 | Completed | To Explore Racial Differences in Potential Risk Factors for Developing Prostate Cancer in the VA Population. | February 1998 | ||
| NCT00244309 | Completed | Phase 3 | Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer | November 2005 | June 2006 |
| NCT04124900 | Completed | Telomere Associated Variables (TAVs) in Prostate Cancer | July 15, 2019 | September 21, 2023 | |
| NCT02388126 | Completed | N/A | Prostate Magnetic Resonance Imaging in Patient With Previous Negative Biopsies | March 2015 | September 2016 |
| NCT00126815 | Completed | Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy | February 2004 | April 2008 | |
| NCT00589966 | Completed | N/A | Coping in African American Prostate Cancer Survivors | May 2007 | April 2010 |
| NCT00535834 | Completed | Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154 | March 2011 | ||
| NCT00117286 | Completed | Phase 2/Phase 3 | Extension Study Investigating the Long-Term Safety of Degarelix One-Month Depots in Patients With Prostate Cancer | March 2005 | November 2009 |
| NCT00060398 | Completed | Phase 3 | Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer | September 29, 2004 | |
| NCT04470843 | Completed | Phase 1 | Impact of Acetazolamide in Reducing Referred Postoperative Pain | August 22, 2018 | March 31, 2021 |
| NCT01620593 | Completed | Phase 2 | Castration Compared to Castration Plus Metformin as First Line Treatment for Patients With Advanced Prostate Cancer | April 2011 | September 2016 |
| NCT02468284 | Completed | Phase 1 | Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer | July 2015 | October 10, 2017 |
| NCT00046826 | Completed | Phase 2 | Docetaxel, Estramustine, and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy | September 2001 | October 2009 |
| NCT02716974 | Completed | Phase 2 | A Study of Definitive Therapy to Treat Prostate Cancer | June 2016 | April 2022 |
| NCT00003871 | Completed | Phase 2 | PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer | September 24, 1999 | |
| NCT01187485 | Completed | Phase 1 | A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer | June 2004 | February 2009 |
| NCT02693860 | Completed | Phase 1 | Neoadjuvant J591 Treatment for Prostate Cancer | February 4, 2016 | February 2, 2020 |
| NCT04605276 | Completed | Threedimensional Multiparametric Ultrasound for Prostate Cancer Detection | June 28, 2021 | March 7, 2024 | |
| NCT02034825 | Completed | Multi-site Decision Impact Study for Decipher | January 2013 | January 2015 | |
| NCT00022412 | Completed | Phase 2 | Doxercalciferol Before Surgery in Treating Localized Prostate Cancer | August 2001 | August 2008 |
| NCT00849082 | Completed | Phase 3 | Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | May 1987 | |
| NCT00925600 | Completed | Phase 3 | Evaluation of New or Worsening Lens Opacifications in Men With Non-metastatic Prostate Cancer Receiving Denosumab for Bone Loss | November 30, 2009 | May 12, 2016 |
| NCT02826382 | Completed | Early Phase 1 | Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041 | September 20, 2016 | December 31, 2022 |
| NCT00982800 | Completed | Phase 4 | Does Postoperative Gabapentin Reduce Pain, Opioid Consumption and Anxiety and Have a Positive Effect on Health Related Quality of Life After Radical Prostatectomy? | June 2007 | January 2010 |
| NCT00036933 | Completed | Phase 1 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | March 2002 | March 2009 |
| NCT01538628 | Completed | Phase 3 | SpaceOAR System Pivotal Study | January 2012 | July 2014 |
| NCT03322891 | Completed | N/A | Improving Health Literacy in African-American Prostate Cancer Patients | July 21, 2016 | January 17, 2019 |
| NCT00038181 | Completed | Phase 2 | Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer | October 5, 2000 | November 29, 2005 |
| NCT06166758 | Completed | N/A | Feasibility Study: Educational Genetic Test Video | December 14, 2023 | March 15, 2024 |
| NCT02088164 | Completed | Long-Term Outcome of Subjects With Elevated PSA in Healthy Taiwanese Men | February 2012 | ||
| NCT00627354 | Completed | Phase 2 | Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | September 2006 | |
| NCT02059213 | Completed | Phase 2 | A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer | June 2014 | June 4, 2019 |
| NCT00524680 | Completed | Phase 2 | Vitamin D in Treating Patients With Prostate Cancer | June 2007 | March 2013 |
| NCT00012935 | Completed | N/A | Treatment Decision Intervention for Veterans With Prostate Cancer | December 2001 | |
| NCT02079025 | Completed | N/A | Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate Cancer | December 2013 | February 2018 |
| NCT00898274 | Completed | Study of Blood Samples From Older Patients at High Risk of Developing Prostate Cancer and From Healthy Male Participants | January 2008 | May 2011 | |
| NCT00058539 | Completed | Phase 2 | Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer | April 2003 | October 2004 |
| NCT00459654 | Completed | Phase 2 | A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate Cancer | February 2004 | May 2007 |
| NCT00617617 | Completed | Phase 2 | The Specific Role of Isoflavones in Reducing Prostate Cancer Risk | February 2002 | May 2007 |
| NCT02460549 | Completed | N/A | Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation | April 2014 | November 2014 |
| NCT02572284 | Completed | Phase 1 | Dose Escalation Study of Preoperative SBRT for High Risk Prostate Cancer | January 27, 2016 | October 23, 2019 |
| NCT00006214 | Completed | Phase 2 | Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate | August 2000 | July 2006 |
| NCT03679260 | Completed | Phase 2 | Carbohydrate Restricted Diet Intervention for Men on Prostate Cancer Active Surveillance | September 25, 2018 | March 24, 2023 |
| NCT02654938 | Completed | Phase 1 | Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer | July 2015 | September 2017 |
| NCT03809078 | Completed | Phase 2 | 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer | January 14, 2019 | March 8, 2022 |
| NCT00335634 | Completed | Sexual Dysfunction and Adaptation in Couples Affected by Prostate Cancer Surgery | June 2006 | July 2009 | |
| NCT01144897 | Completed | Phase 1 | PET Acetate for Castrate-Resistant Prostate Cancer on Chemotherapy | May 2010 | September 2018 |
| NCT01261754 | Completed | Phase 1 | A Study of 99mTc-MIP-1404 and 99mTc-MIP-1405 in Patients With Metastatic Prostate Adenocarcinoma and Healthy Volunteers | December 2010 | |
| NCT03936296 | Completed | N/A | Prostate Cancer Detection Rates of Standard Transrectal Prostate Biopsy and MR-guided Fusion Transrectal Prostate Biopsy | December 6, 2017 | August 28, 2020 |
| NCT03384316 | Completed | Phase 1 | Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer | January 31, 2018 | August 24, 2020 |
| NCT04441775 | Completed | Artificial Intelligence for Prostate Cancer Treatment Planning | June 22, 2020 | March 4, 2022 | |
| NCT03187990 | Completed | N/A | Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA | March 3, 2017 | August 3, 2021 |
| NCT00327288 | Completed | Phase 1 | Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients | October 2005 | July 2008 |
| NCT00791115 | Completed | N/A | Salvage Prostatectomy After Radiotherapy | June 2008 | May 12, 2023 |
| NCT02618161 | Completed | N/A | Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment | September 2014 | November 2018 |
| NCT00067015 | Completed | Phase 3 | Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer | May 2003 | September 2008 |
| NCT05428098 | Completed | N/A | The Effect of the Educatıon and Counselıng of Prostatectomy Patıents | July 10, 2022 | January 10, 2023 |
| NCT00345293 | Completed | Phase 1/Phase 2 | Dendritic Cell Vaccine Study (DC/PC3) for Prostate Cancer | June 2006 | March 2015 |
| NCT02357121 | Completed | Early Phase 1 | Focal Laser Ablation of Prostate Tissue | September 17, 2015 | August 20, 2019 |
| NCT00176605 | Completed | Phase 2 | Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer | May 2005 | October 2008 |
| NCT00089674 | Completed | Phase 3 | AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer | August 1, 2004 | May 11, 2010 |
| NCT00006380 | Completed | Phase 1 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer | September 2000 | March 2002 |
| NCT00139204 | Completed | N/A | Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients | April 2005 | July 2006 |
| NCT00166725 | Completed | Phase 2 | Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients | February 2004 | |
| NCT01308567 | Completed | Phase 3 | Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer | May 5, 2011 | May 2018 |
| NCT00519233 | Completed | Phase 1 | AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer | September 2007 | September 2009 |
| NCT02542501 | Completed | Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues | July 2015 | July 21, 2018 | |
| NCT00667641 | Completed | Phase 1 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | March 2007 | February 2009 |
| NCT02601014 | Completed | Phase 2 | Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7 | March 15, 2016 | October 6, 2021 |
| NCT00970203 | Completed | Phase 2 | Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer | September 2009 | October 5, 2019 |
| NCT02218606 | Completed | Phase 2 | Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer | August 2014 | October 13, 2023 |
| NCT00736645 | Completed | Phase 2 | Selenomethionine and Finasteride Before Surgery or Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer | August 2008 | December 2012 |
| NCT00127816 | Completed | N/A | Improving Assessment (and Ultimately Outcomes) of Permanent Prostate Implant Therapy | April 2005 | April 2013 |
| NCT01558427 | Completed | Phase 2 | Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer | August 1, 2012 | August 15, 2023 |
| NCT01491971 | Completed | Phase 2 | Intramuscular Injections of Degarelix Administered in 1-Month Dosing Regimens in Patients With Prostate Cancer | January 2012 | November 2012 |
| NCT01160705 | Completed | Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2 | November 2009 | ||
| NCT01742962 | Completed | Prevalence of Neglected Side Effects to Radical Prostatectomy | December 2012 | September 2013 | |
| NCT00874211 | Completed | S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases | December 2008 | June 2019 | |
| NCT01420250 | Completed | Phase 1 | Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer | September 22, 2011 | July 21, 2020 |
| NCT02867020 | Completed | Phase 2 | Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels | October 11, 2017 | June 30, 2021 |
| NCT02615067 | Completed | Phase 3 | Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer | December 2015 | December 28, 2017 |
| NCT01751737 | Completed | N/A | Choline PET/CT and MRI for Targeted Prostate Biopsy | November 2012 | June 2017 |
| NCT04290611 | Completed | a Vigibase Pharmacovigilance Study of ENzalutamide Drug-induced neurotoxicitY | January 1, 2019 | April 8, 2023 | |
| NCT01790126 | Completed | Phase 2 | The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer | March 4, 2013 | March 1, 2019 |
| NCT00703638 | Completed | Phase 1 | Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors | May 2008 | November 2010 |
| NCT04742959 | Completed | Phase 1/Phase 2 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | March 14, 2021 | February 20, 2024 |
| NCT00318240 | Completed | N/A | Prostate Cancer Treatment Following Radiation Failure With High Intensity Focused Ultrasound (HIFU) | April 2006 | April 2009 |
| NCT00313599 | Completed | Phase 1 | Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors | February 2006 | December 2013 |
| NCT00081172 | Completed | Phase 2 | Radiolabeled Monoclonal Antibody in Treating Patients With Progressive Metastatic Androgen-Independent Adenocarcinoma (Cancer) of the Prostate | January 2004 | May 2006 |
| NCT00830635 | Completed | N/A | Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer | September 2008 | December 2013 |
| NCT01414296 | Completed | Phase 1 | Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer | January 2009 | November 2013 |
| NCT01162135 | Completed | Phase 2 | Digoxin for Recurrent Prostate Cancer | September 2010 | May 2013 |
| NCT01480375 | Completed | N/A | A Novel 3D Navigation Technology for Improved TRUS Prostate Biopsy | September 22, 2011 | November 15, 2017 |
| NCT02003417 | Completed | Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy | June 2012 | May 4, 2018 | |
| NCT00005632 | Completed | Phase 1 | Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer | June 1999 | March 2009 |
| NCT00859027 | Completed | Phase 4 | Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate Cancer | January 2003 | February 2009 |
| NCT00148772 | Completed | Phase 2 | Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy | August 2005 | August 2008 |
| NCT00045331 | Completed | N/A | Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer | August 2002 | October 2007 |
| NCT00581516 | Completed | Molecular Urine Tests for Prostate Cancer | March 2007 | September 2008 | |
| NCT03480074 | Completed | N/A | Staple vs. Suture in Robotic Prostatectomy | March 1, 2015 | October 1, 2020 |
| NCT00489060 | Completed | Phase 3 | A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Localized Prostate Cancer | December 1997 | April 2007 |
| NCT02020291 | Completed | Phase 1 | Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer | June 2013 | November 2015 |
| NCT01937585 | Completed | N/A | Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men | August 2010 | November 2010 |
| NCT00541047 | Completed | Phase 3 | RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery | November 2007 | July 27, 2022 |
| NCT01501630 | Completed | Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer | December 2011 | December 2014 | |
| NCT00005820 | Completed | Phase 2 | Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy | May 2000 | September 2006 |
| NCT00637871 | Completed | Phase 2 | Casodex - Nolvadex Combination | November 2002 | August 2005 |
| NCT00265070 | Completed | Phase 2 | Trial of Iressa in Prostate Cancer Patients | January 2003 | August 2011 |
| NCT00589420 | Completed | Phase 2 | Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy | July 27, 2007 | February 2, 2011 |
| NCT02093390 | Completed | Phase 1 | A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects | March 2014 | April 2014 |
| NCT01706458 | Completed | Phase 2 | Provenge With or Without pTVG-HP DNA Booster Vaccine in Prostate Cancer | May 20, 2013 | August 13, 2020 |
| NCT01834651 | Completed | Phase 2 | A Phase II Study of Cabozantinib (XL184) Therapy in Castrate Resistant Prostate Cancer (CRPC) With Visceral Metastases | April 30, 2013 | July 18, 2016 |
| NCT00086762 | Completed | N/A | Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors | June 2004 | August 11, 2022 |
| NCT01446991 | Completed | Phase 2 | Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy | April 2012 | December 2017 |
| NCT00916123 | Completed | Phase 1 | Docetaxel/Prednisone Plus Fractionated 177Lu- J591 Antibody for Metastatic, Castrate-resistant Prostate Cancer | May 2009 | December 2018 |
| NCT01191775 | Completed | Phase 1 | A Study of PNT2258 in Patients With Advanced Solid Tumors | August 2010 | April 2012 |
| NCT01901042 | Completed | Phase 2/Phase 3 | Efficacy of Symbiotic in the Reduction of Acute Radiation Proctitis Symptoms | January 2012 | November 2012 |
| NCT00941915 | Completed | N/A | Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer | November 9, 2009 | July 17, 2020 |
| NCT02237170 | Completed | Immune Monitoring on Sipuleucel-T | June 2012 | December 2016 | |
| NCT06168890 | Completed | Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure. | February 4, 2014 | February 25, 2014 | |
| NCT02220517 | Completed | N/A | Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy | November 2011 | October 2014 |
| NCT03148795 | Completed | Phase 2 | A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer | July 4, 2017 | March 31, 2023 |
| NCT00164437 | Completed | Phase 2/Phase 3 | CD-ROM Intervention for Prostate Cancer Screening | September 2002 | September 2004 |
| NCT02966509 | Completed | N/A | Engagement of Patients With Advanced Cancer | August 2013 | December 2016 |
| NCT01551576 | Completed | Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study | February 2014 | December 16, 2019 | |
| NCT02115828 | Completed | Early Phase 1 | A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy | April 2014 | April 2016 |
| NCT04374240 | Completed | Phase 1 | A Clinical Trial of AdNRGM Plus CB1954 in Prostate Cancer | March 19, 2013 | August 2021 |
| NCT01168323 | Completed | N/A | Spaced Education to Optimize Prostate Cancer Screening | January 2007 | February 2009 |
| NCT00033605 | Completed | Phase 3 | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | April 2002 | July 2006 |
| NCT01982058 | Completed | N/A | Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer | August 18, 2011 | August 7, 2017 |
| NCT00607932 | Completed | N/A | Brassica Vegetables or Indole-3-Carbinol in Treating Patients With PSA Recurrence After Surgery for Prostate Cancer | March 2005 | November 2010 |
| NCT02432001 | Completed | Radiologically Guided Biopsies of mCRPC | February 22, 2013 | January 1, 2020 | |
| NCT00001503 | Completed | Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease | September 19, 1996 | June 15, 2023 | |
| NCT03410641 | Completed | Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study | January 15, 1972 | September 30, 2017 | |
| NCT00894933 | Completed | N/A | Performance Evaluation of the AMS CONTINUUM™ Device | May 2009 | December 2010 |
| NCT00853164 | Completed | N/A | A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT) | July 2008 | June 2010 |
| NCT00326586 | Completed | Phase 1 | A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer | May 2006 | March 2009 |
| NCT04219059 | Completed | MR Radiomic Features in Prostate Cancer | September 3, 2019 | March 30, 2021 | |
| NCT01013129 | Completed | Studying Genes, Environment, and Prostate Cancer Risk in Patients With or Without Prostate Cancer | July 2008 | December 2012 | |
| NCT00078845 | Completed | Phase 2 | Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors | May 2004 | May 2007 |
| NCT02957149 | Completed | N/A | Platelet Rich Plasma During Radical Prostatectomy | December 2016 | December 21, 2022 |
| NCT03211104 | Completed | N/A | Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy | August 30, 2007 | August 5, 2015 |
| NCT04281147 | Completed | Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body | February 24, 2020 | June 22, 2021 | |
| NCT01168479 | Completed | Phase 3 | FLAME: Investigate the Benefit of a Focal Lesion Ablative Microboost in Prostate Cancer | September 2009 | January 2016 |
| NCT05423431 | Completed | Retrospective Evaluation of a Commercially Available Hydrogel Spacer (BP-009) | November 9, 2020 | June 30, 2021 | |
| NCT00002651 | Completed | Phase 3 | SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer | May 1995 | June 2013 |
| NCT02643667 | Completed | Phase 2 | Ibrutinib as Neoadjuvant Therapy in Localized Prostate Cancer | July 2016 | April 12, 2023 |
| NCT00050596 | Completed | Phase 2 | Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer | November 2002 | November 2004 |
| NCT01056562 | Completed | An Alternative to A Fixed Schedule In Management Of Prostate Cancer | November 2009 | June 2014 | |
| NCT02036918 | Completed | Phase 1 | Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer | March 2014 | February 6, 2019 |
| NCT02470936 | Completed | N/A | Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8 | June 2015 | March 2018 |
| NCT02887976 | Completed | Phase 3 | Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201 | September 2016 | October 6, 2017 |
| NCT01076335 | Completed | Phase 2 | Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate Cancer | May 2005 | June 2015 |
| NCT01886677 | Completed | N/A | Improving Energy Balance in Men With Prostate Cancer | September 2012 | January 2015 |
| NCT01794793 | Completed | Phase 4 | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies | June 10, 2013 | July 29, 2023 |
| NCT01982786 | Completed | N/A | Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer | April 22, 2014 | October 19, 2018 |
| NCT00833248 | Completed | Phase 3 | Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer | April 2009 | September 2011 |
| NCT00975429 | Completed | Phase 2 | Study Using WST11 in Patients With Localized Prostate Cancer | September 2009 | August 2012 |
| NCT00002602 | Completed | Phase 1/Phase 2 | Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer | May 1994 | November 2013 |
| NCT00483678 | Completed | N/A | Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners | April 2007 | March 1, 2018 |
| NCT00943956 | Completed | Phase 1 | Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer | January 2009 | December 2012 |
| NCT05200039 | Completed | Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part IIB | December 21, 2021 | August 20, 2022 | |
| NCT01676480 | Completed | N/A | The Effect of Endurance Training on Body Composition and Insulin Sensitivity in Prostate Cancer Patients Receiving Androgen Deprivation Therapy | September 2009 | September 2011 |
| NCT00623831 | Completed | Phase 1 | A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen | May 2007 | May 2013 |
| NCT00080678 | Completed | Phase 2 | Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases | May 2003 | March 2008 |
| NCT01071915 | Completed | Phase 3 | Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer | March 2010 | November 2011 |
| NCT02033343 | Completed | N/A | Feasibility Study Into Adjustment of the Radiation Beam to Account for Prostate Motion During Radiotherapy. | October 2013 | February 2018 |
| NCT04015102 | Completed | A Registry for Hereditary Cancer Risk Assessment and Genetic Testing | March 6, 2019 | October 30, 2020 | |
| NCT00402285 | Completed | N/A | Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer | April 2003 | January 2008 |
| NCT00581724 | Completed | Pain in Cancer Survivors | May 2007 | January 2012 | |
| NCT03879486 | Completed | N/A | Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate Biopsy | May 31, 2017 | July 24, 2019 |
| NCT01697384 | Completed | Phase 3 | Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer | April 2000 | October 2004 |
| NCT01161563 | Completed | Phase 4 | Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration | July 2010 | April 2011 |
| NCT00456144 | Completed | Prospective Observation Study of Insulin Sensitivity During and After Gonadotropin Releasing Hormone Agonist Therapy for Prostate Cancer | August 2006 | September 2012 | |
| NCT03524391 | Completed | N/A | Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients | February 12, 2016 | February 25, 2017 |
| NCT00928850 | Completed | N/A | Modifications to Radical Prostatectomy: Feasibility Study | June 2009 | May 4, 2018 |
| NCT00072722 | Completed | Phase 2 | Safety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC) | September 2003 | April 2005 |
| NCT02969564 | Completed | 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients. | May 2016 | September 14, 2020 | |
| NCT00090545 | Completed | Phase 2 | A Phase II Study of BAY 43-9006 (Sorafenib) in Metastatic, Androgen-Independent Prostate Cancer | September 1, 2004 | April 1, 2009 |
| NCT01495130 | Completed | N/A | Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery | October 2011 | December 2012 |
| NCT03458247 | Completed | Phase 2 | Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer | June 22, 2018 | December 27, 2021 |
| NCT00872157 | Completed | Phase 1 | BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets | March 2009 | |
| NCT01692405 | Completed | N/A | Semi-automatic Download of Prostate Biopsy Cores While Keeping the Orientation, Unfolding and Unity of the Sample | April 29, 2013 | April 24, 2017 |
| NCT00129025 | Completed | Phase 1/Phase 2 | Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer | October 2004 | December 2006 |
| NCT00307294 | Completed | Phase 2 | Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC) | March 2006 | January 2012 |
| NCT00060476 | Completed | Phase 3 | Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201) | January 8, 2003 | December 8, 2004 |
| NCT00004054 | Completed | Phase 3 | Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer | January 2000 | November 2013 |
| NCT03424837 | Completed | N/A | A Survivorship Care Plan and Embedded Navigation Tool | January 11, 2019 | November 24, 2020 |
| NCT03215992 | Completed | N/A | Optical Tomography in Prostate Cancer | June 13, 2016 | February 8, 2018 |
| NCT01084655 | Completed | Phase 1/Phase 2 | Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate Cancer | July 2010 | March 2016 |
| NCT03310541 | Completed | Phase 1 | AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations | October 11, 2017 | May 3, 2023 |
| NCT03943368 | Completed | N/A | Using Virtual Reality (VR) Models for Robotic Prostatectomy | January 1, 2019 | September 30, 2023 |
| NCT04488068 | Completed | N/A | Transpelvic Magnetic Stimulation to Improve Urogenital Function | October 1, 2020 | September 30, 2022 |
| NCT03177707 | Completed | N/A | Intimacy and Mindfulness Post-Prostate Cancer Treatment | January 24, 2017 | April 30, 2018 |
| NCT02883166 | Completed | Phase 1 | Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake | August 2016 | March 2019 |
| NCT01020448 | Completed | Phase 3 | Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer | November 2009 | June 2013 |
| NCT01995513 | Completed | Phase 4 | Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients | October 22, 2013 | August 31, 2022 |
| NCT00165399 | Completed | Phase 2 | Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment | March 2004 | December 31, 2005 |
| NCT04804839 | Completed | N/A | Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary Incontinence | April 1, 2021 | March 1, 2022 |
| NCT00708968 | Completed | N/A | Prostate Cancer: Family Care for Patients and Spouses | September 2001 | December 2005 |
| NCT02236637 | Completed | A Registry to Observe the Treatment of Prostate Cancer Under Routine Medical Care | June 14, 2013 | November 21, 2018 | |
| NCT02275754 | Completed | N/A | Redes III Patient Navigator Qol Study | November 2010 | December 31, 2017 |
| NCT00582543 | Completed | N/A | MRI/MRSI in Risk Assessment of Prostate Cancer Patients | October 2005 | October 2011 |
| NCT00032058 | Completed | N/A | Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging in Diagnosing the Extent of Disease in Patients With Prostate Cancer | June 2003 | |
| NCT02179515 | Completed | Phase 1 | Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) | June 28, 2014 | February 28, 2018 |
| NCT03887091 | Completed | N/A | Personal Web Page In Clinical Trial Participant Education | July 21, 2014 | May 2019 |
| NCT02303054 | Completed | N/A | MRI-Targeted Focal Ablation of the Prostate in Men With Prostate Cancer | September 2014 | March 2016 |
| NCT00988208 | Completed | Phase 3 | Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer | November 11, 2009 | November 28, 2016 |
| NCT00836238 | Completed | Questionnaire and Fall Risk Assessment | February 2009 | June 2009 | |
| NCT03508011 | Completed | Phase 1 | A Study of IMP4297 in Patients With Advanced Solid Tumors | August 23, 2017 | December 16, 2020 |
| NCT01917890 | Completed | N/A | Radiosensitizing and Radioprotectve Effects of Curcumin in Prostate Cancer | March 2011 | October 2013 |
| NCT00019344 | Completed | Phase 1 | Flavopiridol in Treating Patients With Refractory Cancer | August 1997 | |
| NCT00003819 | Completed | Phase 1 | Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer | June 1998 | March 2009 |
| NCT00973882 | Completed | Phase 2 | Carboplatin-Etoposide Combination in Hormone-Resistant Prostate Cancers | April 2005 | January 2010 |
| NCT01666314 | Completed | Phase 1/Phase 2 | Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate Cancer | August 20, 2012 | September 1, 2016 |
| NCT03529643 | Completed | N/A | Effect of Anesthetic Method on Optic Nerve Sheath Diameter in Patients Undergoing RALP | May 24, 2018 | August 22, 2018 |
| NCT00305929 | Completed | Phase 2 | Study of WST09 in Prostate Cancer After Radiation: Repeat Procedure | March 2006 | December 2007 |
| NCT00005810 | Completed | Phase 2 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy | March 2000 | June 2006 |
| NCT02799745 | Completed | Phase 2 | A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance | June 9, 2016 | August 28, 2020 |
| NCT03233672 | Completed | N/A | Hypo-fractionated Postoperative IMRT in Prostate Cancer | September 18, 2007 | September 18, 2014 |
| NCT02086266 | Completed | N/A | The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence | March 2012 | March 2014 |
| NCT02933255 | Completed | Phase 1/Phase 2 | PROSTVAC in Combination With Nivolumab in Men With Prostate Cancer | April 18, 2017 | December 1, 2023 |
| NCT04430842 | Completed | Phase 1 | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | July 20, 2020 | December 22, 2022 |
| NCT02064582 | Completed | Phase 2 | Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer | May 2014 | June 9, 2018 |
| NCT00128531 | Completed | Phase 3 | Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer | September 2005 | November 2007 |
| NCT00068731 | Completed | Phase 2 | Lycopene in Treating Patients With Metastatic Prostate Cancer | January 2004 | October 2009 |
| NCT05764005 | Completed | N/A | Optimizing Active Surveillance in Low-Risk Prostate Cancer: a Pilot Study | November 9, 2022 | March 11, 2024 |
| NCT00642018 | Completed | Phase 2 | A Study of an Experimental Chemotherapy Combination to Treat Hormone Refractory Prostate Cancer | March 2008 | April 2012 |
| NCT00116155 | Completed | Phase 1/Phase 2 | Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer | ||
| NCT02812186 | Completed | Phase 4 | Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery | December 27, 2016 | February 6, 2019 |
| NCT02126319 | Completed | N/A | Facilitating Participation in a Prostate Cancer Risk Assessment Program | October 1998 | April 2002 |
| NCT00719030 | Completed | N/A | A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy | February 2009 | May 2012 |
| NCT00260611 | Completed | Phase 2 | Study of Oxaliplatin and Taxotere in Prostate Cancer | November 2004 | September 2007 |
| NCT03328091 | Completed | N/A | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) | November 21, 2017 | February 13, 2020 |
| NCT02954289 | Completed | N/A | Cooking Class Intervention Project for Men With Prostate Cancer and Their Partners | February 2014 | September 2016 |
| NCT01654874 | Completed | Phase 1 | 99mTc-MIP-1404 for Imaging Prostate Cancer: Phase I Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of 99mTc-MIP-1404 | July 2012 | |
| NCT03419585 | Completed | N/A | The "PC-LIGHT" Study | December 12, 2018 | December 31, 2023 |
| NCT00027781 | Completed | Phase 2 | MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | August 2001 | |
| NCT00328614 | Completed | Phase 1 | Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate Cancer | March 2003 | June 2011 |
| NCT01089387 | Completed | Phase 1/Phase 2 | Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction | May 2010 | March 2015 |
| NCT00581815 | Completed | Phase 1 | Spectroscopy With Surface Coils and Decoupling | February 1997 | February 2014 |
| NCT01057810 | Completed | Phase 3 | Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer | July 2010 | July 2015 |
| NCT00003259 | Completed | Phase 2 | Vinorelbine in Treating Patients With Metastatic Prostate Cancer | October 1997 | September 1999 |
| NCT00065208 | Completed | Phase 1/Phase 2 | Reiki/Energy Healing in Prostate Cancer | April 2005 | June 2010 |
| NCT01497925 | Completed | Phase 1 | Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer | September 6, 2011 | August 31, 2018 |
| NCT04221607 | Completed | N/A | An Intimacy Intervention for Couples Completing Breast or Prostate Cancer | December 9, 2019 | December 31, 2020 |
| NCT04962269 | Completed | Application of DWI in Diagnosis of Prostate Cancer | June 12, 2013 | June 21, 2018 | |
| NCT00379561 | Completed | Phase 1 | PSA-Activated PSA-PAH1 for Locally Recurrent Prostate Cancer | March 2006 | July 2008 |
| NCT02070575 | Completed | Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence | February 20, 2014 | October 18, 2023 | |
| NCT02248350 | Completed | N/A | An Exercise Intervention for Prostate Cancer Patients Receiving Androgen Deprivation Therapy | September 2014 | September 2017 |
| NCT00258388 | Completed | Phase 2 | Docetaxel and Prednisone With/Out OGX-011 in Recurrent or Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy | September 28, 2005 | January 18, 2011 |
| NCT00475982 | Completed | N/A | Effect of Weight Loss on Prostate Cancer Pathology | January 2009 | March 2016 |
| NCT00327340 | Completed | Phase 2 | Evaluation of Safety and Feasibility of OGX-011 in Combination With 2nd-line Chemotherapy in Patients With HRPC | July 2006 | October 2010 |
| NCT01394263 | Completed | Phase 3 | Study of Histrelin Subdermal Implant in Patients With Prostate Cancer | May 2000 | December 2003 |
| NCT06027203 | Completed | Transperineal Versus Transrectal Prostate Biopsy | April 15, 2023 | July 18, 2023 | |
| NCT03400150 | Completed | N/A | ProSpace™ Balloon System Pivotal Study BP-007 | January 3, 2018 | December 10, 2021 |
| NCT00516256 | Completed | N/A | CHESS: Human and Computer Mentors for Prostate Cancer Patients | July 3, 2007 | May 11, 2018 |
| NCT02046837 | Completed | Phase 2 | An Exercise Trial and Economic Analysis in Men With Prostate Cancer | November 2013 | January 2018 |
| NCT01486563 | Completed | Phase 4 | Hydroxyethyl Starch and Renal Function After Radical Prostatectomy | January 2012 | June 2013 |
| NCT00078923 | Completed | Phase 2 | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate | November 2001 | May 2010 |
| NCT00106418 | Completed | Phase 2 | A Research Study for Patients With Prostate Cancer | May 7, 2003 | September 1, 2006 |
| NCT03044197 | Completed | N/A | Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy | July 25, 2017 | April 12, 2018 |
| NCT00798876 | Completed | N/A | Low-Fat Fish Oil Diet for Prostate Cancer Prevention | December 18, 2001 | February 12, 2018 |
| NCT00426777 | Completed | Phase 3 | Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer | January 2007 | February 2009 |
| NCT00010244 | Completed | Phase 3 | Comparison of Radiation Therapy Regimens in Treating Patients With Localized Prostate Cancer | September 1999 | March 2018 |
| NCT03382522 | Completed | Prognostic Value of SPECT-CT Quantitative Indices for the Response Assessment of Bone Metastatic Prostate Carcinoma | January 1, 2018 | March 30, 2018 | |
| NCT01320735 | Completed | Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia | February 2011 | May 2014 | |
| NCT03212079 | Completed | N/A | Physical Activities by Technology Help (PATH) | April 3, 2017 | June 30, 2018 |
| NCT03214315 | Completed | Structural Network on Prostate Cancer in the French Greater West Region | November 11, 2014 | September 27, 2016 | |
| NCT02816983 | Completed | SBRT for Oligometastatic Castration-Refractory Prostate Cancer | March 2016 | January 20, 2022 | |
| NCT02559115 | Completed | Phase 2 | 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer | September 21, 2015 | June 18, 2020 |
| NCT00626431 | Completed | Phase 3 | A Study of Leuprolide to Treat Prostate Cancer | February 2008 | September 2009 |
| NCT00712829 | Completed | Phase 1 | Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents | May 2008 | January 2009 |
| NCT00054522 | Completed | Phase 2 | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy | April 2002 | March 2006 |
| NCT06116344 | Completed | Improving Prostate Lesion Classification and Development of a PI-RADS 3 Classifier | January 1, 2018 | August 24, 2023 | |
| NCT00818623 | Completed | Phase 2 | Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients | November 2002 | October 2004 |
| NCT04897958 | Completed | Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data | September 21, 2019 | August 1, 2021 | |
| NCT00122499 | Completed | Phase 3 | A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer | February 2003 | February 2005 |
| NCT01300104 | Completed | N/A | Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer | February 2011 | February 2015 |
| NCT05069584 | Completed | N/A | TransPERineal Fusion Biopsy Versus transrECTal | January 17, 2022 | May 12, 2023 |
| NCT00923416 | Completed | Trans-Rectal Ultrasound-Guided (TRUS) Adverse Events | September 2008 | November 2010 | |
| NCT01672411 | Completed | Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer | April 2012 | December 2012 | |
| NCT03995888 | Completed | Phase 1 | Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer | June 11, 2019 | April 16, 2020 |
| NCT02013414 | Completed | N/A | Fusion Targeted Biopsy of the Prostate | September 2013 | July 23, 2018 |
| NCT02190279 | Completed | Early Phase 1 | 18F-DCFBC PET/CT in Prostate Cancer | July 12, 2014 | January 11, 2018 |
| NCT00652210 | Completed | Phase 1 | Use of Multiphoton Microscopy in the Diagnosis of Cancer | June 2005 | September 2015 |
| NCT02770391 | Completed | Phase 2 | Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer | October 17, 2016 | April 29, 2020 |
| NCT02085252 | Completed | Phase 3 | A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer | June 3, 2013 | November 8, 2016 |
| NCT05181800 | Completed | FIRMAGON Intensive Drug Monitoring Protocol | September 1, 2019 | December 31, 2022 | |
| NCT00115635 | Completed | Phase 1/Phase 2 | Docetaxel and Gemcitabine in Hormonal Refractory Metastatic Prostate Cancer | March 2005 | July 2007 |
| NCT00006002 | Completed | Phase 2 | SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | June 2000 | January 2006 |
| NCT03513211 | Completed | Phase 1/Phase 2 | Phase I/II Study of Hydroxychloroquine With Itraconazole With Biochemically Recurrent Prostate Cancer | August 23, 2018 | October 30, 2023 |
| NCT00841685 | Completed | N/A | The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate | December 2008 | May 1, 2012 |
| NCT01352598 | Completed | N/A | Stereotactic Body Radiotherapy for Prostate Cancer | June 2011 | April 2019 |
| NCT04175730 | Completed | N/A | Prostate Cancer Detection Screening MRI Protocol | May 20, 2019 | December 14, 2020 |
| NCT01205646 | Completed | N/A | PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer | September 2010 | August 2015 |
| NCT01378091 | Completed | Phase 1 | Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate Cancer | August 2005 | September 2013 |
| NCT00716794 | Completed | Phase 1/Phase 2 | A Phase I/II Study of HE3235 in Patients With Prostate Cancer | July 2008 | March 2011 |
| NCT04282967 | Completed | Early Phase 1 | Streaming Web-based Exercise At Home: A Pilot Study | July 7, 2020 | March 30, 2023 |
| NCT02106507 | Completed | Phase 1 | ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate | April 2014 | June 28, 2021 |
| NCT00242554 | Completed | Phase 4 | Open-label Phase IV Clinical Trial to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastases | October 2002 | |
| NCT03692585 | Completed | Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital Behavior | June 2015 | April 2016 | |
| NCT00304759 | Completed | Phase 3 | PROFIT - Prostate Fractionated Irradiation Trial | May 2006 | July 15, 2017 |
| NCT03225222 | Completed | MRI in PROstate Cancer Diagnosis With Prior Risk Assessment | November 1, 2017 | January 31, 2021 | |
| NCT04647474 | Completed | Mental Wellbeing and Quality of Life in Prostate Cancer | January 15, 2021 | March 29, 2023 | |
| NCT00714753 | Completed | Phase 2 | Internal Radiation Therapy With or Without External-Beam Radiation Therapy in Treating Patients With Localized Prostate Cancer | August 2008 | December 2013 |
| NCT02948413 | Completed | Influence of Psychosocial Distress and Lifetime Trauma Exposure on Traumatic Stress Among Oncology Patients on Clinical Trials | November 10, 2016 | May 22, 2020 | |
| NCT00349557 | Completed | Phase 2 | Bevacizumab With Hormonal and Radiotherapy for High-Risk Prostate Cancer | April 2006 | |
| NCT03370016 | Completed | N/A | The Impact of Low Pressure Pneumo in RARP | October 17, 2017 | June 30, 2020 |
| NCT00004029 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | December 1996 | |
| NCT03151356 | Completed | Prostate Health Index for Prostate Cancer Diagnosis | September 18, 2017 | October 19, 2018 | |
| NCT02125084 | Completed | Phase 1 | Enzalutamide Plus Everolimus in Men With Metastatic Castrate-Resistant Prostate Cancer | October 2014 | May 3, 2021 |
| NCT00106392 | Completed | Phase 4 | A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy | February 2005 | November 2008 |
| NCT02812173 | Completed | N/A | Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP | May 2016 | June 2018 |
| NCT00084825 | Completed | Phase 2 | Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008 | May 2003 | June 2008 |
| NCT03263780 | Completed | Phase 2 | High Resolution PET-MRI Before Prostate Cancer HIFU | December 7, 2017 | January 8, 2020 |
| NCT00027599 | Completed | Phase 2 | APC8015 and Bevacizumab in Treating Patients With Prostate Cancer | December 2001 | |
| NCT00043069 | Completed | Phase 3 | Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer | November 2002 | January 2010 |
| NCT03675451 | Completed | Phase 2 | PSMA Imaging of Localized Prostate Cancer | February 8, 2017 | June 27, 2018 |
| NCT04185922 | Completed | N/A | Hemopatch to Prevent Lymphatic Leak After Robotic Prostatectomy and Pelvic Lymph Node Dissection | February 27, 2020 | June 10, 2022 |
| NCT03896178 | Completed | Prostate Cancer in Firemen: Early Diagnosis Because of Increased Diagnostic Pressure? | February 1, 2020 | February 2, 2020 | |
| NCT02663193 | Completed | Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability | December 2015 | January 2017 | |
| NCT03276572 | Completed | Phase 1 | Phase I Trial of 225Ac-J591 in Patients With mCRPC | October 10, 2017 | September 1, 2023 |
| NCT00763152 | Completed | CMT-07-08: The PROstate Bed Evaluation Study | September 2008 | August 2009 | |
| NCT01215513 | Completed | Phase 3 | Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients | September 2010 | April 2012 |
| NCT01896713 | Completed | N/A | The Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate Cancer | April 2010 | December 2012 |
| NCT00057759 | Completed | N/A | Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer | January 2003 | |
| NCT02020135 | Completed | Phase 2 | An Open-label Extension Study of PSMA ADC 2301 in mCRPC | October 2013 | March 2015 |
| NCT04087174 | Completed | Phase 1 | A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer | August 5, 2019 | June 22, 2021 |
| NCT01018901 | Completed | N/A | Goals of Sexual Function in Prostate Cancer Survivors and Their Partners After Cancer Treatment | January 2009 | December 31, 2013 |
| NCT01424930 | Completed | Phase 2 | A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer | October 2011 | May 2013 |
| NCT00176579 | Completed | Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer | June 2003 | July 2008 | |
| NCT01244568 | Completed | N/A | Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2 | December 2010 | January 2013 |
| NCT03493997 | Completed | Phase 2 | Multicentre International STudy for the Prevention With Ialuril® of Radio-induced Cystitis (MISTIC) | April 4, 2017 | May 31, 2020 |
| NCT02518698 | Completed | Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population | August 31, 2015 | September 30, 2017 | |
| NCT03321149 | Completed | N/A | Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy | July 1, 2015 | October 1, 2016 |
| NCT03790995 | Completed | Functional Outcomes and QoL in Patients With High Versus Low and Intermediate Risk Prostate Cancer Treated by RARP | October 2009 | February 2018 | |
| NCT01310894 | Completed | Phase 3 | Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance. | February 2011 | August 2015 |
| NCT02784314 | Completed | N/A | Cost Efficacy Evaluation of Robot Assisted Radical Prostatectomy | May 2010 | August 2016 |
| NCT02551341 | Completed | Phase 3 | Lung Protective Ventilation During Robotic Assisted Prostatectomy | September 2015 | February 2017 |
| NCT00237146 | Completed | Phase 4 | Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy | November 2003 | March 2008 |
| NCT03315585 | Completed | N/A | The Efficacy and Safety of Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Focal Therapy | April 27, 2017 | October 27, 2017 |
| NCT00215709 | Completed | Phase 1 | Bi-Weekly Administration of Docetaxel for Older Men With Hormone Refractory Prostate Cancer | July 2004 | July 2007 |
| NCT00856102 | Completed | N/A | Exercise and Cognitive-psychosocial Functions in Men With Prostate Cancer Receiving Androgen Depletion Therapy | March 2009 | December 2010 |
| NCT00828633 | Completed | Health-Related Quality of Life in Gay Men With Localized Prostate Cancer | August 2008 | June 2015 | |
| NCT03650153 | Completed | N/A | Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal | January 1, 2020 | December 31, 2022 |
| NCT00031746 | Completed | Phase 2 | Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels | February 2000 | June 2006 |
| NCT02747342 | Completed | Phase 1 | A Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate Cancer | September 2016 | June 28, 2020 |
| NCT02388308 | Completed | Evaluation of Clarity Ultrasound Guidance for Prostate Therapy | May 15, 2015 | June 18, 2018 | |
| NCT00779402 | Completed | Phase 3 | PROvenge Treatment and Early Cancer Treatment | October 2001 | May 2015 |
| NCT04094519 | Completed | Phase 1 | A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer | January 27, 2020 | December 27, 2020 |
| NCT05172986 | Completed | N/A | Enhanced Recovery Program After a Robotic-assisted Surgery (RAAC) of Radical Prostatectomy. PROSTA-RAAC | October 27, 2021 | December 31, 2023 |
| NCT05022576 | Completed | N/A | Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy | January 30, 2019 | September 30, 2020 |
| NCT00219219 | Completed | Phase 4 | Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases | September 2003 | October 2006 |
| NCT00427999 | Completed | Phase 2 | Combined Antiinflammatory and Angiostatic Therapy in Patients With Hormone-refractory Prostate Cancer | February 2007 | August 2015 |
| NCT03516110 | Completed | Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy | March 9, 2018 | February 28, 2020 | |
| NCT01611038 | Completed | N/A | Methylselenocysteine Effects on Circadian Rhythm | October 2011 | June 2015 |
| NCT00242060 | Completed | N/A | Functional and Morphologic MRI in the Detection of Prostate Cancer in Patients With Prior Negative Biopsy | November 2002 | November 2008 |
| NCT00087035 | Completed | Phase 2 | Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer | May 2004 | March 2008 |
| NCT00983710 | Completed | Phase 2 | Prostate Cancer Symptom Management for Low Literacy Men | May 2009 | December 2017 |
| NCT00893035 | Completed | Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients | June 2006 | October 29, 2019 | |
| NCT00743379 | Completed | Phase 1/Phase 2 | Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors | August 2008 | March 2014 |
| NCT02825225 | Completed | N/A | A Prospective Randomized Trial of Two Different Prostate Biopsy Schemes | May 2012 | June 2016 |
| NCT01547299 | Completed | Phase 2 | Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer | March 31, 2012 | November 30, 2013 |
| NCT02651948 | Completed | Phase 4 | Transperineal, MRI-guided, Prostate Biopsy | May 1, 2015 | February 1, 2024 |
| NCT01162395 | Completed | Phase 1 | Open Label Prostate Cancer Study | August 2010 | October 2015 |
| NCT04869462 | Completed | DS Titanium Ligation Clip in Urology (Prostatectomy and Nephrectomy) | May 27, 2021 | January 29, 2022 | |
| NCT01136226 | Completed | Phase 4 | Evaluate Recovery of Testosterone for Patients Using Eligard | October 2003 | June 2009 |
| NCT05736094 | Completed | N/A | Ultrasound for Detection of Prostate Cancer | February 14, 2023 | March 31, 2024 |
| NCT00090363 | Completed | Phase 2 | ZD4054 (Zibotentan) in Pain-free or Mildly Symptomatic Patients With Prostate Cancer and Bone Metastases Who Have Rising Serum Prostate Specific Antigen (PSA) | July 2004 | August 2011 |
| NCT02279862 | Completed | Phase 2 | Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive | December 2, 2014 | December 15, 2016 |
| NCT00450619 | Completed | Phase 2 | 153Sm-EDTMP With or Without a PSA/TRICOM Vaccine To Treat Men With Androgen-Insensitive Prostate Cancer | February 2007 | November 2012 |
| NCT01605097 | Completed | N/A | High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule | May 2012 | July 2018 |
| NCT00003400 | Completed | Phase 2 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer | September 1998 | March 2000 |
| NCT03213951 | Completed | Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection and Evaluation of PSMA-PET for Diagnosis of Intraprostatic Lesions | August 18, 2017 | November 13, 2019 | |
| NCT00012142 | Completed | Phase 2 | CCI-779 in Treating Patients With Prostate Cancer | September 2000 | March 2004 |
| NCT05195190 | Completed | Validity, Reliability and Minimum Detectable Changes of 2-Minute Walk , Timed Up and Go, Sit and Stand Test in Patients With Prostate Cancer | February 20, 2022 | October 20, 2022 | |
| NCT01792687 | Completed | Phase 1 | Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate | February 5, 2013 | February 13, 2024 |
| NCT00460031 | Completed | Phase 2 | Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | September 1, 2006 | August 31, 2010 |
| NCT05317143 | Completed | Evaluation of Prostate Cancer Margins | February 22, 2022 | November 10, 2022 | |
| NCT01810627 | Completed | Application of Megavoltage Imaging to Reduce Artifact After Seed Implants | September 2013 | April 2016 | |
| NCT03840200 | Completed | Phase 1 | A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer. | June 12, 2019 | January 4, 2022 |
| NCT00099086 | Completed | Phase 1 | Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer | January 16, 2007 | December 13, 2023 |
| NCT00637208 | Completed | N/A | Sclerotherapy of Internal Spermatic Veins in Patients With Varicocele and Localized Prostate Cancer | November 2007 | March 2008 |
| NCT03927521 | Completed | N/A | Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study | June 23, 2020 | March 11, 2024 |
| NCT00340717 | Completed | Markers for Early Detection of Prostate Cancer | May 2003 | ||
| NCT00466440 | Completed | Phase 2 | A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients | June 2007 | June 2010 |
| NCT00027794 | Completed | Phase 2 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | September 2001 | |
| NCT01987999 | Completed | Phase 2 | Eradication of Prostate Cancer Using F-989 | February 2013 | December 2015 |
| NCT01753297 | Completed | Phase 4 | A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients. | December 11, 2012 | September 9, 2019 |
| NCT06206993 | Completed | N/A | Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical Prostatectomy | September 1, 2019 | April 1, 2024 |
| NCT00245895 | Completed | Phase 2 | Study of Aranesp to Treat Anemia in Prostate Cancer Patients. | April 2003 | February 2005 |
| NCT03675529 | Completed | N/A | The Effect of Exercise on Tumor Hypoxia in Men With Localized Prostate Cancer Undergoing Radical Prostatectomy. | October 1, 2018 | November 24, 2019 |
| NCT00022919 | Completed | Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods | August 2001 | August 2004 | |
| NCT05131815 | Completed | N/A | The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors | January 10, 2022 | August 21, 2023 |
| NCT00853710 | Completed | N/A | Test Semiquantitative Prostate Specific Antigen (PSA) | March 2009 | July 2009 |
| NCT01447186 | Completed | Adaptation of the American Cancer Society (ACS) Early Detection of Prostate Cancer Patient Decision Aid for Spanish Speaking Men | September 21, 2012 | January 13, 2015 | |
| NCT01415960 | Completed | Phase 3 | Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer | September 2011 | November 2013 |
| NCT01946165 | Completed | Phase 2 | Abiraterone Acetate Plus LHRH Agonist and Abiraterone Acetate Plus LHRH Agonist and Enzalutamide | October 31, 2013 | July 28, 2017 |
| NCT01591122 | Completed | Phase 3 | Study of Abiraterone Acetate Plus Prednisone in Patients With Chemo-naive Metastatic Castration-Resistant Prostate Cancer | March 27, 2012 | January 31, 2019 |
| NCT04862533 | Completed | N/A | Effect of Beta-alanine and Pelvic Floor Muscle Training on Urinary Incontinence After Radical Prostatectomy (BELA) | February 1, 2020 | October 1, 2022 |
| NCT01921803 | Completed | Phase 2 | Hypofractionated Radiotherapy as Primary Therapy for Prostate Cancer | August 1, 2013 | July 14, 2020 |
| NCT02035475 | Completed | N/A | Prevention of Lymphoceles After Robotic PLND | August 2014 | December 2014 |
| NCT02156869 | Completed | N/A | Impact of a Printed Decision Aid on Patients' Intent to Undertake Prostate Cancer Screening | November 2012 | June 2014 |
| NCT01578655 | Completed | Phase 3 | Comparison of Cabazitaxel/Prednisone Alone or in Combination With Custirsen for 2nd Line Chemotherapy in Prostate Cancer | August 2012 | July 2016 |
| NCT02262910 | Completed | Phase 1 | Study of ES414 in Metastatic Castration-Resistant Prostate Cancer | January 2015 | February 18, 2019 |
| NCT00003607 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | December 1997 | January 2015 |
| NCT00003626 | Completed | Phase 2 | Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy | October 1998 | May 2000 |
| NCT01252693 | Completed | Phase 2 | International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer | November 2010 | May 2015 |
| NCT03639649 | Completed | N/A | STHLM3 - Prostate Cancer Diagnostic Trial | August 2013 | February 2015 |
| NCT02702453 | Completed | N/A | True NTH Sexual Recovery Intervention for Prostate Cancer Survivors and Their Partners | March 2016 | November 2019 |
| NCT02726009 | Completed | Phase 4 | A Trial to Evaluate Safety of Firmagon® (Degarelix) in Indian Patients Diagnosed With Advanced Hormone-dependent Prostate Cancer | May 2016 | May 15, 2020 |
| NCT03017313 | Completed | To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients | July 13, 2017 | June 14, 2021 | |
| NCT03264456 | Completed | Phase 1/Phase 2 | Pretreatment Staging of High-Risk Prostate Cancer With 18F-Fluciclovine PET/MRI | November 8, 2017 | February 13, 2020 |
| NCT00662324 | Completed | Development of a Clinical Trial Specific Question Prompt List | April 2008 | May 2013 | |
| NCT04060043 | Completed | Early Phase 1 | Pilot Study to Evaluate the Effects of a Generic Goserelin Acetate in Patients With Prostate Cancer | February 21, 2017 | January 2, 2018 |
| NCT03062254 | Completed | Phase 2 | Metabolic Change in Prostate Cancer Bone Metastases on 68Ga-HBED-CC-PSMA PET/CT Following Radium-223 Therapy | March 22, 2018 | July 15, 2021 |
| NCT01572701 | Completed | Phase 1 | Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging in Men With Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection | January 2012 | |
| NCT02437539 | Completed | Phase 1 | Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | May 2015 | August 2015 |
| NCT01784757 | Completed | Phase 1 | Bioavailability Study of ODM-201 in Subjects With Metastatic Chemotherapy-naive Castration-resistant Prostate Cancer | March 2013 | December 2020 |
| NCT00269555 | Completed | N/A | Effects of GCP on Prostate Cancer. | May 2004 | September 2006 |
| NCT01429064 | Completed | Phase 2 | Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001 | June 2011 | November 2015 |
| NCT00003653 | Completed | Phase 3 | Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer | January 5, 1999 | January 10, 2013 |
| NCT02640131 | Completed | N/A | A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study | January 2014 | May 2017 |
| NCT00789607 | Completed | N/A | Fiducial Localization and Individualized Radiotherapy -Prostate Cancer | June 2008 | May 12, 2023 |
| NCT02456571 | Completed | CTC Immune Checkpoint | November 2016 | June 13, 2019 | |
| NCT01199146 | Completed | Phase 2 | Abiraterone Post Ketoconazole for Prostate Cancer | September 10, 2010 | March 14, 2016 |
| NCT04803305 | Completed | Phase 1 | Study to Compare the Effects of Repeated Doses of an Investigational New Drug and a Placebo on Appetite in Advanced Cancer and Anorexia | May 11, 2021 | August 9, 2022 |
| NCT00124410 | Completed | Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation | January 2000 | ||
| NCT02199197 | Completed | Phase 2 | Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer | June 25, 2014 | October 3, 2019 |
| NCT00554229 | Completed | Phase 3 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases | November 2007 | August 2011 |
| NCT02441894 | Completed | Phase 4 | Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer | April 2015 | November 2016 |
| NCT04037800 | Completed | N/A | An RCT to Compare Early Continence Recovery After RARP With or Without Sustainable Functional Urethral Reconstruction | December 8, 2019 | September 28, 2021 |
| NCT00776594 | Completed | Phase 2 | Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy | October 2008 | September 2016 |
| NCT02107430 | Completed | Phase 2 | Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer | March 2012 | October 2018 |
| NCT00777959 | Completed | Phase 2 | Bicalutamide and Ridaforolimus in Men With Prostate Cancer (MK-8669-002) | October 2008 | June 2011 |
| NCT03396874 | Completed | Phase 2 | Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence | February 9, 2018 | August 9, 2022 |
| NCT00869739 | Completed | N/A | Helping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate Cancer | August 2008 | July 2012 |
| NCT04317690 | Completed | Online Trial Examining Validity and Reliability of the Shared Decision Making Process Survey | March 17, 2020 | June 29, 2020 | |
| NCT00038246 | Completed | Phase 1/Phase 2 | Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma | October 2000 | December 2004 |
| NCT00526331 | Completed | Phase 4 | Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | August 2007 | September 2008 |
| NCT02153918 | Completed | Phase 2 | Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy | May 31, 2014 | January 16, 2018 |
| NCT00005627 | Completed | Phase 1 | Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | March 1999 | April 2003 |
| NCT00831623 | Completed | N/A | Study of Hypofractionated Proton Beam Radiation Therapy for Prostate Cancer | February 17, 2009 | July 18, 2019 |
| NCT01088529 | Completed | Phase 2 | Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer | December 2009 | March 2013 |
| NCT01715129 | Completed | Phase 3 | Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer | January 2013 | October 2013 |
| NCT03151512 | Completed | UNDISTORT Correction of Distortions in Diffusion MRI V1.0 | March 29, 2017 | March 31, 2021 | |
| NCT01105130 | Completed | Phase 2 | L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors | October 1, 2010 | February 4, 2014 |
| NCT01905488 | Completed | Perioperative Changes of Cognitive Function According to Jugular Vein Insufficiency in Robot-assisted Prostatectomy | May 2009 | November 2009 | |
| NCT03331068 | Completed | French Validation of the Memorial Anxiety Scale for Patients With Prostate Cancer. | April 26, 2016 | November 1, 2017 | |
| NCT02050542 | Completed | N/A | Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies. | June 2014 | February 2015 |
| NCT00770848 | Completed | Phase 1/Phase 2 | AMG 102 in Combination With Mitoxantrone and Prednisone in Subjects With Previously Treated Castrate Resistant Prostate Cancer | November 2008 | April 2012 |
| NCT00006365 | Completed | Phase 2 | External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer | November 2000 | November 2013 |
| NCT00507351 | Completed | Ambulatory Cancer Pain Management: A Feasibility Study | July 2006 | July 2009 | |
| NCT00005028 | Completed | Phase 2 | Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer | May 2000 | July 2006 |
| NCT04046653 | Completed | N/A | Accumulation of Dietary Bioactives and Prostate Cancer | July 3, 2019 | January 12, 2020 |
| NCT02645136 | Completed | N/A | The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence | January 2014 | July 2015 |
| NCT00348465 | Completed | Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds | May 2006 | March 2008 | |
| NCT03091231 | Completed | Multiparametric Ultrasound-Study for the Detection of Prostate Cancer | May 15, 2017 | March 31, 2018 | |
| NCT01525914 | Completed | Response of Patients on Surveillance for Prostate Cancer to Dutasteride | May 2010 | August 2010 | |
| NCT02022371 | Completed | Phase 1/Phase 2 | Prostate Cancer Genomic Heterogeneity | September 2014 | June 2016 |
| NCT01025479 | Completed | Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent | November 2009 | March 2010 | |
| NCT00562315 | Completed | Phase 2 | FACBC PET/CT for Recurrent Prostate Cancer | October 2007 | July 2015 |
| NCT02362464 | Completed | Phase 2 | Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 | May 12, 2015 | March 25, 2022 |
| NCT00588640 | Completed | Phase 1/Phase 2 | Study of D-Methadone in Patients With Chronic Pain | October 2004 | July 2008 |
| NCT00270166 | Completed | Phase 3 | The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | February 1995 | May 1998 |
| NCT02135484 | Completed | N/A | Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases | September 19, 2014 | November 11, 2020 |
| NCT03335631 | Completed | N/A | Preference-Based Exercise RCT for Men With PC on ADT | October 19, 2017 | April 30, 2020 |
| NCT00417040 | Completed | N/A | Collection of Patient-Reported Symptoms and Performance Status Via the Internet | December 2006 | June 1, 2017 |
| NCT02402621 | Completed | N/A | Comparison Between Conventional and Model-based Infusion Strategy of IV PCA in Patients Undergoing RALP | April 2015 | September 2015 |
| NCT00241475 | Completed | Phase 2 | Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy | December 2003 | October 2005 |
| NCT01601691 | Completed | N/A | Protection of Rectum From High Radiation Doses | April 2012 | March 2013 |
| NCT00959335 | Completed | Phase 1 | Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions | August 2006 | August 2006 |
| NCT02001597 | Completed | Intra-operative Trans-rectal Ultrasound Guidance for Robot-assisted Radical Prostatectomy | March 2013 | November 2013 | |
| NCT00379782 | Completed | N/A | Kukui Ahi Navigator Cancer Screening and Treatment Demonstration Project | October 2006 | March 2011 |
| NCT02024178 | Completed | N/A | Ultrasound Imaging in Finding Prostate Cancer in Patients Undergoing Surgery | June 2011 | May 2012 |
| NCT00811265 | Completed | Phase 1 | Safety Evaluation of ExAblate MRgFUS for Prostate Cancer | January 2009 | June 2013 |
| NCT01588262 | Completed | N/A | Early Rehabilitation of Cancer Patients | May 2011 | August 2015 |
| NCT01615120 | Completed | Phase 2 | Study of the Effect of GTx-758 on Serum PSA and Testosterone in Men With Prostate Cancer | August 14, 2012 | November 9, 2016 |
| NCT03961217 | Completed | Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes | January 1991 | December 2016 | |
| NCT00003394 | Completed | Phase 1/Phase 2 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | April 1998 | April 2003 |
| NCT03397160 | Completed | N/A | Pioneering Advances in Care and Education (PACE) | July 19, 2018 | September 30, 2020 |
| NCT00006023 | Completed | Phase 2 | Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | March 2000 | June 2001 |
| NCT01692587 | Completed | N/A | Does Protein Restriction Inhibit Prostrate Cancer Growth | January 2011 | March 2015 |
| NCT01511874 | Completed | Phase 4 | Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer | January 2011 | December 2013 |
| NCT02981797 | Completed | Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 | July 22, 2015 | November 5, 2020 | |
| NCT00450463 | Completed | Phase 2 | Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer | February 23, 2007 | June 8, 2017 |
| NCT01496131 | Completed | Phase 2 | Tecemotide (L-BLP25) in Prostate Cancer | October 24, 2011 | November 25, 2016 |
| NCT00541788 | Completed | Phase 1 | Evaluation of the Efficacy and Safety of Common Sage in Controlling Hot Flashes in Prostate Cancer Patients Treated by Androgen Deprivation | October 2007 | June 2010 |
| NCT00670553 | Completed | Phase 1 | A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer | September 2008 | January 2010 |
| NCT00023686 | Completed | Phase 3 | Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer | October 2001 | April 2004 |
| NCT05527483 | Completed | Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients | April 21, 2022 | October 10, 2022 | |
| NCT01410656 | Completed | N/A | Prostate Cancer Survivors Moving Toward Exercise (PROMOTE) Trial | May 2011 | September 2012 |
| NCT03911310 | Completed | Phase 3 | [18F]PSMA-11 PET/CT Phase 3 Clinical Study | April 1, 2019 | September 20, 2020 |
| NCT00025116 | Completed | Phase 2 | ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | April 24, 2001 | September 22, 2008 |
| NCT00005916 | Completed | Phase 2 | PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer | June 13, 2000 | December 22, 2005 |
| NCT02282644 | Completed | N/A | Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry | September 8, 2014 | August 25, 2017 |
| NCT03017456 | Completed | N/A | PC 360 Survivorship | May 29, 2017 | January 31, 2020 |
| NCT00446901 | Completed | N/A | Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene Expression | June 2007 | January 2011 |
| NCT00590213 | Completed | Phase 4 | Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX | June 2003 | |
| NCT00977860 | Completed | N/A | Hypofractionated SBRT For Prostate Cancer | October 7, 2010 | July 8, 2022 |
| NCT00268593 | Completed | Phase 2 | Pilot Efficacy Study of PI-88 With Docetaxel to Treat Prostate Cancer | August 2005 | February 2008 |
| NCT03911999 | Completed | Exosomal microRNA in Predicting the Aggressiveness of Prostate Cancer in Chinese Patients | May 3, 2018 | December 31, 2020 | |
| NCT00451958 | Completed | Phase 3 | A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy | March 2007 | December 2011 |
| NCT00450229 | Completed | Phase 1 | Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer | February 2007 | February 2010 |
| NCT03182998 | Completed | N/A | Decision Aids to Improve Knowledge in Patients With Prostate Cancer | July 14, 2017 | February 4, 2022 |
| NCT00026377 | Completed | Phase 1 | SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer | November 2001 | April 2003 |
| NCT00005096 | Completed | Phase 2 | Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer | December 1999 | June 2002 |
| NCT00341939 | Completed | Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data | September 7, 2004 | June 12, 2024 | |
| NCT00400517 | Completed | Phase 2 | GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer | March 2003 | June 2008 |
| NCT00002881 | Completed | Phase 3 | Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer | October 1996 | |
| NCT01204710 | Completed | Phase 2 | A Study of Olaratumab (IMC-3G3) in Prostate Cancer | October 2010 | October 2013 |
| NCT01041326 | Completed | Phase 1 | Preoperative Radiation Therapy for High Risk Prostate Cancer | April 2005 | April 2013 |
| NCT00984919 | Completed | Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers | November 2009 | February 2011 | |
| NCT05141760 | Completed | Phase 2 | 18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients | February 10, 2022 | June 15, 2023 |
| NCT03262103 | Completed | Phase 1 | Neoadjuvant Hiltonol® (PolyICLC) for Prostate Cancer | June 16, 2017 | May 6, 2022 |
| NCT02390063 | Completed | Phase 1 | Vaccination in Prostate Cancer (VANCE) | June 2015 | May 15, 2019 |
| NCT00692653 | Completed | N/A | Personal Patient Profile Prostate (P4) Randomized, Multisite Trial | February 2007 | December 2009 |
| NCT02745496 | Completed | N/A | Advanced Magnetic Resonance Imaging (MRI) in Men With Suspected Prostate Cancer | December 2014 | December 2020 |
| NCT00241384 | Completed | Phase 3 | Low Dose Supplemental External Radiation With Pd-103 Versus Pd-103 Alone for Prostate Cancer | January 2005 | November 2015 |
| NCT00014352 | Completed | Phase 2 | Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer | September 2000 | |
| NCT00199849 | Completed | Phase 1 | NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine | September 27, 2004 | September 2007 |
| NCT03228108 | Completed | Phase 4 | Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. | April 3, 2018 | September 26, 2021 |
| NCT04299997 | Completed | Evaluation of the PI-RADS v2.1 Score Using Multiple Readers | September 1, 2019 | June 30, 2020 | |
| NCT00558272 | Completed | Phase 2 | Study to Evaluate the Safety and Effects AZD0530 on Prostate and Breast Cancer Subjects With Metastatic Bone Disease | February 2008 | August 2012 |
| NCT00072930 | Completed | Phase 2 | MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer | December 2003 | June 2007 |
| NCT00142506 | Completed | Phase 3 | Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer | February 2005 | April 2014 |
| NCT03412786 | Completed | Phase 1 | Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases | May 1, 2018 | December 8, 2021 |
| NCT01886547 | Completed | 2013 Annual National Digital Rectal Exam (DRE) Day Study | June 2013 | October 2014 | |
| NCT03160365 | Completed | N/A | Innovative Planning and Guidance System for Prostate Focal Brachytherapy | April 6, 2018 | May 25, 2021 |
| NCT03822871 | Completed | Phase 1 | A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer | April 1, 2019 | February 8, 2023 |
| NCT00003690 | Completed | Phase 1 | Flavopiridol Plus Cisplatin or Carboplatin in Treating Patients With Advanced Solid Tumors | December 1998 | September 2003 |
| NCT05332340 | Completed | Phase 1 | Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered | November 16, 2022 | November 30, 2022 |
| NCT00004045 | Completed | Phase 2 | Chemotherapy in Treating Patients With Prostate Cancer | June 1999 | August 2001 |
| NCT03418324 | Completed | Phase 2 | Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy | March 5, 2018 | November 6, 2019 |
| NCT00093561 | Completed | Phase 1 | Lycopene in Preventing Prostate Cancer in Healthy Participants | August 2004 | February 2006 |
| NCT01459653 | Completed | Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor | March 2010 | August 2013 | |
| NCT00695851 | Completed | Phase 1 | Dose-Seeking Trial of PCK3145 in Asymptomatic, Castrate Metastatic Prostate Cancer Patients. | March 2005 | March 2009 |
| NCT00002874 | Completed | Phase 3 | Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy | February 1998 | May 20, 2022 |
| NCT02689271 | Completed | CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr | April 2016 | December 2019 | |
| NCT05506735 | Completed | The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family History | May 1, 2022 | August 17, 2022 | |
| NCT00913068 | Completed | N/A | Postoperative Pain Control for Prostatectomy | July 2009 | September 2011 |
| NCT01444456 | Completed | Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia | October 2011 | ||
| NCT00688532 | Completed | Study of Coronary Heart Disease (CHD) & Heart Failure (HF) Risk in Prostate Cancer Patients, Taking Casodex or Not | December 2007 | June 2009 | |
| NCT02108431 | Completed | N/A | Prospective Randomized Trial Comparing Urinary Diversion After Robot-assisted Radical Prostatectomy | February 2013 | November 2013 |
| NCT04892914 | Completed | N/A | Embr Thermal Device for Hot Flash Management in Prostate Cancer | May 28, 2021 | December 5, 2021 |
| NCT00037024 | Completed | N/A | Study of Health Promotion in Patients With Early-Stage Breast or Prostate Cancer | April 2002 | October 2004 |
| NCT00223665 | Completed | Phase 2 | Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer | January 8, 1997 | September 6, 2012 |
| NCT00321646 | Completed | Phase 2 | Neoadjuvant Bevacizumab Plus Docetaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy | June 2006 | December 2012 |
| NCT00499408 | Completed | Phase 2 | Vitamin D and Soy Supplements in Treating Patients With Recurrent Prostate Cancer | April 2007 | December 2012 |
| NCT00365105 | Completed | Phase 3 | Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast Cancer | July 11, 2006 | February 27, 2017 |
| NCT01229618 | Completed | Phase 1 | Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer | October 2010 | August 2013 |
| NCT03292874 | Completed | N/A | High Resolution MRI Study for Prostate Cancer | September 13, 2017 | December 14, 2022 |
| NCT00769431 | Completed | N/A | Evaluating Symptom Management Educational Materials for Patients With Prostate Cancer | May 2008 | July 2009 |
| NCT00949338 | Completed | N/A | Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer. ICORG 05-04 | March 2006 | |
| NCT00151047 | Completed | Phase 2 | Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer | March 2003 | October 2007 |
| NCT00553878 | Completed | Phase 2/Phase 3 | Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer | March 2007 | December 2012 |
| NCT00373308 | Completed | Quality of Life Following Radical Prostatectomy | September 2002 | December 25, 2020 | |
| NCT00739791 | Completed | N/A | Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer | September 2003 | June 2005 |
| NCT01234350 | Completed | A Safety Study in Patients With Advanced Prostate Cancer Treated With FIRMAGON | January 2011 | March 27, 2018 | |
| NCT00859768 | Completed | N/A | The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients | April 2008 | October 2010 |
| NCT05960669 | Completed | N/A | Nerve-sparing, Robot-assisted Radical Prostatectomy Using a Personalized, 3D-printed Prostate Model for Selective Resection of Positive Surgical Margins | August 1, 2018 | August 26, 2022 |
| NCT05525806 | Completed | N/A | Clinical Utility Study for MyProstateScore+ | September 12, 2022 | June 4, 2023 |
| NCT00200187 | Completed | Phase 2 | A Randomized Study of the Efficacy of Low Venous Pressure General Anesthesia Versus Combined Spinal-Epidural Anesthesia in Decreasing Blood Loss During Prostate Surgery | February 2005 | January 2007 |
| NCT03077126 | Completed | N/A | Feasibility Study of Ultrasound Elastography Detecting Prostate Cancer | April 11, 2013 | September 18, 2015 |
| NCT00878436 | Completed | Phase 1/Phase 2 | Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castration | June 2009 | July 2015 |
| NCT02280356 | Completed | Phase 2 | Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer | October 28, 2014 | January 9, 2023 |
| NCT00898326 | Completed | PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer | April 1, 2011 | December 31, 2016 | |
| NCT00499694 | Completed | N/A | Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel | October 2007 | November 2012 |
| NCT03602079 | Completed | Phase 1/Phase 2 | Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene | July 16, 2018 | January 12, 2022 |
| NCT00002480 | Completed | Phase 1 | Radiation Therapy in Treating Patients With Prostate Cancer | February 1991 | August 2005 |
| NCT01006395 | Completed | Phase 2/Phase 3 | Prevention of Micro-architectural Bone Decay in Males With Non-metastatic Prostate Cancer Receiving Androgen Deprivation Therapy (ADT) | January 2011 | April 2019 |
| NCT00138918 | Completed | Phase 2 | Study of OGX-011 Given Prior to Radical Prostatectomy in Patients With Localized Prostate Cancer | June 2005 | May 13, 2008 |
| NCT02409212 | Completed | Phase 2 | Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer | May 2015 | December 2018 |
| NCT02107404 | Completed | Phase 2 | Phase II Study of DCVAC/PCa Added After Radical Primary Prostatectomy for Patients With Localized Prostate Cancer | April 2012 | May 22, 2017 |
| NCT00207259 | Completed | N/A | Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial | March 2005 | June 15, 2017 |
| NCT00582530 | Completed | Men Undergoing Radical Prostatectomy | December 28, 2004 | June 21, 2022 | |
| NCT00293696 | Completed | Phase 4 | Casodex/Zoladex Biomarkers in Localised Prostate Cancer | October 2004 | November 2006 |
| NCT04555343 | Completed | Phase 1/Phase 2 | Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention | March 1, 2021 | October 30, 2021 |
| NCT04867603 | Completed | Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions | June 29, 2021 | October 3, 2022 | |
| NCT02090114 | Completed | Phase 2 | RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) | August 25, 2014 | November 11, 2021 |
| NCT00002637 | Completed | Phase 1/Phase 2 | Biological Therapy in Treating Patients With Prostate Cancer | January 1995 | February 2001 |
| NCT00485303 | Completed | Phase 2 | An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy | June 2007 | October 2011 |
| NCT04066361 | Completed | N/A | OPTimizing Treatment Focused Genetic Testing IN Cancer | December 19, 2019 | November 30, 2022 |
| NCT02324998 | Completed | Phase 1 | Study of Olaparib (± Degarelix) Given to Men With Intermediate/High Risk Prostate Cancer Before Prostatectomy | December 2016 | May 2019 |
| NCT03275857 | Completed | Early Phase 1 | Cisplatin in Castration Resistant Prostate Cancer | September 21, 2018 | July 31, 2023 |
| NCT00201916 | Completed | Phase 3 | Shorter Radiation Schedule for the Treatment of Prostate Cancer | March 1995 | December 2009 |
| NCT00061867 | Completed | Phase 1 | Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer | March 2003 | August 2005 |
| NCT00289341 | Completed | Phase 1/Phase 2 | Safety and Effectiveness of a Vaccine for Prostate Cancer That Uses Each Patients' Own Immune Cells. | March 2002 | November 2008 |
| NCT00002981 | Completed | N/A | PET Scan in Treating Patients With Metastatic Prostate Cancer | January 1997 | June 12, 2023 |
| NCT05109884 | Completed | N/A | Comparison of PET Imaging Patterns With PSMA and AR Expression in Prostate Cancer and Bladder Cancer | February 1, 2020 | April 19, 2021 |
| NCT00819247 | Completed | Phase 2 | The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer | March 2001 | August 2002 |
| NCT03365297 | Completed | Phase 2 | Therapeutics in Active Prostate Cancer Surveillance | June 5, 2018 | July 25, 2019 |
| NCT00243048 | Completed | Phase 2 | Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer | May 2002 | October 2007 |
| NCT00062309 | Completed | Phase 3 | Comparison of Two Radiation Therapy Regimens in Treating Patients With Stage II or Stage III Prostate Cancer | June 2002 | |
| NCT00214162 | Completed | N/A | CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer | August 2004 | April 2008 |
| NCT02397629 | Completed | Using Serum Parathyroid Hormones and Calcium to Improve Prostate Cancer Diagnosis | May 2013 | May 2016 | |
| NCT02761135 | Completed | Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique? | January 2011 | March 2018 | |
| NCT02121639 | Completed | Phase 1/Phase 2 | Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy | January 29, 2014 | September 13, 2021 |
| NCT00831792 | Completed | Phase 2 | TKI258 in Castrate Resistant Prostate Cancer | April 7, 2010 | June 12, 2017 |
| NCT03194516 | Completed | Ketogenic Diet and Prostate Cancer Surveillance Pilot | June 12, 2017 | November 13, 2019 | |
| NCT00093457 | Completed | Phase 2 | Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer | August 10, 2004 | January 18, 2011 |
| NCT00138008 | Completed | Phase 3 | Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy | May 2004 | May 2016 |
| NCT00181584 | Completed | Phase 2 | Zoledronic Acid to Prevent Bone Loss During Androgen Deprivation Therapy for Prostate Cancer | September 2003 | |
| NCT03081481 | Completed | Phase 2 | Intraprostatic PRX302 Injection to Treat Localised Prostate Cancer | June 7, 2017 | April 5, 2019 |
| NCT02457715 | Completed | Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis | July 2015 | October 2017 | |
| NCT02149628 | Completed | Phase 4 | The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide | May 2014 | February 2015 |
| NCT00282906 | Completed | N/A | FDG Positron Emission Tomography and Computed Tomography (PET-CT) in Metastatic Prostate Cancer | October 3, 2005 | August 19, 2014 |
| NCT00790595 | Completed | Phase 1 | Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy | June 2006 | |
| NCT03486886 | Completed | N/A | PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility | October 2, 2017 | April 30, 2018 |
| NCT00375765 | Completed | Phase 4 | Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer | April 2005 | July 2007 |
| NCT00928434 | Completed | Phase 3 | A Study of Degarelix in Patients With Prostate Cancer | May 2009 | August 2012 |
| NCT02678832 | Completed | Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease | December 2015 | January 2019 | |
| NCT01148069 | Completed | Phase 2 | Surgery Combined With Intensity Modulated Radiation Therapy - Image-Guided Radiation Therapy (IMRT-IGRT) in Locally-advanced Prostate Cancers | July 30, 2010 | July 4, 2018 |
| NCT02132975 | Completed | N/A | Motorised Probe Holder Assisting Prostate Biopsies | May 2014 | May 2016 |
| NCT00081601 | Completed | Phase 2 | Study of CEP-701 in Treatment of Prostate Cancer | March 2004 | June 2005 |
| NCT00514267 | Completed | Phase 1/Phase 2 | An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors | May 2007 | March 2010 |
| NCT03950180 | Completed | N/A | Assessing The Impact Of Incorporating Charlson Comorbidity Scores On Patient Anxiety And Satisfaction | July 12, 2013 | February 27, 2015 |
| NCT02130700 | Completed | Phase 2 | Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer | April 2014 | November 2017 |
| NCT00016393 | Completed | Phase 2 | BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | June 2001 | April 2006 |
| NCT02001571 | Completed | Phase 1 | A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function | August 2009 | April 2010 |
| NCT01695044 | Completed | Phase 2 | A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC) | September 2012 | February 2015 |
| NCT03489057 | Completed | N/A | Efficacy of a Couple-Focused mHealth Symptom Self-management Program | May 30, 2018 | July 31, 2022 |
| NCT04604158 | Completed | N/A | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | December 2, 2020 | May 17, 2024 |
| NCT00338026 | Completed | Phase 1 | A Phase I Study of ECO-4601 in Patients With Advanced Cancer | February 2006 | August 2007 |
| NCT01046916 | Completed | Phase 2 | Safety and Efficacy Study of TAK-700 in Patients With Nonmetastatic Castration-resistant Prostate Cancer and a Rising Prostate-specific Antigen | May 2010 | March 2013 |
| NCT00183937 | Completed | Phase 2 | Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer | April 30, 2005 | June 11, 2012 |
| NCT04501055 | Completed | N/A | Anesthesia in PROstate Biopsy Pain Obstruction Study | August 13, 2020 | July 27, 2022 |
| NCT01317641 | Completed | Phase 1/Phase 2 | Safety and Pharmacokinetics Study of ODM-201 in Castrate Resistant Prostate Cancer | March 2011 | July 2013 |
| NCT00588679 | Completed | N/A | Magnetic Resonance Spectroscopic Imaging of the Prostate at 3 Tesla | August 22, 2006 | March 6, 2019 |
| NCT03726320 | Completed | N/A | Trial of Community Health Worker-led Decision Coaching | October 15, 2019 | September 20, 2023 |
| NCT00030290 | Completed | Phase 1 | Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate | October 2001 | February 2006 |
| NCT00939510 | Completed | Phase 1/Phase 2 | Lenalidomide and GM-CSF in Treating Patients With Prostate Cancer | July 2005 | December 2012 |
| NCT02034812 | Completed | Decision Impact Study to Measure the Influence of DECIPHER on Treatment Recommendations for Radiation Oncologists | July 2013 | July 2014 | |
| NCT03245736 | Completed | Phase 2 | Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | August 23, 2017 | January 10, 2019 |
| NCT00214097 | Completed | Phase 1/Phase 2 | Phase I/II Hypofractionated Radiotherapy for Prostate Cancer | October 14, 2002 | August 21, 2017 |
| NCT00523484 | Completed | Casodex/Zoladex Hormonal therApy Study for assessMent of Correlation Between PSA & BAI in prOstate Cancer patieNts | May 2007 | ||
| NCT00574899 | Completed | Prostate Biomarker Study | May 2007 | May 2011 | |
| NCT04838626 | Completed | Phase 2/Phase 3 | Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection | September 7, 2021 | November 24, 2023 |
| NCT00702104 | Completed | Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco Area | January 2003 | ||
| NCT00780754 | Completed | Phase 3 | Prevention of Prostate Cancer With Dutasteride in Case of High Grade PIN Neoplasia | April 2007 | December 2010 |
| NCT03558711 | Completed | Phase 1 | PSMA-PET/CT for Prostate Cancer | January 4, 2018 | March 29, 2018 |
| NCT00069888 | Completed | Phase 2 | A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following Prostatectomy | November 2001 | January 2007 |
| NCT04563936 | Completed | Phase 3 | Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX® | January 6, 2020 | March 9, 2021 |
| NCT03730324 | Completed | N/A | Predicting Prostate Biopsy Results With Biomarkers and mpMRI. | November 5, 2018 | June 1, 2022 |
| NCT03852017 | Completed | N/A | Investigating Mindfulness and Music to Ease Radiation Side Effects in Prostate Cancer | November 11, 2015 | January 8, 2018 |
| NCT00790374 | Completed | Phase 1 | BN83495 in Prostate Cancer | January 2009 | February 2011 |
| NCT01909440 | Completed | N/A | Resistance Training and Protein Supplementation for Prostate Cancer Survivors | July 8, 2013 | August 7, 2018 |
| NCT04853095 | Completed | N/A | Effect of Peritoneal Fixation on Lymphocele Formation | December 1, 2019 | January 1, 2022 |
| NCT01751451 | Completed | Phase 2 | 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy | December 18, 2012 | September 28, 2020 |
| NCT03149185 | Completed | N/A | Technology Based Psychosocial Intervention for Symptom Management and HRQOL in Men Living With Advanced Prostate Cancer | May 25, 2012 | April 22, 2018 |
| NCT00003045 | Completed | N/A | Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer | April 1997 | December 31, 2003 |
| NCT02131779 | Completed | N/A | Men's Prostate Awareness Church Training | February 2012 | January 4, 2018 |
| NCT02534376 | Completed | Early Phase 1 | Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal | September 2015 | February 28, 2019 |
| NCT01326286 | Completed | Comparative Effectiveness Analysis of Surgery and Radiation (CEASAR) for Localized Prostate Cancer | March 2011 | September 2018 | |
| NCT00779168 | Completed | Phase 1 | White Button Mushroom Extract in Treating Patients With Recurrent Prostate Cancer After Local Therapy | January 29, 2009 | June 10, 2021 |
| NCT00511498 | Completed | N/A | Effect of Nightly Versus Prn Sildenafil on Early Return of Erectile Function Following Laparoscopic Radical Prostatectomy | March 2006 | October 2008 |
| NCT05197257 | Completed | Phase 3 | 68Ga-PSMA-11 PET in Patients With Prostate Cancer | September 29, 2021 | April 14, 2022 |
| NCT00288080 | Completed | Phase 3 | Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer | December 2005 | May 20, 2022 |
| NCT02225093 | Completed | Phase 1 | A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer | October 2, 2013 | February 3, 2014 |
| NCT00587964 | Completed | Phase 2 | Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases | June 2004 | January 2009 |
| NCT00039624 | Completed | Phase 2 | Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer | June 3, 2002 | July 31, 2018 |
| NCT02233842 | Completed | Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors | September 2014 | August 2015 | |
| NCT01717053 | Completed | Phase 2 | Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer | January 17, 2014 | August 31, 2021 |
| NCT00992745 | Completed | Phase 1 | A Phase I Pilot Study Comparing 123I MIP 1072 Versus 111In Capromab Pendetide in Subjects With Metastatic Prostate Cancer | October 2009 | September 2011 |
| NCT02269982 | Completed | Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY | May 14, 2015 | April 30, 2019 | |
| NCT00140400 | Completed | Phase 1/Phase 2 | Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer | May 1999 | January 2001 |
| NCT00928174 | Completed | Phase 1/Phase 2 | Measurement of Anti-Androgen Response Using Fluorine-18 Fluorocholine PET/CT in Androgen-Insensitive Prostate Cancer | June 2009 | July 2013 |
| NCT00264420 | Completed | Phase 1 | Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation | December 2005 | March 2007 |
| NCT02321358 | Completed | N/A | Trial of a Behavior Change Intervention to Increase Aerobic and Resistance Exercise and Quality of Life in Older Prostate and Breast Cancer Survivors | September 2014 | September 2018 |
| NCT03232411 | Completed | Biobank for African American Prostate Cancer Research in Florida | March 22, 2017 | January 23, 2024 | |
| NCT03692104 | Completed | US-CT Fusion for Post Implant Dosimetry | November 3, 2017 | December 31, 2019 | |
| NCT04428203 | Completed | Phase 1 | Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer | August 3, 2020 | August 20, 2021 |
| NCT02411786 | Completed | Phase 1 | A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF | August 24, 2015 | November 28, 2020 |
| NCT01715064 | Completed | Phase 2/Phase 3 | Acute Effects of Exercise on the Cortical Silent Period in Prostate Cancer Patients | July 2012 | May 2013 |
| NCT01296672 | Completed | Phase 4 | 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer | February 2011 | January 2017 |
| NCT03617588 | Completed | Phase 2 | 68Ga-THP-PSMA PET/CT Imaging in High Risk Primary Prostate Cancer or Biochemical Recurrence of Prostate Cancer | June 18, 2018 | June 12, 2019 |
| NCT01867333 | Completed | Phase 2 | Enzalutamide With or Without Vaccine Therapy for Advanced Prostate Cancer | August 12, 2013 | October 26, 2022 |
| NCT02353832 | Completed | Phase 2 | Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer | November 6, 2014 | January 5, 2021 |
| NCT00004014 | Completed | Phase 2 | Liposomal Doxorubicin in Treating Patients With Prostate Cancer | April 1999 | November 2001 |
| NCT06029088 | Completed | Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer | January 12, 2023 | June 16, 2023 | |
| NCT00116779 | Completed | Phase 2 | A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer | February 2004 | August 2005 |
| NCT01193257 | Completed | Phase 3 | Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer. | November 15, 2010 | February 29, 2016 |
| NCT02570919 | Completed | N/A | Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer | September 1, 2015 | December 31, 2017 |
| NCT02974231 | Completed | Intensity-modulated Radiation Therapy From 70Gy to 80Gy in Localized Prostate Cancer | December 2014 | March 2015 | |
| NCT00108290 | Completed | Phase 2 | Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer | April 2004 | March 2007 |
| NCT01172028 | Completed | Phase 1 | Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors | September 2005 | July 2014 |
| NCT02494921 | Completed | Phase 1/Phase 2 | LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC | November 20, 2015 | July 30, 2021 |
| NCT00590993 | Completed | Magnetic Resonance Imaging and Spectroscopy of the Prostate | December 2000 | February 2013 | |
| NCT03348527 | Completed | Phase 2 | A Study to Evaluate the Safety, Tolerability and Efficacy of a Liproca® Depot Injection in Patients With Prostate Cancer | May 12, 2017 | November 30, 2020 |
| NCT01289067 | Completed | Phase 2 | Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca | December 2010 | May 2013 |
| NCT01660152 | Completed | N/A | Vacuum Erection Device in Improving Recovery of Erectile Function in Patients With Prostate Cancer Undergoing Surgery | September 2011 | July 17, 2013 |
| NCT00059943 | Completed | Phase 2 | Docetaxel in Treating Older Patients With Metastatic Breast, Lung, or Prostate Cancer | September 2002 | |
| NCT01535898 | Completed | Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers | February 2012 | February 2015 | |
| NCT01578356 | Completed | Oncological and Functional Outcomes After Radical Prostatectomy for Prostate Cancer: Comparing Open With Robot-assisted Surgery | January 1, 2009 | October 31, 2012 | |
| NCT01325961 | Completed | N/A | Medico-economic Evaluation Comparing Intensity-Modulated Radiation Therapy (IMRT) Performed by Helical Tomotherapy and Dynamic Arc Therapy in Prostate, Cervical and Anal Canal Cancers | March 2011 | February 2020 |
| NCT01174017 | Completed | Phase 3 | Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate | September 2010 | December 2011 |
| NCT00471432 | Completed | Phase 1 | OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors | April 4, 2003 | December 21, 2009 |
| NCT04337060 | Completed | N/A | Open Radical Prostatectomy and Erector Spinae Plane Block | May 1, 2020 | January 11, 2021 |
| NCT01317199 | Completed | Phase 1/Phase 2 | Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer | July 2011 | November 2015 |
| NCT00953225 | Completed | Phase 2 | Vitamin D Supplementation in Veterans With Early-Stage Prostate Cancer | January 7, 2010 | October 30, 2014 |
| NCT00738140 | Completed | Phase 2 | Lifestyle Intervention to Improve Insulin Sensitivity and Markers of Cardiovascular Risk in Prostate Cancer Survivors | September 2007 | September 2012 |
| NCT04550416 | Completed | N/A | Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study | May 2014 | January 2015 |
| NCT01193244 | Completed | Phase 3 | Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer | October 1, 2010 | April 7, 2016 |
| NCT00937833 | Completed | N/A | Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling | November 2009 | November 2014 |
| NCT03290417 | Completed | N/A | Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer | September 7, 2017 | December 20, 2019 |
| NCT05680675 | Completed | N/A | Dual-Tracer Theranostic PET | December 8, 2022 | June 4, 2024 |
| NCT00899912 | Completed | Changes in DNA After Radiation Therapy in Patients With Prostate Cancer | June 2006 | November 2013 | |
| NCT00270647 | Completed | N/A | Physicians' Health Study II | July 1997 | June 2011 |
| NCT02066961 | Completed | A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer | December 31, 2013 | November 14, 2019 | |
| NCT02680587 | Completed | Phase 2 | Stereotactic Body Radiation for Prostate Oligometastases | April 28, 2016 | October 31, 2022 |
| NCT02451345 | Completed | N/A | Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model | March 25, 2015 | April 30, 2020 |
| NCT03368378 | Completed | N/A | Early DVC Ligation and Urinary Continence Recovery After RARP | November 28, 2017 | February 10, 2020 |
| NCT00003329 | Completed | Identification of Genes Associated With Cancer in Patients and Siblings Who Have Cancer | April 7, 1998 | ||
| NCT02423889 | Completed | Phase 2 | Stereotactic Volumetric Radiotherapy in Prostate Cancer | April 2013 | |
| NCT00899665 | Completed | Proteases in Patients With Prostate Cancer That Has Spread to the Bone | July 2001 | January 2008 | |
| NCT00488982 | Completed | Phase 2 | Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC) | April 2007 | May 2014 |
| NCT03271502 | Completed | N/A | Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy | September 4, 2017 | October 1, 2017 |
| NCT00669162 | Completed | Phase 1/Phase 2 | Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer | August 2012 | April 2017 |
| NCT00441337 | Completed | Phase 1 | A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies | August 2006 | November 2009 |
| NCT01347320 | Completed | N/A | Preoperative Magnetic Resonance (MR) Imaging of Prostate Cancer | November 2009 | July 2012 |
| NCT00919035 | Completed | Phase 2 | Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients | June 2009 | October 2013 |
| NCT02785887 | Completed | N/A | Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients | August 1, 2014 | September 25, 2018 |
| NCT00554918 | Completed | Phase 2 | Docetaxel and Prednisolone With or Without Zoledronic Acid and/or Strontium Chloride Sr 89 in Treating Patients With Prostate Cancer Metastatic to Bone That Has Not Responded to Hormone Therapy | February 2005 | June 2013 |
| NCT01578902 | Completed | N/A | Hypofractionated Accelerated Radiotherapy for Low Risk Localized Prostate Cancer | October 2006 | April 2013 |
| NCT00027859 | Completed | Phase 3 | Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer | October 8, 2003 | |
| NCT00134355 | Completed | Phase 2 | Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer | July 2005 | March 2007 |
| NCT00303914 | Completed | Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer | March 14, 2006 | March 4, 2013 | |
| NCT01484665 | Completed | N/A | Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening | December 2011 | June 2012 |
| NCT00036075 | Completed | Phase 2 | Study Using CP-461 to Treat Advanced Prostate Cancer | August 2001 | December 2005 |
| NCT03388346 | Completed | Phase 2/Phase 3 | 68Ga PSMA in Preprostatectomy Patients | February 16, 2018 | July 22, 2021 |
| NCT01455792 | Completed | N/A | Biopsy Study Comparing MRI and Ultrasound Soft Image Fusion Guided Biopsies and Gold Standard Prostate Biopsies. | September 2011 | September 2013 |
| NCT00005848 | Completed | Phase 2 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | April 2000 | May 2007 |
| NCT00849121 | Completed | Phase 2 | Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer | March 16, 2009 | February 17, 2014 |
| NCT00151086 | Completed | Phase 1/Phase 2 | Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer | December 2001 | August 2006 |
| NCT01584960 | Completed | N/A | The Effect of Endurance Training in Patients With Prostate Cancer | April 2008 | May 2012 |
| NCT02198859 | Completed | Phase 1 | Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer | April 2014 | August 2016 |
| NCT00314782 | Completed | Phase 1 | Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC | March 2006 | March 2009 |
| NCT00283829 | Completed | Phase 1/Phase 2 | Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer | September 2002 | July 2006 |
| NCT02139371 | Completed | Early Phase 1 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | May 2014 | October 2014 |
| NCT00425204 | Completed | Phase 2 | Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment | March 2004 | March 2008 |
| NCT02225704 | Completed | Phase 2 | Radium-223 in Combination With Enzalutamide | June 3, 2015 | November 23, 2021 |
| NCT01793077 | Completed | Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard® 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients | December 2011 | December 2013 | |
| NCT00015977 | Completed | Phase 2 | Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | November 2001 | January 2005 |
| NCT04936243 | Completed | N/A | TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) | August 1, 2021 | November 1, 2022 |
| NCT05573789 | Completed | Tumor Molecular Profiling in Patients With Prostate Cancer | January 1, 2018 | September 1, 2022 | |
| NCT00110188 | Completed | Phase 2 | Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017) | May 2005 | August 2007 |
| NCT03100981 | Completed | N/A | Online Mindfulness for Women Treated for Breast Cancer and Men Treated for Prostate Cancer | February 24, 2016 | June 27, 2018 |
| NCT03084913 | Completed | N/A | Olive Oil v Prostate Cancer Foundation Diet for Treatment of Prostate Cancer | January 1, 2015 | November 30, 2016 |
| NCT00616291 | Completed | Phase 1 | Vaccine Therapy in Treating Patients With Metastatic, Progressive Prostate Cancer | April 2006 | July 2011 |
| NCT01045109 | Completed | Phase 2 | Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen. | October 2007 | July 2011 |
| NCT00895115 | Completed | Phase 1 | Vitamin E Supplements in Preventing Cancer in Patients at Risk of Prostate Cancer or Who Have Prostate Cancer | April 2009 | May 2012 |
| NCT00379743 | Completed | N/A | Partnership for Healthy Seniors | October 2006 | December 2010 |
| NCT00683475 | Completed | Phase 2 | A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer | August 2008 | September 2011 |
| NCT01013025 | Completed | Vantas Implant Retrieval Study | July 2006 | June 2007 | |
| NCT00225420 | Completed | Phase 1/Phase 2 | Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer | August 2005 | August 2012 |
| NCT00242073 | Completed | N/A | The Potential Use of BOLD MRI as a Noninvasive Measure of Tumor Hypoxia in Prostate Cancer | October 2001 | August 2008 |
| NCT01832870 | Completed | Phase 1 | Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer | April 2013 | February 2016 |
| NCT02213107 | Completed | Phase 2 | Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. | September 2014 | October 31, 2023 |
| NCT00433602 | Completed | Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors | November 2006 | ||
| NCT00033631 | Completed | Phase 3 | Radiation Therapy in Treating Patients With Stage II Prostate Cancer | March 2002 | December 22, 2022 |
| NCT00025194 | Completed | Phase 1/Phase 2 | Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer | July 2001 | July 2006 |
| NCT00715104 | Completed | Phase 2 | Sipuleucel-T as Neoadjuvant Treatment in Prostate Cancer | July 2008 | December 2013 |
| NCT04063566 | Completed | N/A | ReIMAGINE Prostate Cancer Screening | October 21, 2019 | September 30, 2021 |
| NCT00350051 | Completed | Phase 2 | ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer | August 1, 2006 | December 21, 2009 |
| NCT00635856 | Completed | Phase 2 | Open Label Trial to Assess Iressa in Prostate Cancer Patients | May 2001 | February 2003 |
| NCT01248741 | Completed | N/A | CT-validation of Ultrasound Based Planning for High Dose Rate (HDR) Prostate Brachytherapy Using Vitesse | December 2010 | May 2012 |
| NCT03387527 | Completed | N/A | Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening | February 1, 2018 | November 3, 2018 |
| NCT00915031 | Completed | N/A | Use of Hypothermia During Robotic Prostatectomy | August 2009 | June 2015 |
| NCT03677076 | Completed | Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer | March 4, 2019 | December 31, 2023 | |
| NCT03858452 | Completed | N/A | Relations Between Pelvic Floor, Diaphragm and Trunk Muscles | September 1, 2010 | December 30, 2012 |
| NCT00554086 | Completed | Phase 2 | Open Label,Phase II Trial of MAB Dose Escalation OF Bicalutamide For Biochemical Failure In Prostate Cancer Patients. | November 2005 | September 2010 |
| NCT03297385 | Completed | Phase 2 | Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen Ablation | August 28, 2014 | April 1, 2017 |
| NCT02786459 | Completed | N/A | Detection and Localization of Carcinoma Using High Resolution Transrectal Imaging - Proof of Concept Study | April 2016 | April 2019 |
| NCT04163068 | Completed | The Improving Cancer Aftercare Study. | January 8, 2020 | November 4, 2021 | |
| NCT00377156 | Completed | Phase 3 | Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases | July 2006 | December 15, 2019 |
| NCT01275404 | Completed | N/A | Therapy for Erectile Dysfunction Adaptation of ACT for Compliance With an Erectile Rehabilitation Program | December 28, 2010 | July 10, 2019 |
| NCT01238172 | Completed | Phase 3 | Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance | January 2011 | January 15, 2019 |
| NCT01176526 | Completed | The Role of Social Comparisons in Coping and Quality of Life Following a Prostate Cancer Diagnosis | July 19, 2010 | January 27, 2016 | |
| NCT00578006 | Completed | N/A | Internet-based System for Cancer Patients to Self-report Toxicity | March 2004 | January 2017 |
| NCT00002855 | Completed | Phase 3 | Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer | August 1996 | June 2005 |
| NCT01385228 | Completed | Phase 1 | Pazopanib, Docetaxel, Prednisone Prostate | June 2011 | February 2016 |
| NCT01764347 | Completed | N/A | Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Image-Guided Prostate Biopsy Following Radical Prostatectomy in Patients With Prostate Cancer | November 2010 | September 2013 |
| NCT06131853 | Completed | N/A | Kinesiophobia in Prostate Cancer | November 9, 2023 | December 4, 2023 |
| NCT00433706 | Completed | Phase 3 | Image Guided Radiation Therapy For Prostate Cancer | June 2007 | November 2012 |
| NCT00029224 | Completed | Phase 4 | Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions | October 2001 | November 2002 |
| NCT02713022 | Completed | Body Composition and White Adipose Tissue Inflammation | November 4, 2015 | November 7, 2023 | |
| NCT02229734 | Completed | Phase 2 | Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer - Protocol 2 | December 2014 | June 1, 2021 |
| NCT00104715 | Completed | Phase 3 | Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer | October 18, 2004 | December 15, 2015 |
| NCT00578123 | Completed | N/A | Clinical and Quality of Life Outcomes After Open or Robotic-Assisted Laparoscopic Radical Prostatectomy | July 2005 | June 3, 2022 |
| NCT00482807 | Completed | Phase 1 | Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer | August 31, 2004 | March 9, 2010 |
| NCT00487721 | Completed | Phase 2 | The Effect of High-dose Silybin-phytosome in Men With Prostate Cancer | August 2006 | November 2010 |
| NCT00334139 | Completed | Phase 4 | Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer | May 2006 | July 2009 |
| NCT04827446 | Completed | N/A | Lighting Intervention for Cancer-related Fatigue | July 15, 2021 | March 9, 2023 |
| NCT00706966 | Completed | N/A | MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer | June 2005 | August 2011 |
| NCT01230905 | Completed | Phase 4 | Study to Monitor the Effects of Androgen Suppression Treatment on the Heart | July 2008 | September 2011 |
| NCT03407963 | Completed | N/A | Feasibility of Prostatic Arterial Embolization in Low-risk Patients With Unilateral Prostate Cancer Under Active Surveillance: Monocentric Pilot Study | June 26, 2018 | June 11, 2019 |
| NCT00060437 | Completed | Phase 2 | Perifosine in Treating Patients With Metastatic, Androgen-Independent Prostate Cancer | October 2003 | April 2004 |
| NCT01240629 | Completed | Phase 1/Phase 2 | Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | November 2, 2010 | February 2, 2017 |
| NCT06014853 | Completed | Phase 1 | A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of SOL-804 in Healthy Male Subjects | August 10, 2023 | November 16, 2023 |
| NCT04593420 | Completed | Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment. | November 30, 2020 | December 8, 2022 | |
| NCT00214136 | Completed | Phase 2 | Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes | March 2005 | March 2016 |
| NCT00494546 | Completed | Phase 3 | High Versus Low Dose Supplemental External Radiation With Pd-103 for Prostate Cancer | January 1999 | June 2007 |
| NCT05323747 | Completed | Prospective Evaluation of a Commercially Available Hydrogel Spacer | November 20, 2020 | February 8, 2022 | |
| NCT00433407 | Completed | N/A | T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors | August 2005 | |
| NCT00376298 | Completed | Urology Database to Evaluate Clinical Information and Improve Patient Care. | February 2004 | December 2015 | |
| NCT00006078 | Completed | Phase 1 | Lycopene In Preventing of Prostate Cancer | June 2000 | January 2005 |
| NCT00800813 | Completed | Change in Penile Length Following Bilateral Nerve-Sparing Radical Prostatectomy | November 2008 | July 2014 | |
| NCT00424385 | Completed | Phase 1 | Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC) | January 2007 | February 2012 |
| NCT00002503 | Completed | Phase 3 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | October 1992 | |
| NCT04863352 | Completed | Health Status, Quality of Life and Function in Survivors After Radical Treatment for Prostate Cancer. Part I and IIA | May 4, 2021 | November 19, 2021 | |
| NCT02430948 | Completed | N/A | Improving Compliance With Medical Testing Guidelines | January 2014 | February 2017 |
| NCT00960310 | Completed | Phase 1 | Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions | June 2006 | June 2006 |
| NCT02376166 | Completed | N/A | Metformin for Rising PSA Remote Trial | July 2014 | December 2016 |
| NCT03735680 | Completed | Phase 2 | A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer | August 9, 2019 | November 18, 2021 |
| NCT00002889 | Completed | Phase 2 | Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer | May 1997 | June 2009 |
| NCT00018538 | Completed | Phase 2 | Calcifidol Therapy in Men With Cancer | October 1999 | September 2002 |
| NCT00255606 | Completed | Phase 3 | Docetaxel and Prednisone in Treating Patients With Hormone-Refractory Metastatic Prostate Cancer | August 2005 | August 2010 |
| NCT01529086 | Completed | For Cause Prostate Biopsy in REDUCE Population Trial | February 2012 | February 2012 | |
| NCT03383107 | Completed | Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome | January 22, 2018 | July 31, 2021 | |
| NCT02057237 | Completed | Phase 1 | A Safety and Feasibility Study of Mitotane in Prostate Cancer | September 2013 | October 2015 |
| NCT00003674 | Completed | Phase 3 | Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | December 1998 | April 2004 |
| NCT00003391 | Completed | Phase 1 | Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | June 1998 | |
| NCT00582140 | Completed | Phase 1 | Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer | March 2005 | August 2008 |
| NCT00828308 | Completed | Phase 2 | Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer | February 2009 | December 2016 |
| NCT00005857 | Completed | Phase 2 | Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | August 2000 | October 2002 |
| NCT00581672 | Completed | Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men | July 25, 2010 | May 3, 2022 | |
| NCT00116142 | Completed | Phase 3 | Hormone Suppression and Radiation Therapy for 6 Months With/Without Docetaxel for High Risk Prostate Cancer | June 2005 | June 29, 2020 |
| NCT02379559 | Completed | N/A | Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men | July 2013 | February 16, 2017 |
| NCT01008969 | Completed | N/A | Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer Patients | November 2009 | December 2010 |
| NCT01666808 | Completed | Phase 2/Phase 3 | FACBC Outcomes for Post Prostatectomy | September 2012 | April 18, 2022 |
| NCT04424654 | Completed | Phase 2 | Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy | September 22, 2020 | July 1, 2022 |
| NCT02238366 | Completed | Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer | November 2013 | June 6, 2019 | |
| NCT00196339 | Completed | Phase 2 | A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients | June 2005 | January 2008 |
| NCT02611882 | Completed | Phase 2 | Evaluation of Gallium-68-HBED-CC-PSMA Imaging in Prostate Cancer Patients | December 18, 2015 | October 24, 2016 |
| NCT00085228 | Completed | Phase 2 | Docetaxel With or Without Oblimersen in Treating Patients With Hormone-Refractory Adenocarcinoma (Cancer) of the Prostate | April 2004 | |
| NCT01856855 | Completed | N/A | Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203) | February 2013 | December 2022 |
| NCT00060086 | Completed | N/A | Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer | November 30, 2004 | May 25, 2021 |
| NCT00253643 | Completed | N/A | Fish Oil and Green Tea Extract in Preventing Prostate Cancer in Patients Who Are at Risk for Developing Prostate Cancer | July 2005 | December 2013 |
| NCT00081159 | Completed | Phase 2 | Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases | July 2004 | September 2014 |
| NCT00242567 | Completed | Phase 3 | Study of Zoledronic Acid for Patients With Hormone-sensitive Bone Metastases From Prostate Cancer | December 2005 | January 2012 |
| NCT00076531 | Completed | Phase 3 | Clinical Trial for Prostate Cancer | December 2003 | |
| NCT01414283 | Completed | Phase 1 | Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer | October 2008 | September 2013 |
| NCT00548600 | Completed | Phase 3 | Radical Radiotherapy by External Beam Radiation Versus Radical Radiotherapy With Temporary Iridium Implant Plus External Beam Radiation in Carcinoma of the Prostate | May 1992 | September 2006 |
| NCT00004124 | Completed | Phase 3 | S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | October 15, 1999 | May 1, 2018 |
| NCT01605227 | Completed | Phase 3 | Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100 | July 2012 | March 2015 |
| NCT01277562 | Completed | Pilot Study of Secondary Causes of Osteopenia/Osteoporosis in Adults With Breast and Prostate Cancer | November 2010 | December 2012 | |
| NCT02167893 | Completed | Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)" | October 2005 | December 2010 | |
| NCT02941029 | Completed | RADTOX: Measuring Radiation Toxicity Using Circulating DNA | October 2016 | July 2017 | |
| NCT01304485 | Completed | Phase 2 | PET Imaging Characteristics of C11-Acetate in Patients With Recurrent Prostate Carcinoma | April 2011 | January 2019 |
| NCT04334239 | Completed | Effectiveness of Care in Certified Cancer Centres in Germany | May 1, 2017 | August 31, 2021 | |
| NCT04341324 | Completed | Effect of ADT in Chinese Male With Prostate Cancer | July 14, 2011 | December 4, 2019 | |
| NCT02919111 | Completed | Phase 2/Phase 3 | Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients | September 23, 2016 | December 31, 2019 |
| NCT00048841 | Completed | Phase 3 | Prevention of Osteoporosis in Men With Prostate Cancer | May 2002 | December 2005 |
| NCT00480090 | Completed | Phase 2 | A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer | April 2007 | July 2011 |
| NCT04692207 | Completed | Prostate Biopsies With Target Lesion on MRI | June 1, 2017 | October 30, 2020 | |
| NCT03424694 | Completed | N/A | HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer | June 22, 2015 | February 22, 2022 |
| NCT04000464 | Completed | N/A | Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer | October 9, 2018 | December 30, 2019 |
| NCT00090376 | Completed | Phase 2 | Evaluate the Effects of GPI 1485 on Erectile Function Following Bilateral Nerve-Sparing Prostatectomy | December 2003 | |
| NCT01804465 | Completed | Phase 2 | Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer | April 22, 2014 | August 31, 2020 |
| NCT02431676 | Completed | Phase 2 | Survivorship Promotion In Reducing IGF-1 Trial | May 2015 | December 2018 |
| NCT00305669 | Completed | Phase 1 | GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer | July 2006 | June 2014 |
| NCT03178383 | Completed | N/A | Integration of Cancer Health Activities Into African American Churches | July 1, 2016 | June 30, 2022 |
| NCT03135444 | Completed | N/A | PSA TOOL for Prostate Cancer Screening Discussions | May 2, 2017 | April 23, 2018 |
| NCT00623090 | Completed | Phase 3 | Internet-Based Education for Prostate Cancer Screening | October 2007 | August 2011 |
| NCT00538668 | Completed | Phase 1 | Radioimmunotherapy in Prostate Cancer Using 177Lu-J591 Antibody | August 2007 | June 2020 |
| NCT00978718 | Completed | Phase 3 | Selenium in Preventing Prostate Cancer | August 2001 | June 2004 |
| NCT03459820 | Enrolling by invitation | Phase 2/Phase 3 | Prostate Cancer Patient Management With 18F-DCFPyL PET/CT | June 22, 2018 | June 2028 |
| NCT03181867 | Enrolling by invitation | Phase 2 | 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer | August 3, 2017 | December 31, 2030 |
| NCT03173924 | Enrolling by invitation | Phase 2 | 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer | June 6, 2017 | June 30, 2027 |
| NCT05700370 | Enrolling by invitation | N/A | MyProstateScore Equivalency With and Without DRE | November 1, 2022 | April 2023 |
| NCT06317948 | Enrolling by invitation | Improving the Quality of Radiotherapy by Multi-Institution Knowledge-Based Planning Optimization Models (Acronym: MIKAPOCo, Multi-Institutional Knowledge-based Approach in Plan Optimization for the Community) | October 28, 2022 | October 28, 2025 | |
| NCT06313775 | Enrolling by invitation | N/A | Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy | June 1, 2024 | December 31, 2024 |
| NCT00026754 | Enrolling by invitation | Eligibility Screening for the NIH Intramural Research Program Clinical Protocols | January 14, 2004 | ||
| NCT05160480 | Enrolling by invitation | N/A | A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG | June 2024 | March 1, 2026 |
| NCT06101927 | Enrolling by invitation | Phase 1 | Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413 | October 19, 2023 | October 30, 2024 |
| NCT05753046 | Enrolling by invitation | Phase 4 | Laparoscopic TAP Block During Robotic Assisted Laparoscopic Radical Prostatectomy for Improvement in Postoperative Pain | February 19, 2024 | August 2025 |
| NCT06080113 | Enrolling by invitation | N/A | Cancer of the Prostate Treated With Focal Implantation of a RadioactivE Source | November 1, 2023 | June 2033 |
| NCT01968538 | Enrolling by invitation | Metabolomic Study for Localized Prostate Cancer | January 2009 | December 2024 | |
| NCT00102544 | Enrolling by invitation | N/A | Use of Tracking Devices to Locate Abnormalities During Invasive Procedures | February 23, 2005 | December 2, 2024 |
| NCT04399876 | Enrolling by invitation | Phase 1 | Pilot Study of an Implantable Microdevice for Evaluating Drug Responses in Situ in Prostate Cancer | June 22, 2020 | March 1, 2026 |
| NCT05223218 | Enrolling by invitation | Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study | August 25, 2021 | December 2023 | |
| NCT02873013 | Enrolling by invitation | Asia Study Group of Prostate Cancer (A-CaP Study) | March 2016 | March 2026 | |
| NCT03423303 | Enrolling by invitation | N/A | A Randomized Trial of Early Detection of Clinically Significant Prostate Cancer (ProScreen) | April 23, 2018 | December 31, 2032 |
| NCT03503643 | Enrolling by invitation | Hemi-Gland Cryoablation for Prostate Cancer at UCLA | September 14, 2017 | December 31, 2025 | |
| NCT05929300 | Enrolling by invitation | N/A | A Yoga Program for Patients Undergoing Prostate Cancer Surgery | October 18, 2023 | December 31, 2024 |
| NCT03948204 | Enrolling by invitation | Quality of Life and Shared Decision Making in Prostate Cancer | January 1, 2017 | December 31, 2024 | |
| NCT04465214 | Enrolling by invitation | Mobile Sensor Technologies to Assess General Symptomology of People With Cancer | November 23, 2020 | April 1, 2025 | |
| NCT02609269 | Enrolling by invitation | Decipher Genomics Resource for Intelligent Discovery | October 2015 | December 2040 | |
| NCT04800068 | No longer available | Expanded Access [Ga-68] PSMA-11 PET Imaging | |||
| NCT02826395 | No longer available | C11 Sodium Acetate PET/CT Imaging of PCa | |||
| NCT03005262 | No longer available | MLN8237 for a Subject With Adenocarcinoma of the Prostate | |||
| NCT05002465 | No longer available | Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer | |||
| NCT02531672 | No longer available | Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography | |||
| NCT01777061 | No longer available | Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan | |||
| NCT03554434 | No longer available | An Expanded Access Program for AM0010 (Pegilodecakin) | |||
| NCT04993508 | Not yet recruiting | N/A | Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging | January 1, 2022 | September 30, 2028 |
| NCT05815316 | Not yet recruiting | Phase 2 | 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer | April 30, 2023 | April 29, 2026 |
| NCT06430411 | Not yet recruiting | Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study | May 31, 2024 | December 31, 2031 | |
| NCT06194461 | Not yet recruiting | LTFU for All Cell and Gene Therapy Studies | June 12, 2024 | November 29, 2041 | |
| NCT05690399 | Not yet recruiting | Evaluation of Clinical and Pathological Characteristics and Routine Treatment of Patients With Prostate Cancer | January 2023 | April 2024 | |
| NCT06463457 | Not yet recruiting | Phase 2 | Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) | August 2024 | August 31, 2028 |
| NCT05720910 | Not yet recruiting | N/A | Streamlined Geriatric and Oncological Evaluation Based On IC Technology | April 2023 | January 2026 |
| NCT05644197 | Not yet recruiting | N/A | Multidisciplinary Care After Prostatectomy | January 2023 | January 2026 |
| NCT06391034 | Not yet recruiting | Phase 2 | Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer | June 1, 2024 | June 30, 2032 |
| NCT05568537 | Not yet recruiting | Phase 4 | Prostate MRI and Pylarify PSMA PET/CT | June 15, 2024 | October 2025 |
| NCT05522907 | Not yet recruiting | Investigation of Tumor Microenvironment After CRPC Along With Before and After Neoadjuvant Therapy for Prostate Cancer | September 1, 2022 | December 31, 2025 | |
| NCT06165302 | Not yet recruiting | N/A | Exercise in Prostate Cancer | July 2, 2024 | July 2028 |
| NCT04243473 | Not yet recruiting | Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer | June 2024 | December 2033 | |
| NCT06460454 | Not yet recruiting | PROnostic Interest of 18F-FDG PET/CT in Patients With Metastatic Castration-resistant Prostate Cancer (mCPRC) Progressing | July 1, 2024 | January 1, 2026 | |
| NCT05856630 | Not yet recruiting | Phase 1 | Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg | May 2023 | December 2023 |
| NCT04457882 | Not yet recruiting | N/A | Evaluation of the Safety of Intraperitoneal Laparoscopic Radical Prostatectomy With or Without Drainage Tube | August 1, 2023 | October 1, 2024 |
| NCT06435702 | Not yet recruiting | Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy in Prostate Cancer Patients With Lymph Node-positive After Radical Prostatectomy: A Prospective Observational Cohort Study | June 1, 2024 | December 31, 2029 | |
| NCT06138067 | Not yet recruiting | N/A | Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients | July 2024 | December 2026 |
| NCT04271527 | Not yet recruiting | N/A | Non-inferiority Randomized Controlled Trial of Cognitive Targeted Biopsy Versus Software Targeted Biopsy | March 1, 2024 | March 14, 2025 |
| NCT06298838 | Not yet recruiting | High-resolution Intra-operative PSMA PET-CT in Prostate Cancer | April 2024 | March 2025 | |
| NCT04220398 | Not yet recruiting | N/A | Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer | January 10, 2020 | December 31, 2024 |
| NCT05060835 | Not yet recruiting | ONCOlogy-targeted NLP-powered Federated Hyper-archItecture and Data Sharing Framework for Health Data Reusability | June 2023 | December 2025 | |
| NCT05989854 | Not yet recruiting | N/A | The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer | October 2023 | September 2024 |
| NCT06424275 | Not yet recruiting | Prostate Cancer Awareness and Initiative for Screening in the European Union | June 1, 2024 | April 1, 2026 | |
| NCT06359964 | Not yet recruiting | N/A | Infective Complications in TP Biopsy Without Antibiotic Prophylaxis | April 1, 2024 | March 31, 2027 |
| NCT05333432 | Not yet recruiting | N/A | Evaluation of a Multimodal Strategy for Early Diagnosis of Men at High Genetic Risk of Prostate Cancer (HRPCa-II) | June 1, 2024 | July 1, 2029 |
| NCT04278261 | Not yet recruiting | N/A | Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer | July 1, 2022 | September 1, 2026 |
| NCT05761912 | Not yet recruiting | Application of Ultrasound Radiomics in Ultrasound Fusion Targeted Prostate Biopsy | March 15, 2023 | September 30, 2023 | |
| NCT06462014 | Not yet recruiting | Description of Relugolix Use in Patients With Prostate Cancer Within the VHA | June 28, 2024 | December 31, 2025 | |
| NCT06171269 | Not yet recruiting | N/A | Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life | February 14, 2024 | October 20, 2028 |
| NCT05576766 | Not yet recruiting | N/A | Enhanced Recovery After Surgery (ERAS) Pathway in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy | October 2022 | July 2024 |
| NCT04176081 | Not yet recruiting | Phase 2 | Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer | July 2, 2024 | December 2028 |
| NCT06183905 | Not yet recruiting | N/A | Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection | December 2023 | December 31, 2025 |
| NCT06384222 | Not yet recruiting | Phase 2 | Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone | June 30, 2024 | July 31, 2027 |
| NCT06366308 | Not yet recruiting | Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population | April 15, 2024 | June 1, 2024 | |
| NCT06226129 | Not yet recruiting | Phase 4 | Gadopiclenol in Contrast Enhanced MRI of the Prostate | February 1, 2024 | February 1, 2028 |
| NCT06200558 | Not yet recruiting | ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa | January 31, 2024 | July 31, 2024 | |
| NCT06400160 | Not yet recruiting | Phase 1/Phase 2 | Clinical Trial of TB511 in Advanced Solid Tumors | October 2024 | October 2025 |
| NCT05819606 | Not yet recruiting | Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients | April 15, 2023 | April 15, 2024 | |
| NCT06449781 | Not yet recruiting | Phase 2 | 177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer | June 2024 | November 2030 |
| NCT06271551 | Not yet recruiting | Phase 2 | Transdermal Estradiol and Exercise in Mitigating Adverse Effects of Androgen Deprivation Therapy for Prostate Cancer Radiation Therapy | March 2024 | December 2029 |
| NCT04889742 | Not yet recruiting | Phase 2 | Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors | May 10, 2024 | January 2028 |
| NCT06062355 | Not yet recruiting | Phase 1 | Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer | October 2023 | December 2023 |
| NCT05712473 | Not yet recruiting | An Observational Registry Assessing the Impact of PYLARIFY® (Piflufolastat F18) PET in Patients With Prostate Cancer | February 2023 | June 2029 | |
| NCT05681416 | Not yet recruiting | N/A | Prostate Cancer Prevention Clinic for Men With Risk of Familial Prostate Cancer | February 1, 2023 | February 1, 2027 |
| NCT05896371 | Not yet recruiting | Phase 1/Phase 2 | A Phase 1/2 Study of Personalized PSMA Radiopharmaceutical Therapy | January 29, 2024 | June 15, 2032 |
| NCT06434649 | Not yet recruiting | N/A | Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer | June 1, 2024 | June 1, 2025 |
| NCT06258486 | Not yet recruiting | Phase 4 | Ultrasound Guided Inguinal Indocyanine Green Injection to Identify and Pre-emptively Seal Lymphatic Leaks | February 2024 | February 2026 |
| NCT06145958 | Not yet recruiting | Radiotherapy and Androgen Deprivation In Combination After Local Surgery (RADICALS) Translational Study | January 1, 2024 | August 30, 2028 | |
| NCT06437574 | Not yet recruiting | Phase 2 | Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer | July 1, 2024 | May 31, 2028 |
| NCT06303622 | Not yet recruiting | N/A | Comparing MRI-Ultrasound Fusion and Cognitive-guided Biopsy for the Detection of csPCa: the PROFUSION Trial | June 1, 2024 | March 31, 2027 |
| NCT06034431 | Not yet recruiting | N/A | Increasing Access to Definitive Treatment for Prostate Cancer | September 2023 | June 2026 |
| NCT06440018 | Not yet recruiting | INSPIRE: A Multi-Cancer Early Detection Study | June 20, 2024 | February 28, 2025 | |
| NCT05873192 | Not yet recruiting | Phase 2 | Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer | September 30, 2024 | December 31, 2028 |
| NCT06280781 | Not yet recruiting | N/A | Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance) | July 2024 | June 2032 |
| NCT06144099 | Not yet recruiting | Phase 4 | Prothrombin Complex Concentrate vs Fresh Frozen Plasma in Goal-directed Bleeding Management in Non-cardiac Surgery | March 1, 2024 | April 1, 2025 |
| NCT06389097 | Not yet recruiting | SPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization | May 2024 | May 2029 | |
| NCT06399757 | Not yet recruiting | Phase 1/Phase 2 | A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors | May 2024 | May 2027 |
| NCT05614700 | Not yet recruiting | N/A | Prostate Reirradiation Toxicity Outcomes Feasibility Study | November 15, 2022 | November 15, 2026 |
| NCT06099093 | Not yet recruiting | Phase 4 | Pilot of 18F-DCFPyL-PSMA PET in mCRPC Patients Receiving 117Lu-Vipivotide Tetraxetan | April 2024 | December 1, 2025 |
| NCT05957653 | Not yet recruiting | Phase 4 | Lidocaine Combined With Sufentanil for Preventing Catheter-related Bladder Discomfort | October 7, 2023 | October 30, 2025 |
| NCT06312670 | Not yet recruiting | Phase 2 | Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer | August 1, 2024 | March 1, 2026 |
| NCT04571762 | Not yet recruiting | N/A | Adaptive MR-guided SBRT for Localized Prostate Cancer | September 30, 2024 | May 30, 2026 |
| NCT05755490 | Not yet recruiting | N/A | PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care Intervention | March 2023 | December 31, 2023 |
| NCT06465069 | Not yet recruiting | Phase 1 | A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors | June 2024 | May 2027 |
| NCT06238661 | Not yet recruiting | N/A | Prostate Cancer Screening: a Pilot Study | May 1, 2024 | July 1, 2025 |
| NCT05512663 | Not yet recruiting | N/A | Safety and Efficacy Evaluation of Transperineal Irreversible Electroporation (IRE) of Anterior Prostate Cancer | September 2022 | September 2024 |
| NCT06355050 | Not yet recruiting | Ultrahypofractionated, Adaptive Radiation Therapy of Prostate Cancer | June 30, 2024 | September 30, 2031 | |
| NCT04736108 | Not yet recruiting | Phase 2 | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | May 2021 | December 2024 |
| NCT06434909 | Not yet recruiting | Early Phase 1 | CYTALUX™for the Intraoperative Imaging of Prostate Cancer | July 2024 | April 2025 |
| NCT05958082 | Not yet recruiting | N/A | Utilization of Educational Interventions in Completion of Genetic Testing in Black Patients With High-Risk Prostate Cancer | June 2024 | June 2026 |
| NCT06402357 | Not yet recruiting | Phase 2 | High Intensity Focused Ultrasound in Prostate Cancer | August 2024 | August 2029 |
| NCT06360523 | Not yet recruiting | To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence | May 1, 2024 | July 20, 2025 | |
| NCT06215508 | Not yet recruiting | Geriatric Assessment and Technology Evaluation in Prostate Cancer | April 2026 | April 2031 | |
| NCT05778097 | Not yet recruiting | Phase 2 | Adjutant Apalutamide Plus ADT in Post-RP Patients With High Risk of Recurrence (ARES Study) | April 1, 2023 | December 31, 2026 |
| NCT06111313 | Not yet recruiting | Phase 2 | The University of Miami Adapt (UAdapt) Trial | September 1, 2024 | September 1, 2032 |
| NCT06453785 | Not yet recruiting | N/A | Comparing pOrtable MRI and TRUS-Fusion Prostate Biopsy to Assess aCcuracy of Prostate Cancer Detection | March 2025 | July 2027 |
| NCT05978232 | Not yet recruiting | N/A | NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients | June 1, 2024 | July 11, 2028 |
| NCT05373316 | Not yet recruiting | Phase 2 | Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided Radiotherapy | December 1, 2022 | July 1, 2029 |
| NCT05802121 | Not yet recruiting | Early Phase 1 | Akkermansia Muciniphilia and Metabolic Side Effects of ADT | June 2023 | June 2026 |
| NCT05046782 | Not yet recruiting | Phase 2 | Abbreviated Biparametric MRI (RSI + T2WI) for Prostate Cancer Detection: Correlation With Histopathology | March 31, 2024 | June 1, 2024 |
| NCT05974774 | Not yet recruiting | Phase 3 | Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors | June 15, 2024 | December 15, 2030 |
| NCT02588404 | Not yet recruiting | The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient | December 2016 | ||
| NCT06122584 | Not yet recruiting | Phase 3 | Diagnostic Performance of [18F]PSMA-1007 PET/CT Imaging in Patients With Newly-Diagnosed Prostate Cancer | January 2024 | April 2025 |
| NCT05232578 | Not yet recruiting | Phase 3 | Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness | September 2022 | December 2032 |
| NCT06446401 | Not yet recruiting | The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer | June 3, 2024 | December 31, 2031 | |
| NCT05610852 | Not yet recruiting | N/A | Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound | June 1, 2024 | July 1, 2028 |
| NCT05773183 | Not yet recruiting | Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men | March 12, 2023 | August 2024 | |
| NCT06435871 | Not yet recruiting | N/A | Developing Inclusive Support and Intervention for Spanish-speaking Latiné Prostate Cancer Survivors | July 1, 2024 | July 1, 2026 |
| NCT06450106 | Not yet recruiting | Phase 1 | Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy | September 2024 | March 2026 |
| NCT06451614 | Not yet recruiting | N/A | SpaceIT Hydrogel System for Perirectal Spacing | October 1, 2024 | December 31, 2026 |
| NCT06279260 | Not yet recruiting | National Robotics-Assisted Radical Prostatectomy Database | April 2024 | December 2030 | |
| NCT04312191 | Not yet recruiting | N/A | Using Meditation for Oncology Anxiety | January 31, 2024 | February 1, 2025 |
| NCT05411354 | Not yet recruiting | Analyzing Clinical Trial Experiences of Prostate Cancer Patients | September 2024 | September 2026 | |
| NCT06462963 | Not yet recruiting | N/A | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT) | December 15, 2024 | November 15, 2028 |
| NCT06202820 | Not yet recruiting | N/A | CV CARE: CardioVascular Care in PC Patients | June 2024 | December 31, 2026 |
| NCT06458855 | Not yet recruiting | N/A | Nerve Grafting Technique to Restore Erectile Function Post Radical Prostatectomy | June 2024 | June 2027 |
| NCT06168487 | Not yet recruiting | Early Phase 1 | Telmisartan in Prostate Cancer | June 1, 2024 | April 1, 2027 |
| NCT05982418 | Not yet recruiting | N/A | Improvement of RARP Outcomes Via 3D Printed/Virtual Prostate Models | July 31, 2023 | January 31, 2024 |
| NCT04569461 | Not yet recruiting | Phase 2 | Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON) | July 1, 2024 | December 1, 2026 |
| NCT06441292 | Not yet recruiting | N/A | Multi-Modal Image Fusion for Precision Prostate Biopsy Navigation | July 1, 2024 | July 15, 2025 |
| NCT04622761 | Not yet recruiting | Phase 2 | Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome | January 15, 2021 | May 2, 2026 |
| NCT05590624 | Not yet recruiting | N/A | Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer | August 2024 | December 31, 2025 |
| NCT05025527 | Not yet recruiting | N/A | Biparametric MRI in Prostate Cancer Screening: a Noninferior Randomized Controlled Study | December 1, 2022 | December 1, 2024 |
| NCT06353321 | Not yet recruiting | Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1 | September 1, 2024 | December 1, 2025 | |
| NCT05574647 | Not yet recruiting | N/A | Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer | October 1, 2022 | January 31, 2026 |
| NCT06117696 | Not yet recruiting | Optimizing the Announcement of Advanced or Metastatic Prostate Cancer Using Animated Videos (CartDiag PROSTATE) | March 2024 | October 2024 | |
| NCT06274684 | Not yet recruiting | N/A | Feasibility of Virtual Reality Assistance in Prostate Biopsy Under Local Anesthesia. | February 19, 2024 | July 1, 2025 |
| NCT06274047 | Not yet recruiting | Phase 3 | PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer. | August 31, 2024 | June 30, 2029 |
| NCT05973149 | Not yet recruiting | Phase 1 | Trial of QLH12016 in Patients With Metastatic Castration Resistant Prostate Cancer | August 31, 2023 | January 1, 2026 |
| NCT05923684 | Not yet recruiting | N/A | NLP-Based Feedback to Improve Risk Comms and Informed Shared Decision Making | July 15, 2023 | July 15, 2025 |
| NCT05816668 | Not yet recruiting | Phase 3 | Tranexamic Acid's Effects in Patients Undergoing Laparoscopic Radical Prostatectomy | April 2023 | September 2024 |
| NCT05430737 | Recruiting | N/A | A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer | June 30, 2022 | June 30, 2025 |
| NCT05533515 | Recruiting | Circulating Tumour Cells as Biomarkers to Predict Prostate Cancer Metastasis for Treatment Stratification of Cancer | February 8, 2022 | May 1, 2027 | |
| NCT05850182 | Recruiting | N/A | Lifestyle Intervention in Patients With Metastatic Prostate Cancer | November 27, 2023 | December 31, 2025 |
| NCT04081636 | Recruiting | N/A | Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications | September 2, 2019 | December 31, 2025 |
| NCT04249154 | Recruiting | Phase 2 | Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer | September 3, 2019 | December 15, 2025 |
| NCT04319146 | Recruiting | N/A | Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer | January 25, 2022 | September 2024 |
| NCT05252390 | Recruiting | Phase 1/Phase 2 | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors | March 29, 2022 | November 2026 |
| NCT04181203 | Recruiting | Phase 3 | Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy | January 9, 2020 | December 28, 2033 |
| NCT06347705 | Recruiting | Phase 2 | A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer | March 28, 2024 | March 28, 2029 |
| NCT06172478 | Recruiting | Phase 2 | A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors | February 26, 2024 | April 30, 2026 |
| NCT05647564 | Recruiting | N/A | PET/CT Characterization of Treatment Resistance | March 6, 2023 | March 2027 |
| NCT02914873 | Recruiting | N/A | SPCG17: Prostate Cancer Active Surveillance Trigger Trial | October 2016 | December 2034 |
| NCT05179824 | Recruiting | Tempus Priority Study: A Pan-tumor Observational Study | October 19, 2020 | October 19, 2030 | |
| NCT05258526 | Recruiting | N/A | Home Based Exercise for Patients With Breast or Prostate Cancer (The BENEFIT-CA Study) | April 7, 2022 | December 30, 2023 |
| NCT05975775 | Recruiting | Outpatient Laparoscopic Radical Prostatectomy | October 20, 2023 | December 2024 | |
| NCT00588185 | Recruiting | N/A | [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer | February 2003 | February 2026 |
| NCT06064149 | Recruiting | N/A | The CArdiovascular Risk Evaluation in Men With Prostate Cancer Study (CARE-PC) Pilot Feasibility Study | November 14, 2023 | June 30, 2026 |
| NCT06282588 | Recruiting | Phase 2/Phase 3 | Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers | December 13, 2023 | December 31, 2030 |
| NCT06430749 | Recruiting | N/A | Targeted Microwave Tissue Coagulation for Prostate Cancer | May 1, 2024 | October 31, 2027 |
| NCT03933670 | Recruiting | Phase 2 | Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active Surveillance | July 18, 2018 | October 31, 2025 |
| NCT05707182 | Recruiting | Early Phase 1 | 18F-rhPSMA-7.3 PET/MRI in Prostate Cancer Active Surveillance: A Pilot Study | April 30, 2025 | December 2026 |
| NCT06250751 | Recruiting | N/A | Behavioral Exercise TRaining for Men Undergoing Androgen Depr Therapy for Prostate Ca | February 5, 2024 | August 31, 2025 |
| NCT05413850 | Recruiting | Phase 1/Phase 2 | Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection | July 20, 2022 | October 27, 2026 |
| NCT01990521 | Recruiting | N/A | Prostate Screening Study Using MRI in BRCA Carriers | January 2014 | January 2025 |
| NCT05064670 | Recruiting | N/A | Exercise as Medicine for People With Cancer Sweden | January 11, 2022 | November 2024 |
| NCT03492424 | Recruiting | Ablative Therapy in the Management of Prostate Cancer | January 2, 2018 | September 2039 | |
| NCT05477823 | Recruiting | Early Phase 1 | Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer | March 8, 2023 | August 2027 |
| NCT03924466 | Recruiting | Phase 2 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients | April 1, 2019 | December 2024 |
| NCT06462495 | Recruiting | Early Phase 1 | Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | April 10, 2024 | December 31, 2025 |
| NCT05056077 | Recruiting | N/A | Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit) | October 21, 2021 | December 31, 2027 |
| NCT06052683 | Recruiting | N/A | A Trial Evaluating Toxicity of SBRT and LDRB in Localized Prostate Cancer. | September 30, 2019 | September 30, 2026 |
| NCT04808427 | Recruiting | N/A | Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer | November 20, 2023 | September 1, 2027 |
| NCT04331535 | Recruiting | N/A | The Genomic Medicine at VA Study | July 17, 2020 | September 30, 2025 |
| NCT05946603 | Recruiting | Phase 2 | IS-002 in Prostate Cancer | June 16, 2023 | April 1, 2026 |
| NCT04100174 | Recruiting | Phase 2 | Focal HDR Brachytherapy Boost to Stereotactic Radiotherapy | July 1, 2019 | June 30, 2025 |
| NCT05162846 | Recruiting | N/A | Methods for Increasing Genetic Testing Uptake in Michigan | April 21, 2022 | December 31, 2026 |
| NCT05220501 | Recruiting | N/A | Optimization of Prostate Biopsy - Micro-Ultrasound Versus MRI | January 21, 2021 | March 2025 |
| NCT06255041 | Recruiting | Detection of Cancer in Breath Samples by Trained Detection Dogs | February 10, 2021 | March 2024 | |
| NCT03833921 | Recruiting | Phase 2 | Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer | May 23, 2019 | April 2034 |
| NCT04641078 | Recruiting | Phase 2 | Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer | February 12, 2021 | February 12, 2026 |
| NCT04083937 | Recruiting | N/A | Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies | September 12, 2018 | January 2029 |
| NCT06040125 | Recruiting | N/A | Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial | January 1, 2024 | February 28, 2027 |
| NCT06054789 | Recruiting | N/A | Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer | October 1, 2022 | October 1, 2024 |
| NCT04194554 | Recruiting | Phase 1/Phase 2 | A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer | November 6, 2020 | May 2027 |
| NCT04896801 | Recruiting | N/A | MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days | August 10, 2021 | July 2029 |
| NCT05327452 | Recruiting | N/A | Testing Home-based Exercise Strategies in Underserved Minority Cancer Patients Undergoing Chemotherapy: the THRIVE Study | October 31, 2022 | January 31, 2025 |
| NCT05767307 | Recruiting | Danish Prostate Cancer Consortium Study-1 | August 1, 2022 | January 1, 2040 | |
| NCT03763253 | Recruiting | Phase 2 | Additional Treatments to the Local Tumour for Metastatic Prostate Cancer: Assessment of Novel Treatment Algorithms | April 10, 2019 | January 31, 2027 |
| NCT05223803 | Recruiting | Phase 2 | TERPS Trial for de Novo Oligometastic Prostate Cancer | October 18, 2022 | July 31, 2027 |
| NCT05366842 | Recruiting | Phase 2 | Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care | April 1, 2022 | March 1, 2025 |
| NCT05787587 | Recruiting | Phase 1 | A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors | April 5, 2023 | September 2025 |
| NCT05520255 | Recruiting | Phase 3 | 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028 | July 25, 2023 | December 2029 |
| NCT03920033 | Recruiting | N/A | Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After Prostatectomy | May 1, 2019 | January 1, 2027 |
| NCT03914391 | Recruiting | To Identify Potential New Urine Markers for the Screening of Prostate Cancer | January 16, 2019 | December 31, 2025 | |
| NCT04832113 | Recruiting | N/A | Impact of Patient's Therapeutic Education in APA and Dietetic on Radiotherapy Reproducibility Sessions for Prostate Cancer | June 21, 2021 | April 2025 |
| NCT04599218 | Recruiting | N/A | MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer | August 21, 2020 | January 15, 2026 |
| NCT05753566 | Recruiting | Phase 2 | Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | March 2023 | March 2028 |
| NCT04293406 | Recruiting | pCHIP: Prostate Cancer Health Impact Program | February 10, 2021 | December 2025 | |
| NCT05582876 | Recruiting | N/A | Multicenter Assessment of Clinical Utility PET / MR With the Use of the Radiotracer 68Ga-PSMA-11 in Therapy Planning Personalized in Patients With Prostate Cancer | December 12, 2022 | November 30, 2024 |
| NCT05455736 | Recruiting | STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence After prostatectomy-a Prospective Observational Study | March 11, 2021 | July 11, 2024 | |
| NCT06408597 | Recruiting | N/A | Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy | May 12, 2024 | November 2024 |
| NCT05899361 | Recruiting | N/A | A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest | August 30, 2023 | December 25, 2026 |
| NCT05546268 | Recruiting | Phase 1/Phase 2 | Study of Oral MRT-2359 in Selected Cancer Patients | October 12, 2022 | November 2027 |
| NCT05710861 | Recruiting | N/A | Cost-utility of Focal HIFU vs Prostatectomy | March 6, 2023 | February 20, 2027 |
| NCT04035642 | Recruiting | N/A | Phase II Study of Single-Dose Image-Guided Radiotherapy (SDRT) for Prostate Cancer | June 1, 2019 | June 2026 |
| NCT03474913 | Recruiting | Upright MRI for Prostate Cancer Screening | October 1, 2018 | July 1, 2026 | |
| NCT03294889 | Recruiting | Phase 1/Phase 2 | ONE-SHOT Trial - Ultra-hypofractionated Single-dose SBRT for Prostate Cancer | September 1, 2017 | October 1, 2030 |
| NCT02643511 | Recruiting | Phase 2 | Hemiablative Focal Brachytherapy Pilot Study | September 2015 | July 2025 |
| NCT04595019 | Recruiting | N/A | Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer | July 29, 2021 | April 30, 2028 |
| NCT06375629 | Recruiting | ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer | April 20, 2023 | April 20, 2027 | |
| NCT04240327 | Recruiting | Marker Driven Selection of Patients for Prostate Biopsy and Management | June 29, 2020 | June 1, 2025 | |
| NCT05352178 | Recruiting | Phase 3 | Metastasis-directed Therapy for Oligorecurrent Prostate Cancer | April 20, 2022 | April 25, 2032 |
| NCT00923221 | Recruiting | Collection of Blood From Patients With Prostate Cancer | February 28, 2007 | ||
| NCT06116019 | Recruiting | Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS) | October 11, 2023 | October 9, 2027 | |
| NCT03971591 | Recruiting | N/A | Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors | June 1, 2019 | June 30, 2024 |
| NCT06141993 | Recruiting | ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials | May 13, 2024 | October 2026 | |
| NCT06084338 | Recruiting | Phase 2 | Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc | December 14, 2023 | December 31, 2028 |
| NCT05931419 | Recruiting | High-Risk prostatE Cancer radiatiOn Versus surgERy | February 16, 2023 | June 30, 2030 | |
| NCT04698564 | Recruiting | Phase 2 | Utility of Hyperpolarized 13C-pyruvate Metabolic Magnetic Resonance Imaging | December 1, 2020 | February 1, 2027 |
| NCT04642027 | Recruiting | Phase 3 | PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy | September 1, 2020 | September 1, 2030 |
| NCT05996289 | Recruiting | Inter-observer Variability in the Segmentation of Prostate Tumour Lesions Using Multiparametric MRI (VARIOP) | August 1, 2023 | July 1, 2024 | |
| NCT04997018 | Recruiting | Phase 2 | A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer | August 4, 2021 | August 4, 2026 |
| NCT05513443 | Recruiting | N/A | Prostate Cancer IRE Study (PRIS) | September 1, 2022 | September 1, 2025 |
| NCT05269550 | Recruiting | N/A | PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) | May 3, 2022 | June 2028 |
| NCT04172753 | Recruiting | N/A | Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac | May 9, 2018 | May 9, 2027 |
| NCT06461416 | Recruiting | N/A | A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework | June 10, 2024 | December 30, 2024 |
| NCT06144619 | Recruiting | Non-Invasive Biomarkers in Prostate Cancer Disease Management | November 21, 2023 | January 31, 2029 | |
| NCT03034187 | Recruiting | Radiation-induced Toxicity in Prostate Cancer/ Standard-Follow-Up Program Prostate | April 1999 | January 2028 | |
| NCT03860272 | Recruiting | Phase 1 | Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer | April 1, 2019 | December 2026 |
| NCT05799248 | Recruiting | Phase 3 | Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management | April 27, 2023 | May 28, 2024 |
| NCT03769766 | Recruiting | Phase 3 | Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance | March 11, 2019 | November 2028 |
| NCT06184867 | Recruiting | Early Phase 1 | Choices About Genetic Testing And Learning Your Risk With Smart Technology | October 26, 2023 | January 31, 2025 |
| NCT04549688 | Recruiting | N/A | Active Surveillance Plus (AS+): High-intensity Focused Ultrasound (HIFU) in Patients With Localized Prostate Cancer | September 1, 2020 | September 2030 |
| NCT06392295 | Recruiting | Phase 2 | PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer | August 1, 2024 | August 1, 2029 |
| NCT06397651 | Recruiting | N/A | A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live 1:1 Exercise Coaching and Personalised Digital Application on Cancer Survivors' Cost of Care | May 12, 2024 | February 28, 2026 |
| NCT05116475 | Recruiting | Phase 3 | Evaluation of dAroLutamide Addition to anDrogen Deprivation Therapy and radIatioN Therapy in Newly Diagnosed Prostate Cancer With Pelvic Lymph Nodes Metastases | August 30, 2022 | February 2027 |
| NCT04984343 | Recruiting | Phase 2 | Randomized Trial of Five or Two MRI-Guided Adaptive Radiotherapy Treatments for Prostate Cancer | February 11, 2022 | December 31, 2027 |
| NCT05081193 | Recruiting | Phase 2 | Safety and Efficacy of Oral Testosterone Undecanoate Followed by Enzalutamide as Therapy for Men With Metastatic Castrate Resistant Prostate Cancer | March 7, 2022 | December 30, 2027 |
| NCT02573636 | Recruiting | The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy | March 2016 | March 2025 | |
| NCT05209243 | Recruiting | N/A | START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC | January 26, 2023 | January 2027 |
| NCT06307704 | Recruiting | N/A | Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients | April 1, 2024 | October 2024 |
| NCT05075577 | Recruiting | Phase 1/Phase 2 | EPI-7386 in Combination With Enzalutamide Compared With Enzalutamide Alone in Subjects With mCRPC | December 21, 2021 | January 2026 |
| NCT05820932 | Recruiting | Predicting Cognitive Decline From Androgen Deprivation Therapy | May 22, 2023 | May 31, 2026 | |
| NCT05900973 | Recruiting | Phase 2 | A Phase 2 Trial of Darolutamide as a Prostate-Specific Membrane Antigen (PSMA) Expression Enhancer in Patients With Localized Prostate Cancer | July 20, 2023 | May 24, 2025 |
| NCT06101290 | Recruiting | N/A | Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER) | October 5, 2023 | January 5, 2031 |
| NCT05297162 | Recruiting | N/A | PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial | April 1, 2022 | January 1, 2025 |
| NCT05415696 | Recruiting | N/A | Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy | September 19, 2023 | September 2024 |
| NCT05726292 | Recruiting | Phase 2 | A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer | October 9, 2023 | April 1, 2029 |
| NCT06451497 | Recruiting | Phase 1 | Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors | May 22, 2024 | April 2027 |
| NCT01794403 | Recruiting | N/A | Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer | April 4, 2013 | August 1, 2024 |
| NCT06236373 | Recruiting | The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia | April 20, 2023 | October 2024 | |
| NCT05586360 | Recruiting | Phase 2 | T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer | March 11, 2024 | August 1, 2026 |
| NCT06395753 | Recruiting | Phase 2 | A Dose Finding Study of Debio 4228 in Participants With Locally Advanced/Metastatic Prostate Cancer | June 2024 | April 2026 |
| NCT05215574 | Recruiting | Phase 1 | Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors | March 31, 2022 | March 2026 |
| NCT04045756 | Recruiting | N/A | Focal Laser Ablation for the Treatment of Focal Low-Intermediate Risk Prostate Cancer | August 2, 2019 | August 2, 2024 |
| NCT02303327 | Recruiting | Phase 3 | Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients | January 2015 | January 2029 |
| NCT06457919 | Recruiting | Phase 1/Phase 2 | A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer | June 4, 2024 | June 2027 |
| NCT04420702 | Recruiting | N/A | Diffusion Basis Spectrum Imaging of the Prostate | February 27, 2020 | May 31, 2027 |
| NCT06320223 | Recruiting | PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer | March 5, 2024 | March 5, 2035 | |
| NCT05754658 | Recruiting | African Cancer Genome: GMD | November 28, 2022 | July 1, 2024 | |
| NCT05762198 | Recruiting | N/A | Comparing Water Vapour Thermal Therapy (Rezūm) and TURP | May 1, 2023 | June 30, 2026 |
| NCT06402552 | Recruiting | N/A | Comparing Bp-MRI and Mp-MRI for Prostate Cancer Screening Accuracy | May 1, 2024 | December 31, 2025 |
| NCT05000294 | Recruiting | Phase 1/Phase 2 | Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types | December 7, 2021 | December 2025 |
| NCT02391051 | Recruiting | Phase 2 | Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial | October 2014 | December 2029 |
| NCT04545957 | Recruiting | N/A | Jump: MR Simulation For Radiation Therapy Master Protocol | October 14, 2020 | October 22, 2026 |
| NCT03936127 | Recruiting | N/A | Comparison of a Novel Transperineal Targeted Fusion Biopsy System to Conventional Transrectal Targeted Fusion Biopsy | October 11, 2022 | December 2024 |
| NCT05683691 | Recruiting | N/A | Water Vapor Ablation for Localized Intermediate Risk Prostate Cancer | May 16, 2023 | April 2029 |
| NCT06330909 | Recruiting | N/A | Image-guided Focal Dose Escalation- Primary pc Treated With Primary External Beam Hypofract.Stereotactic rt | August 18, 2022 | February 2030 |
| NCT06235099 | Recruiting | Phase 3 | Copper Cu 64 PSMA I&T PET Imaging in Men With Suspected Recurrence of Prostate Cancer | April 1, 2024 | July 2025 |
| NCT06065592 | Recruiting | Phase 1 | Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms | February 1, 2019 | December 2024 |
| NCT03344835 | Recruiting | Hong Kong Prostate Cancer Study Group Database | January 1, 2016 | December 31, 2040 | |
| NCT05903781 | Recruiting | Value of Ultra-fast Prostate MRI in Prostate Cancer | July 1, 2023 | July 1, 2025 | |
| NCT06362291 | Recruiting | N/A | Comparison of MRI AI-cTB Versus Routine cTB in Prostate Cancer Diagnosis: a Prospective Randomized Controlled Trial | August 1, 2023 | April 30, 2025 |
| NCT05616650 | Recruiting | Phase 2 | Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor | October 19, 2023 | December 1, 2028 |
| NCT04269512 | Recruiting | N/A | Role of Lymphnode Dissection in Men With Prostate Cancer Treated With Radical Prostatectomy | October 15, 2019 | December 2027 |
| NCT04335682 | Recruiting | Phase 2 | Androgen Receptor Directed Therapy on Cognitive Function in Patients Treated With Darolutamide or Enzalutamide | August 17, 2021 | August 2024 |
| NCT03802851 | Recruiting | N/A | HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer | September 19, 2019 | January 2035 |
| NCT05311527 | Recruiting | Phase 1 | UroLift System With SAbR for Prostate Cancer and BPH | January 11, 2023 | March 1, 2025 |
| NCT04167722 | Recruiting | How Does Prostate Cancer Metastasize? Studying the Role of Secreted Packages (Exosomes) From Fat Tissue in Lean and Obese Patients | October 1, 2019 | October 1, 2024 | |
| NCT05467176 | Recruiting | A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX | October 4, 2022 | May 31, 2028 | |
| NCT06433349 | Recruiting | A Multi-center Investigation of Family Health. | May 13, 2024 | December 31, 2025 | |
| NCT05539677 | Recruiting | Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research | September 1998 | December 2030 | |
| NCT02600156 | Recruiting | N/A | Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors | September 1, 2015 | December 2025 |
| NCT05893381 | Recruiting | Phase 2 | Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST) | June 27, 2023 | April 2028 |
| NCT05438524 | Recruiting | The Performance of MRI Prostate in Men With Different Prostate Health Index (Phi) Values | November 11, 2021 | June 30, 2024 | |
| NCT03784924 | Recruiting | EDRN Prostate MRI Biomarker Study | February 4, 2019 | December 31, 2028 | |
| NCT03354416 | Recruiting | Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer | February 26, 2018 | December 31, 2033 | |
| NCT05819827 | Recruiting | Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics | April 19, 2023 | March 27, 2025 | |
| NCT03861507 | Recruiting | N/A | Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound | March 4, 2020 | December 2024 |
| NCT05810467 | Recruiting | The Active Surveillance Study | August 22, 2023 | December 2027 | |
| NCT04506567 | Recruiting | Phase 1/Phase 2 | Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC | August 18, 2020 | June 30, 2027 |
| NCT05888532 | Recruiting | Phase 1/Phase 2 | 64Cu-GRIP B in Patients With Advanced Malignancies | May 25, 2023 | January 31, 2027 |
| NCT05803941 | Recruiting | Phase 4 | Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer | August 14, 2023 | July 21, 2033 |
| NCT04745871 | Recruiting | N/A | Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ). | May 20, 2021 | June 1, 2025 |
| NCT03821246 | Recruiting | Phase 2 | Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy | October 30, 2019 | February 28, 2025 |
| NCT04565457 | Recruiting | N/A | A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality | April 21, 2023 | September 30, 2025 |
| NCT04763915 | Recruiting | N/A | Improving Care After Inherited Cancer Testing | August 5, 2022 | December 2028 |
| NCT06072911 | Recruiting | N/A | Continence, Sexual Function, Fitness and the Health of Men After Surgery for Prostate Cancer | February 27, 2024 | June 30, 2026 |
| NCT05597852 | Recruiting | N/A | Using Rectal Hydrogel Spacer for Salvage SABR in Prostate Cancer | November 30, 2021 | November 30, 2027 |
| NCT02971085 | Recruiting | Seoul National University Prospectively Enrolled Registry for Prostate Cancer With Active Surveillance | December 2016 | January 2027 | |
| NCT03756077 | Recruiting | A Study of the Value of Hybrid PET/MR and PET/CT in Prostate Cancer | April 26, 2018 | December 31, 2023 | |
| NCT05471128 | Recruiting | MRI Fusion Biopsy vs. Micro-Ultrasound Guided Biopsy | January 27, 2023 | June 2025 | |
| NCT06392737 | Recruiting | N/A | Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis | May 1, 2024 | April 30, 2026 |
| NCT06257758 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors | January 10, 2024 | December 28, 2028 |
| NCT05879913 | Recruiting | N/A | ASCVD Management Using CCTA in Prostate Cancer Patients on ADT | December 15, 2023 | December 2026 |
| NCT05938270 | Recruiting | Phase 1 | A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer. | September 21, 2023 | February 25, 2025 |
| NCT04337580 | Recruiting | Phase 2 | Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer | March 5, 2021 | September 2024 |
| NCT05600400 | Recruiting | N/A | Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer | March 1, 2024 | June 2029 |
| NCT05366881 | Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease | May 3, 2022 | December 2026 | |
| NCT05313815 | Recruiting | N/A | Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer | July 18, 2022 | July 2030 |
| NCT06435546 | Recruiting | N/A | Adherence to Oral Therapies in Advanced Breast and Prostate Cancers | June 4, 2024 | June 4, 2025 |
| NCT05965180 | Recruiting | Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe | October 16, 2023 | October 2025 | |
| NCT04705038 | Recruiting | N/A | Effect of Education on Treatment Decision Making for Patients With Prostate Cancer on Chronic Hormone Treatments | December 18, 2020 | December 2025 |
| NCT05645510 | Recruiting | LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study | November 24, 2022 | May 30, 2025 | |
| NCT05702619 | Recruiting | Hypoxia-driven Prostate Cancer Genomics (HYPROGEN) | October 3, 2021 | June 30, 2023 | |
| NCT06190899 | Recruiting | Phase 1/Phase 2 | Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer | January 1, 2024 | November 2027 |
| NCT05301114 | Recruiting | N/A | Social Risk Factors and Discrimination in Cancer Survivorship | May 5, 2022 | September 30, 2026 |
| NCT06357416 | Recruiting | N/A | The Man Van Project | April 13, 2022 | December 1, 2026 |
| NCT05549024 | Recruiting | Early Phase 1 | 68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients | August 16, 2022 | December 31, 2023 |
| NCT04992728 | Recruiting | Prostate Assessment With Restriction Spectrum Imaging (RSI) MRI | November 2, 2021 | November 1, 2026 | |
| NCT03424850 | Recruiting | Phase 1/Phase 2 | Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy | February 27, 2018 | February 28, 2029 |
| NCT06074510 | Recruiting | Phase 4 | PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer | February 8, 2024 | January 2026 |
| NCT04655365 | Recruiting | Phase 2 | Detecting Metastases by PyL PET/CT in Subjects Starting Enzalutamide for Untreated Castration Resistant Prostate Cancer. | March 22, 2022 | June 1, 2025 |
| NCT04729114 | Recruiting | Phase 1/Phase 2 | Open-label, Multicenter Study of Intramuscular PRL-02 Depot in Patients With Advanced Prostate Cancer | June 14, 2021 | April 30, 2025 |
| NCT05712174 | Recruiting | Phase 2 | A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer | September 14, 2023 | December 2025 |
| NCT04197414 | Recruiting | Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA | December 6, 2019 | December 2029 | |
| NCT02016248 | Recruiting | N/A | Evaluation of CyberKnife Stereotactic Radiotherapy in Prostate Cancer | June 2012 | June 2029 |
| NCT05851365 | Recruiting | Early Phase 1 | Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer | July 6, 2023 | December 31, 2025 |
| NCT05826470 | Recruiting | N/A | Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging | May 30, 2023 | May 30, 2025 |
| NCT05751941 | Recruiting | Phase 2 | Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer | February 14, 2023 | October 2025 |
| NCT05010200 | Recruiting | Phase 1 | The Safety and Tolerability of PGV001-based Personalized Multi-peptide Vaccines in the Adjuvant Setting. | January 5, 2022 | January 2028 |
| NCT06441994 | Recruiting | Phase 1 | Clinical Trial of Targeted Alpha Therapy for Prostate Cancer | May 24, 2024 | March 31, 2027 |
| NCT04421222 | Recruiting | Phase 1 | Oral EPI-7386 in Patients With Castration-Resistant Prostate Cancer | June 23, 2020 | September 2026 |
| NCT04242017 | Recruiting | Phase 2/Phase 3 | Long-term Better Than Short-term ADT With Salvage RT | July 7, 2020 | February 1, 2031 |
| NCT05171387 | Recruiting | Phase 2 | Darolutamide + Androgen Deprivation Therapy (ADT) in Chinese Men With High Risk, Nonmetastatic Prostate Cancer | November 30, 2021 | March 3, 2025 |
| NCT05348577 | Recruiting | Phase 3 | Study of Capivasertib + Docetaxel vs Placebo + Docetaxel as Treatment for Metastatic Castration Resistant Prostate Cancer (mCRPC) | March 25, 2022 | December 21, 2026 |
| NCT04812366 | Recruiting | Phase 2 | Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer | September 21, 2021 | April 1, 2026 |
| NCT06331013 | Recruiting | N/A | CyberKnife Ultra-hypofractionated SBRT for Localized PROStatE cancEr | February 20, 2023 | December 31, 2029 |
| NCT05957822 | Recruiting | Phase 4 | Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery | February 10, 2024 | January 1, 2025 |
| NCT03822494 | Recruiting | N/A | CyberKnife Dose Escalation Prostate Cancer Trial | July 12, 2018 | July 12, 2028 |
| NCT06167629 | Recruiting | Monocentric Observational Study on the Diagnostic and Prognostic Role of 18F-PSMA PET (PET/CT and PET/MR) in Prostate Cancer | October 13, 2022 | July 13, 2027 | |
| NCT05613023 | Recruiting | Phase 3 | A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT | September 9, 2022 | June 2030 |
| NCT05375539 | Recruiting | Phase 1 | AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients | May 2, 2023 | November 30, 2024 |
| NCT06235697 | Recruiting | Phase 3 | Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment | April 25, 2024 | April 30, 2033 |
| NCT04656678 | Recruiting | N/A | Focal US-guided Cryo-ablation Using DynaCAD / UroNAV Preplanning / Guidance of Intermediate Risk Prostate Cancer | November 25, 2020 | October 30, 2025 |
| NCT05097274 | Recruiting | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation. | October 15, 2015 | December 31, 2025 | |
| NCT05678322 | Recruiting | Phase 3 | Optimizing Timing of rhPSMA-7.3 (18F) for Assessing Site(s) of Recurrent Disease Following Radical Prostatectomy | January 31, 2023 | June 2025 |
| NCT06145243 | Recruiting | N/A | Comparison of the Effectiveness of Supervised, Video-based and Home-based Resistance Exercise Program in Patients With Prostate Cancer | October 1, 2023 | June 15, 2024 |
| NCT05017181 | Recruiting | Novel MRI Assessment of Prostate Cancer VALIDATE-PRO | January 29, 2021 | June 1, 2024 | |
| NCT05109910 | Recruiting | N/A | The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy | November 17, 2021 | November 2027 |
| NCT02766686 | Recruiting | N/A | Preference-based Comparative Study on Definitive Radiotherapy of Prostate Cancer With Protons | September 2016 | February 2026 |
| NCT04891536 | Recruiting | N/A | Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy | May 1, 2021 | May 1, 2026 |
| NCT05715502 | Recruiting | N/A | Focal Salvage Brachytherapy Study (FocaSaBra) | May 1, 2022 | December 31, 2028 |
| NCT05249712 | Recruiting | Phase 2 | Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer | January 1, 2022 | December 1, 2025 |
| NCT05106699 | Recruiting | N/A | Carbon Ion Followed by Proton Radiotherapy for Prostate Cancer With Pelvic Lymph Nodes Metastases | June 8, 2021 | May 31, 2026 |
| NCT05940415 | Recruiting | Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer | October 8, 2023 | June 30, 2026 | |
| NCT05796973 | Recruiting | Phase 3 | Measuring Oncological Value of Exercise and Statin | March 31, 2023 | December 31, 2027 |
| NCT06041555 | Recruiting | MRI Guided Radiotherapy and Radiobiological Data: the ISRAR Database (Irm Sequences for Radiobiological Adaptative Radiotherapy) | January 8, 2024 | January 8, 2029 | |
| NCT05154162 | Recruiting | Phase 3 | PSMA PET Additive Value for Prostate Cancer Diagnosis in Men With Negative/Equivocal MRI | March 2, 2022 | March 2028 |
| NCT05946993 | Recruiting | N/A | Linking In With Advice and Supports for Men Impacted by Metastatic Cancer | May 8, 2023 | April 2025 |
| NCT05469269 | Recruiting | N/A | Cleveland African American Prostate Cancer Project | June 9, 2023 | March 31, 2027 |
| NCT03558048 | Recruiting | The Effect of IBD Flares on Serum PSA | August 1, 2019 | October 1, 2025 | |
| NCT06003556 | Recruiting | Phase 2 | PSMA-Guided Ablation of the Prostate | April 2, 2024 | February 26, 2029 |
| NCT04706962 | Recruiting | Phase 1 | TH1902 in Patients With Advanced Solid Tumors | March 4, 2021 | December 2024 |
| NCT05331638 | Recruiting | N/A | Prostate Cancer Genius App Education and Home-based PSA Screening for African American Men | February 24, 2023 | February 24, 2025 |
| NCT04638088 | Recruiting | Comparison of Radical Prostatectomy Performed by Robot-assisted Laparoscopy or Conventional Laparoscopy or by Laparotomy | March 1, 2021 | March 1, 2029 | |
| NCT05596851 | Recruiting | Radio-guided Surgery With DROP-IN Beta Probe for 68Ga-PSMA, in High-risk Prostate Cancer Patients Eligible for Robotic-assisted Radical Prostatectomy. | March 21, 2022 | December 1, 2023 | |
| NCT06150417 | Recruiting | Phase 2 | MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA) | May 24, 2024 | July 1, 2026 |
| NCT05840549 | Recruiting | N/A | A Study Comparing Urolift and TURP Ahead of Radiotherapy in Men With Urinary Symptoms Secondary to Prostate Enlargement | May 9, 2023 | May 9, 2025 |
| NCT01231932 | Recruiting | Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors | February 4, 2011 | ||
| NCT04662580 | Recruiting | Phase 1 | ARX517 in Subjects With Metastatic Castration-Resistant Prostate Cancer | July 27, 2021 | March 2027 |
| NCT04894188 | Recruiting | N/A | Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer | January 27, 2022 | July 1, 2041 |
| NCT05765500 | Recruiting | Phase 2 | RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | February 12, 2024 | January 1, 2026 |
| NCT04049747 | Recruiting | N/A | Comparative Health Research Outcomes of NOvel Surgery in Prostate Cancer | December 11, 2019 | May 2027 |
| NCT05343936 | Recruiting | Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population | August 19, 2022 | December 2026 | |
| NCT03819101 | Recruiting | Phase 3 | Trial of Acetylsalicylic Acid and Atorvastatin in Patients With Castrate-resistant Prostate Cancer | June 6, 2019 | March 2038 |
| NCT05133440 | Recruiting | Phase 2 | A Study of Stereotactic Body Radiation Therapy and Radium (Ra-223) Dichloride in Prostate Cancer That Has Spread to the Bones | November 12, 2021 | November 12, 2027 |
| NCT06091072 | Recruiting | N/A | Image-guided Navigation During Robotic Sentinel Node Removal | July 1, 2021 | August 1, 2024 |
| NCT04009967 | Recruiting | Phase 2 | Biomarkers for Neoadjuvant Pembrolizumab in Non-Metastatic Prostate Cancer Positive by 18FDG-PET Scanning | January 10, 2020 | March 30, 2025 |
| NCT00969111 | Recruiting | N/A | Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy | August 2009 | August 2050 |
| NCT05167175 | Recruiting | Phase 2 | The Study of Olaparib Combined With Abiraterone and Prednisone in mHSPC Patients With HRR Gene Mutation | March 1, 2022 | December 1, 2024 |
| NCT02705846 | Recruiting | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations | September 2014 | December 2035 | |
| NCT01766492 | Recruiting | Quality of Life in Patients With Clinically Localized Prostate Cancer Treated With Radiosurgery | December 2012 | April 2025 | |
| NCT05129605 | Recruiting | Prostate Cancer Genetic Risk Evaluation and Screening Study | February 12, 2020 | December 2040 | |
| NCT06001619 | Recruiting | Phase 4 | Prostate Medication, Metabolism and Gut Microbiota | December 1, 2022 | December 31, 2026 |
| NCT02769962 | Recruiting | Phase 1/Phase 2 | Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer | May 9, 2016 | December 31, 2027 |
| NCT05547061 | Recruiting | Phase 1/Phase 2 | A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Dosimetry, and Anti-tumor Activity of Ga-68-NGUL / Lu-177-DGUL in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Refractory to Standard Therapy | April 12, 2021 | December 31, 2024 |
| NCT05328505 | Recruiting | N/A | Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer | August 5, 2022 | August 2030 |
| NCT03594760 | Recruiting | Phase 3 | PSMA-PET: Deep Radiomic Biomarkers of Progression and Response Prediction in Prostate Cancer | December 1, 2018 | December 2029 |
| NCT03976843 | Recruiting | Phase 2 | Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer | December 4, 2019 | August 31, 2025 |
| NCT03808077 | Recruiting | Phase 2 | The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer | January 14, 2019 | January 2025 |
| NCT05617040 | Recruiting | Phase 1/Phase 2 | Prime-boost Immunotherapeutic Trial in Men With Biochemical Recurrence After Definitive Local Therapy for Prostate Cancer | January 30, 2023 | April 2027 |
| NCT06139575 | Recruiting | Phase 1/Phase 2 | Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer | December 22, 2023 | July 2027 |
| NCT06380660 | Recruiting | Phase 1/Phase 2 | Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors | March 22, 2024 | March 21, 2029 |
| NCT05424783 | Recruiting | N/A | MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC) | October 15, 2022 | December 31, 2025 |
| NCT02960022 | Recruiting | Phase 2 | A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study | December 22, 2016 | July 31, 2026 |
| NCT02759380 | Recruiting | N/A | Can Dietary Phytoestrogens Slow Down Prostate Tumor Proliferation? | March 2016 | December 2024 |
| NCT05557604 | Recruiting | Phase 2 | Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer | February 2, 2021 | February 2, 2027 |
| NCT04186585 | Recruiting | Phase 1 | Recommended Dose Estimation of BP-C2 | April 1, 2023 | September 30, 2024 |
| NCT05946161 | Recruiting | N/A | Testing an e-Health Intervention for Prostate Cancer Survivors' Mental and Sexual Health | June 20, 2023 | August 1, 2024 |
| NCT03585660 | Recruiting | N/A | Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy | June 19, 2018 | December 2025 |
| NCT06423976 | Recruiting | Microbiome Molecular Charaterisation | October 23, 2023 | October 2038 | |
| NCT06212583 | Recruiting | Phase 2 | High-Risk Metachronous Oligometastatic Prostate Cancer Trial | April 17, 2024 | December 31, 2029 |
| NCT03753334 | Recruiting | Phase 2 | Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer. | July 10, 2017 | December 2025 |
| NCT05786742 | Recruiting | N/A | Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost. | April 2014 | December 2033 |
| NCT05019846 | Recruiting | Phase 3 | SRT Versus SRT+ADT in Prostate Cancer | September 30, 2021 | December 1, 2029 |
| NCT03079323 | Recruiting | Phase 2 | Trial to Investigate the Benefit of Elective Para-Aortic Radiotherapy (PART) for pN1 Prostate Cancer | February 6, 2017 | February 1, 2025 |
| NCT06099977 | Recruiting | N/A | Binaural Sound for Remimazolam Induction | November 1, 2023 | October 30, 2025 |
| NCT06262633 | Recruiting | N/A | A Multi-centre Trial on Targeted Microwave Ablation (TMA) for Localized Prostate Cancer | March 15, 2024 | June 30, 2026 |
| NCT06259279 | Recruiting | N/A | High Impact Training to Patients With Prostate Cancer and Bone Metastases | February 6, 2024 | December 31, 2026 |
| NCT04081428 | Recruiting | Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal TissUe and Tumour Response During Prostate Cancer SBRT | October 11, 2018 | January 11, 2026 | |
| NCT04393376 | Recruiting | N/A | PSA Glycomics Assay for Early Detection of Prostate Cancer | August 1, 2020 | August 1, 2025 |
| NCT03408964 | Recruiting | Valid Biomarkers in Blood to Predict the Response to Therapy in Prostate Cancer Patients | December 15, 2017 | December 31, 2023 | |
| NCT04104529 | Recruiting | N/A | Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department | October 28, 2019 | October 2026 |
| NCT06334809 | Recruiting | INSIDE: Identification of Genomic Screening Pathways in Cancer Patients With DNA Repair Alterations | March 9, 2023 | December 31, 2027 | |
| NCT04895839 | Recruiting | N/A | Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program | September 29, 2021 | October 1, 2025 |
| NCT05568550 | Recruiting | Phase 2 | Pembro With Radiation With or Without Olaparib | July 27, 2023 | July 2, 2029 |
| NCT04302454 | Recruiting | Phase 3 | Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy | March 19, 2020 | December 1, 2024 |
| NCT04631744 | Recruiting | Phase 2 | Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) | March 3, 2021 | May 31, 2025 |
| NCT05672485 | Recruiting | N/A | 99mTc-P137 SPECT/CT in Prostate Cancer | January 5, 2023 | January 31, 2027 |
| NCT05384535 | Recruiting | N/A | Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort | August 15, 2022 | October 31, 2026 |
| NCT05306600 | Recruiting | Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System | November 9, 2022 | December 31, 2026 | |
| NCT06397755 | Recruiting | Observational Study of Patients Who Underwent Diagnostic Investigation (Prostate Biopsy) and/or Radical Prostatectomy Surgery. | January 8, 2015 | January 8, 2065 | |
| NCT04989946 | Recruiting | Phase 1/Phase 2 | Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer | December 16, 2021 | December 2028 |
| NCT05470036 | Recruiting | N/A | Improving Germline Testing in At-Risk Patients With Prostate Cancer | September 27, 2022 | December 2024 |
| NCT05123300 | Recruiting | N/A | PRISMA-PET - Primary Staging of Prostate Cancer With PSMA | October 4, 2021 | October 1, 2030 |
| NCT06274892 | Recruiting | N/A | Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process | April 1, 2024 | November 30, 2024 |
| NCT03465579 | Recruiting | N/A | Mp-3TMRI and 68Ga-PSMA PET/CT Guided Prostate Biopsy and Tumor Node Metastasis (TNM) Staging. | May 23, 2018 | January 2024 |
| NCT03495427 | Recruiting | Phase 2/Phase 3 | PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher Test Scores | December 18, 2019 | May 2029 |
| NCT06284304 | Recruiting | N/A | A Pilot Study of Dose dE-eScalaTion IN prostATe radIOtherapy usiNg the MRL | February 29, 2024 | April 1, 2027 |
| NCT04484038 | Recruiting | N/A | Multicenter Study of Hypofractionated Postoperative Radiotherapy in Patients Diagnosed With Prostate Carcinoma | March 9, 2019 | March 2025 |
| NCT02917798 | Recruiting | Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes | July 12, 2016 | September 2025 | |
| NCT05443412 | Recruiting | Artificial Intelligence (AI)-Assisted Risk-based Prostate Cancer Detection | August 1, 2023 | October 30, 2026 | |
| NCT05745844 | Recruiting | N/A | Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program | December 20, 2023 | June 2026 |
| NCT04263025 | Recruiting | Phase 2/Phase 3 | AMNIOX CORD Study - Radical Prostatectomy With and Without Cryopreserved Umbilical Cord Allograft | January 30, 2020 | October 1, 2025 |
| NCT04887935 | Recruiting | Phase 1 | Neoadjuvant SGLT2 Inhibition in High-Risk Localized Prostate Cancer | June 4, 2024 | August 31, 2026 |
| NCT05478239 | Recruiting | Phase 2 | ArtemiCoffee in Patients With Rising PSA | August 11, 2023 | December 31, 2025 |
| NCT05633342 | Recruiting | Project CADENCE (CAncer Detected Early caN be CurEd) | July 7, 2022 | May 2025 | |
| NCT05422105 | Recruiting | Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient | July 1, 2023 | December 31, 2024 | |
| NCT04287088 | Recruiting | N/A | bpMRI and Risk Based Shared Clinical Decision Making in Prostate Cancer Diagnosis | February 17, 2020 | December 31, 2041 |
| NCT00949819 | Recruiting | Active Surveillance for Cancer of the Prostate (ASCaP) | July 4, 2009 | December 2028 | |
| NCT04787744 | Recruiting | Phase 2/Phase 3 | Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer | July 1, 2021 | December 1, 2025 |
| NCT06229366 | Recruiting | Phase 1 | [Ac-225]-PSMA-62 Trial in Biochemically Recurrent and Metastatic Castration Resistant Prostate Cancer | March 26, 2024 | March 2032 |
| NCT05472532 | Recruiting | N/A | Evaluation of an Automated System to Culture Metastatic Patient Circulating Tumor Cells in Embryonated Chicken Eggs (in Ovo Culture) | February 14, 2023 | December 14, 2024 |
| NCT05104515 | Recruiting | Phase 1 | First-in-human Study of OVM-200 as a Therapeutic Cancer Vaccine | November 1, 2021 | December 31, 2024 |
| NCT05361902 | Recruiting | N/A | A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer | July 7, 2022 | February 2027 |
| NCT02543905 | Recruiting | The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment | March 9, 2015 | December 31, 2025 | |
| NCT06096870 | Recruiting | Phase 2 | Enzalutamide and M9241 in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy | April 22, 2024 | December 31, 2029 |
| NCT05893394 | Recruiting | Core Stability as a Prognostic Factor of Urinary Incontinence in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy | March 1, 2023 | November 30, 2023 | |
| NCT06305832 | Recruiting | Phase 2 | Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer | September 7, 2023 | March 2028 |
| NCT05826509 | Recruiting | Phase 2 | SUrGery With or Without dARolutamide in High-risk and/or Locally Advanced Prostate Cancer | August 10, 2023 | May 2030 |
| NCT03572621 | Recruiting | N/A | Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their Sexuality | February 3, 2020 | September 2024 |
| NCT05515978 | Recruiting | Early Phase 1 | Pragmatic Trial of Metformin for Glucose Intolerance or Increased BMI in Prostate Cancer Patients | October 17, 2022 | November 6, 2036 |
| NCT05558241 | Recruiting | N/A | Micro-UltraSound In Cancer - Active Surveillance | January 1, 2023 | June 30, 2026 |
| NCT06055946 | Recruiting | Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical Prostatectomy | November 7, 2023 | May 2025 | |
| NCT06355076 | Recruiting | N/A | New Urethral Reconstruction in Robot-assisted Laparoscopic Radical Resection | February 5, 2023 | June 2026 |
| NCT06257264 | Recruiting | Phase 1 | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors | February 28, 2024 | December 31, 2026 |
| NCT05947188 | Recruiting | N/A | Circulating Tumor Cells and mpMRI for Non-invasive Diagnosis of Prostate Cancer(CMNDPC) | November 1, 2023 | December 2024 |
| NCT06018311 | Recruiting | N/A | Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads | September 28, 2023 | February 28, 2025 |
| NCT06303713 | Recruiting | Phase 1 | LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer | May 22, 2024 | July 19, 2026 |
| NCT05345444 | Recruiting | N/A | Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) | May 26, 2022 | April 2025 |
| NCT03668652 | Recruiting | N/A | Focal Prostate Ablation Versus Radical Prostatectomy | September 30, 2017 | September 30, 2024 |
| NCT05114746 | Recruiting | Phase 2 | Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan | January 25, 2022 | April 30, 2026 |
| NCT04694924 | Recruiting | Prospective Prostate Cancer and Patient-reported Outcomes Registry | October 1, 2020 | October 2030 | |
| NCT05864144 | Recruiting | Phase 1/Phase 2 | A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors | May 31, 2023 | June 2027 |
| NCT05432687 | Recruiting | N/A | Impact of Abdominal Incompetence on Urinary Incontinence After Prostatectomy (PROSTABDO) | September 1, 2022 | October 2025 |
| NCT03151629 | Recruiting | International Registry for Men With Advanced Prostate Cancer (IRONMAN) | July 21, 2017 | January 2029 | |
| NCT04462926 | Recruiting | N/A | Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly Diagnosed | September 20, 2020 | September 20, 2024 |
| NCT04731844 | Recruiting | Phase 2 | Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer | December 14, 2021 | May 31, 2024 |
| NCT04751435 | Recruiting | N/A | Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients | November 16, 2021 | August 31, 2026 |
| NCT05364229 | Recruiting | N/A | MR-guided Tumour Boost | February 6, 2023 | June 2030 |
| NCT05462392 | Recruiting | N/A | Robot-assisted Urological Surgeries Using the MicroHand S Robot | July 28, 2022 | December 2023 |
| NCT05327465 | Recruiting | N/A | Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy | August 11, 2022 | March 31, 2025 |
| NCT05020522 | Recruiting | N/A | Comparison of Diagnostic Accuracy of Luminal Index and MP MRI for Accelerated deTEction of Significant Prostate Cancer | May 1, 2022 | March 1, 2025 |
| NCT03908684 | Recruiting | Ultrasound Spectroscopy as Early Indicators of Radiation Treatment Response in Prostate, Rectum and Head & Neck Cancers | December 17, 2014 | December 17, 2029 | |
| NCT05628363 | Recruiting | N/A | Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer | January 18, 2023 | January 31, 2031 |
| NCT03891732 | Recruiting | MRI Prostate for Chinese Men Being Screened for Prostate Cancer | January 19, 2019 | December 31, 2024 | |
| NCT05014295 | Recruiting | N/A | Patient Recall of Cancer Screening and Diagnosis | October 30, 2024 | June 2025 |
| NCT05099679 | Recruiting | N/A | Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study | November 18, 2021 | November 2024 |
| NCT06125145 | Recruiting | N/A | Geriatric Assessment and Promotores (GAP) Pilot Feasibility Study | March 21, 2024 | September 10, 2025 |
| NCT05739812 | Recruiting | N/A | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | February 5, 2023 | April 2024 |
| NCT02064673 | Recruiting | Phase 3 | Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy | May 2014 | June 2026 |
| NCT04188535 | Recruiting | N/A | Serial MRI Scans During Radiation Therapy | January 15, 2020 | July 31, 2025 |
| NCT05597878 | Recruiting | Phase 2/Phase 3 | Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy | April 18, 2023 | February 2025 |
| NCT04221542 | Recruiting | Phase 1 | Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer | March 4, 2020 | July 30, 2028 |
| NCT05008900 | Recruiting | Phase 2 | Timing of Post-prostatectomy PSMA Imaging | March 22, 2022 | September 2031 |
| NCT04486755 | Recruiting | Phase 1 | Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048) | November 19, 2020 | August 2027 |
| NCT04685928 | Recruiting | N/A | Extended Systematic Versus Mri-Assisted pRostate Transperineal Biopsy | May 27, 2021 | March 31, 2025 |
| NCT02012699 | Recruiting | Integrated Cancer Repository for Cancer Research | November 1, 2013 | December 2099 | |
| NCT05279287 | Recruiting | Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS) | February 1, 2023 | August 31, 2024 | |
| NCT01742403 | Recruiting | N/A | Continuous Monitoring of Prostate Position During Radiotherapy | January 1, 2013 | June 30, 2028 |
| NCT02558946 | Recruiting | N/A | Physical Therapy for Men Undergoing Prostatectomy | May 2015 | January 2025 |
| NCT03787056 | Recruiting | N/A | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients | December 4, 2018 | January 4, 2028 |
| NCT05683964 | Recruiting | Early Phase 1 | Androgen Receptor Signaling and Prostate-Specific Membrane Antigen Expression | January 19, 2023 | February 1, 2025 |
| NCT04769817 | Recruiting | ProsTIC Registry of Men Treated With PSMA Theranostics | May 1, 2021 | December 31, 2028 | |
| NCT05840484 | Recruiting | Comprehensive Monitoring of Men With Prostate Cancer Cared for by "Active Surveillance | March 29, 2023 | July 30, 2029 | |
| NCT05396872 | Recruiting | N/A | Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate Cancer | May 12, 2022 | December 31, 2027 |
| NCT04485767 | Recruiting | N/A | RESIST-ADT (Androgen Deprivation Therapy) | December 1, 2020 | October 31, 2024 |
| NCT05350475 | Recruiting | N/A | Protons vs. Photons for High-risk Prostate Cancer | March 1, 2022 | March 1, 2037 |
| NCT04861194 | Recruiting | N/A | EREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT) | July 14, 2021 | August 10, 2025 |
| NCT06029036 | Recruiting | Phase 2 | A Phase II Neoadjuvant Study of Darolutamide Plus ADT in Men With Localized Prostate Cancer | August 5, 2023 | July 31, 2026 |
| NCT04048252 | Recruiting | Development of a Therapeutic Education Program for Patients With Metastatic Prostate Cancer Treated With New Generation Hormone Therapy | September 10, 2019 | December 2023 | |
| NCT05285319 | Recruiting | Phase 2 | Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer | February 9, 2020 | April 1, 2023 |
| NCT05847166 | Recruiting | N/A | A Phase 2/3,PSMA-T4, Prostate Cancer | May 10, 2023 | December 28, 2024 |
| NCT05189457 | Recruiting | Phase 2 | First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer | January 25, 2022 | January 2027 |
| NCT05995236 | Recruiting | Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy | August 2, 2023 | August 2, 2024 | |
| NCT04543799 | Recruiting | Evaluation of Sleep Quality in Prostate Cancer Patients Undergoing Treatment With Hormonal Therapeutic Approaches and in Patients With Full-resected Early Breast Cancer | September 24, 2020 | December 31, 2025 | |
| NCT05169970 | Recruiting | Phase 2 | A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer | December 9, 2021 | December 2024 |
| NCT00451022 | Recruiting | Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies | September 13, 2004 | ||
| NCT03674814 | Recruiting | Phase 1 | Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer | October 23, 2018 | March 10, 2026 |
| NCT04004312 | Recruiting | N/A | Single Fractions SBRT for Prostate Cancer | November 7, 2018 | December 20, 2026 |
| NCT03574571 | Recruiting | Phase 3 | A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer | June 19, 2018 | June 1, 2026 |
| NCT05384002 | Recruiting | An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum | February 24, 2021 | September 30, 2024 | |
| NCT05948657 | Recruiting | N/A | Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr | February 26, 2024 | December 2028 |
| NCT04766190 | Recruiting | N/A | DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer | February 10, 2021 | August 31, 2025 |
| NCT06270043 | Recruiting | Focal Therapy for Localized Prostate Cancer | February 1, 2024 | February 1, 2034 | |
| NCT04832997 | Recruiting | N/A | Micro-ultrasound for Prostate Cancer Diagnosis | September 14, 2020 | September 30, 2025 |
| NCT05766163 | Recruiting | N/A | Comparison of Outcomes of Multiple Platforms for Assisted Robotic - Prostate | March 14, 2023 | September 2024 |
| NCT06398613 | Recruiting | N/A | Preoperative PSMA PET/CT as Triage for ePLND in Patients Scheduled for RALP (PrePSMA) | April 26, 2024 | December 31, 2029 |
| NCT06398639 | Recruiting | N/A | Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer | May 7, 2024 | April 30, 2030 |
| NCT05822726 | Recruiting | N/A | The Combination of PSMA-PET/MR and p2PSA in Early Diagnosis of Prostate Cancer | October 1, 2022 | June 30, 2025 |
| NCT03386045 | Recruiting | N/A | Optimal Prostate Study | October 2, 2018 | August 1, 2028 |
| NCT04349501 | Recruiting | Phase 2 | Biomarker Monitoring of Prostate Cancer Patients With RSI MRI (ProsRSI) | December 29, 2020 | December 1, 2026 |
| NCT04905069 | Recruiting | N/A | Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy | December 21, 2021 | April 2030 |
| NCT06081686 | Recruiting | Phase 1/Phase 2 | Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer | September 13, 2023 | December 2025 |
| NCT05722392 | Recruiting | Safety and Efficacy of Two-step Radical Prostatectomy | February 15, 2023 | February 15, 2033 | |
| NCT01194648 | Recruiting | N/A | Focal Therapy for Prostate Cancer Using HIFU | June 29, 2011 | June 2029 |
| NCT04261777 | Recruiting | Phase 3 | Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients | May 27, 2020 | December 2025 |
| NCT06085729 | Recruiting | Phase 1/Phase 2 | Phase I/II Study of PEGylated Arginine Deiminase (ADI-PEG20) With Carboplatin and Cabazitaxel in Men With Aggressive Variant Prostate Cancers (AVPC) | February 29, 2024 | December 31, 2027 |
| NCT04478279 | Recruiting | Phase 1/Phase 2 | A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors | July 1, 2020 | December 2025 |
| NCT04231006 | Recruiting | N/A | Salvage HDR for Locally Recurrent Prostate Cancer | April 1, 2021 | March 1, 2035 |
| NCT03836196 | Recruiting | N/A | Optimizing Prostate Cancer Treatment in Men With Advanced Local Disease | September 13, 2019 | February 2028 |
| NCT05864196 | Recruiting | Phase 1 | Two Fraction Prostate SBRT With DIL SIB | July 17, 2023 | June 2026 |
| NCT04402151 | Recruiting | Phase 2 | Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer | June 30, 2020 | December 31, 2025 |
| NCT05141383 | Recruiting | N/A | Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy | May 4, 2022 | October 24, 2024 |
| NCT06363435 | Recruiting | AI-based Measurements of Tumour Burden in PSMA PET-CT | March 29, 2024 | March 2033 | |
| NCT04550845 | Recruiting | N/A | Understanding of Genetics by Men at Risk for Prostate Cancer | May 1, 2023 | September 27, 2027 |
| NCT05403177 | Recruiting | Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O) | June 23, 2022 | October 2026 | |
| NCT04394676 | Recruiting | N/A | The Impact of Low Pressure Pneumo in RARP II | August 4, 2020 | June 30, 2025 |
| NCT05884632 | Recruiting | N/A | Daily Adaptive RadioTherapy in Postoperative HypofrActionated Salvage radiothERapy for Prostate Cancer Patients | April 3, 2023 | April 30, 2030 |
| NCT05820633 | Recruiting | N/A | Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer. | September 1, 2022 | December 2035 |
| NCT05751434 | Recruiting | Phase 2 | A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer | February 10, 2023 | February 10, 2027 |
| NCT05380518 | Recruiting | An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum | May 1, 2022 | October 1, 2024 | |
| NCT04732156 | Recruiting | N/A | Detection of ISUP≥2 Prostate Cancers Using Multiparametric MRI: Prospective Multicenter Comparison of the PI-RADS Score and an Artificial Intelligence System | April 14, 2021 | June 15, 2026 |
| NCT05804318 | Recruiting | N/A | Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer | April 13, 2023 | March 2030 |
| NCT04995198 | Recruiting | N/A | PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness | May 3, 2021 | February 26, 2036 |
| NCT06056830 | Recruiting | Phase 3 | Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy | November 30, 2023 | February 2025 |
| NCT03830788 | Recruiting | N/A | Erectile Dysfunction in Good Prognosis Prostate Cancer : Comparison Between Brachytherapy and Stereotactic Body Radiotherapy | October 4, 2019 | October 4, 2030 |
| NCT04300855 | Recruiting | Phase 2 | Clinical Trial of Green Tea Catechins in Men on Active Surveillance | August 21, 2020 | June 30, 2025 |
| NCT05940298 | Recruiting | Phase 1 | Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8 | July 3, 2023 | July 1, 2024 |
| NCT04794777 | Recruiting | Phase 3 | Comparing "Salvage" Radiotherapy and Individualized PSMA PET/CT Targeted Treatment in With Relapsing Prostate Cancer | October 30, 2018 | October 30, 2027 |
| NCT06163924 | Recruiting | The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT | December 10, 2023 | March 31, 2029 | |
| NCT06177093 | Recruiting | N/A | De-escalated Dose SBRT in Localized Prostate Cancer (DESTINATION-MRL) | December 11, 2023 | December 1, 2027 |
| NCT05572099 | Recruiting | ExoDx Prostate Evaluation in Active Surveillance Patient Population | October 1, 2022 | October 2023 | |
| NCT06022757 | Recruiting | Phase 1/Phase 2 | Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) | September 20, 2023 | August 2028 |
| NCT05096338 | Recruiting | Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Prostate Cancer | October 27, 2021 | October 2028 | |
| NCT04536805 | Recruiting | Phase 1/Phase 2 | Relapse in Previously Irradiated Prostate Bed : Stereotactic Ablative Reirradiation Potentiated by Metformin | November 17, 2020 | November 2030 |
| NCT04019964 | Recruiting | Phase 2 | Nivolumab in Biochemically Recurrent dMMR Prostate Cancer | January 13, 2020 | January 2025 |
| NCT06385847 | Recruiting | Phase 2 | To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer | May 2024 | December 2025 |
| NCT06235151 | Recruiting | Phase 3 | Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancer | April 1, 2024 | July 2025 |
| NCT06199050 | Recruiting | N/A | The Effect of 360° Virtual Reality Movies on Fear and Anxiety | June 16, 2023 | June 30, 2025 |
| NCT05225428 | Recruiting | N/A | Video Education With Result Dependent dIsclosure | August 4, 2022 | September 1, 2026 |
| NCT05955677 | Recruiting | Early Phase 1 | Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | July 10, 2023 | December 31, 2024 |
| NCT05539300 | Recruiting | N/A | PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - Enzalutamide | March 1, 2023 | January 1, 2026 |
| NCT04627948 | Recruiting | STHLM3 AS NorDCaP - a Followup Study of Men on Active Surveillance of Prostate Cancer | July 1, 2019 | December 1, 2024 | |
| NCT05645237 | Recruiting | HRQOL in Prostate Cancer Patients Treated With Radiotherapy | April 8, 2019 | January 1, 2028 | |
| NCT04028479 | Recruiting | The Registry of Oncology Outcomes Associated With Testing and Treatment | May 5, 2021 | October 1, 2031 | |
| NCT04981223 | Recruiting | N/A | Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging | April 1, 2022 | July 1, 2024 |
| NCT04396808 | Recruiting | N/A | Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer | November 5, 2020 | July 2025 |
| NCT04854343 | Recruiting | SLPI for Prostate Cancer | December 1, 2020 | July 1, 2024 | |
| NCT05161728 | Recruiting | N/A | PSMA Response in Metastasized Hormone Sensitive Prostate Cancer | October 19, 2021 | October 19, 2025 |
| NCT04443062 | Recruiting | Phase 2 | Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer | July 20, 2020 | January 1, 2025 |
| NCT06462508 | Recruiting | Early Phase 1 | Head-to-head Comparison of [18F]F-PSMA-N5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis | April 20, 2024 | December 31, 2025 |
| NCT05322356 | Recruiting | N/A | Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System | April 4, 2023 | June 2025 |
| NCT05910229 | Recruiting | N/A | Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients With Prostate Cancer | November 9, 2022 | March 9, 2025 |
| NCT02189486 | Recruiting | Prostate Cancer Upgrading Reference Set | August 2014 | December 2025 | |
| NCT02186925 | Recruiting | A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. | August 2014 | August 2025 | |
| NCT05882253 | Recruiting | N/A | Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial) | December 4, 2023 | April 2028 |
| NCT04557449 | Recruiting | Phase 1/Phase 2 | Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors | September 23, 2020 | May 4, 2028 |
| NCT05580107 | Recruiting | Phase 1 | MDPK67b in Patients With Prostate Cancer | August 9, 2021 | June 30, 2024 |
| NCT05558007 | Recruiting | Phase 2 | Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients | November 22, 2023 | September 2024 |
| NCT03893929 | Recruiting | The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population | October 7, 2015 | December 31, 2025 | |
| NCT06199986 | Recruiting | N/A | DeADT - Living Well With Prostate Cancer | October 4, 2022 | May 1, 2024 |
| NCT05169112 | Recruiting | Phase 3 | Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy | March 6, 2023 | November 2028 |
| NCT04465500 | Recruiting | Phase 2 | EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer | July 30, 2020 | January 1, 2029 |
| NCT05351424 | Recruiting | N/A | AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc | May 3, 2022 | December 31, 2026 |
| NCT05603351 | Recruiting | N/A | Prostate Cancer Screening With Abbreviated MRI Protocol | May 1, 2022 | December 31, 2025 |
| NCT05155501 | Recruiting | N/A | Clinical Trial of Approaches to Prostate Cancer Surgery | May 15, 2023 | December 2026 |
| NCT06242119 | Recruiting | Clinical Application of the J-PET Scanner Prototype | March 7, 2024 | October 14, 2024 | |
| NCT05448547 | Recruiting | Phase 3 | Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer | November 4, 2022 | December 31, 2036 |
| NCT04692675 | Recruiting | N/A | Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer | November 18, 2022 | September 1, 2027 |
| NCT06218667 | Recruiting | Phase 1/Phase 2 | A Study of Copanlisib in Combination With Degarelix in People With Prostate Cancer | January 11, 2024 | January 2027 |
| NCT04903873 | Recruiting | Phase 1/Phase 2 | A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors | May 31, 2021 | December 2025 |
| NCT04796467 | Recruiting | Phase 2/Phase 3 | 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients | October 1, 2020 | October 1, 2022 |
| NCT05253053 | Recruiting | Phase 1/Phase 2 | To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | April 13, 2022 | December 2024 |
| NCT05346848 | Recruiting | Phase 2 | Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate Cancer | February 24, 2023 | February 2030 |
| NCT05737004 | Recruiting | Effects of Prostate Cancer on Brain Function | April 13, 2023 | April 1, 2024 | |
| NCT06397703 | Recruiting | Phase 3 | ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer | April 16, 2024 | April 16, 2028 |
| NCT04228211 | Recruiting | Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation | February 5, 2020 | February 5, 2033 | |
| NCT03232164 | Recruiting | Early Phase 1 | PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer | February 2, 2017 | December 2024 |
| NCT06237179 | Recruiting | Phase 1/Phase 2 | Behavioral Exercise Training to Reduce Cardiovascular Disease Risk | February 21, 2024 | January 31, 2028 |
| NCT05818631 | Recruiting | Cognitive Fusion Prostate Biopsy With Biparametric Magnetic Resonance in the Detection of Prostate Cancer | March 1, 2021 | February 2024 | |
| NCT04831983 | Recruiting | ABlative Radiotherapy (for) Unfavorable Prostate Tumors | April 15, 2021 | April 1, 2029 | |
| NCT05383079 | Recruiting | Phase 1/Phase 2 | Combination of Radium-223 and Lutetium-177 PSMA-I&T in Men With Metastatic Castration-Resistant Prostate Cancer | September 13, 2022 | December 1, 2026 |
| NCT02040610 | Recruiting | N/A | Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer | January 2014 | December 2025 |
| NCT01407263 | Recruiting | Phase 3 | Trial of Modifications to Radical Prostatectomy | July 2011 | July 2025 |
| NCT05710380 | Recruiting | N/A | MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy | April 26, 2023 | May 1, 2026 |
| NCT05231915 | Recruiting | N/A | Prevalence of the c.853delT Mutation of the HOXB13 Gene in Prostate Cancer in Martinique | April 9, 2021 | April 9, 2025 |
| NCT04212715 | Recruiting | Phase 2 | Prostate SABR With Intra-Prostatic SABR Boost | December 26, 2019 | December 2026 |
| NCT05100121 | Recruiting | N/A | To Live Better and Longer With Prostate Cancer: | November 1, 2023 | December 1, 2026 |
| NCT06014255 | Recruiting | Phase 2 | Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer | February 16, 2024 | March 1, 2029 |
| NCT04340024 | Recruiting | Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients | September 30, 2015 | December 31, 2026 | |
| NCT02313623 | Recruiting | MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research | July 2013 | October 2025 | |
| NCT06238479 | Recruiting | Phase 1 | A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors | March 5, 2024 | March 4, 2027 |
| NCT04978519 | Recruiting | N/A | Effectiveness of Cryotherapy Study for Prostate Cancer | August 2, 2021 | March 31, 2025 |
| NCT05519449 | Recruiting | Phase 1 | Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) | September 15, 2022 | March 2025 |
| NCT06027892 | Recruiting | N/A | Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer | December 29, 2022 | December 2032 |
| NCT05961514 | Recruiting | N/A | the Beijing Randomized Study Of Prostate Cancer Screening | October 31, 2023 | December 31, 2024 |
| NCT01607008 | Recruiting | N/A | MRI for Assessing Prostate Cancer Response | November 16, 2012 | December 2027 |
| NCT03392233 | Recruiting | Phase 2 | Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors | August 18, 2017 | December 31, 2027 |
| NCT05555017 | Recruiting | Phase 2 | Tracer-Guided Surgery for Recurrent Prostate Cancer | February 15, 2023 | November 2025 |
| NCT06111781 | Recruiting | Phase 2 | The SUGAR Study: (SBRT and Ultrashort GnRH Antagonist-Relugolix) for Clinicogenomic Unfavorable Intermediate Risk Prostate Cancer | April 15, 2024 | February 2028 |
| NCT05584787 | Recruiting | N/A | Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis | May 1, 2021 | March 30, 2024 |
| NCT04580667 | Recruiting | Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly From Plasma | October 1, 2020 | December 31, 2023 | |
| NCT05705921 | Recruiting | N/A | Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer | April 26, 2023 | January 1, 2032 |
| NCT05120973 | Recruiting | Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer. | November 1, 2021 | November 2025 | |
| NCT02526368 | Recruiting | Early Phase 1 | Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer | March 22, 2016 | December 31, 2024 |
| NCT04842890 | Recruiting | Phase 2 | Phase II Study of Pencil Beam Scanning Proton Stereotactic Body Radiation Therapy for Prostate Cancer | January 8, 2021 | January 2026 |
| NCT05761093 | Recruiting | Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment | September 7, 2022 | December 31, 2024 | |
| NCT05540782 | Recruiting | A Study of Cognitive Health in Survivors of Prostate Cancer | September 8, 2022 | September 8, 2025 | |
| NCT05669443 | Recruiting | N/A | Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy | April 3, 2023 | November 10, 2024 |
| NCT05720832 | Recruiting | N/A | Feasibility of Technology-Based SSIP in Prostate Cancer Patients | August 23, 2023 | June 30, 2025 |
| NCT06200259 | Recruiting | N/A | Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement | January 8, 2024 | January 2, 2040 |
| NCT02804815 | Recruiting | Phase 3 | Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | October 2015 | October 2026 |
| NCT05841992 | Recruiting | Phase 2/Phase 3 | Al18F-PSMA-617 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients | July 1, 2021 | May 1, 2023 |
| NCT04053842 | Recruiting | Phase 2 | Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomy | February 4, 2021 | August 31, 2024 |
| NCT03580109 | Recruiting | N/A | Spa Therapy for Upper or Lower Limb Lymphoedema | June 20, 2019 | December 2025 |
| NCT04271579 | Recruiting | N/A | Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s) | October 15, 2019 | December 31, 2025 |
| NCT02334579 | Recruiting | N/A | Stereotactic Body Radiotherapy for Stage I-III Prostate Cancer | December 2014 | December 2024 |
| NCT02594202 | Recruiting | Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue | December 21, 2015 | January 1, 2027 | |
| NCT05902637 | Recruiting | N/A | The Efficacy Of Mapping For Cognitive Prostate Biopsy | March 1, 2023 | September 1, 2023 |
| NCT05038332 | Recruiting | Phase 2 | Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT]) | November 12, 2021 | November 2029 |
| NCT01961713 | Recruiting | Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy | April 2010 | December 2025 | |
| NCT06116851 | Recruiting | Prostate Metabolism, Cancer Risk and Gut Microbiota | June 1, 2022 | September 15, 2026 | |
| NCT05698576 | Recruiting | N/A | TRANBERG® Transperineal MR/US Fusion Laser--Induced Thermal Therapy for Men With Prostate Cancer | March 16, 2022 | January 30, 2033 |
| NCT05656573 | Recruiting | Phase 1 | CART-PSMA Cells for Advanced Prostate Cancer | March 1, 2023 | December 1, 2025 |
| NCT04702633 | Recruiting | Immuno-molecular Approaches for Non-invasive Diagnosis of Prostate Cancer | March 19, 2021 | March 19, 2024 | |
| NCT05011188 | Recruiting | Phase 1/Phase 2 | FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer | January 19, 2022 | March 31, 2027 |
| NCT06011304 | Recruiting | Phase 3 | Study of 18F-Florastamin PET/CT Imaging in Patients With at Least Intermediate Risk Prostate Cancer | October 20, 2023 | January 2025 |
| NCT05815394 | Recruiting | Early Phase 1 | 177Lu-labeled NY108 SPECT Imaging in Patients | March 3, 2023 | December 12, 2024 |
| NCT06451445 | Recruiting | N/A | A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer | May 16, 2024 | May 2032 |
| NCT05847348 | Recruiting | Phase 3 | 68Ga-PSMA-11 Efficacy in Detecting BCR Prostate Cancer in Chinese Patients | July 19, 2023 | July 30, 2026 |
| NCT03845751 | Recruiting | Phase 2 | EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control. | January 2023 | January 2025 |
| NCT05212857 | Recruiting | Phase 2 | Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer | April 2022 | September 2024 |
| NCT05191680 | Recruiting | Phase 3 | TherApeutics in Early ProState Cancer (TAPS02) | April 24, 2023 | April 2031 |
| NCT06389695 | Recruiting | Phase 1 | Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients | May 2024 | December 2024 |
| NCT05781217 | Recruiting | Phase 3 | Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624 | March 14, 2023 | December 2032 |
| NCT05033301 | Recruiting | N/A | Evaluating the Effectiveness of the Nurse Ned Clinic | November 15, 2021 | September 30, 2024 |
| NCT04644068 | Recruiting | Phase 1/Phase 2 | Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies | November 12, 2020 | December 15, 2026 |
| NCT06281769 | Recruiting | N/A | Prostate Cancer Detection Rate of Targeted Biopsies With PCaVision | February 26, 2024 | January 1, 2025 |
| NCT04066335 | Recruiting | Study to Evaluate the Safety of Nanoxel M Inj. | September 18, 2019 | August 2024 | |
| NCT04576871 | Recruiting | Early Phase 1 | Re-treatment 225Ac-J591 for mCRPC | October 29, 2020 | December 31, 2026 |
| NCT04556916 | Recruiting | N/A | Early Detection of Prostate Cancer | February 19, 2021 | September 15, 2033 |
| NCT06223022 | Recruiting | N/A | Nurse-led Proactive Telephone Follow-up With Patients After Completion of Primary Cancer Treatment | January 20, 2024 | December 2025 |
| NCT04832958 | Recruiting | Phase 2 | Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients | May 15, 2021 | November 15, 2024 |
| NCT01834001 | Recruiting | Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy | November 13, 2013 | ||
| NCT03861676 | Recruiting | Early Phase 1 | Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT | August 3, 2023 | December 2033 |
| NCT04612907 | Recruiting | N/A | Different Fractionation Schedules of Radiotherapy to the Primary Tumour in Metastatic Hormone Sensitive Prostate Cancer | October 31, 2022 | September 30, 2032 |
| NCT04625556 | Recruiting | Development of Urologic Registry for Personalized Medicine in Patients With Urologic Malignant Diseases by Analyzing Microbiome | December 19, 2022 | October 2030 | |
| NCT05805436 | Recruiting | Phase 4 | Preop Laxatives in Robotic Urologic Surgery | June 1, 2023 | March 3, 2025 |
| NCT04861415 | Recruiting | N/A | SBRT vs. Conventional Fractionation With HDR Boost for Prostate Cancer | December 23, 2020 | December 23, 2027 |
| NCT04560452 | Recruiting | Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese Patients | March 15, 2021 | December 31, 2025 | |
| NCT04075305 | Recruiting | The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | February 1, 2019 | May 1, 2025 | |
| NCT06220435 | Recruiting | N/A | Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer | September 25, 2023 | September 1, 2031 |
| NCT05588128 | Recruiting | Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL | March 21, 2023 | December 31, 2025 | |
| NCT05540392 | Recruiting | Phase 1/Phase 2 | An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues | September 9, 2022 | September 2024 |
| NCT00034216 | Recruiting | Collection of Blood From Patients With Cancer | July 16, 2002 | ||
| NCT05435495 | Recruiting | Mechanisms of Resistance to PSMA Radioligand Therapy | October 21, 2021 | December 31, 2024 | |
| NCT05000827 | Recruiting | N/A | Dutch National Randomized Study: PSMA-PET/CT as a Triage Tool for Pelvic Lymph Node Dissection in Prostatectomy Patients | July 28, 2021 | August 31, 2026 |
| NCT03482089 | Recruiting | N/A | Cystoprostatectomy Versus Radiotherapy Combined With ADT for the Treatment of cT4 Prostate Cancer With Bladder Invasion | June 12, 2018 | June 12, 2023 |
| NCT04025372 | Recruiting | Phase 2 | INTREPId (INTermediate Risk Erection PreservatIon Trial) | June 1, 2020 | March 1, 2028 |
| NCT05679388 | Recruiting | Phase 1 | A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients | February 13, 2023 | April 1, 2025 |
| NCT05530655 | Recruiting | Early Phase 1 | A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer | February 20, 2024 | January 1, 2026 |
| NCT06171139 | Recruiting | N/A | Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate Cancer | December 1, 2023 | August 31, 2025 |
| NCT05700903 | Recruiting | Phase 4 | Contributions to Hypertension With Androgen Deprivation Therapy | September 20, 2023 | March 31, 2028 |
| NCT03606837 | Recruiting | Phase 2 | 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Intermediate Risk Prostate Cancer Imaging | July 11, 2019 | August 17, 2023 |
| NCT01492972 | Recruiting | Phase 3 | Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer | January 2012 | |
| NCT05381103 | Recruiting | Phase 2/Phase 3 | PSMA-PET to Guide Prostatectomy | October 1, 2021 | March 31, 2028 |
| NCT05501548 | Recruiting | Phase 2 | Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer | June 30, 2023 | March 2028 |
| NCT05708950 | Recruiting | Phase 1/Phase 2 | A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) | March 3, 2023 | December 31, 2024 |
| NCT04167969 | Recruiting | Phase 1 | The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer | February 17, 2021 | November 2026 |
| NCT05001477 | Recruiting | Customized TULSA-PRO Ablation Registry | October 27, 2021 | October 2061 | |
| NCT06223295 | Recruiting | N/A | Effectiveness of Focal Therapy in Men With Prostate Cancer | February 1, 2024 | February 2031 |
| NCT04748042 | Recruiting | Phase 2 | Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) | May 28, 2021 | May 2025 |
| NCT06363123 | Recruiting | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | March 29, 2024 | April 2025 | |
| NCT04585750 | Recruiting | Phase 1/Phase 2 | The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) | October 29, 2020 | July 14, 2026 |
| NCT04357925 | Recruiting | Quality of Life in Prostate Cancer Patients | May 6, 2020 | May 6, 2027 | |
| NCT06037954 | Recruiting | N/A | A Study of Mental Health Care in People With Cancer | September 7, 2023 | September 2026 |
| NCT04478851 | Recruiting | N/A | EXCEL: Exercise for Cancer to Enhance Living Well | September 2, 2020 | December 31, 2027 |
| NCT05918263 | Recruiting | N/A | Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial | January 1, 2024 | March 31, 2027 |
| NCT04700332 | Recruiting | Phase 2 | PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer | February 1, 2021 | December 15, 2022 |
| NCT02307058 | Recruiting | N/A | Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy | February 5, 2015 | July 31, 2031 |
| NCT02865330 | Recruiting | Spanish Urological Association Registry of Patients on Active Surveillance | July 2014 | July 2034 | |
| NCT04645810 | Recruiting | Early Phase 1 | A Study of Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence | October 29, 2021 | May 31, 2024 |
| NCT04379362 | Recruiting | Phase 2 | MRI-guided Focal Laser Ablation | December 14, 2018 | July 1, 2024 |
| NCT06059118 | Recruiting | Phase 2 | Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer | October 4, 2023 | November 30, 2029 |
| NCT05627752 | Recruiting | Phase 2/Phase 3 | Docetaxel Alone or in Combination With Enzalutamide for mCRPC Previously Treated With Abiraterone at mHSPC Stage | June 1, 2024 | December 31, 2025 |
| NCT06292897 | Recruiting | Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer Progression | March 20, 2023 | January 15, 2027 | |
| NCT04687969 | Recruiting | Multimodal Machine Learning Characterization of Solid Tumors | October 23, 2022 | August 31, 2024 | |
| NCT06259123 | Recruiting | Phase 2 | Neoadjuvant PSMA-RLT in Oligometastatic PCa | February 1, 2024 | June 2027 |
| NCT05069467 | Recruiting | N/A | Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL) | June 1, 2022 | June 30, 2024 |
| NCT06306612 | Recruiting | N/A | CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer | March 21, 2024 | December 31, 2028 |
| NCT05471414 | Recruiting | N/A | Whole-Food Plant-Based Diet to Control Weight and MetaboInflammation in Overweight/Obese Men With Prostate Cancer | September 22, 2022 | July 2025 |
| NCT03716739 | Recruiting | Phase 2 | Improving Quality of Life of Prostate Cancer Survivors With Androgen Deficiency | March 19, 2019 | October 1, 2024 |
| NCT05759273 | Recruiting | A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy | April 24, 2023 | June 30, 2024 | |
| NCT03127631 | Recruiting | N/A | A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients | October 21, 2015 | December 2025 |
| NCT05739565 | Recruiting | N/A | Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients | April 25, 2023 | September 30, 2026 |
| NCT06239194 | Recruiting | Phase 1/Phase 2 | Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors | June 12, 2024 | February 2029 |
| NCT05478694 | Recruiting | Outcomes of Focal Ablation for Prostate Cancer | February 1, 2023 | August 2026 | |
| NCT01441089 | Recruiting | Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis | May 21, 2012 | ||
| NCT04706663 | Recruiting | Precision-Based Genomics in Prostate Cancer | September 14, 2021 | June 30, 2027 | |
| NCT05732948 | Recruiting | Phase 1 | PD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer | August 2, 2018 | December 31, 2024 |
| NCT05644821 | Recruiting | N/A | Influence of Electronic Patient Reported Outcomes (ePROMs) in Surgical Therapy for Prostate Cancer on Postoperative Outcome | August 1, 2023 | March 2025 |
| NCT05163197 | Recruiting | Transperineal Laser Ablation Treatment (TPLA) for Prostate Cancer (PCa) Registry | October 1, 2021 | October 1, 2027 | |
| NCT02899312 | Recruiting | PSMA PET/CT for Assessment of Recurrent Prostate Cancer | March 16, 2017 | June 2026 | |
| NCT06395519 | Recruiting | Phase 1 | A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies | May 2024 | December 2026 |
| NCT04404894 | Recruiting | Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing | April 30, 2020 | November 2029 | |
| NCT05497024 | Recruiting | Older Men's Decision Making About Active Surveillance for Prostate Cancer - Aim 3: Decision Aid Cognitive and Usability Testing | August 15, 2022 | February 2, 2027 | |
| NCT02724670 | Recruiting | N/A | Study of MR-based IGRT for Prostate Cancer | March 2016 | September 2028 |
| NCT02706561 | Recruiting | N/A | Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery | December 8, 2015 | December 2025 |
| NCT02997709 | Recruiting | Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients | June 24, 2016 | June 2031 | |
| NCT04831541 | Recruiting | Early Phase 1 | 68Ga-PSMA-11 PET/CT in Patients With Various Types of Cancer | October 10, 2020 | December 30, 2024 |
| NCT05842057 | Recruiting | Phase 2 | Human Amnion Membrane Allograft and Early Return of Erectile Function After Radical Prostatectomy | August 24, 2023 | August 31, 2028 |
| NCT05629494 | Recruiting | Phase 4 | Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test | September 27, 2022 | September 1, 2024 |
| NCT02717156 | Recruiting | Phase 2 | Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors | November 21, 2016 | November 21, 2026 |
| NCT05697198 | Recruiting | PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine | April 19, 2021 | September 2024 | |
| NCT05871008 | Recruiting | N/A | Integrated Actionable Aging Assessment for Cancer Patients Pilot | March 1, 2024 | December 2026 |
| NCT03824652 | Recruiting | Phase 2 | WALNUTS for POWER: Polyphenols, Omega-3 Fatty Acids, Weight Loss, and EneRgy | April 22, 2019 | January 2026 |
| NCT06355336 | Recruiting | Real World Prostate Cancer Registry | March 18, 2024 | March 18, 2034 | |
| NCT05650021 | Recruiting | N/A | Rectal Spacer for Prostate Cancer Radiation Image Guidance | March 8, 2024 | September 1, 2025 |
| NCT04763317 | Recruiting | Precision Medicine in the Prostate Cancer Care Pathway | February 14, 2019 | December 2030 | |
| NCT03620786 | Recruiting | HIFU for Focal Ablation of Prostate Tissue: An Observational Study | September 26, 2018 | January 31, 2028 | |
| NCT05027477 | Recruiting | N/A | A Comparison of TULSA Procedure vs. Radical Prostatectomy in Participants With Localized Prostate Cancer | November 1, 2021 | December 9, 2034 |
| NCT05022914 | Recruiting | PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE | January 19, 2021 | January 19, 2027 | |
| NCT04146077 | Recruiting | Active Surveillance for Low Risk Prostate Cancer | October 1, 2019 | October 2026 | |
| NCT05722925 | Recruiting | Phase 4 | Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET | October 4, 2023 | January 1, 2026 |
| NCT05832736 | Recruiting | N/A | Robotic Hemi-Prostatectomy With Urethral Preservation in Low and Intermediate Risk Monolateral Prostate Cancer | April 12, 2023 | October 2028 |
| NCT04654338 | Recruiting | Phase 2/Phase 3 | 2 Ablative RadioTherapy Treatments for Prostate Cancer | July 29, 2020 | July 29, 2028 |
| NCT05043012 | Recruiting | N/A | Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance Imaging Of Prostate With Flexible AIR Coil (DoNEMAC Study) | July 18, 2022 | February 2, 2027 |
| NCT05146297 | Recruiting | N/A | Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials | December 24, 2022 | April 2025 |
| NCT06039085 | Recruiting | Microendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment | November 3, 2023 | December 31, 2026 | |
| NCT06296147 | Recruiting | N/A | Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy | June 1, 2024 | November 1, 2024 |
| NCT05766371 | Recruiting | Phase 2 | Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer | December 15, 2023 | May 31, 2031 |
| NCT05245006 | Recruiting | Phase 1 | PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer | March 18, 2022 | December 31, 2025 |
| NCT05612204 | Recruiting | N/A | Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study | November 21, 2022 | June 30, 2024 |
| NCT05926102 | Recruiting | N/A | The Prostate Cancer, Genetic Risk, and Equitable Screening Study (ProGRESS) | February 1, 2024 | September 30, 2030 |
| NCT05917860 | Recruiting | Phase 1 | Neoadjuvant ADT With TULSA in the Treatment of Intermediate Risk Prostate Cancer | October 1, 2023 | December 31, 2030 |
| NCT04553926 | Recruiting | 'OLAP' (OLAparib Regulatory Post-marketing Surveillance) | February 1, 2021 | June 30, 2025 | |
| NCT04354064 | Recruiting | Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors | May 29, 2019 | December 31, 2025 | |
| NCT04507698 | Recruiting | N/A | INTERVAL - Intense Exercise Trial for Men With Metastatic Castrate-Resistant Prostate Cancer | September 1, 2017 | September 2024 |
| NCT04017104 | Recruiting | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | November 1, 2019 | August 1, 2024 | |
| NCT06066437 | Recruiting | Phase 1/Phase 2 | NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial | March 29, 2024 | June 30, 2026 |
| NCT04996602 | Recruiting | Early Phase 1 | Therapeutic Efficiency and Response to 2.0 GBq (55mCi) 177Lu-EB-PSMA in Patients With mCRPC | January 14, 2019 | December 1, 2022 |
| NCT04589468 | Recruiting | N/A | Researching the Effect of Exercise on Cancer | October 2, 2020 | October 2, 2024 |
| NCT05668351 | Recruiting | N/A | Stereotactic Ablative Radiation Therapy for Prostate Cancer | May 12, 2023 | January 15, 2026 |
| NCT05608746 | Recruiting | N/A | Prehabilitation in Prostate Cancer Patients, TelePrehabTrial | November 8, 2022 | December 2024 |
| NCT04946370 | Recruiting | Phase 1/Phase 2 | Phase I/II Trial of Pembrolizumab and Androgen-receptor Pathway Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer | August 12, 2021 | June 2028 |
| NCT04718987 | Recruiting | N/A | Potency pReservation In Prostate cAncer Patients Treated With UltraSound-guided Low-dose Rate Brachytherapy | June 1, 2021 | December 2025 |
| NCT06085664 | Recruiting | Phase 1/Phase 2 | A Pilot Presurgical Trial of REGN5678 (Anti-PSMA x CD28) in Patients With High-risk, Localized Prostate Cancer Followed by Radical Prostatectomy | December 4, 2023 | June 15, 2026 |
| NCT05709535 | Recruiting | PSMA-PET/CT Registry | July 11, 2023 | August 1, 2028 | |
| NCT05854940 | Recruiting | Multicenter, Prospective Clinical Study of the Serum Raman Spectroscopy Intelligent System for the Diagnosis of Prostate Cancer | June 10, 2023 | June 30, 2023 | |
| NCT06172283 | Recruiting | N/A | Intermittent Fasting in Prostate Cancer Patients Receiving Androgen Deprivation Therapy | December 5, 2023 | December 31, 2028 |
| NCT06071195 | Recruiting | All-in-One Prostate Cancer Staging With MRI | December 22, 2021 | August 22, 2026 | |
| NCT05454488 | Recruiting | Phase 2 | An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer | July 25, 2022 | January 31, 2026 |
| NCT06378346 | Recruiting | Phase 2 | GU-01: Glycyrrhizin in Prostate Cancer | May 2024 | March 2026 |
| NCT04773821 | Recruiting | N/A | Performance of Prostate MRI and Following Biopsy to Detect Prostate Cancer Recurrence After Focal Therapy | June 2, 2021 | October 2024 |
| NCT06449664 | Recruiting | N/A | Training for Men Undergoing Androgen Deprivation Therapy. | May 1, 2024 | December 20, 2028 |
| NCT06051162 | Recruiting | N/A | HPI Effect in Robotic Urological Surgery on AKI | November 7, 2023 | July 31, 2024 |
| NCT04105920 | Recruiting | N/A | Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies | October 5, 2021 | October 31, 2023 |
| NCT01567800 | Recruiting | N/A | Prostate Hypoxia FAZA | April 2012 | March 2025 |
| NCT05246774 | Recruiting | Study of Serum and Urinary Biomarkers and Radiation Cystitis in Patients Treated With Radiotherapy for Localized Prostate Cancer | March 1, 2022 | September 2024 | |
| NCT06219746 | Recruiting | N/A | 99mTc-MIP-1404 SPECT/CT in Primary Staging of Prostate Cancer | June 1, 2022 | December 31, 2026 |
| NCT02918253 | Recruiting | N/A | HDR Focal: Feasibility Study | October 14, 2016 | December 2024 |
| NCT05344235 | Recruiting | Observational Study on Extreme Hypofractionation for Localized Prostate Cancer | April 25, 2022 | April 2032 | |
| NCT04346225 | Recruiting | Phase 2 | Magnetic Resonance Imaging (MRI) With Hyperpolarized Pyruvate (13C) as Diagnostic Tool in Advanced Prostate Cancer | July 16, 2020 | November 30, 2026 |
| NCT04969835 | Recruiting | Phase 1 | A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours | July 16, 2021 | June 30, 2023 |
| NCT04858880 | Recruiting | Phase 3 | Personalized Radiotherapy for Biochemical Recurrence of Prostate Cancer After Prostatectomy. | April 9, 2021 | April 2030 |
| NCT04552509 | Recruiting | N/A | TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer | June 5, 2018 | June 2023 |
| NCT06335693 | Recruiting | N/A | Adjuvant Hypofractionated Radiotherapy for Prostate Cancer | March 28, 2024 | February 28, 2027 |
| NCT06237114 | Recruiting | Novel Robotic Prostatectomy Technique for Early Urinary Continence | March 8, 2024 | March 8, 2026 | |
| NCT05596188 | Recruiting | Anxiety Before Non-cardiac Surgery in Adults | November 10, 2022 | March 31, 2024 | |
| NCT05481372 | Recruiting | N/A | PINPOINT Feasibility Study | August 2022 | December 2023 |
| NCT05295407 | Recruiting | Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy | December 13, 2021 | December 13, 2025 | |
| NCT02871726 | Recruiting | N/A | Transrectal Ultrasound Robot-Assisted Prostate Biopsy | November 24, 2021 | August 2026 |
| NCT05354882 | Recruiting | N/A | Interventional Study on DEterminants and Factors of Physical ACtivity After Treatments in Oncology | March 29, 2022 | December 2023 |
| NCT05498272 | Recruiting | Phase 2 | Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations | February 1, 2023 | December 2026 |
| NCT06398470 | Recruiting | Phase 1/Phase 2 | Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy | May 15, 2024 | February 14, 2025 |
| NCT03225235 | Recruiting | N/A | Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer | August 26, 2013 | August 2025 |
| NCT05553327 | Recruiting | N/A | Impact of a Multimodal Prehabilitation Program Before Robotic-assisted Radical Prostatectomy. | May 31, 2022 | September 1, 2024 |
| NCT03426748 | Recruiting | N/A | LDR vs. HDR Brachytherapy for Prostate Cancer | February 15, 2018 | December 31, 2026 |
| NCT05313191 | Recruiting | N/A | Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors | January 24, 2022 | January 2027 |
| NCT06355843 | Suspended | N/A | Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer. | April 28, 2022 | March 31, 2027 |
| NCT00909558 | Suspended | Phase 1 | Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer | May 2009 | |
| NCT04115254 | Suspended | N/A | Stereotactic Magnetic Resonance Guided Radiation Therapy | October 22, 2019 | June 2024 |
| NCT03862170 | Suspended | Phase 3 | Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer | February 10, 2015 | February 2023 |
| NCT05064111 | Suspended | Utility of Adding MR Fusion to Standard US Guided Prostate Biopsy | September 1, 2024 | September 1, 2027 | |
| NCT06185478 | Suspended | N/A | Prostate Diffusion Imaging With Distortion Correction | March 1, 2024 | January 1, 2027 |
| NCT00127088 | Suspended | Phase 2 | Study of Peri-Operative Docetaxel Plus Laparoscopic Radical Prostatectomy in Prostate Cancer Patients | October 2004 | |
| NCT05361915 | Suspended | Phase 2 | Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer | September 2025 | January 2028 |
| NCT00664196 | Suspended | Phase 1 | Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning | April 2008 | December 2018 |
| NCT00103623 | Suspended | Phase 4 | The Plenaxis® Experience Study | June 2004 | December 2008 |
| NCT03734575 | Suspended | N/A | ClariCore System Used in Transperineal Prostate Biopsy | October 10, 2018 | July 9, 2019 |
| NCT05790213 | Suspended | Phase 2 | Focal Prostate Ablation With Androgen Deprivation and Novel Hormonal Therapy for Intermediate Risk Prostate Cancer | August 17, 2023 | April 1, 2028 |
| NCT03321864 | Suspended | N/A | Capture of Prostatic Trans-rectal Ultrasound Scans for Research | January 1, 2018 | December 31, 2022 |
| NCT02478112 | Suspended | N/A | Use of a Biodegradable Balloon for the Treatment of Prostate Cancer by Intensity Modulated Radiotherapy (BioPro-RCMI) | November 25, 2016 | January 2021 |
| NCT04886986 | Suspended | Phase 1/Phase 2 | Phase I/II 225Ac-J591 Plus 177Lu-PSMA-I&T for Progressive Metastatic Castration Resistant Prostate Cancer | June 30, 2021 | December 27, 2027 |
| NCT00999960 | Suspended | N/A | Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator | February 2010 | December 2017 |
| NCT03694483 | Suspended | Prostasomes as Diagnostic Tool for Prostate Cancer Detection | October 3, 2018 | October 1, 2024 | |
| NCT03134027 | Suspended | Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers | October 19, 2017 | November 2024 | |
| NCT02091661 | Suspended | Phase 3 | Radical Retropubic Prostatectomy Versus Conventional External Beam Radiotherapy for Clinically Localized Prostate Cancer | January 1997 | March 24, 2020 |
| NCT04684628 | Suspended | Phase 3 | 68Ga-PSMA PET/CT in Prostate Cancer | December 9, 2020 | December 2025 |
| NCT02759744 | Suspended | N/A | Fusion Guided Focal Laser Ablation of Prostate Cancer | October 13, 2017 | January 21, 2026 |
| NCT04809584 | Temporarily not available | 18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate Cancer | |||
| NCT00638378 | Terminated | Phase 2 | Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer | February 2008 | January 2009 |
| NCT00582582 | Terminated | Phase 2 | Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer | April 2002 | April 2007 |
| NCT01994590 | Terminated | Phase 2 | Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) | May 19, 2014 | June 5, 2017 |
| NCT01215032 | Terminated | Phase 2 | Metformin in Castration-Resistant Prostate Cancer | September 2010 | January 2015 |
| NCT03777982 | Terminated | Phase 3 | Conventional ADT w/ or w/Out Abiraterone Acetate + Prednisone and Apalutamide Following a Detectable PSA After Radiation and ADT | April 20, 2020 | February 13, 2024 |
| NCT03574194 | Terminated | N/A | Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy | June 12, 2018 | December 31, 2021 |
| NCT00024167 | Terminated | Phase 3 | Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | April 2002 | |
| NCT00949962 | Terminated | Phase 3 | Post-operative or Early Salvage XRT and ADT for High Risk PCa | October 2009 | June 2016 |
| NCT03632655 | Terminated | N/A | A Prospective, Randomized Trial Comparing Office-based MR-guided Prostate Biopsy Approaches | December 23, 2017 | October 8, 2020 |
| NCT00824902 | Terminated | N/A | Evaluation Ultrasound Elasticity/Tissue Strain-Hardening Imaging for Prostate Cancer Patients Undergoing Radical Prostatectomy | December 2008 | November 2013 |
| NCT00773318 | Terminated | N/A | SPECT-CT Guided Lymphatic Mapping and Sentinel Lymphadenectomy (LM/SL) in Prostate Cancer | April 2008 | February 2012 |
| NCT01376661 | Terminated | Outcome Assessment of an Active Surveillance Program for Low Risk Prostate Cancer: An Observational Study | May 2009 | September 1, 2016 | |
| NCT00004026 | Terminated | Phase 2 | CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy | December 1998 | January 2005 |
| NCT03439033 | Terminated | Phase 2 | Comparison Study of PET/CT or PET/MRI Imaging to Magnetic Resonance Imaging (MRI) Alone in Men With Prostate Cancer | April 3, 2018 | May 5, 2021 |
| NCT00217464 | Terminated | Phase 2 | Fulvestrant in Treating Patients With Recurrent Prostate Cancer | June 2004 | March 2010 |
| NCT02968784 | Terminated | N/A | Focal ExAblate MR-Guided Focused Ultrasound Treatment for Management of Organ-Confined Intermediate Risk Prostate Cancer | June 2016 | February 2, 2023 |
| NCT05910697 | Terminated | N/A | Clinical Utility of MyProstateScore 2.0 P2 | March 31, 2023 | October 18, 2023 |
| NCT03927573 | Terminated | Phase 1 | Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA Marker | April 15, 2019 | June 28, 2023 |
| NCT03545165 | Terminated | Phase 1/Phase 2 | 177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC | April 18, 2018 | July 15, 2020 |
| NCT02564549 | Terminated | N/A | MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca | October 5, 2015 | October 13, 2017 |
| NCT02438007 | Terminated | Phase 3 | A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC | June 2015 | November 2016 |
| NCT00678015 | Terminated | Phase 2 | Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate Cancer | May 2008 | June 2011 |
| NCT00313534 | Terminated | Phase 1 | Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer | June 2005 | October 2006 |
| NCT01717677 | Terminated | N/A | Evaluation of Four Treatment Modalities in Prostate Cancer With Low or "Early Intermediate" Risk | October 2012 | April 30, 2018 |
| NCT03211052 | Terminated | Phase 2 | A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone | February 18, 2013 | June 2, 2015 |
| NCT05744115 | Terminated | Phase 3 | Ga-68-PSMA-11 in Men With Prostate Cancer | July 27, 2021 | April 14, 2022 |
| NCT00919022 | Terminated | Androcur Non-interventional Study Among Patients With Carcinoma of the Prostate | August 2009 | August 2011 | |
| NCT00780975 | Terminated | Phase 2 | A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer | February 2005 | March 2008 |
| NCT00288444 | Terminated | Phase 1 | Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer | January 2006 | March 2009 |
| NCT00565227 | Terminated | Phase 1 | Phase I Study of Vorinostat in Combination With Docetaxel in Patients With Advanced and Relapsed Solid Malignancies. | April 2007 | September 2009 |
| NCT00510224 | Terminated | Phase 2 | Sandostatin for Patients With Androgen Independent Prostate Cancer | July 2007 | August 2009 |
| NCT04221828 | Terminated | Phase 2 | Trial of NanoPac Focal Therapy for Prostate Cancer | October 20, 2020 | February 8, 2021 |
| NCT02307552 | Terminated | N/A | Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer | June 2013 | May 2014 |
| NCT01709734 | Terminated | Phase 2 | A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer | December 2012 | September 2016 |
| NCT03927924 | Terminated | N/A | High-intensity Focused Ultrasound Study | June 25, 2019 | January 28, 2021 |
| NCT03741712 | Terminated | Phase 1/Phase 2 | A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC | November 20, 2018 | December 8, 2020 |
| NCT00823771 | Terminated | A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment | October 2007 | April 1, 2014 | |
| NCT00702923 | Terminated | Phase 1 | CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate Cancer | July 2008 | March 2013 |
| NCT01724619 | Terminated | Early Phase 1 | Update and Biodistribution of [F-18]FMDHT pET/CT in Normal Healthy Volunteers and Patients With Metastatic Prostate Cancer - A First in Human Subject Study With [F-18] FMDHT | November 2012 | March 2013 |
| NCT00176631 | Terminated | Phase 2 | Licorice Root Extract and Docetaxel in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | September 2007 | May 2008 |
| NCT03652298 | Terminated | Phase 2 | Effects of a Neuroscience-based Technique on Cancer Patients Announced of a Palliative Disease Progression and Partners | July 25, 2018 | August 27, 2019 |
| NCT01845792 | Terminated | Phase 2 | Study of Abiraterone Acetate and Prednisone in Combination With Cabazitaxel in Patients With Prostate Cancer | July 2013 | February 2017 |
| NCT00096304 | Terminated | Phase 1 | Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate Cancer | June 8, 2004 | November 30, 2007 |
| NCT00932672 | Terminated | Phase 2 | Atkins Diet and Prostate Cancer Clinical Trial | June 2009 | October 2014 |
| NCT02450201 | Terminated | Early Phase 1 | MRI With C13 Pilot Study Prostate Cancer | October 12, 2016 | January 17, 2017 |
| NCT00050297 | Terminated | Phase 2 | YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer | February 2004 | |
| NCT00924807 | Terminated | Phase 1/Phase 2 | Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate Cancer | September 2008 | December 2013 |
| NCT02933801 | Terminated | Phase 2 | ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. | March 31, 2017 | November 15, 2023 |
| NCT03152448 | Terminated | Prospective Prolaris Value and Efficacy | September 1, 2015 | March 21, 2022 | |
| NCT04357717 | Terminated | ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting | March 15, 2020 | September 1, 2021 | |
| NCT00459810 | Terminated | Phase 2 | Paclitaxel Poliglumex and Estradiol in Treating Patients With Stage IV Prostate Cancer | February 2007 | July 2009 |
| NCT00002668 | Terminated | N/A | Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer | February 14, 1996 | September 1998 |
| NCT02494713 | Terminated | Phase 2 | Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer | October 2015 | September 14, 2017 |
| NCT00244894 | Terminated | N/A | Acupuncture in Treating Hot Flashes in Patients With Prostate Cancer | September 2002 | April 2010 |
| NCT00879619 | Terminated | Phase 1/Phase 2 | Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients | July 2009 | November 2011 |
| NCT00243646 | Terminated | Phase 3 | Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial | August 2004 | July 2009 |
| NCT00122252 | Terminated | Biological Imaging for Optimising Clinical Target Volume (CTV) and Gross Tumour Volume (GTV) Contouring in Prostate Cancer to Improve the Possibilities for Intensity Modulated RadioTherapy (IMRT) Dose Escalation | May 2004 | February 2007 | |
| NCT06065059 | Terminated | Phase 1/Phase 2 | Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors | December 8, 2023 | May 22, 2024 |
| NCT02840162 | Terminated | Phase 2 | Pre-Prostatectomy Celecoxib or Placebo | May 2001 | May 2011 |
| NCT02279693 | Terminated | N/A | Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer | December 22, 2014 | August 6, 2019 |
| NCT00294437 | Terminated | Phase 3 | ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases | December 2003 | November 2007 |
| NCT00503984 | Terminated | Phase 1/Phase 2 | A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients | May 2007 | June 2015 |
| NCT02710422 | Terminated | Phase 2 | Miami Membrane for Potency (MMEP) Trial | May 17, 2016 | January 22, 2019 |
| NCT03180398 | Terminated | N/A | Multi-parametric Magnetic Resonance Imaging for Prostate Cancer Patients | October 4, 2017 | February 15, 2022 |
| NCT00585117 | Terminated | N/A | Pilot Study of (61)CuATSM-PET Imaging in Cancer Patients | December 2006 | January 2012 |
| NCT03031821 | Terminated | Phase 3 | Metformin in Patients Initiating ADT as Prevention and Intervention of Metabolic Syndrome | July 12, 2018 | November 24, 2023 |
| NCT00635167 | Terminated | N/A | Contrast Enhanced Transrectal Ultrasonography (TRUS) to Assess Prostatic Vascularity After Radiotherapy (XRT) | June 2007 | May 12, 2011 |
| NCT02247960 | Terminated | N/A | Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy | July 2014 | May 2016 |
| NCT00480857 | Terminated | Phase 2 | Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy | March 2007 | July 2014 |
| NCT00117312 | Terminated | Phase 2 | Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients | October 2002 | November 2005 |
| NCT00619515 | Terminated | N/A | Stereotactic Radiation Therapy in Treating Patients With Prostate Cancer | December 2007 | February 2013 |
| NCT02758132 | Terminated | Phase 2 | Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases | March 1, 2016 | September 6, 2016 |
| NCT00918385 | Terminated | Phase 2 | Genomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate Cancer | May 2009 | August 2013 |
| NCT00003516 | Terminated | Phase 2 | Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer | March 27, 1996 | March 18, 2004 |
| NCT02963051 | Terminated | Phase 1 | A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer | July 11, 2017 | February 1, 2020 |
| NCT04393831 | Terminated | N/A | A Prospective Trial on Nerve Sparing Techniques Performed in Radical Prostatectomy | June 15, 2021 | September 15, 2021 |
| NCT02042885 | Terminated | Phase 1/Phase 2 | A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer | January 2014 | February 2015 |
| NCT03227744 | Terminated | N/A | A Pilot Study of Prostate Cancer-specific Anxiety in Active Surveillance | April 19, 2017 | December 28, 2018 |
| NCT00391950 | Terminated | Phase 3 | Maintaining Bone Strength in Men With Prostate Cancer | October 2006 | |
| NCT01155791 | Terminated | Phase 1 | Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate Cancer | April 2010 | October 2012 |
| NCT00348816 | Terminated | Phase 2 | Docetaxel, Radiation Therapy, and Prednisone in Treating Patients Who Have Undergone Surgery For Prostate Cancer | May 2006 | July 8, 2016 |
| NCT00458549 | Terminated | N/A | Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery | May 27, 2003 | May 1, 2012 |
| NCT00429338 | Terminated | N/A | 3T Endorectal Magnetic Resonance Spectroscopic Imaging (MRSI) of Prostate | January 2007 | October 2013 |
| NCT01817738 | Terminated | Phase 1/Phase 2 | Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer | August 2012 | January 2017 |
| NCT01603420 | Terminated | Phase 2/Phase 3 | External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer | July 2012 | May 2014 |
| NCT03006562 | Terminated | Phase 4 | PREvention of VENous ThromboEmbolism Following Radical Prostatectomy | July 1, 2017 | November 1, 2019 |
| NCT01705652 | Terminated | Phase 2 | Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients | July 2011 | March 2014 |
| NCT02766478 | Terminated | Phase 2 | Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer | October 16, 2017 | July 23, 2021 |
| NCT03076242 | Terminated | Genetic Evaluation of Men (GEM) | October 23, 2014 | May 16, 2019 | |
| NCT02480010 | Terminated | Phase 2 | A Study of Pertuzumab in Participants With Prostate Cancer | September 2003 | September 2005 |
| NCT00952666 | Terminated | Early Phase 1 | Transrectal Ultrasound Imaging of the Prostate Gland and Neurovascular Bundles During Robot-Assisted Laparoscopic Radical Prostatectomy | November 2008 | December 2009 |
| NCT00133224 | Terminated | Phase 3 | Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients | July 2005 | June 2009 |
| NCT04382898 | Terminated | Phase 1/Phase 2 | PRO-MERIT (Prostate Cancer Messenger RNA Immunotherapy) | December 19, 2019 | January 23, 2024 |
| NCT00798187 | Terminated | Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis | May 2009 | March 26, 2019 | |
| NCT01533753 | Terminated | Phase 2 | Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer | February 2012 | May 2014 |
| NCT00757757 | Terminated | Phase 1/Phase 2 | A Phase I/II Open-label Study of MCS110 in Patients With Prostate Cancer and Bone Metastases | September 2008 | August 2009 |
| NCT00577356 | Terminated | Phase 2 | Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer | February 2008 | September 2008 |
| NCT03550040 | Terminated | N/A | 3D Versus Robot Assisted Laparoscopic Prostatectomy. | May 31, 2018 | July 30, 2022 |
| NCT01100866 | Terminated | N/A | Study of POMELLA™ Extract to Treat Prostate Cancer | January 2010 | November 2012 |
| NCT00633087 | Terminated | Phase 1/Phase 2 | A Phase I/II Trial of 2-Deoxyglucose (2DG) for the Treatment of Advanced Cancer and Hormone Refractory Prostate Cancer | November 2006 | March 2011 |
| NCT02006927 | Terminated | N/A | A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile Function | July 2014 | April 2017 |
| NCT03657108 | Terminated | N/A | CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation | March 27, 2018 | February 1, 2023 |
| NCT00010127 | Terminated | Phase 1 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer | November 2000 | March 2003 |
| NCT01354951 | Terminated | Phase 2 | Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Early Stage, Low Volume Prostate Cancer | May 2011 | October 6, 2017 |
| NCT01098331 | Terminated | N/A | Implant Radiation Therapy or Surgery in Treating Patients With Prostate Cancer | June 1, 2008 | June 1, 2013 |
| NCT00132756 | Terminated | Phase 1/Phase 2 | Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer | December 2003 | |
| NCT00379119 | Terminated | Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate Cancer | January 2005 | October 2009 | |
| NCT00215657 | Terminated | Phase 2 | Extension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer Patients | March 2003 | March 2006 |
| NCT03619655 | Terminated | Phase 1 | Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy | November 15, 2019 | November 14, 2022 |
| NCT02349139 | Terminated | Phase 1 | Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer | January 19, 2015 | August 17, 2017 |
| NCT00499174 | Terminated | N/A | Observation or Radical Treatment in Patients With Prostate Cancer | December 6, 2007 | January 10, 2013 |
| NCT02648919 | Terminated | Phase 2 | Clinical Study of Noni Extract in Men With Very Low Risk or Low Risk Prostate Cancer | December 2015 | December 2018 |
| NCT01735396 | Terminated | Phase 2 | Abiraterone Acetate Trial in African American Prostate Cancer Patients | December 2012 | March 2016 |
| NCT00080782 | Terminated | Phase 2 | Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone Metastases | February 2002 | January 2005 |
| NCT01262664 | Terminated | Phase 1 | A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity | May 24, 2012 | January 2, 2019 |
| NCT02844647 | Terminated | Phase 1 | Hyperpolarized Carbon-13 Imaging of Metastatic Prostate Cancer | December 15, 2016 | March 23, 2023 |
| NCT01940237 | Terminated | N/A | A Pilot Trial of Interpersonal Psychotherapy for the Treatment of Depression in Patients With Prostate, Colorectal, Lung and Pancreatic Cancer | April 2012 | May 2015 |
| NCT03630393 | Terminated | N/A | Ultralow Versus Standard Pneumoperitoneum Pressure | May 9, 2019 | February 10, 2021 |
| NCT00734851 | Terminated | Phase 2 | Multimodality Phase II Study in Prostate Cancer | December 2008 | November 2014 |
| NCT00388804 | Terminated | Phase 3 | External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | February 2005 | April 2011 |
| NCT00073970 | Terminated | Phase 2 | Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy | April 2003 | January 2006 |
| NCT00911027 | Terminated | Phase 3 | SonoVue Guided Prostate Biopsy | February 2009 | March 2011 |
| NCT03440879 | Terminated | N/A | Androgen Deprivation Therapy Muscle Protein Metabolism and Blood Glucose | September 21, 2018 | March 2, 2023 |
| NCT00861471 | Terminated | Phase 1/Phase 2 | Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancer | May 2005 | May 2010 |
| NCT00630799 | Terminated | Phase 3 | Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients | May 2008 | July 2009 |
| NCT01996852 | Terminated | N/A | Improving Erectile Function and Quality of Life After Prostate Cancer Treatment | July 2013 | August 2016 |
| NCT01313559 | Terminated | Phase 2 | Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer | June 2011 | November 29, 2012 |
| NCT02365883 | Terminated | Transrectal Photoacoustic Imaging of the Prostate | September 2011 | June 3, 2019 | |
| NCT01220427 | Terminated | Micro-RNA Expression Profiles in High Risk Prostate Cancer | June 2007 | ||
| NCT00626548 | Terminated | Phase 3 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer | January 2008 | May 2011 |
| NCT01374087 | Terminated | Phase 2 | Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer | November 2011 | December 2014 |
| NCT01483586 | Terminated | Phase 2 | Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer | November 2011 | December 2013 |
| NCT02478125 | Terminated | Phase 1 | Pilot Study of Mobilization and Treatment of Disseminated Tumor Cells in Men With Metastatic Prostate Cancer | July 2016 | May 2017 |
| NCT02121600 | Terminated | N/A | 18F-FCH PET/MRI to Assess Tumor Response in Castration Resistant Prostate Cancer | September 2014 | March 2018 |
| NCT03824808 | Terminated | Phase 4 | Effect of Perioperative Intravenous Lidocaine Infusion in Robotic-Assisted Urologic Surgery | February 26, 2019 | March 26, 2020 |
| NCT00118066 | Terminated | Phase 2 | Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia | May 2004 | August 2011 |
| NCT03796195 | Terminated | Phase 4 | (SGB) in Men Treated for Prostate Cancer Improve Hot Flashes | November 13, 2019 | July 16, 2021 |
| NCT00798837 | Terminated | N/A | Intraprostatic MAXimal Simultaneous Boost | December 2008 | October 2016 |
| NCT03458234 | Terminated | N/A | RAD 1801: Pilot Study of Intra-Urethral Radiotransponder Beacon Guided Focal Prostate Stereotactic Body Radiotherapy | January 28, 2020 | June 22, 2023 |
| NCT01748890 | Terminated | N/A | A Pilot Trial of Sonoelastography for Planning Tumor-targeted Prostate Biopsy | December 2009 | December 2012 |
| NCT00014586 | Terminated | Phase 3 | Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | January 2001 | |
| NCT01420861 | Terminated | Phase 2 | GTx-758 on Serum Prostate-specific Antigen (PSA) in Men With Castrate Resistant Prostate Cancer | September 2011 | December 2012 |
| NCT03837353 | Terminated | Phase 1/Phase 2 | A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1 | April 1, 2019 | September 20, 2022 |
| NCT00176527 | Terminated | Phase 2 | Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | November 2002 | August 2007 |
| NCT00515112 | Terminated | Phase 2 | Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer | July 2007 | August 2012 |
| NCT03093272 | Terminated | Phase 2 | A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer | June 23, 2017 | December 31, 2019 |
| NCT01832831 | Terminated | Anatomical and Functional Differences Between Continent and Incontinent Men Post Radical Prostatectomy | May 2010 | December 2014 | |
| NCT00788307 | Terminated | Phase 1 | Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy | November 3, 2008 | February 7, 2018 |
| NCT01174199 | Terminated | Phase 1 | Temsirolimus and Vorinostat in Treating Patients With Metastatic Prostate Cancer | February 2012 | August 2016 |
| NCT03367819 | Terminated | Phase 1/Phase 2 | Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies | January 4, 2018 | March 10, 2021 |
| NCT01531205 | Terminated | Phase 2 | Neoadjuvant Chemohormonal Therapy Followed by Salvage Surgery for High Risk PSA | May 2012 | October 2013 |
| NCT03432897 | Terminated | Phase 2 | BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes | May 25, 2018 | December 7, 2021 |
| NCT00355758 | Terminated | UCI 03-72 Prostate Cancer Detection by Serum Proteomic Profiling | April 2005 | June 2009 | |
| NCT00006371 | Terminated | Phase 2 | A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer | May 2000 | December 2001 |
| NCT00250757 | Terminated | Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions | October 2005 | April 2012 | |
| NCT03533946 | Terminated | Phase 2 | Rucaparib in Nonmetastatic prOstAte With BRCAness | May 20, 2019 | January 12, 2023 |
| NCT01414712 | Terminated | Circulating Tumor Cells in Prostate Cancer Patients | July 2011 | December 2011 | |
| NCT02362451 | Terminated | Phase 2 | Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer | July 10, 2015 | February 13, 2020 |
| NCT02284971 | Terminated | Phase 1 | Pilot Study of SBRT and CDX-1127 in Prostate Cancer | November 2014 | April 7, 2016 |
| NCT01338012 | Terminated | Phase 2 | Sipuleucel-T in Metastatic Castrate Resistant Prostate Cancer | December 2011 | April 2015 |
| NCT01644136 | Terminated | N/A | Microspheres in Preventing Lymphatic Fluid Collection After Surgery in Patients With Prostate Cancer | July 14, 2011 | May 6, 2014 |
| NCT00004261 | Terminated | Phase 1 | EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | December 1999 | |
| NCT02459912 | Terminated | Phase 2 | Unilateral Nerve-Sparing Cryoablation for Low-Risk, Clinically Localized, Unilateral Prostate Cancer | April 2015 | April 26, 2018 |
| NCT01119118 | Terminated | Phase 2 | ZD4054 With Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for Prostate Cancer | April 2010 | November 2011 |
| NCT04264208 | Terminated | Phase 2 | HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer | February 5, 2020 | December 14, 2022 |
| NCT05437679 | Terminated | Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System | July 5, 2022 | August 22, 2023 | |
| NCT01326312 | Terminated | Phase 2 | Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer | June 2011 | December 2012 |
| NCT01762956 | Terminated | N/A | Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled Trial | July 2015 | December 2016 |
| NCT02146833 | Terminated | Phase 2 | SHIP (Selinexor in Hormone Insensitive Prostate Cancer) | May 2014 | April 1, 2016 |
| NCT00918645 | Terminated | N/A | Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis | September 2009 | June 2013 |
| NCT01242748 | Terminated | Phase 3 | A Degarelix Trial in Patients With Prostate Cancer | October 2010 | January 2012 |
| NCT03532308 | Terminated | Phase 3 | Nutrition and Prostate Cancer | November 21, 2018 | December 14, 2019 |
| NCT00058266 | Terminated | Phase 2 | Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy | December 2002 | September 2009 |
| NCT02749825 | Terminated | Phase 4 | Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer | September 2002 | July 2006 |
| NCT00956904 | Terminated | Early Phase 1 | Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy | August 2009 | June 2013 |
| NCT01673984 | Terminated | Phase 4 | GP Extended Action Triptorelin | August 2012 | February 2014 |
| NCT01761812 | Terminated | N/A | Multiparametric MRI for Prostate Cancer Localization and Characterization: New Methods | September 2012 | December 2014 |
| NCT00480623 | Terminated | Phase 1 | A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence | May 2007 | April 2008 |
| NCT01741753 | Terminated | Phase 1 | BKM120+Abiraterone Acetate for Metastatic CRPC | November 2012 | September 1, 2016 |
| NCT00103376 | Terminated | Phase 2 | Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer | October 2004 | June 2011 |
| NCT02995330 | Terminated | Phase 1 | Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer | February 9, 2017 | June 16, 2021 |
| NCT00881725 | Terminated | Phase 2 | A Study of Pre-operative Metformin in Prostate Cancer | June 2009 | June 2012 |
| NCT01341288 | Terminated | Phase 1 | Robotic Seed Implantation for Prostate Cancer Brachytherapy | July 29, 2008 | February 27, 2015 |
| NCT02483884 | Terminated | Phase 1/Phase 2 | PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer | May 2015 | December 2016 |
| NCT00769652 | Terminated | N/A | Medical Nutrition Therapy or Standard Care in Treating Patients With Lung Cancer, Pancreatic Cancer, or Stage III or Stage IV Prostate Cancer | October 2006 | August 2009 |
| NCT02913131 | Terminated | Phase 1/Phase 2 | Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies | October 20, 2016 | April 5, 2021 |
| NCT00786682 | Terminated | Phase 2 | Docetaxel and Hydroxychloroquine in Treating Patients With Metastatic Prostate Cancer | December 2008 | October 2012 |
| NCT01705405 | Terminated | N/A | Merging of Endoscopic and Ultrasound Images for Laparoscopic Surgery | October 2012 | September 2016 |
| NCT00585416 | Terminated | Phase 2 | Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer | June 2006 | March 2009 |
| NCT03111914 | Terminated | N/A | Applications of Dual Energy CT in Patients With Osseous Metastases From Castrate-resistant Prostate Cancer | July 3, 2017 | October 9, 2017 |
| NCT02685267 | Terminated | Phase 2 | Docetaxel/Prednisone Versus Docetaxel/Prednisone and Enzalutamide in Castration-Resistant Prostate Cancer | February 2016 | August 2017 |
| NCT01987193 | Terminated | Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01) | July 2012 | May 2018 | |
| NCT02432820 | Terminated | Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate Radiotherapy | April 2015 | September 30, 2016 | |
| NCT00831233 | Terminated | Phase 3 | Symptomatic Study Investigating Degarelix in Patients Suffering From Prostate Cancer | April 2009 | July 2010 |
| NCT01439542 | Terminated | Phase 2 | FASTR: Fairly Brief Androgen Suppression and Stereotactic Radiotherapy for High Risk Prostate Cancer | September 2011 | November 2017 |
| NCT01377389 | Terminated | Phase 2 | Ipilimumab + Androgen Depravation Therapy in Prostate Cancer | June 17, 2011 | April 7, 2017 |
| NCT00464724 | Terminated | N/A | 3T Perfluorocarbon-Filled Endorectal Magnetic Resonance Spectroscopic Imaging of Prostate | March 2007 | December 12, 2019 |
| NCT01478828 | Terminated | N/A | Pre-Prostatectomy Lovastatin on Prostate Cancer | July 13, 2012 | April 8, 2013 |
| NCT00104130 | Terminated | Phase 2 | Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer | December 2004 | February 2005 |
| NCT03689582 | Terminated | Phase 2 | Radiolabeled Gallium-68 (68Ga-PSMA) for PET/CT Imaging to Detect Prostate Cancer | November 13, 2018 | February 27, 2020 |
| NCT00629330 | Terminated | Phase 4 | Dissemination of Prostate Cancer Screening to PCP's in African American Communities | January 2004 | November 2010 |
| NCT03964337 | Terminated | Phase 2 | Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer | March 17, 2020 | June 4, 2021 |
| NCT00953576 | Terminated | Phase 1/Phase 2 | Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer | September 29, 2009 | April 11, 2013 |
| NCT03366792 | Terminated | N/A | Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer | October 17, 2017 | February 26, 2021 |
| NCT04266262 | Terminated | N/A | High-Intensity Training for Men With Prostate Cancer on Active Surveillance: A Feasibility Study | July 9, 2018 | March 20, 2020 |
| NCT01007214 | Terminated | N/A | Guided Biopsy for Mapping Prostate Cancer | May 2010 | February 2014 |
| NCT02626377 | Terminated | N/A | Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté | October 2015 | May 2019 |
| NCT00887640 | Terminated | Phase 2 | Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer | July 2009 | August 2012 |
| NCT01385293 | Terminated | Phase 2 | BKM120 in Metastatic Castration-resistant Prostate Cancer | August 2011 | February 2016 |
| NCT03290508 | Terminated | Long-term Study to Evaluate and Clinical Outcomes in Patients With Favorable Intermediate Risk Localized Prostate Cancer | September 14, 2017 | January 14, 2022 | |
| NCT04424641 | Terminated | Phase 1/Phase 2 | A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors | July 15, 2020 | October 29, 2021 |
| NCT03572478 | Terminated | Phase 1/Phase 2 | Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer | August 14, 2018 | October 1, 2020 |
| NCT02582749 | Terminated | Phase 2 | Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases | April 2016 | September 14, 2017 |
| NCT00127387 | Terminated | Phase 2/Phase 3 | Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia | May 2001 | November 2005 |
| NCT00581113 | Terminated | Phase 3 | Neural Stem Cell Preserving Brain Radiation Therapy & Stereotactic Radiosurgery in Patients With 1-6 Brain Metastases | March 2007 | June 2009 |
| NCT04727736 | Terminated | Phase 2 | 18F-DCFPyL Positron Emission Tomography (PET) in Intermediate or High Risk Prostate Cancer | May 1, 2021 | December 31, 2022 |
| NCT00585741 | Terminated | N/A | Pilot Study of 18F-FLT PET | December 2006 | December 2011 |
| NCT04423913 | Terminated | Phase 2 | Safety, Tolerability, Distribution & Dose Effect of Neoadjuvant Transarterial Chemoembolization With Doxorubicin in Prostate Cancer Patients Before Radical Prostatectomy | May 4, 2022 | October 31, 2022 |
| NCT00651326 | Terminated | Phase 3 | Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer | June 2, 2008 | January 18, 2011 |
| NCT00103428 | Terminated | Phase 1/Phase 2 | Intravenous CG7870 in Combination With Docetaxel in Patients With Metastatic Hormone-Refractory Prostate Cancer | August 2004 | |
| NCT01562522 | Terminated | Phase 2 | Evaluation of the Effect of Psycho-oncological Intervention on Well-being of Patients With Advanced Prostate Cancer on LHRH Analogs and Their Partners. A Randomized Controlled Pilot Study. | March 2012 | July 2013 |
| NCT00524589 | Terminated | Phase 2 | Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | April 2006 | September 2010 |
| NCT03365076 | Terminated | N/A | Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox) | May 1, 2018 | January 5, 2023 |
| NCT01176513 | Terminated | Phase 2 | GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate Cancer | July 2010 | March 2012 |
| NCT02640534 | Terminated | Phase 2 | Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone | June 10, 2016 | March 16, 2023 |
| NCT00686036 | Terminated | Phase 2 | Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal Therapy | May 2008 | October 2010 |
| NCT00005075 | Terminated | Phase 3 | Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer | July 1999 | |
| NCT02203513 | Terminated | Phase 2 | A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer | January 20, 2015 | August 27, 2021 |
| NCT03724253 | Terminated | Phase 2 | [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) | July 3, 2018 | July 5, 2019 |
| NCT00911079 | Terminated | N/A | Pilot Study of a Catheter-based Ultrasound Hyperthermia System | December 18, 2009 | July 23, 2020 |
| NCT01481441 | Terminated | N/A | Quantification of Contrast Enhanced Ultrasound (CEUS) in the Detection of Prostate Cancer | November 2011 | November 2015 |
| NCT00753220 | Terminated | Phase 1/Phase 2 | Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer | August 2009 | December 2011 |
| NCT03478904 | Terminated | Phase 1 | Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer | March 10, 2020 | November 30, 2020 |
| NCT03441464 | Terminated | Phase 1/Phase 2 | Feasibility of the LUM Imaging System for Detection of Prostate Cancer | March 20, 2019 | February 11, 2021 |
| NCT00511576 | Terminated | Phase 1 | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors | August 2007 | March 2009 |
| NCT05010759 | Terminated | N/A | Study of Focal Ablation of the Prostate With NanoTherm® Therapy System for Intermediate-Risk Prostate Cancer | November 30, 2021 | July 28, 2023 |
| NCT04541225 | Terminated | Phase 1 | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors | December 8, 2020 | August 31, 2022 |
| NCT01020305 | Terminated | Phase 1/Phase 2 | Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer | October 2009 | April 2012 |
| NCT00288106 | Terminated | S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT | September 2005 | May 2009 | |
| NCT02404428 | Terminated | N/A | Utilizing MRI to Study the Effect of Sulforaphane on Prostate Cancer | February 2015 | September 2016 |
| NCT02628535 | Terminated | Phase 1 | Safety Study of MGD009 in B7-H3-expressing Tumors | September 2015 | November 25, 2019 |
| NCT04305379 | Terminated | N/A | Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy | January 16, 2020 | March 1, 2021 |
| NCT01794936 | Terminated | N/A | Pilot Study of VTI Doppler Probe Use to Identify Neurovascular Bundle During Prostate Surgery | August 2011 | April 2012 |
| NCT00444639 | Terminated | Phase 2 | Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT) | February 2007 | June 2008 |
| NCT01902823 | Terminated | Phase 2/Phase 3 | Effect of Cancer Nurse Navigators on Patient Outcomes | November 2011 | May 2012 |
| NCT02694380 | Terminated | Measuring the Effect of Radiation Therapy on Patient Activity Levels | July 2015 | July 2018 | |
| NCT02139774 | Terminated | Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer | October 2013 | June 2014 | |
| NCT00124917 | Terminated | Phase 1 | Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer | July 21, 2005 | May 9, 2017 |
| NCT02173522 | Terminated | N/A | Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients | July 2014 | June 16, 2017 |
| NCT02042053 | Terminated | N/A | PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer | January 2014 | October 2015 |
| NCT01602783 | Terminated | N/A | 11C Acetate Imaging Post Prostatectomy | December 2011 | February 2014 |
| NCT01650350 | Terminated | Phase 2 | Low Dose Naltrexone for Metastatic Melanoma, Castrate Resistant Prostate Cancer and Renal Cancer | November 2012 | October 2013 |
| NCT03043989 | Terminated | Phase 1 | Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin | March 21, 2017 | July 26, 2019 |
| NCT02131207 | Terminated | MRI Before Biopsy in Diagnosing Patients With Prostate Cancer | September 10, 2014 | December 8, 2017 | |
| NCT00809458 | Terminated | Phase 3 | Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer | September 2008 | February 2013 |
| NCT00176293 | Terminated | Phase 2 | Randomized Phase II Trial of Doxil With or Without Dexamethasone for Metastatic Hormone Refractory Prostate Cancer | October 2005 | February 2007 |
| NCT03634579 | Terminated | N/A | MRI Guided Prostate Cancer Focal Laser Ablation | June 1, 2018 | March 15, 2019 |
| NCT00332280 | Terminated | Phase 2/Phase 3 | Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo | May 2006 | March 2010 |
| NCT00354432 | Terminated | Phase 3 | Soy Protein/Effexor Hormone Therapy for Prostate Cancer | February 1, 2007 | August 1, 2010 |
| NCT01699672 | Terminated | N/A | Group-based or Individual Information About Disease and Treatment Plan | October 2012 | July 2015 |
| NCT00634582 | Terminated | Phase 2 | Paricalcitol in Treating Patients With Advanced Prostate Cancer and Bone Metastases | January 2009 | June 2015 |
| NCT01677845 | Terminated | Phase 1 | Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer | May 2012 | August 25, 2017 |
| NCT03256630 | Terminated | Evaluation of a Blood Biomarker to Try and Distinguish Between the Presence or Absence of Aggressive Prostate Cancer | January 10, 2018 | February 28, 2019 | |
| NCT00594620 | Terminated | Phase 2 | Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy | August 2004 | April 2010 |
| NCT04873427 | Terminated | In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies | April 15, 2021 | January 15, 2023 | |
| NCT00482274 | Terminated | Phase 2 | Docetaxel in Treating Patients With Relapsed Prostate Cancer | May 2007 | July 2009 |
| NCT04409288 | Terminated | Phase 3 | Patient Preference of Apalutamide Versus Enzalutamide in Patients With Recurrent or Metastatic Hormone-Sensitive Prostate Cancer | July 20, 2020 | October 16, 2023 |
| NCT00539968 | Terminated | Phase 1/Phase 2 | A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) | June 2007 | December 2009 |
| NCT00933426 | Terminated | Phase 1 | Lenalidomide and Paclitaxel in Prostate Cancer | August 2009 | December 2015 |
| NCT04677855 | Terminated | Phase 1 | Study of PCUR-101 in Combination With ADT in Patients With mCRPC | March 30, 2021 | November 20, 2023 |
| NCT00215631 | Terminated | Phase 3 | Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? | October 2005 | November 2005 |
| NCT04085991 | Terminated | Phase 2 | Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate Cancer | July 31, 2020 | January 15, 2023 |
| NCT00176644 | Terminated | Phase 2 | Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer | May 2005 | December 2008 |
| NCT00479635 | Terminated | Phase 2 | A Phase II Trial of TPI 287 in Patients With Metastatic Prostate Cancer | January 2007 | August 2008 |
| NCT00523471 | Terminated | Blood Test to Measure DNA Damage in Blood | July 2007 | June 2010 | |
| NCT00848601 | Terminated | Phase 1 | Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma | February 2009 | October 2010 |
| NCT00258765 | Terminated | Phase 2 | Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. | May 2006 | |
| NCT00483561 | Terminated | Phase 2 | Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy | January 2004 | January 2010 |
| NCT00921258 | Terminated | Active Control of Prostatic Cancer With Criteria of Latence | December 2007 | December 2013 | |
| NCT00714376 | Terminated | Phase 2 | Phase II Study of Docetaxel for Clinically Asymptomatic High Risk Prostate Cancer Patients | May 2008 | July 2008 |
| NCT00245466 | Terminated | Phase 2 | Study Investigating the Long-Term Safety and Tolerability of Repeated Doses of Degarelix in Prostate Cancer Patients | October 2001 | March 2006 |
| NCT00814892 | Terminated | Phase 2 | Vaccine Therapy in Treating Patients With Non-Metastatic Prostate Cancer | January 2009 | March 2010 |
| NCT01681433 | Terminated | Phase 2 | OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone | December 2012 | June 21, 2017 |
| NCT00293371 | Terminated | Phase 1/Phase 2 | Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate Cancer | February 2005 | September 2006 |
| NCT01132404 | Terminated | Phase 1/Phase 2 | Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 | November 2010 | December 2011 |
| NCT01558492 | Terminated | Phase 2 | Carboplatin and Paclitaxel in Patients With Metastatic, Castrate-Resistant Prostate Cancer | March 2011 | November 2013 |
| NCT05169372 | Terminated | Retrospective Analysis of 68Ga-PSMA-PET in Patients With Prostate Cancer: Experience From Brazil | May 11, 2022 | January 19, 2024 | |
| NCT00526591 | Terminated | Phase 2 | Everolimus in Treating Patients With Newly Diagnosed Localized Prostate Cancer | September 2007 | August 2011 |
| NCT01335204 | Terminated | Phase 1/Phase 2 | Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer | June 2011 | March 2013 |
| NCT00122265 | Terminated | Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer | April 2003 | January 2012 | |
| NCT01983709 | Terminated | Phase 1 | Allogeneic Human Bone Marrow Derived Mesenchymal Stem Cells in Localized Prostate Cancer | October 2013 | June 2017 |
| NCT02809846 | Terminated | N/A | Quell Opioid Reduction and Pain Relief in Patients With Cancer | July 2016 | October 2017 |
| NCT01313273 | Terminated | Phase 3 | Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients | June 2011 | June 2013 |
| NCT00945477 | Terminated | Phase 2 | Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade | July 2009 | October 2012 |
| NCT00851682 | Terminated | N/A | Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate Carcinoma | January 2009 | February 2014 |
| NCT02250313 | Terminated | PASCUAL (Prostate Assay Specific Clinical Utility at Launch) Study | September 2014 | July 2018 | |
| NCT03810105 | Terminated | Phase 2 | A Study of Olaparib and Durvalumab in Prostate Cancer | March 7, 2019 | July 6, 2023 |
| NCT00023634 | Terminated | Phase 1 | S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer | June 2001 | November 2008 |
| NCT04960956 | Terminated | Glycosylation of Exosomes in Prostate and Urothelial Carcinoma | October 13, 2016 | February 2, 2017 | |
| NCT04032704 | Terminated | Phase 2 | A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors | October 9, 2019 | November 28, 2023 |
| NCT00670046 | Terminated | Phase 2 | Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer | May 2008 | July 2012 |
| NCT01816048 | Terminated | Phase 2 | NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis | May 2013 | November 2016 |
| NCT01045226 | Terminated | N/A | Proton Radiation Therapy in Treating Patients With Prostate Cancer | August 2009 | March 17, 2022 |
| NCT00312442 | Terminated | Phase 2/Phase 3 | Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy | May 2006 | December 2009 |
| NCT03921996 | Terminated | Phase 3 | Extended Pelvic Lymph Node Dissection vs. no Pelvic Lymph Node Dissection at Radical Prostatectomy for intermediate-and High-risk Prostate Cancer | August 27, 2019 | November 11, 2021 |
| NCT01000948 | Terminated | Phase 2 | A Safety Study of ZD4054 in Prior Chemotherapy Treated Patients With Metastatic Hormone-resistant Prostate Cancer | October 2009 | July 2011 |
| NCT01510288 | Terminated | Phase 1 | Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate Cancer | November 2004 | November 2011 |
| NCT02454595 | Terminated | Registry to Measure the Impact of Adding Genomic Testing | November 2014 | July 3, 2017 | |
| NCT02185170 | Terminated | N/A | DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections | July 2014 | September 2015 |
| NCT00004050 | Terminated | Phase 2 | Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer | June 1999 | April 2003 |
| NCT01859338 | Terminated | Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI | March 6, 2012 | January 24, 2017 | |
| NCT01445054 | Terminated | Early Phase 1 | 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer | March 1, 2007 | August 20, 2014 |
| NCT00383487 | Terminated | Phase 2 | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | March 2005 | July 2007 |
| NCT00471718 | Terminated | Phase 1/Phase 2 | ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy | January 2004 | August 2009 |
| NCT00005073 | Terminated | Phase 3 | Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms | September 1999 | March 2003 |
| NCT00089856 | Terminated | Phase 3 | GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer | July 2004 | October 2008 |
| NCT02805894 | Terminated | Phase 1/Phase 2 | NBTXR3 Nanoparticles and EBRT or EBRT With Brachytherapy in the Treatment of Prostate Adenocarcinoma | November 15, 2017 | March 19, 2020 |
| NCT04727710 | Terminated | N/A | Testing the Effect of Mindfulness for Prostatectomy Outcomes | August 26, 2020 | August 26, 2020 |
| NCT03712371 | Terminated | Phase 1/Phase 2 | Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients | January 16, 2019 | September 7, 2021 |
| NCT04586335 | Terminated | Phase 1 | Study of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors. | September 28, 2020 | February 15, 2023 |
| NCT00985738 | Terminated | Phase 2 | Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer | September 2009 | January 2013 |
| NCT00003645 | Terminated | Phase 3 | Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence | June 14, 1999 | March 20, 2017 |
| NCT04535908 | Terminated | N/A | Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older. | September 16, 2020 | May 25, 2022 |
| NCT00447616 | Terminated | Prostatectomy Prospective Database | October 2003 | April 7, 2015 | |
| NCT05177770 | Terminated | Phase 2 | Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer | January 17, 2022 | April 5, 2023 |
| NCT00415246 | Terminated | Phase 3 | Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer | November 2006 | October 2007 |
| NCT00273338 | Terminated | Phase 3 | DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) | January 2006 | November 2007 |
| NCT01727154 | Terminated | Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T | October 2012 | July 2017 | |
| NCT01913197 | Terminated | Phase 1/Phase 2 | Using Magnetic Resonance Imaging (MRI) to Guide Differential-Dose Prostate Brachytherapy | August 2013 | November 2016 |
| NCT01828476 | Terminated | Phase 2 | Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer | June 2013 | March 3, 2016 |
| NCT00005072 | Terminated | Phase 1/Phase 2 | Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer | November 2000 | April 2003 |
| NCT00179738 | Terminated | Phase 2 | A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer. | April 2005 | April 2007 |
| NCT04607135 | Terminated | N/A | ARFI Imaging for Targeted Prostate Biopsy | October 22, 2021 | March 28, 2023 |
| NCT00450970 | Terminated | Phase 3 | Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) | February 2007 | December 2009 |
| NCT01950871 | Terminated | Phase 4 | Prostate Guided Biopsy Study Evaluating the Diagnostic Performance of Prostate HistoScanning | October 2013 | July 2014 |
| NCT01522443 | Terminated | Phase 3 | Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancer | March 2012 | January 13, 2015 |
| NCT00898833 | Terminated | Plasma and Urine Samples From Patients With Hormone-Refractory Prostate Cancer Enrolled on Clinical Trials CALGB-9480 or CALGB-9583 | July 2003 | June 2016 | |
| NCT00003682 | Terminated | Phase 3 | Methylprednisolone With or Without Doxorubicin in Treating Patients With Metastatic Prostate Cancer | October 1998 | March 2001 |
| NCT00313456 | Terminated | Phase 1 | A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel | March 2006 | March 2009 |
| NCT00544076 | Terminated | Phase 3 | ED Recovery in Men Age </=65 Treated With Bilateral Nerve Sparing Robotic Assisted Prostatectomy for Prostate Cancer | January 2006 | April 2012 |
| NCT00860158 | Terminated | Phase 2 | Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer | March 2009 | December 2010 |
| NCT00147238 | Terminated | N/A | A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast | July 2005 | January 2007 |
| NCT03886493 | Terminated | Phase 2 | Neoadjuvant Dupilumab in Men With Localized High-Risk Prostate Cancer | August 28, 2019 | October 6, 2020 |
| NCT01499043 | Terminated | Phase 2 | Pilot Study of PLX3397 in Patients With Advanced Castration-Resistant Prostate Cancer (CRPC) | May 25, 2012 | March 11, 2013 |
| NCT00084864 | Terminated | Phase 2 | Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate | September 2002 | May 2010 |
| NCT00901420 | Terminated | Urodynamic Evaluation in Post-radiation Salvage Prostatectomy Patients | June 2007 | May 2010 | |
| NCT00996502 | Terminated | Phase 1/Phase 2 | Study of Bevacizumab and Erlotinib for Patients With Hormone Refractory Prostate Cancer | July 2006 | March 2010 |
| NCT00991315 | Terminated | Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate | December 12, 2008 | April 10, 2017 | |
| NCT01995058 | Terminated | Phase 2 | Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer | December 2013 | November 2014 |
| NCT01450683 | Terminated | Phase 2 | Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy | September 2010 | April 2011 |
| NCT01226888 | Terminated | Changes in Brown Adipose Tissue Activity In Men Receiving Androgen Deprivation Therapy for Prostate Cancer | September 2010 | October 2012 | |
| NCT00058188 | Terminated | Phase 3 | Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation | March 2003 | November 2008 |
| NCT01642732 | Terminated | Phase 1 | Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer | October 2012 | August 2014 |
| NCT02911467 | Terminated | Phase 1 | Magnetic Resonance (MR) Imaging With Hyperpolarized Pyruvate (HP) (13C) in Castration-Resistant Prostate Cancer | November 8, 2016 | July 20, 2020 |
| NCT01650285 | Terminated | Phase 2 | Cabazitaxel and Radiation For Patients With Prostate Cancer | January 2013 | July 2014 |
| NCT02945813 | Terminated | Phase 2 | SAKK 08/15 - PROMET - Salvage Radiotherapy +/- Metformin for Patients With Prostate Cancer After Prostatectomy | October 24, 2017 | February 28, 2022 |
| NCT01393119 | Terminated | Phase 2 | Phase II, Dose Finding Study of GTx-758 | August 2011 | December 2012 |
| NCT00126230 | Terminated | Phase 2 | Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer | January 2004 | |
| NCT02745587 | Terminated | Phase 3 | Evaluating the Impact of Prostate Only Versus Pelvic Radiation for N+ Prostate Cancer. | April 1, 2016 | September 22, 2022 |
| NCT00989105 | Terminated | Phase 1 | Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer | June 2009 | December 2011 |
| NCT02663908 | Terminated | Phase 3 | A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease | April 19, 2016 | March 29, 2021 |
| NCT03300505 | Terminated | Phase 1 | ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer | May 31, 2019 | January 24, 2023 |
| NCT02911922 | Terminated | N/A | Randomized Trial of Image -Guided Stereotactic Radiation Therapy (IG-SRT) in Prostate Cancer | September 2016 | April 17, 2018 |
| NCT02656615 | Terminated | Phase 2 | Abiraterone-Rechallenge Study for CRPC Patients | January 2016 | February 2017 |
| NCT04633148 | Terminated | Phase 1 | Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA Marker | November 23, 2020 | March 28, 2024 |
| NCT01704027 | Terminated | Phase 2 | Safety Study of Pelvic and Prostatic SIB-IMRT With Long-term Androgen Deprivation for High Risk Localized Prostate Cancer | October 2012 | |
| NCT04587284 | Unknown status | Economic Evaluation of Robot-assisted Laparoscopic Radical Prostatectomy vs Conventional Laparoscopic Radical Prostatectomy and Open Retropubic Radical Prostatectomy in Prostate Cancer: a Real-life Study Based on the French National Healthcare Data System (SNDS) | January 1, 2020 | January 1, 2023 | |
| NCT00188383 | Unknown status | Phase 1/Phase 2 | Effects of N-Methyl-D-Aspartate (NMDA)-Receptor Antagonism on Hyperalgesia, Opioid Use, and Pain After Radical Prostatectomy | January 2004 | December 2006 |
| NCT00667888 | Unknown status | Phase 3 | A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation | January 3, 2001 | October 2021 |
| NCT02225262 | Unknown status | N/A | A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors | January 2008 | December 2020 |
| NCT00326638 | Unknown status | N/A | 3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer | March 2005 | June 30, 2020 |
| NCT01409876 | Unknown status | Phase 2 | HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy | September 2011 | September 2016 |
| NCT01006564 | Unknown status | N/A | Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer | March 2009 | June 2011 |
| NCT00850941 | Unknown status | Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy | January 26, 2009 | January 2021 | |
| NCT03996993 | Unknown status | Defining Recurrent Disease With Axumin™ | July 1, 2019 | December 30, 2020 | |
| NCT00561444 | Unknown status | Quality of Life Study for Prostate Cancer Patients | November 14, 2007 | November 2020 | |
| NCT01673581 | Unknown status | Shared Decision Making in Low Risk Prostate Cancer | August 2012 | ||
| NCT00524823 | Unknown status | Early Detection of Prostate Cancer by FACS | August 2007 | ||
| NCT04632251 | Unknown status | N/A | Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer | September 16, 2020 | August 2021 |
| NCT03327675 | Unknown status | N/A | High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer | September 22, 2017 | December 2022 |
| NCT03396848 | Unknown status | N/A | Sexual Health and Rehabilitation eClinic (SHAReClinic) | August 23, 2017 | December 31, 2021 |
| NCT00122005 | Unknown status | Phase 1/Phase 2 | GVAX in Advanced Prostate Cancer Patients Made Lymphopenic | July 2005 | July 2005 |
| NCT00003717 | Unknown status | Phase 2 | Paclitaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | October 1998 | |
| NCT00657982 | Unknown status | Phase 2 | Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer | April 2008 | |
| NCT00405574 | Unknown status | Phase 2 | Study of ATN-224 in Patients With Prostate Cancer | November 2006 | September 2008 |
| NCT00625430 | Unknown status | Phase 1 | A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer | March 2008 | December 2012 |
| NCT04102904 | Unknown status | The Prostate Liquid Study (PLiS) | October 1, 2019 | March 2021 | |
| NCT01562223 | Unknown status | N/A | Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer | August 27, 2012 | December 2022 |
| NCT02220829 | Unknown status | Phase 3 | Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy | June 2016 | December 2021 |
| NCT05078359 | Unknown status | Optimizing Positive Predicting Value of Prostate MRI | January 1, 2022 | December 31, 2022 | |
| NCT01530295 | Unknown status | N/A | Biochemical Recurrence Rate of Radical Prostatectomy Combined With Neoadjuvant and Adjuvant Chemotherapy in High Risk Prostate Cancer | July 2008 | July 2012 |
| NCT03876912 | Unknown status | N/A | The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer | March 1, 2019 | March 1, 2023 |
| NCT00946543 | Unknown status | Phase 1 | Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer | March 2000 | |
| NCT04985110 | Unknown status | Phase 2 | Administration of Antibiotic Prophylaxis for Transperineal Prostate Biopsy in Cipto Mangunkusumo Hospital | July 6, 2021 | July 6, 2023 |
| NCT03253458 | Unknown status | N/A | Focal Prostate Imaging With CLE and OCT | May 11, 2018 | July 1, 2020 |
| NCT01311856 | Unknown status | Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors | March 2011 | March 2021 | |
| NCT00043576 | Unknown status | Phase 2/Phase 3 | ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | August 2002 | December 2005 |
| NCT00542100 | Unknown status | N/A | PCMRI - an MRI/TRUS System for the Evaluation of the Prostate | November 2007 | November 2008 |
| NCT01191099 | Unknown status | Comprehensive Analysis of Hypoxia in Prostate Cancer: Diagnostic Markers and Prognostic Significance | August 2010 | August 2020 | |
| NCT05324332 | Unknown status | N/A | 68Ga-P16-093 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Primary Prostate Cancer Patients | April 15, 2022 | December 31, 2023 |
| NCT00895466 | Unknown status | Phase 1/Phase 2 | Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients | October 2008 | |
| NCT02895854 | Unknown status | N/A | LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients | January 8, 2013 | December 31, 2021 |
| NCT04571840 | Unknown status | N/A | Prostate Imaging Using MRI +/- Contrast Enhancement | April 5, 2022 | March 2024 |
| NCT04034953 | Unknown status | N/A | Prevention of Obesity-related Cancers: Setting up of a Multi-Cancer Education and Prevention Program in Hong Kong | August 6, 2018 | December 31, 2023 |
| NCT01803503 | Unknown status | Phase 2 | Docetaxel With or Without Low-dose, Short Course Sunitinib in Refractory Solid Tumors | May 2013 | April 2018 |
| NCT00550810 | Unknown status | Phase 2 | Sutent Maintenance After Response to Taxotere | October 2007 | November 2012 |
| NCT02704832 | Unknown status | Phase 3 | Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) | March 2016 | February 2021 |
| NCT01784913 | Unknown status | Phase 1/Phase 2 | A Phase I/IIa Study of UV1 Vaccine in Patients With Prostate Cancer | April 15, 2013 | April 2023 |
| NCT04228055 | Unknown status | N/A | Comprehensive Lifestyle Improvement Program for Men With Prostate Cancer2 (CLIPP2) | August 7, 2020 | October 31, 2022 |
| NCT00303784 | Unknown status | Phase 3 | Prostate Adenocarcinoma TransCutaneous Hormones | March 2006 | August 2021 |
| NCT02723526 | Unknown status | Expression of Tumor Markers in Circulating Tumor Cells of Metastatic Hormone-sensitive Prostate Cancer | March 2016 | March 2019 | |
| NCT03857113 | Unknown status | Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study | March 11, 2020 | March 1, 2022 | |
| NCT02861209 | Unknown status | N/A | Collaborative Network to Take Responsibility for Oral Anticancer Therapy | November 2015 | November 2022 |
| NCT05156424 | Unknown status | Phase 1/Phase 2 | A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer | September 9, 2021 | March 1, 2023 |
| NCT01852864 | Unknown status | Early Phase 1 | Degarelix Before Radical Prostatectomy | July 2011 | December 2015 |
| NCT03987737 | Unknown status | N/A | Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the Prostate | August 2019 | October 2020 |
| NCT00218205 | Unknown status | Phase 2 | A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer | July 2002 | June 2006 |
| NCT04107142 | Unknown status | Phase 1 | Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour | December 1, 2019 | March 1, 2021 |
| NCT03644303 | Unknown status | N/A | Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients. | August 13, 2018 | October 1, 2021 |
| NCT01909388 | Unknown status | Phase 2 | Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy | June 2013 | July 2016 |
| NCT00770822 | Unknown status | N/A | Clinical Study of the Sonablate® 500 to Treat Localized (T1c/T2a) Prostate Cancer | April 2007 | December 2020 |
| NCT02844699 | Unknown status | Phase 1/Phase 2 | A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer | July 2016 | January 2018 |
| NCT00167024 | Unknown status | Application of Genetic Polymorphisms of DNA Repair in The Prediction of Prostate Cancer Susceptibility and Its Clinical Outcome | March 2005 | ||
| NCT04825002 | Unknown status | N/A | Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor | March 22, 2021 | December 31, 2023 |
| NCT03609736 | Unknown status | PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life | August 10, 2018 | December 2019 | |
| NCT02545881 | Unknown status | Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness | July 2015 | ||
| NCT05427864 | Unknown status | N/A | Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging | January 1, 2020 | March 5, 2023 |
| NCT03650595 | Unknown status | N/A | MRI Guided Focal Laser Ablation of Prostate Cancer | March 29, 2018 | June 30, 2022 |
| NCT00005939 | Unknown status | Phase 1/Phase 2 | Brachytherapy in Treating Patients With Recurrent Prostate Cancer | November 1999 | |
| NCT01839994 | Unknown status | Phase 3 | Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer | June 2013 | December 2018 |
| NCT02739048 | Unknown status | Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation. | September 2015 | September 2018 | |
| NCT01221168 | Unknown status | Epidemiologic and Genetic Study on Familial Prostate Cancer | October 1996 | December 2016 | |
| NCT02181192 | Unknown status | N/A | Point in Time of Radiotherapy for Patients With Biochemical Recurrent Prostate Carcinoma | July 2017 | July 2020 |
| NCT04577222 | Unknown status | N/A | The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy | April 15, 2018 | July 15, 2022 |
| NCT03307460 | Unknown status | Phase 2 | uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness | November 21, 2017 | April 1, 2022 |
| NCT00758173 | Unknown status | Study of Genes and the Environment in Patients With Prostate Cancer Residing in the East Anglia, Trent, or West Midlands Regions of the United Kingdom | February 2008 | ||
| NCT02271659 | Unknown status | N/A | Medical and Economic Evaluation for Intermediate-risk Prostate Cancer | June 2013 | June 2021 |
| NCT03623425 | Unknown status | Phase 3 | Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer | February 1, 2019 | May 1, 2020 |
| NCT00223171 | Unknown status | Phase 3 | Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers | October 2000 | December 31, 2023 |
| NCT03174054 | Unknown status | The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions | June 1, 2017 | June 1, 2019 | |
| NCT03650946 | Unknown status | Clinical Application of 68Ga-PSMA PET in Prostate Cancer | August 2018 | July 30, 2021 | |
| NCT03255135 | Unknown status | N/A | Initial Experience in Brazilian Single Center With High Intensity Focalized Ultrasound (HIFU) Prostate Cancer Therapy: Morbidity, Oncological and Functional Outcomes. | May 31, 2018 | July 2019 |
| NCT03961737 | Unknown status | N/A | Study of the Response to Irradiation on Prostatic Explants ex Vivo, as a Predictive Factor of the Clinical Response to Irradiation of Prostate Cancers | April 2, 2019 | June 2023 |
| NCT03237026 | Unknown status | Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients | October 11, 2017 | July 31, 2023 | |
| NCT03284151 | Unknown status | Focused Stereotactic Radiation Treatment of Prostatic Adenocarcinoma | January 2015 | January 2023 | |
| NCT00363285 | Unknown status | Phase 3 | Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer | January 2003 | |
| NCT04953351 | Unknown status | N/A | MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate Biopsy | August 2021 | July 2022 |
| NCT01448798 | Unknown status | N/A | Athermal Nerve-sparing During Robotic-assisted Radical Prostatectomy Using a Hemostatic Matrix. | October 2011 | January 2014 |
| NCT00868868 | Unknown status | Pedometer and Exercise Study in Prostate Cancer Patients With Hormonal Therapy | June 2008 | September 2011 | |
| NCT04062162 | Unknown status | N/A | Walking Football as a Supportive Medicine for Patients With Prostate Cancer | July 11, 2019 | June 30, 2020 |
| NCT04251546 | Unknown status | Prediction Model fo Screening and Diagnosis of Prostate Cancer in PSA Gray Zone Based on Serum PHI Combined With TPV | January 4, 2020 | September 30, 2022 | |
| NCT05286840 | Unknown status | Phase 1/Phase 2 | 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer | March 28, 2022 | September 30, 2023 |
| NCT04792138 | Unknown status | Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis. | October 23, 2020 | October 2023 | |
| NCT00321698 | Unknown status | Phase 1/Phase 2 | Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer | January 31, 2006 | December 31, 2022 |
| NCT00987675 | Unknown status | Phase 2 | High-Intensity Focused Ultrasound Ablation in Treating Patients With Progressive Prostate Cancer | July 2009 | |
| NCT00024414 | Unknown status | Phase 2 | DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer | April 2001 | |
| NCT00005960 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | October 1999 | |
| NCT00494039 | Unknown status | Phase 3 | I-125 Versus Pd-103 for Low Risk Prostate Cancer | January 1998 | January 2010 |
| NCT02138760 | Unknown status | N/A | Comparison of MRI Fusion Biopsy Techniques in Men With Elevated PSA and Prior Negative Prostate Biopsy | August 2014 | December 2015 |
| NCT00354497 | Unknown status | Phase 2 | Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men | March 2002 | |
| NCT01177865 | Unknown status | N/A | Study of Treatment Choice in Patients With Localized Prostate Cancer | September 2010 | |
| NCT02322931 | Unknown status | N/A | C-arm Cone-beam CT in Prostate Brachytherapy | January 2015 | December 2019 |
| NCT05021952 | Unknown status | N/A | Postoperative Prognosis Management Service Based mHealth for Prostate Cancer Patients | May 21, 2021 | May 30, 2024 |
| NCT04102124 | Unknown status | Phase 2 | A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC | April 8, 2019 | November 1, 2022 |
| NCT03294122 | Unknown status | Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer | February 2, 2017 | December 31, 2019 | |
| NCT03431753 | Unknown status | N/A | Early and Accurate Detection of Prostate Cancer in General Practice | January 1, 2018 | December 31, 2021 |
| NCT00110162 | Unknown status | Phase 3 | Androgen Deprivation Therapy in Treating Patients With Prostate Cancer | October 2004 | |
| NCT00421265 | Unknown status | Active Surveillance for Prostate Cancer With Indolent Features | |||
| NCT04317625 | Unknown status | N/A | Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL | April 2020 | December 2022 |
| NCT02691169 | Unknown status | Early Phase 1 | Integrated 18F-labelled PSMA Project | April 2016 | December 2017 |
| NCT00003734 | Unknown status | Phase 3 | Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer | December 1998 | |
| NCT00375687 | Unknown status | N/A | Investigation of Early Hormonotherapy Efficacy of Prostate Cancer | August 2005 | January 2020 |
| NCT03356444 | Unknown status | Phase 2 | Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate | November 2017 | December 2020 |
| NCT03561857 | Unknown status | N/A | Clinical Trial for a Robotic Endomicroscopy to Better Define Resection Strategies Applied to Urology Surgery | January 16, 2019 | June 2020 |
| NCT01555086 | Unknown status | N/A | Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy | August 2011 | |
| NCT03692000 | Unknown status | Designing a Digital Tool to Support Healthy Lifestyle in Men With Prostate Cancer | February 23, 2018 | October 1, 2018 | |
| NCT03541928 | Unknown status | Phase 2 | Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery | August 2, 2018 | July 2023 |
| NCT02313298 | Unknown status | Phase 2 | Stereotactic Body Radiotherapy for Organ Confined Prostate Cancer | June 2013 | December 2021 |
| NCT03164837 | Unknown status | Phase 1 | 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients | November 2016 | November 2018 |
| NCT03580239 | Unknown status | Phase 3 | Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency | January 1, 2019 | December 1, 2023 |
| NCT00928603 | Unknown status | Phase 1 | Investigative Study of the Role of Focal Therapy for Prostate Cancer Treatment | September 2009 | September 2014 |
| NCT03101176 | Unknown status | N/A | Multiparametric Ultrasound Imaging in Prostate Cancer | September 7, 2017 | September 1, 2022 |
| NCT03027986 | Unknown status | N/A | Evaluation of a Postural Rehabilitation Program Based on Sensory-motor Control in Men With Urinary Incontinence After Prostatectomy | September 2018 | December 2022 |
| NCT03344822 | Unknown status | Phase 2/Phase 3 | Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients | January 2, 2018 | December 31, 2019 |
| NCT00955435 | Unknown status | Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 | February 2006 | ||
| NCT03990194 | Unknown status | Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer | March 30, 2021 | March 30, 2022 | |
| NCT01444820 | Unknown status | Phase 3 | Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate | January 2012 | January 2023 |
| NCT00851292 | Unknown status | Phase 3 | The BIOPRES Trial: Transrectal BIOpsies of the PRostate: End Versus Side-firing | October 2009 | September 2012 |
| NCT00045123 | Unknown status | Phase 2 | R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence | February 2002 | |
| NCT02934685 | Unknown status | Phase 3 | IG-VMAT for Localized Prostate Cancer | June 2016 | May 2021 |
| NCT04297410 | Unknown status | N/A | 177Lu-PSMA-I&T Prior to Radical Prostatectomy for Locally Advanced Disease | November 20, 2019 | April 20, 2022 |
| NCT02844829 | Unknown status | N/A | Improved Prostate Cancer Diagnosis - Combination of Rapid Prebiopsy Magnetic Resonance Imaging and Biomarkers | July 2016 | December 2018 |
| NCT03392181 | Unknown status | Early Phase 1 | PET/MRI for the Staging of Newly Diagnosed Prostate Cancer | June 8, 2018 | June 1, 2023 |
| NCT01484808 | Unknown status | The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage | January 2012 | May 2012 | |
| NCT00870714 | Unknown status | N/A | Neoadjuvant Therapy With Docetaxel and Ketoconazole in Patients With High-Risk Prostate Cancer: A Pilot Study | September 2004 | |
| NCT00126802 | Unknown status | Phase 1/Phase 2 | The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer | April 2005 | March 2017 |
| NCT03588819 | Unknown status | N/A | Stereotactic MRI-Guided Radiation for Localized Prostate Cancer | April 23, 2018 | April 23, 2024 |
| NCT00988130 | Unknown status | Phase 2 | High-Intensity Focused Ultrasound Focal Ablation in Treating Patients With Progressive Prostate Cancer | July 2009 | |
| NCT04581109 | Unknown status | N/A | Detection of Viable CTCs Using the EPIDROP Technology in Metastatic Prostate Cancer (EPIDROP) | May 27, 2021 | October 2023 |
| NCT04628806 | Unknown status | Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells | February 17, 2021 | May 2022 | |
| NCT04292041 | Unknown status | Fasting Mimicking Diet in Prostate Cancer and Metabolic Syndrome | January 15, 2019 | June 15, 2020 | |
| NCT02397317 | Unknown status | Phase 2 | Stereotactic Prostate Adaptive Radiotherapy Utilising Kilovoltage Intrafraction Monitoring | February 2016 | December 2020 |
| NCT00959023 | Unknown status | Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer | June 1993 | ||
| NCT00207636 | Unknown status | Phase 3 | Community Interventions in Non-Medical Settings to Increase Informed Decision Making for Prostate Cancer Screening | December 2004 | September 2007 |
| NCT03457805 | Unknown status | N/A | Prostatic Artery Embolization in Advanced Prostate Cancer | March 2, 2018 | August 2, 2021 |
| NCT02524860 | Unknown status | N/A | Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device | September 2015 | September 2017 |
| NCT04882618 | Unknown status | Phase 4 | Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. | November 8, 2019 | November 8, 2021 |
| NCT00967954 | Unknown status | N/A | Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer | September 2008 | |
| NCT03425240 | Unknown status | N/A | Intra-operative Neuromodulation of the Pelvic Plexus | September 10, 2014 | December 2018 |
| NCT03031613 | Unknown status | N/A | Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical Prostatectomy | January 2017 | November 2017 |
| NCT00400894 | Unknown status | Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma | September 2005 | September 2006 | |
| NCT03040791 | Unknown status | Phase 2 | Nivolumab in Prostate Cancer With DNA Repair Defects (ImmunoProst Trial) | June 1, 2018 | March 1, 2022 |
| NCT04322045 | Unknown status | N/A | Combined Prostate-specific Antigen, Multi-parametric MRI and Targeted Prostate Biopsy for Prostate Cancer Screening | April 2020 | December 2022 |
| NCT01436214 | Unknown status | Phase 1/Phase 2 | Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer | August 2011 | August 2017 |
| NCT02049190 | Unknown status | Phase 1/Phase 2 | Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer | February 2014 | December 2017 |
| NCT01193855 | Unknown status | Phase 2 | Dutasteride in Treating Patients With Prostate Cancer | June 2010 | |
| NCT04278443 | Unknown status | Fertility After Prostate Brachytherapy | February 24, 2017 | August 5, 2021 | |
| NCT05382182 | Unknown status | Outcome Of Treatment Of Prostate Cancer at Sohag University Hospital Between 2017 to 2021 | June 1, 2022 | December 31, 2022 | |
| NCT05137561 | Unknown status | N/A | Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate Biopsy | October 25, 2021 | December 31, 2022 |
| NCT04050397 | Unknown status | N/A | Exercise and Quality of Life During Androgen Deprivation Therapy | August 15, 2019 | August 15, 2021 |
| NCT02747290 | Unknown status | Early Phase 1 | 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients | July 2014 | |
| NCT00703768 | Unknown status | Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year | June 2006 | July 2010 | |
| NCT03880851 | Unknown status | N/A | MR-based Hypofractionated Adaptive IGRT of Prostate Cancer (M-base HyPro 2.0) | January 23, 2019 | January 31, 2024 |
| NCT03264209 | Unknown status | N/A | Smart After-Care in Patients With Prostate Cancer | September 11, 2017 | December 2018 |
| NCT02292914 | Unknown status | N/A | Prospective Analysis of Robot-Assisted Surgery | March 10, 2014 | July 10, 2020 |
| NCT03238066 | Unknown status | N/A | Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy | April 2015 | April 2022 |
| NCT03525652 | Unknown status | Phase 1/Phase 2 | Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment | February 22, 2018 | August 30, 2021 |
| NCT05187026 | Unknown status | Electrical Patient Reported Outcome of Prostate Cancer RadioTherapy | December 9, 2016 | December 31, 2022 | |
| NCT01589939 | Unknown status | Reduced Planning Target Volume (PTV) Margins for the Treatment of Prostate Cancer Using the Calypso 4D Localization System | March 2009 | August 2017 | |
| NCT05179707 | Unknown status | A Research for Combination of Prostate Health Index (Phi) and mpMRI PI-RADS in the Diagnosis of Prostate Cancer | February 1, 2022 | October 1, 2023 | |
| NCT01685190 | Unknown status | Phase 2 | A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer | June 2011 | December 2019 |
| NCT02757365 | Unknown status | Phase 4 | Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer | April 2014 | April 2019 |
| NCT01842750 | Unknown status | N/A | The Use of Rectal Balloons in Radical Pelvic Radiotherapy - a Feasibility Study | August 2013 | |
| NCT01769950 | Unknown status | N/A | Choline-PET for Evaluating the Incidence of Nodal Metastases Among Newly Diagnosed Patients of Prostate Cancer | January 2013 | February 2014 |
| NCT01089881 | Unknown status | The Effectiveness of 18F-fluorocholine Positron Emission Tomography (PET) in Detecting, Staging and Following-up Prostate Cancer | January 2008 | December 2010 | |
| NCT04983706 | Unknown status | N/A | Optimization of the Core Number and Location for Targeted Prostate Biopsy | July 5, 2021 | May 2022 |
| NCT03406169 | Unknown status | Phase 3 | Erectile Recovery After Robotic-Assisted Laparoscopic Prostatectomy | February 13, 2017 | March 2022 |
| NCT03786848 | Unknown status | N/A | Personalized Mini-PDX for Metastatic CRPC | January 28, 2019 | January 27, 2021 |
| NCT02123862 | Unknown status | Cultured Circulating Tumor Cells in Prostate and Other Cancers | April 2014 | April 2018 | |
| NCT02145494 | Unknown status | Phase 2 | The SPARC Trial: Stereotactic Prostate Ablative Radiotherapy Using Cyberknife | June 2013 | December 2018 |
| NCT01849471 | Unknown status | Socioeconomic Aspects Before and After Radiation Therapy in Patient With Prostate Cancer | April 2013 | May 2019 | |
| NCT03679819 | Unknown status | Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer | September 5, 2019 | December 31, 2021 | |
| NCT03351088 | Unknown status | N/A | Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy | August 2016 | December 2017 |
| NCT02282137 | Unknown status | Phase 2 | 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer | May 2015 | December 2023 |
| NCT01296243 | Unknown status | Phase 2 | Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer | February 2011 | February 2015 |
| NCT05319145 | Unknown status | N/A | PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study) | May 1, 2022 | January 31, 2023 |
| NCT04159051 | Unknown status | N/A | Charité HT-Prostate | October 2016 | January 2024 |
| NCT00601406 | Unknown status | N/A | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | March 2006 | |
| NCT01355185 | Unknown status | Seed Movement in Prostate Brachytherapy Implants: Clinical Measurement and Dosimetric Consequences | August 2011 | June 2015 | |
| NCT00002775 | Unknown status | Phase 1/Phase 2 | Docetaxel Plus Estramustine in Treating Patients With Metastatic Prostate Cancer | February 1998 | |
| NCT02928692 | Unknown status | Phase 3 | Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium | November 2016 | December 2021 |
| NCT02367404 | Unknown status | Phase 3 | Prospective RCT on Post Prostatectomy Urine Leak | May 2015 | June 2017 |
| NCT03734757 | Unknown status | N/A | Interest of Trimodality PET-CT Choline MRI Before Radiotherapy in High Risk Prostate Cancer | October 16, 2018 | December 31, 2020 |
| NCT00536055 | Unknown status | Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses | October 2007 | August 2008 | |
| NCT02913859 | Unknown status | Phase 2 | Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer | September 1, 2018 | December 2020 |
| NCT00294151 | Unknown status | Phase 3 | Potential Vertebroplasty Use in the Treatment of Vertebral Metastasis From Breast and Prostate Cancer | September 2005 | |
| NCT02935816 | Unknown status | Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques | January 2015 | January 2018 | |
| NCT04300673 | Unknown status | Phase 1/Phase 2 | Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients | September 1, 2020 | April 1, 2023 |
| NCT04831307 | Unknown status | N/A | 68Ga-HTK03149 for Use as a Diagnostic Radiopharmaceutical | August 30, 2021 | August 2022 |
| NCT01978873 | Unknown status | Phase 3 | Efficacy Study Evaluating Chemotherapy in Prostate Cancer | November 2012 | November 2019 |
| NCT04191980 | Unknown status | Deep Learning for Prostate Segmentation | February 1, 2019 | June 2020 | |
| NCT04846894 | Unknown status | N/A | Ga-68 PSMA-11 PET/CT in Patients With Biochemical Recurrence of Prostate Cancer: Digital PET/CT Versus Analog PET/CT | April 13, 2021 | June 2023 |
| NCT02426216 | Unknown status | Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention | March 2015 | July 2018 | |
| NCT02016040 | Unknown status | Phase 2/Phase 3 | Focal Therapy Using HIFU for Localised Prostate Cancer | March 17, 2013 | November 2017 |
| NCT02440802 | Unknown status | Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer | April 2013 | September 2017 | |
| NCT03740854 | Unknown status | N/A | The Effects of Two Different Ventilation Strategies on Lung Ventilation: An Ultrasonographic Evaluation. | December 4, 2018 | July 1, 2020 |
| NCT04724577 | Unknown status | N/A | 12 Fractions Carbon Ion Radiotherapy for Localized Prostate Cancer | December 1, 2019 | June 1, 2023 |
| NCT01087268 | Unknown status | Phase 3 | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer | January 2009 | |
| NCT00006114 | Unknown status | Phase 2 | Combination Chemotherapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | May 1999 | |
| NCT04356430 | Unknown status | Phase 2 | Neoadjuvant Therapy of Abiraterone Plus ADT for High Risk Prostate Cancer | April 1, 2019 | December 1, 2023 |
| NCT02342054 | Unknown status | Phase 2 | Single Fraction Real-time High-Dose-Rate Brachytherapy in Patients With Low and Intermediate Risk Prostate Cancer | October 2014 | December 2017 |
| NCT02785627 | Unknown status | Assessment of Bone Loss in Men Receiving Treatment for Prostate Cancer | September 2016 | September 2019 | |
| NCT00681694 | Unknown status | Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer | March 2002 | March 2011 | |
| NCT01314456 | Unknown status | N/A | 3D Recording of a Trans-rectal Prostate Biopsy | March 2011 | December 2011 |
| NCT02041559 | Unknown status | The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study | January 2014 | December 2014 | |
| NCT00006430 | Unknown status | Phase 1 | A Safety and Feasibility Study of Active Immunotherapy in Patients With Metastatic Prostate Carcinoma Using Autologous Dendritic Cells Pulsed With Antigen Encoded in Amplified Autologous Tumor RNA | ||
| NCT00295802 | Unknown status | Phase 2/Phase 3 | Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer | April 2006 | September 2014 |
| NCT02278679 | Unknown status | Digital Rectal Exam Proficiency Tool | October 2014 | June 2018 | |
| NCT02742675 | Unknown status | Phase 2 | Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) | September 2015 | March 2023 |
| NCT04783636 | Unknown status | Phase 1 | To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers | March 11, 2021 | July 20, 2021 |
| NCT02294903 | Unknown status | N/A | Focal Prostate Radiofrequency Ablation | March 2015 | May 30, 2018 |
| NCT02869282 | Unknown status | STUDY OF THE EXPRESSION OF CIRCULATING AND INTRA-TUMORAL CHEMOKINES IN PATIENTS WITH PROSTATE CANCER | June 2011 | December 2017 | |
| NCT02511665 | Unknown status | Phase 4 | Metformin And Longevity | July 2015 | July 2017 |
| NCT02712684 | Unknown status | Cancer Diagnosis by Multiparametric UltraSound of the Prostate | July 2015 | July 2017 | |
| NCT03687918 | Unknown status | External Validation of Prostate MRI QCAD/Lyon | June 1, 2018 | October 1, 2018 | |
| NCT00322114 | Unknown status | N/A | Lycopene in Preventing Prostate Cancer in Healthy Participants | February 2006 | |
| NCT00024063 | Unknown status | Phase 1 | SU006668 in Treating Patients With Advanced Solid Tumors | ||
| NCT03061760 | Unknown status | Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy | March 1, 2017 | December 31, 2019 | |
| NCT05187949 | Unknown status | Promoting Shared-decision Making in Opportunistic Screening for Prostate Cancer | July 2022 | December 2023 | |
| NCT01492270 | Unknown status | N/A | Imaging for Significant Prostate Cancer Risk Evaluation | December 2011 | July 2013 |
| NCT03787823 | Unknown status | N/A | RCT-evaluation of Retzius-sparing Robotic Prostatectomy | August 27, 2018 | November 30, 2020 |
| NCT05180305 | Unknown status | A Study to Assess Mitomic Prostate Test for Prostate Cancer Screening | April 27, 2021 | December 31, 2022 | |
| NCT04116775 | Unknown status | Phase 2 | Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. | October 30, 2019 | October 2023 |
| NCT04369508 | Unknown status | PD-L1-expressing Regulatory T Cells in Localized Prostate Cancer Patients Undergoing Iodine-125 Permanent Brachytherapy | July 1, 2020 | December 31, 2022 | |
| NCT04192890 | Unknown status | N/A | Efficacy and Safety Assessment of IRE of Localized Prostate Cancer | January 27, 2020 | December 1, 2021 |
| NCT01292291 | Unknown status | N/A | MRI in Diagnosing Prostate Cancer | April 2011 | |
| NCT00670527 | Unknown status | N/A | [18F] Fluorocholine FCH Positron Emission Tomography (PET)/Computed Tomography (CT) for Detection of Prostate Cancer Lymph Nodes Metastases | January 2008 | April 2013 |
| NCT04390880 | Unknown status | Phase 2 | 18F-DCFPyL PET/CT Impact on Treatment Strategies for Patients With Prostate Cancer | April 7, 2020 | September 2023 |
| NCT00957606 | Unknown status | Phase 3 | Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer | August 2009 | September 2013 |
| NCT02911636 | Unknown status | N/A | 5 Fractions of Pelvic SABR With Intra Prostatic SABR | October 2016 | October 2022 |
| NCT02408497 | Unknown status | Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy | April 2015 | December 2018 | |
| NCT03017417 | Unknown status | N/A | A COMbined progRamme of Exercise and Dietary ADvice in mEn With Castrate Resistant Prostate Cancer | February 8, 2017 | June 2020 |
| NCT03960112 | Unknown status | N/A | Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference | October 1, 2020 | December 1, 2022 |
| NCT00348998 | Unknown status | Phase 2 | Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer | April 2006 | |
| NCT03967080 | Unknown status | Adaptive Radiotherapy for High-risk Prostate Cancer Using Multiparametric MRI | February 5, 2019 | September 30, 2022 | |
| NCT02450266 | Unknown status | N/A | Study Comparing MRI/Ultrasound Fusion-guided Prostate Biopsy Versus Systematic Transrectal Ultrasound-guided Biopsy | February 2015 | February 2018 |
| NCT03124615 | Unknown status | Phase 2 | Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer | May 2017 | June 2021 |
| NCT03275181 | Unknown status | Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer | August 1, 2017 | December 31, 2018 | |
| NCT04582656 | Unknown status | N/A | Efficacy Assessment of a Novel 3D Cartography-based Targeted Focal Microwave Therapy in Men With Localized Intermediate-risk Prostate Cancer | February 11, 2021 | May 2023 |
| NCT04565496 | Unknown status | Phase 2 | Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients | January 1, 2021 | January 1, 2024 |
| NCT03516045 | Unknown status | Phase 1/Phase 2 | A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer | April 23, 2018 | December 30, 2020 |
| NCT04182594 | Unknown status | Phase 2 | Cardiovascular Events in GnRH Agonist vs. Antagonist | January 17, 2020 | January 17, 2023 |
| NCT02799303 | Unknown status | N/A | MRI Versus PSA in Prostate Cancer Screening | June 2016 | June 2020 |
| NCT00005992 | Unknown status | Phase 1 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | December 2000 | |
| NCT04575402 | Unknown status | Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients | February 19, 2021 | December 31, 2022 | |
| NCT04158414 | Unknown status | N/A | Applying PET/MR in Oncology - a Prospective Project | November 28, 2019 | November 28, 2021 |
| NCT04108871 | Unknown status | N/A | Whether Transperineal Prostate Biopsy Under Local-anaesthesia Using a Transperineal-access System is Non-inferior to Standard Transrectal Biopsy to Detect Prostate Cancer in Biopsy-naïve Men | October 3, 2018 | September 1, 2021 |
| NCT05248282 | Unknown status | Clinical Validation of the Prognostic Value of the PrTS on Prostate Cancer Patients | September 1, 2021 | December 31, 2022 | |
| NCT02821793 | Unknown status | Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer | January 2016 | July 2020 | |
| NCT01225471 | Unknown status | Phase 1/Phase 2 | Novel Peptide Vaccination for Patients With Advanced Prostate Cancer | June 2009 | May 2012 |
| NCT04206280 | Unknown status | N/A | Use of Pedometer Following Radical Prostatectomy | February 10, 2020 | February 2021 |
| NCT03658525 | Unknown status | N/A | Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study) | August 7, 2018 | August 2023 |
| NCT03202381 | Unknown status | Phase 4 | Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix | June 26, 2017 | March 2020 |
| NCT01379742 | Unknown status | Phase 4 | Comparison of Between ThinSeed™ and OncoSeed™ for Permanent Prostate Brachytherapy | April 2010 | |
| NCT01454037 | Unknown status | Immune Profiles and Circulating Tumor Cell Status Following Prostate Cryotherapy | October 2011 | October 2015 | |
| NCT02747563 | Unknown status | Phase 1 | Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination | May 2016 | May 2017 |
| NCT03082274 | Unknown status | Prospective Validation of Prostate Biomarkers for Repeat Biopsy | March 31, 2017 | December 30, 2019 | |
| NCT00741364 | Unknown status | Phase 2 | Vitamin D Effects on Prostate Pathology | September 2008 | July 2012 |
| NCT04320147 | Unknown status | N/A | MR-target Biopsy vs. TRUS-biopsy in Men With Suspicious Prostate Cancer | March 23, 2020 | April 1, 2023 |
| NCT03838432 | Unknown status | N/A | The Composite Steep-pulse Treatment Apparatus Used in Prostate Cancer Ablation Therapy | May 2, 2018 | January 18, 2020 |
| NCT02295449 | Unknown status | N/A | Quantitative Prostate Cancer Contrast-enhanced Ultrasound | June 9, 2015 | June 2020 |
| NCT02840617 | Unknown status | Phase 1 | ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes | March 2016 | |
| NCT02597725 | Unknown status | Salvage Radiotherapy After Radical Prostatectomy | November 2015 | July 2016 | |
| NCT00223145 | Unknown status | Phase 3 | Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone | December 2000 | December 31, 2023 |
| NCT02678481 | Unknown status | N/A | MR-targeted vs. Random TRUS-guided Prostate Biopsy | November 2014 | December 2016 |
| NCT02816840 | Unknown status | Phase 1/Phase 2 | PET-CT/MRI in the Radiotherapy for Prostate Cancer | September 2016 | August 2019 |
| NCT03579654 | Unknown status | Phase 2 | Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance | February 28, 2019 | June 30, 2022 |
| NCT05024162 | Unknown status | N/A | Can MRI of the Prostate Combined With a Radiomics Evaluation Determine the Invasive Capacity of a Tumour | January 4, 2022 | September 1, 2023 |
| NCT00966095 | Unknown status | PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy | December 2009 | ||
| NCT02577627 | Unknown status | Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC | September 2015 | September 2019 | |
| NCT01168141 | Unknown status | N/A | Window Study of ZD4054 in Metastatic Prostate Cancer | July 2009 | September 2010 |
| NCT03212456 | Unknown status | N/A | Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia | January 12, 2017 | December 30, 2020 |
| NCT00514072 | Unknown status | Phase 2 | Vaccine Therapy in Treating Patients With Stage D0 Prostate Cancer | March 2007 | |
| NCT01804712 | Unknown status | Early Phase 1 | Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy | July 2013 | April 2019 |
| NCT03770351 | Unknown status | Early Prostate Cancer: Predicting Treatment Response | January 2017 | July 2021 | |
| NCT01505075 | Unknown status | Phase 1/Phase 2 | Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer | September 2011 | September 2021 |
| NCT01826565 | Unknown status | N/A | Comparison of Two Insertion Technique of I-gel | May 2013 | July 2014 |
| NCT01830166 | Unknown status | N/A | Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy | May 2013 | January 2019 |
| NCT05192694 | Unknown status | N/A | Evaluation of Fapi-pet in Prostate Cancer. | March 10, 2022 | December 15, 2022 |
| NCT02070952 | Unknown status | N/A | CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer | July 2013 | July 2018 |
| NCT04110782 | Unknown status | Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad) | September 2015 | January 2020 | |
| NCT00503646 | Unknown status | N/A | Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners | May 2007 | |
| NCT03662958 | Unknown status | N/A | Comparison of a Novel Leuprolide With Market Leuprolide | August 1, 2018 | December 2018 |
| NCT01615965 | Unknown status | N/A | Detection of Micrometastases in Lymph Nodes of Patients With Prostate Cancer | February 2010 | December 2021 |
| NCT03413007 | Unknown status | Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial | February 9, 2018 | December 2018 | |
| NCT04154280 | Unknown status | N/A | Combination of 68Ga-PSMA PET Data With Magnetic Resonance Spectroscopy Data (MRS) for Evaluating Prostate Cancer | April 10, 2020 | April 10, 2022 |
| NCT00175396 | Unknown status | Phase 3 | Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy | May 2004 | June 2014 |
| NCT00731848 | Unknown status | Phase 2 | Open-label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer | February 2008 | January 2015 |
| NCT02460861 | Unknown status | N/A | Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy | November 2011 | December 2015 |
| NCT04011865 | Unknown status | N/A | Robot-assisted vs Laparoscopic Radical Prostatectomy for Prostate Cancer Treatment | January 1, 2019 | December 31, 2020 |
| NCT03418207 | Unknown status | N/A | The Accuracy of Modified TTMB in the Spatial Distribution of Prostate Cancer | February 1, 2018 | December 31, 2019 |
| NCT00133900 | Unknown status | Circulating Tumor Cells and Survival in Hormone Refractory Prostate Cancer (HRPC) Patients Receiving Chemotherapy | December 2004 | February 2009 | |
| NCT01801852 | Unknown status | N/A | Autologous Natural Killer T Cells Infusion for the Treatment of Cancer | January 2013 | June 2017 |
| NCT03013712 | Unknown status | Phase 1/Phase 2 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer | January 2017 | December 2020 |
| NCT00009750 | Unknown status | Phase 1 | Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | March 2001 | |
| NCT03982706 | Unknown status | Examination of Focal Therapies- MRI-Fusion, HIFU, NanoKnife and Cryotherapy | October 28, 2015 | June 6, 2020 | |
| NCT03979573 | Unknown status | N/A | Prospective Evaluation of Mp-MRI, MR-guided Biopsy, and Molecular Markers for Active Surveillance of Prostate Cancer | October 1, 2017 | September 30, 2021 |
| NCT04982536 | Unknown status | N/A | Assessment of VMCore Biopsy Versus Standard of Care Biopsy | July 19, 2020 | August 1, 2022 |
| NCT05179694 | Unknown status | N/A | The TRANSLATE Trial | December 3, 2021 | October 31, 2023 |
| NCT00997464 | Unknown status | An Exploration of Genetic Testing for Prostate Cancer Susceptibility | August 2009 | February 2011 | |
| NCT00201630 | Unknown status | Phase 3 | Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy | September 2005 | September 2005 |
| NCT00486499 | Unknown status | Phase 3 | I-125 Versus Pd-103 for Medium Risk Prostate Cancer | March 2003 | |
| NCT01716702 | Unknown status | N/A | A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer | November 2012 | December 2014 |
| NCT00003633 | Unknown status | Phase 1 | Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer | August 1998 | |
| NCT02944201 | Unknown status | Phase 2 | Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | April 1, 2017 | December 31, 2021 |
| NCT00228124 | Unknown status | PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition | April 2004 | April 2008 | |
| NCT00967889 | Unknown status | Study of Tissue, Blood, and Urine Samples From Patients With Advanced Prostate Cancer | January 2002 | ||
| NCT05179720 | Unknown status | N/A | The Application Research of Ultrasound Guided Puncture Stent Assisted Transperineal Prostate Biopsy | January 1, 2022 | December 31, 2023 |
| NCT04037488 | Unknown status | Changes in Body Composition With Patients Under Androgen Deprivation Therapy | August 2019 | October 30, 2021 | |
| NCT05252806 | Unknown status | Quantitative mpMRI to Predict Metastatic Potential of Prostate Cancer | July 2022 | March 2023 | |
| NCT02037464 | Unknown status | Phase 2 | CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer | January 2014 | January 2018 |
| NCT02724618 | Unknown status | Phase 2 | Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) | March 2016 | April 2022 |
| NCT03223064 | Unknown status | N/A | Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI | December 30, 2016 | December 31, 2017 |
| NCT03313726 | Unknown status | N/A | The Effect of ADT on PSMA-PET. | September 20, 2017 | September 30, 2018 |
| NCT03851211 | Unknown status | Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation | February 21, 2019 | October 30, 2020 | |
| NCT01687049 | Unknown status | Phase 2 | Red Yeast Rice in Subjects With Clinically Localized Prostate Cancer Undergoing Active Surveillance | January 2013 | December 2017 |
| NCT02165020 | Unknown status | Phase 2 | Hyaluronic Acid for Hypofractionated Prostate Radiotherapy | November 2010 | May 2017 |
| NCT02265159 | Unknown status | Phase 2/Phase 3 | Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer | May 2014 | May 2020 |
| NCT03709485 | Unknown status | N/A | Evaluation of Gut Microbiome in Patients With Prostate Cancer | November 1, 2018 | December 30, 2019 |
| NCT01437085 | Unknown status | A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant | October 2011 | August 2017 | |
| NCT00003183 | Unknown status | Phase 1/Phase 2 | Mitoxantrone and G-CSF in Treating Patients With Metastatic Prostate Cancer | March 1997 | |
| NCT04284020 | Unknown status | N/A | Educational Program Plus Physiotherapy After Prostatectomy | December 1, 2019 | December 31, 2022 |
| NCT03137186 | Unknown status | Phase 2 | Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer | January 2017 | January 2020 |
| NCT00309439 | Unknown status | Phase 2 | ALA and Prostate Cancer | ||
| NCT03706508 | Unknown status | Pentafecta Outcomes After Robot-assisted Laparoscopic Radical Prostatectomy | August 9, 2013 | November 30, 2018 | |
| NCT01398657 | Unknown status | Phase 3 | Cryotherapy With or Without Short-term Adjuvant Androgen-Deprivation Therapy in Prostate Cancer | July 2011 | June 2016 |
| NCT01350180 | Unknown status | Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis | September 2010 | October 1, 2021 | |
| NCT04180592 | Unknown status | N/A | Real Time MRI Fused to Cone Beam CT Guided Biopsies of the Prostate. | November 6, 2019 | August 2020 |
| NCT05403190 | Unknown status | N/A | The Performance of da Vinci SP System on Extraperitoneal Approach Radical Prostatectomy | August 1, 2022 | November 30, 2023 |
| NCT00796458 | Unknown status | Phase 3 | Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer | April 2005 | |
| NCT03080116 | Unknown status | Phase 2 | Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy | March 28, 2019 | December 30, 2021 |
| NCT02058680 | Unknown status | Phase 1 | Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients | April 2012 | December 2018 |
| NCT05188911 | Unknown status | Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial | July 15, 2020 | July 15, 2022 | |
| NCT03389451 | Unknown status | Phase 2/Phase 3 | 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer | February 16, 2018 | December 31, 2022 |
| NCT00376792 | Unknown status | Phase 3 | Docetaxel Compared With Observation in Treating Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer | October 2005 | |
| NCT04177056 | Unknown status | N/A | Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief | December 4, 2020 | January 1, 2023 |
| NCT04484246 | Unknown status | Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy | December 11, 2019 | December 31, 2020 | |
| NCT03356912 | Unknown status | Phase 2 | CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy | November 22, 2017 | May 4, 2021 |
| NCT00653848 | Unknown status | Phase 3 | Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy | May 2007 | August 30, 2023 |
| NCT03998657 | Unknown status | N/A | Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate Lesions | December 19, 2019 | December 30, 2022 |
| NCT00392535 | Unknown status | N/A | Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer | October 18, 2002 | June 17, 2021 |
| NCT01953055 | Unknown status | Phase 1/Phase 2 | SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN) | November 2013 | September 2023 |
| NCT05073653 | Unknown status | N/A | A Study of 68Ga-GRP PET/CT for Imaging in Low and Intermediate Risk Prostate Cancer | October 11, 2021 | December 31, 2022 |
| NCT03496142 | Unknown status | N/A | Perineal Versus Rectal Approach for Prostate Biopsy to Prevent Iatrogenic Infections | April 2018 | May 2020 |
| NCT02886546 | Unknown status | N/A | Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy | September 2016 | |
| NCT00732043 | Unknown status | Phase 2 | Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer | December 2007 | January 2015 |
| NCT03753243 | Unknown status | Phase 2 | Neoadjuvant Pembrolizumab Plus Androgen Axis Blockade Prior to Prostatectomy for High Risk Localized Prostate Cancer | December 3, 2018 | April 30, 2023 |
| NCT03050996 | Unknown status | Retrograde Perfusion Sphinterometry and Autologous Sling to Improve Urinary Continence in Robotic Radical Prostatectomy | June 1, 2016 | June 30, 2017 | |
| NCT00155025 | Unknown status | Family History in Prostate Cancer Patients in Taiwan | May 2004 | ||
| NCT03201380 | Unknown status | Evaluation of the Practice of the TEP Choline at Patients With Prostate Cancer | November 1, 2014 | December 1, 2017 | |
| NCT04004858 | Unknown status | N/A | Prostate Margin Reduction to Reduce Acute Rectal Toxicity (PROTRACT) | August 1, 2019 | August 1, 2021 |
| NCT03098160 | Unknown status | Phase 1 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | May 10, 2017 | April 2019 |
| NCT04506710 | Unknown status | Improvement of Communicational Skills Between Health Workers and Oncological Patients During Medical Consultative Conversations | August 1, 2019 | January 2022 | |
| NCT01045148 | Unknown status | Phase 2 | CyberKnife Radiosurgery for Localized Prostatic Carcinoma | March 2006 | |
| NCT00407875 | Unknown status | N/A | Intensity Modulated Versus Interstitial - Radiation Therapy | March 2007 | March 2020 |
| NCT03336983 | Unknown status | Phase 2 | Luteinizing Hormone-releasing Hormone Analogue and Enzalutamide +/- Zoledronic Acid in Prostate Cancer Patients | December 1, 2017 | December 1, 2023 |
| NCT02776436 | Unknown status | Phase 1 | Reducing Dexamethasone Around Docetaxel Infusion | January 2016 | May 2021 |
| NCT00573586 | Unknown status | N/A | Treatment of Localized Prostate Cancer With High Intensity Focused Ultrasound Using the Sonablate® 500 System in Canada | December 2020 | December 2020 |
| NCT04116086 | Unknown status | N/A | Using PSMA PET-CT as a Diagnostic Tool for Detection of Prostatic Cancer at an Early Stage | September 11, 2019 | December 31, 2020 |
| NCT02936258 | Unknown status | N/A | PRostate Evaluation for Clinically Important Disease: MRI vs Standard Evaluation Procedures | November 2016 | November 2019 |
| NCT03440554 | Unknown status | N/A | Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization | March 24, 2016 | January 1, 2023 |
| NCT01624623 | Unknown status | Daily Target Guided Radiation Therapy Using the Calypso 4D Localization System in Patients Who Have Had a Prostatectomy for Prostate Cancer | March 2010 | August 2016 | |
| NCT02623647 | Unknown status | N/A | A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer | November 2015 | January 2022 |
| NCT02773940 | Unknown status | N/A | ClariCore™ Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy | May 2016 | June 2020 |
| NCT02721784 | Unknown status | Phase 1/Phase 2 | Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy | June 2016 | January 2018 |
| NCT02375035 | Unknown status | Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer | January 2015 | September 2019 | |
| NCT05355727 | Unknown status | N/A | PROSAIC-DS Study (PROState AI in Cancer - Decision Support) | June 2022 | December 2022 |
| NCT03630926 | Unknown status | Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones. | October 16, 2018 | December 2019 | |
| NCT02831920 | Unknown status | N/A | CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate Cancer | December 7, 2015 | December 2019 |
| NCT00489814 | Unknown status | Study of Quality of Life for Prostate Proton Therapy | May 24, 2006 | May 24, 2020 | |
| NCT02790216 | Unknown status | Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy | June 2016 | June 2020 | |
| NCT03819751 | Unknown status | N/A | MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer Detection | March 18, 2019 | July 2022 |
| NCT00175383 | Unknown status | Phase 3 | Long Acting LHRH Versus Short Acting LHRH in the Treatment of Prostate Cancer | June 2004 | December 2013 |
| NCT02555397 | Unknown status | Phase 1 | Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer | August 2015 | February 14, 2023 |
| NCT03029533 | Unknown status | Phase 1 | Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer | February 2017 | |
| NCT04159090 | Unknown status | N/A | Head- to Head Comparison of [68Ga]Ga-PSMA-11 With [18F]PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard | January 15, 2018 | January 1, 2020 |
| NCT00969202 | Unknown status | Phase 1 | Stereotactic Hypofractionated Radiosurgery for Early Stage Prostate Cancer | August 2009 | December 2016 |
| NCT04775602 | Unknown status | Phase 2 | Experimental Study to Evaluate the Impact of 18 Fluoro-PSMA (18F-PSMA) PET / CT in the Management of Patients With Prostate Cancer. | May 2021 | August 2022 |
| NCT05389202 | Unknown status | N/A | Study of Prostate Perfusion Before Embolization in Patients With Symptomatic Prostate Adenoma | May 1, 2022 | December 31, 2023 |
| NCT05183074 | Unknown status | N/A | MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer | February 1, 2021 | January 31, 2024 |
| NCT05262608 | Unknown status | Phase 2 | The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation | December 7, 2021 | April 26, 2024 |
| NCT03488706 | Unknown status | Assessing Circulating Tumor Cell as a Biomarker for Prostate Cancer Detection in Patients With Gray Zone PSA Level | January 17, 2018 | June 2, 2021 | |
| NCT01054001 | Unknown status | N/A | Early Start of Oral Sildenafil 100mg for Erectile Dysfunction After Robotic Assisted Laparoscopic Radical Prostatectomy | June 2010 | January 2013 |
| NCT01588938 | Unknown status | External Immobilization Compared to Limited Immobilization Using a Novel Real-time Localization System of the Prostate | December 2009 | August 2017 | |
| NCT04235556 | Unknown status | Integrated Care Pathway in Oncology (PASSION) | February 21, 2020 | December 31, 2022 | |
| NCT01726894 | Unknown status | N/A | Focal Therapy for Localised Prostate Cancer Using Irreversible Electroporation | October 2013 | |
| NCT00207649 | Unknown status | N/A | Shared Decision Making: Prostate Cancer Screening | November 2005 | February 2011 |
| NCT04642833 | Unknown status | Prostate Cancer in Renal Transplants Recipients | November 18, 2020 | August 2021 | |
| NCT03207113 | Unknown status | N/A | Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care. | October 2017 | March 2019 |
| NCT01394042 | Unknown status | Early Phase 1 | Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint | June 2011 | March 2012 |
| NCT02123888 | Unknown status | N/A | Simultaneous CBCT Acquisition During Arc Radiotherapy | June 2011 | December 2015 |
| NCT01354171 | Unknown status | Phase 3 | Active Surveillance Magnetic Resonance Imaging Study | November 2011 | December 2017 |
| NCT00122239 | Unknown status | A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers | January 2005 | February 2017 | |
| NCT03380806 | Unknown status | Phase 2 | Prostate Boost Irradiation With Stereotactic Body RT (SBRT) | January 1, 2019 | January 1, 2022 |
| NCT00215345 | Unknown status | Phase 2 | A Phase II Trial of Combination Therapy With Celecoxib and Taxotere for the Treatment of Stage D3 Prostate Cancer | August 2002 | December 2006 |
| NCT01826838 | Withdrawn | Phase 1 | Study of Dasatinib, Androgen Deprivation Therapy and Radiation | January 2013 | April 2013 |
| NCT02054793 | Withdrawn | Phase 1/Phase 2 | Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) | June 2014 | July 2016 |
| NCT04483414 | Withdrawn | Phase 2 | 68Ga PSMA-11 PET/CT in Recurrent Prostate Cancer | March 19, 2021 | April 5, 2023 |
| NCT02252978 | Withdrawn | Phase 2 | Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy | July 2016 | July 2016 |
| NCT00922818 | Withdrawn | Study of Anatomic Nerve Sparing Radical Perineal Prostatectomy | June 2009 | May 26, 2011 | |
| NCT03800784 | Withdrawn | Phase 2/Phase 3 | Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer | October 1, 2019 | October 21, 2021 |
| NCT01279785 | Withdrawn | A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy | March 2011 | July 2011 | |
| NCT00796874 | Withdrawn | N/A | Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance | October 2008 | July 2013 |
| NCT00244920 | Withdrawn | Phase 2 | Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer | January 2002 | June 2007 |
| NCT01792882 | Withdrawn | Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples | February 2013 | February 27, 2023 | |
| NCT01617174 | Withdrawn | Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer | June 2012 | June 2014 | |
| NCT00581503 | Withdrawn | Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer | March 2007 | July 2018 | |
| NCT03817216 | Withdrawn | N/A | Prostatic Urethral Lift (PUL) Pre-/Post-Radiation Treatment for Prostate Cancer | December 2019 | March 30, 2023 |
| NCT00323180 | Withdrawn | Investigation of Protein Biomarkers of Prostate Cancer | August 2005 | August 2005 | |
| NCT02290366 | Withdrawn | N/A | Prospective Evaluation of Focal Brachytherapy Using Cesium-131 For Patients With Low Risk Prostate Cancer | November 2014 | July 31, 2022 |
| NCT02053311 | Withdrawn | Phase 3 | Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents | August 19, 2014 | August 19, 2034 |
| NCT00323388 | Withdrawn | Identification of Risk Allels for Prostate Cancer | November 2005 | September 2007 | |
| NCT00937417 | Withdrawn | Phase 1 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | September 2008 | September 2009 |
| NCT01087580 | Withdrawn | Phase 2 | Docetaxel + Prednisone With or Without Radiation for Castrate Resistant Prostate Cancer | March 2011 | July 2011 |
| NCT02420587 | Withdrawn | Phase 2 | AMG 208 Tumor Microenvironment in Metastatic Castration Resistant Prostate Cancer (mCRPC) | October 2014 | |
| NCT01379378 | Withdrawn | Male Stress Urinary Incontinence and Sexual Health | October 2011 | December 2011 | |
| NCT00043212 | Withdrawn | Phase 3 | Study of a Drug [DCVax (tm)-Prostate] to Treat Prostate Cancer When Hormone Therapy is no Longer Effective. | ||
| NCT02110849 | Withdrawn | Prostate Cancer Parameters for Patients Receiving Proton Treatment | January 2013 | April 2016 | |
| NCT05705700 | Withdrawn | Phase 2 | Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) | February 2023 | January 2030 |
| NCT03035357 | Withdrawn | Phase 2 | Neoadjuvant Listeria or Daratumumab in Prostate Cancer | March 1, 2017 | March 1, 2019 |
| NCT00559481 | Withdrawn | N/A | Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy | October 2007 | |
| NCT01566045 | Withdrawn | N/A | MRI/TRUS Fusion Guided Prostate Biopsy- An Improved Way to Detect and Quantify Prostate Cancer | May 2012 | April 2015 |
| NCT02295163 | Withdrawn | N/A | Stellate Ganglion Block for Hot Flushes in Men Treated With ADT | July 2014 | January 2021 |
| NCT01658527 | Withdrawn | Phase 2 | TAK-700 in Castration Resistant Prostate Cancer | January 2014 | January 2017 |
| NCT03823001 | Withdrawn | N/A | Virtual Prostate Biopsy Protocol for Patients on Active Surveillance and at Risk of Prostate Cancer | October 2022 | June 2023 |
| NCT02822963 | Withdrawn | Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate | March 2016 | August 2016 | |
| NCT05742334 | Withdrawn | N/A | Evaluating Return to Continence and Potency Following Radical Prostatectomy | July 2023 | May 2025 |
| NCT03338712 | Withdrawn | Micro-RNA Expression Profiles in Localised Prostate Cancer | February 1, 2010 | April 1, 2016 | |
| NCT02065323 | Withdrawn | Phase 2 | A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT | ||
| NCT04781374 | Withdrawn | Phase 2 | Neratinib in Patients With Metastatic Castration-Resistant Prostate Cancer | May 21, 2021 | September 24, 2021 |
| NCT03293602 | Withdrawn | N/A | MISOBOLD - Prostate Cancer Hypoxia Using BOLD MRI and 18F-MISO PET Imaging | September 1, 2019 | January 1, 2020 |
| NCT04339920 | Withdrawn | Spermine Measuring Device Evaluation Protocol | September 1, 2021 | December 2021 | |
| NCT05191017 | Withdrawn | Phase 1/Phase 2 | Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC | September 2022 | July 2026 |
| NCT01766869 | Withdrawn | Improving Cancer Foci Detection in Prostate Cancer Using Multiparametric MRI/MRS | April 2015 | April 2015 | |
| NCT03459755 | Withdrawn | N/A | Evaluating Race Specific AGE Accumulation as a Behavioral Biomarker Prostate Cancer Survivors | November 27, 2019 | November 27, 2019 |
| NCT01163448 | Withdrawn | Phase 1 | Feasibility and Safety Study Using Preoperative High-Dose Single-Fraction Image-Guided Radiotherapy for Men Undergoing Radical Prostatectomy at High-Risk for Extraprostatic Cancer | July 2010 | August 2011 |
| NCT00562341 | Withdrawn | Effect of Lap-Band Induced Weight Loss on Serum PSA Levels | November 2007 | December 31, 2009 | |
| NCT03589781 | Withdrawn | N/A | Investigating the Effects of Mikei® Red Reishi Essence EX on the Immune System of Prostate Cancer Patients and Patients With Non-cancerous Conditions of the Prostate | November 5, 2020 | March 1, 2021 |
| NCT04486846 | Withdrawn | N/A | Electronic Post-Treatment Surveillance Program for Prostate Cancer Survivors (eHealth) | June 2021 | March 2022 |
| NCT04027270 | Withdrawn | N/A | Pelvic Health and Physical Therapy to Improve Lives of Prostate Cancer Patients Undergoing Prostatectomy | January 2021 | March 2022 |
| NCT00005827 | Withdrawn | Phase 1 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | December 1999 | May 2003 |
| NCT01275651 | Withdrawn | Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole | December 2010 | August 2015 | |
| NCT00161252 | Withdrawn | Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly | March 2005 | December 2008 | |
| NCT00767845 | Withdrawn | Symptom Management in African-American Men With Localized Prostate Cancer | June 2006 | May 2008 | |
| NCT01733836 | Withdrawn | Phase 2 | Prostate Cancer Active Surveillance Metformin Trial | January 2013 | October 2014 |
| NCT04995978 | Withdrawn | Phase 2 | Insulin Resistance and Androgen Deprivation Therapy | December 1, 2021 | January 18, 2023 |
| NCT00258466 | Withdrawn | Phase 3 | Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer | May 2005 | November 2006 |
| NCT03122470 | Withdrawn | N/A | Correlation of Imaging Findings With Clinical Findings and Patient Outcomes in Prostate Cancer | August 1, 2017 | June 20, 2023 |
| NCT00963300 | Withdrawn | N/A | MRI in Assessing Hypoxia in Patients With Localized Prostate Cancer Undergoing Stereotactic Body Radiation Therapy | September 2009 | September 2011 |
| NCT00877617 | Withdrawn | Quality of Life in Men With High Risk Localized Prostate Cancer | May 2006 | February 2010 | |
| NCT03173807 | Withdrawn | N/A | Prostate Nutrition and Exercise STudy (ProNEST) | August 31, 2017 | December 31, 2021 |
| NCT00685633 | Withdrawn | Phase 2 | Bicalutamide With or Without Enzastaurin in Treating Patients With Prostate Cancer | December 2008 | |
| NCT00736164 | Withdrawn | Phase 2 | Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I or Stage II Prostate Cancer | August 2008 | |
| NCT06159998 | Withdrawn | New Markers for Treatment Response to Radiotherapy in Prostate Cancer | July 2009 | July 2019 | |
| NCT02396368 | Withdrawn | Phase 1 | A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer | March 2015 | July 2017 |
| NCT01565512 | Withdrawn | Phase 1/Phase 2 | Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort | November 2011 | July 2014 |
| NCT01748110 | Withdrawn | N/A | Health Interventions in Men Undergoing Radical Prostatectomy | December 2012 | July 2014 |
| NCT04296578 | Withdrawn | Phase 1 | Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone | October 2020 | October 2023 |
| NCT04403568 | Withdrawn | Early Phase 1 | Testing the Synergism of Phytonutrients, Curcumin and Ursolic Acid, to Target Molecular Pathways in the Prostate | October 2021 | December 2023 |
| NCT03987568 | Withdrawn | N/A | Characterize Tumor Hypoxia by Magnetic Resonance Imaging | July 10, 2019 | November 15, 2021 |
| NCT02645591 | Withdrawn | Phase 2 | Randomized AmnioFix Study During Radical Prostatectomy | November 2016 | |
| NCT01691976 | Withdrawn | N/A | Mild Cognitive Impairment in Men Following Androgen Deprivation | October 2012 | December 2013 |
| NCT00922129 | Withdrawn | Phase 2/Phase 3 | Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer | September 2009 | January 2011 |
| NCT00691977 | Withdrawn | Phase 1 | Radiation Therapy Followed by Surgery in High-Risk, Localized Carcinoma of the Prostate | September 2007 | December 2009 |
| NCT04742972 | Withdrawn | N/A | Prostate PMSABR Study | February 25, 2021 | September 16, 2022 |
| NCT03465345 | Withdrawn | Phase 1 | Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients | July 11, 2018 | July 11, 2018 |
| NCT00084565 | Withdrawn | Phase 2 | Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer | November 2003 | November 2004 |
| NCT01478308 | Withdrawn | Phase 2 | Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer | June 2011 | October 2011 |
| NCT03296124 | Withdrawn | Prognostic Value of Androgen Receptor Expression and Mutations Within Oncogenes and Tumor Suppressor Genes in Patients Treated for High Risk Prostate Cancer With Proton Therapy (PRX32) | December 7, 2017 | September 2020 | |
| NCT03909893 | Withdrawn | N/A | A Study of Adaptive Radiation Therapy for Pelvic Genitourinary Cancer | October 2023 | January 2025 |
| NCT00003858 | Withdrawn | Phase 2 | Mitoxantrone Following Surgery in Treating Patients With Prostate Cancer at High Risk for Recurrence | ||
| NCT02159690 | Withdrawn | Phase 2 | A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy | September 2014 | January 2015 |
| NCT00769990 | Withdrawn | Phase 1/Phase 2 | Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases | September 2008 | April 2010 |
| NCT00537849 | Withdrawn | N/A | Investigational Study For the Treatment of Localized (T1c/T2a) Prostate Cancer With High Intensity Focused Ultrasound (HIFU) Using the Sonablate 500 (SB-500) System in Canada | December 2007 | March 2008 |
| NCT02182622 | Withdrawn | Phase 1 | LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel | July 2014 | December 2015 |
| NCT02608359 | Withdrawn | A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer | May 31, 2016 | May 31, 2022 | |
| NCT02793765 | Withdrawn | Phase 2 | Docetaxel Followed by Provenge in Metastatic Prostate Cancer | December 2016 | July 2021 |
| NCT01320787 | Withdrawn | Phase 1 | 18-F-Fluoroacetate as PET Imaging Agent | October 2014 | |
| NCT03494803 | Withdrawn | Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC | June 1, 2018 | December 1, 2021 | |
| NCT00691899 | Withdrawn | Phase 3 | A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030) | September 2008 | September 2008 |
| NCT01409473 | Withdrawn | Phase 2 | Stereotactic Body Radiotherapy (SBRT) With Concurrent Boost for Low- and Intermediate-Risk Prostate Cancer | August 2011 | August 2022 |
| NCT04243941 | Withdrawn | Phase 2 | PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer | November 29, 2022 | February 7, 2024 |
| NCT01274572 | Withdrawn | Blood for Immune Response to Provenge® in HRPC | January 2011 | June 2011 | |
| NCT01838265 | Withdrawn | Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management | August 2012 | ||
| NCT02108613 | Withdrawn | N/A | Living Well on Androgen Deprivation Therapy | April 2014 | March 2017 |
| NCT00771017 | Withdrawn | Phase 2 | Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer | July 2008 | |
| NCT01197209 | Withdrawn | Phase 1 | Neoadjuvant Study of In-situ REIC/Dkk-3 in Prostate Cancer | September 2010 | December 2010 |
| NCT01188408 | Withdrawn | Phase 2 | Efficacy and Safety Study of LE-DT to Treat Metastatic Castrate Resistant Prostate Cancer | June 2010 | September 2011 |
| NCT01530984 | Withdrawn | Phase 2 | Ipilimumab and GMCSF Immunotherapy for Prostate Cancer | June 2015 | December 2018 |
| NCT02678520 | Withdrawn | Phase 2 | Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients | December 2015 | February 2016 |
| NCT00728533 | Withdrawn | Phase 3 | Open-Label, Randomised Parallel-Group Study | ||
| NCT00621413 | Withdrawn | Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer | February 2007 | February 2007 | |
| NCT00482157 | Withdrawn | N/A | Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance | February 2007 | November 2007 |
| NCT02588846 | Withdrawn | N/A | Multi-target Tracking in Prostate Radiotherapy Using MLC and KIM | July 1, 2020 | December 2023 |
| NCT01132599 | Withdrawn | Phase 2 | Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer | May 2010 | |
| NCT00694291 | Withdrawn | Phase 2 | Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer | June 2008 | |
| NCT00242931 | Withdrawn | Phase 2 | Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy | January 2005 | March 2008 |
| NCT00980993 | Withdrawn | Quantification of Respiratory-induced Prostate Motion | September 2012 | September 2014 | |
| NCT04304079 | Withdrawn | N/A | A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery | January 1, 2022 | May 31, 2024 |
| NCT00811031 | Withdrawn | Phase 2 | Preoperative Docetaxel for Localized Progressive Castration-resistant Prostate Cancer (CRPC) | ||
| NCT03495479 | Withdrawn | Aneustat Treatment of Localized Prostate Cancer Under Active Surveillance | January 2025 | January 2029 | |
| NCT03970863 | Withdrawn | Focal Therapy for Localized Prostate Cancer | August 1, 2020 | November 10, 2021 | |
| NCT02811809 | Withdrawn | Phase 2 | Apalutamide Plus Intermittent Hormone Therapy Versus Intermittent Hormone Therapy Alone in Prostate Cancer | December 2020 | December 2025 |
| NCT02793219 | Withdrawn | Phase 2 | Provenge Followed by Docetaxel in Castration-Resistant Prostate Cancer | December 2016 | July 2021 |
| NCT05098327 | Withdrawn | Phase 3 | Pioglitazone and Insulin Resistance in ADT | August 1, 2021 | March 31, 2023 |
| NCT05454371 | Withdrawn | N/A | Investigation of Urinary Biomarkers for the Detection of Prostate Cancer | December 2023 | December 2023 |
| NCT01173146 | Withdrawn | Imaging of Residual Tumor During Prostatectomy | December 2011 | June 2015 | |
| NCT02621684 | Withdrawn | N/A | Physical Activity Intervention in African American Men After Radical Prostatectomy | November 2014 | December 2015 |
| NCT01899391 | Withdrawn | Periperal Blood Lymphocytes During Prostate RT | August 2009 | March 2013 | |
| NCT03308734 | Withdrawn | N/A | Effects of 6 Week Reduced Exertion High Intensity Interval Training Protocol in Patients With Prostate Cancer | May 1, 2019 | February 2020 |
| NCT01802307 | Withdrawn | Phase 2 | Focal Therapy for Prostate Cancer | February 2013 | March 2018 |
| NCT02232672 | Withdrawn | N/A | Choline PET/CT vs. MeAIB PET/CT in Prostate Cancer | November 2016 | August 2017 |
| NCT01688414 | Withdrawn | N/A | Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer | September 2012 | |
| NCT02424513 | Withdrawn | Phase 2 | A Study of Positron Emission Tomography (PET) With [89]Zr-Df-IAb2M in Patients With High-risk Prostate Cancer | March 2015 | March 2016 |
| NCT05363644 | Withdrawn | Phase 3 | BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy | April 1, 2023 | June 30, 2024 |
| NCT00801996 | Withdrawn | Epidemiologic, Clinical and Genetic Profile of Prostate Cancer in Arab Countries | September 2008 | September 2009 | |
| NCT03157947 | Withdrawn | N/A | Culturally Tailored Decision Aid for Hispanic Patients Diagnosed With Prostate Cancer | August 1, 2017 | December 2019 |
| NCT01079793 | Withdrawn | Phase 1/Phase 2 | Radiation Therapy and Ixabepilone in Treating Patients With High-Risk Stage III Prostate Cancer After Surgery | May 26, 2010 | October 17, 2011 |
| NCT02538432 | Withdrawn | Phase 2 | Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors | June 2017 | December 2021 |
| NCT02022904 | Withdrawn | N/A | Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology | May 2012 | June 2015 |
| NCT03748719 | Withdrawn | N/A | Single Arm Trial of Preoperative Stereotactic Body Radiation Therapy (SBRT) for T3a or Gleason Grade Group 4 Prostate Cancer | November 19, 2018 | December 4, 2019 |
| NCT04272645 | Withdrawn | Phase 2 | Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer | October 2020 | October 2022 |
| NCT01520441 | Withdrawn | Early Phase 1 | BOTOX in Men With Prostate Cancer With Lower Urinary Tract Symptoms(LUTS)/Benign Prostatic Hyperplasia (BPH) | March 2011 | March 2014 |
| NCT02512120 | Withdrawn | N/A | Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation | August 2015 | December 2017 |
| NCT00598858 | Withdrawn | Phase 2 | Neoadjuvant Docetaxel on Newly Diagnosed Intermediate and High Grade Cancer of the Prostate | January 2009 | June 2010 |
| NCT00577980 | Withdrawn | Phase 2 | Testosterone in Castration-Resistant Prostate Cancer | December 2007 | June 2008 |
| NCT04797078 | Withdrawn | N/A | US/MRI Fusion Local Anestesia TransPerineal Prostate Biopsies for Detection of Prostate Cancer | April 1, 2023 | November 15, 2025 |
| NCT01481233 | Withdrawn | Phase 2 | Oral Colchicine in Men With Castrate Resistant Prostate Cancer | May 2013 | August 2013 |
| NCT01745718 | Withdrawn | N/A | Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer | October 2012 | September 2013 |
| NCT05035732 | Withdrawn | N/A | A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study) | March 25, 2021 | January 17, 2024 |
| NCT01260909 | Withdrawn | Real-Time MV/kV Image Guided Radiation Therapy | January 2014 | January 2015 | |
| NCT00681148 | Withdrawn | Phase 2 | Botulinum Toxin Injection With Prostate Brachytherapy | July 2012 | |
| NCT02546427 | Withdrawn | N/A | Hypofractionated Whole Pelvic Radiotherapy of the Prostate | December 9, 2016 | June 2022 |
| NCT04658849 | Withdrawn | Early Phase 1 | Insulin Resistance Following ADT for Prostate CA | December 2, 2020 | March 29, 2023 |
| NCT05567679 | Withdrawn | Early Phase 1 | A Study of Tazemetostat (Tazverik) Before Prostatectomy in Men With Prostate Cancer | December 2023 | December 2025 |
| NCT05574712 | Withdrawn | Phase 2 | A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate Cancer | January 1, 2024 | July 2026 |
| NCT03274778 | Withdrawn | N/A | Effect of Ruxolitinib on Tumor Infiltrating Myeloid Cells | September 1, 2017 | March 24, 2020 |
| NCT02656563 | Withdrawn | Phase 2 | Radium 223 Following Intermittent ADT | October 2015 | October 2020 |
| NCT03488810 | Withdrawn | Phase 3 | Apalutamide With Radiotherapy and Androgen Deprivation Therapy in Prostate Cancer | March 10, 2020 | June 15, 2026 |
| NCT03014973 | Withdrawn | N/A | Castration-resistant Prostate Cancer and Intra-prostatic Hormonal Status | January 2017 | December 2018 |
| NCT05245435 | Withdrawn | N/A | Diagnostic and Prognostic Accuracy of FDHT-PET and Liquid Biopsies in Prostate Cancer | April 2022 | September 2024 |
| NCT00003622 | Withdrawn | Phase 2 | Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy | January 1999 | February 22, 2017 |
| NCT01811810 | Withdrawn | N/A | Proton Therapy for High Risk Prostate Cancer | March 2013 | April 2014 |
| NCT02497638 | Withdrawn | Phase 2 | LIpitor and biGuanide to Androgen Delay Trial | December 2021 | December 2022 |
- Disase is a (Disease Ontology)
- DOID:3856
- Cross Reference ID (Disease Ontology)
- ICD10CM:C61
- Cross Reference ID (Disease Ontology)
- ICD9CM:185
- Cross Reference ID (Disease Ontology)
- KEGG:05215
- Cross Reference ID (Disease Ontology)
- MESH:D011471
- Cross Reference ID (Disease Ontology)
- MIM:176807
- Cross Reference ID (Disease Ontology)
- MIM:300147
- Cross Reference ID (Disease Ontology)
- MIM:300704
- Cross Reference ID (Disease Ontology)
- MIM:601518
- Cross Reference ID (Disease Ontology)
- MIM:602759
- Cross Reference ID (Disease Ontology)
- MIM:608656
- Cross Reference ID (Disease Ontology)
- MIM:608658
- Cross Reference ID (Disease Ontology)
- MIM:609299
- Cross Reference ID (Disease Ontology)
- MIM:609558
- Cross Reference ID (Disease Ontology)
- MIM:610321
- Cross Reference ID (Disease Ontology)
- MIM:610997
- Cross Reference ID (Disease Ontology)
- MIM:611100
- Cross Reference ID (Disease Ontology)
- MIM:611868
- Cross Reference ID (Disease Ontology)
- MIM:611928
- Cross Reference ID (Disease Ontology)
- MIM:611955
- Cross Reference ID (Disease Ontology)
- MIM:611958
- Cross Reference ID (Disease Ontology)
- MIM:611959
- Cross Reference ID (Disease Ontology)
- NCI:C3343
- Cross Reference ID (Disease Ontology)
- NCI:C7378
- Cross Reference ID (Disease Ontology)
- ORDO:1331
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:126906006
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:93974005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0033578
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0376358
- Exact Synonym (Disease Ontology)
- hereditary prostate cancer
- Exact Synonym (Disease Ontology)
- malignant tumor of the prostate
- Exact Synonym (Disease Ontology)
- NGP - new growth of prostate
- Exact Synonym (Disease Ontology)
- prostate cancer, familial
- Exact Synonym (Disease Ontology)
- prostate neoplasm
- Exact Synonym (Disease Ontology)
- prostatic cancer
- Exact Synonym (Disease Ontology)
- prostatic neoplasm
- Exact Synonym (Disease Ontology)
- tumor of the prostate
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0012125